
<html lang="en"     class="pb-page"  data-request-id="22d4837d-915b-43fd-8f9e-d58aa54e85bb"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2020.63.issue-23;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.0c01581;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Design, Synthesis, and Structure–Activity Relationship Studies of (4-Alkoxyphenyl)glycinamides and Bioisosteric 1,3,4-Oxadiazoles as GPR88 Agonists" /></meta><meta name="dc.Creator" content="Md Toufiqur  Rahman" /></meta><meta name="dc.Creator" content="Ann M.  Decker" /></meta><meta name="dc.Creator" content="Tiffany L.  Langston" /></meta><meta name="dc.Creator" content="Kelly M.  Mathews" /></meta><meta name="dc.Creator" content="Lucas  Laudermilk" /></meta><meta name="dc.Creator" content="Rangan  Maitra" /></meta><meta name="dc.Creator" content="Weiya  Ma" /></meta><meta name="dc.Creator" content="Emmanuel  Darcq" /></meta><meta name="dc.Creator" content="Brigitte L.  Kieffer" /></meta><meta name="dc.Creator" content="Chunyang  Jin" /></meta><meta name="dc.Description" content="Increasing evidence implicates the orphan G protein-coupled receptor 88 (GPR88) in a number of striatal-associated disorders. In this study, we report the design and synthesis of a series of novel ..." /></meta><meta name="Description" content="Increasing evidence implicates the orphan G protein-coupled receptor 88 (GPR88) in a number of striatal-associated disorders. In this study, we report the design and synthesis of a series of novel ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 18, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01581" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01581" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01581" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01581" /></link>
        
    
    

<title>Design, Synthesis, and Structure–Activity Relationship Studies of (4-Alkoxyphenyl)glycinamides and Bioisosteric 1,3,4-Oxadiazoles as GPR88 Agonists | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01581" /></meta><meta property="og:title" content="Design, Synthesis, and Structure–Activity Relationship Studies of (4-Alkoxyphenyl)glycinamides and Bioisosteric 1,3,4-Oxadiazoles as GPR88 Agonists" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/large/jm0c01581_0018.jpeg" /></meta><meta property="og:description" content="Increasing evidence implicates the orphan G protein-coupled receptor 88 (GPR88) in a number of striatal-associated disorders. In this study, we report the design and synthesis of a series of novel (4-alkoxyphenyl)glycinamides (e.g., 31) and the corresponding 1,3,4-oxadiazole bioisosteres derived from the 2-AMPP scaffold (1) as GPR88 agonists. The 5-amino-1,3,4-oxadiazole derivatives (84, 88–90) had significantly improved potency and lower lipophilicity compared to 2-AMPP. Compound 84 had an EC50 of 59 nM in the GPR88 overexpressing cell-based cAMP assay. In addition, 84 had an EC50 of 942 nM in the [35S]GTPγS binding assay using mouse striatal membranes but was inactive in membranes from GPR88 knockout mice, even at a concentration of 100 μM. In vivo pharmacokinetic testing of 90 in rats revealed that the 5-amino-1,3,4-oxadiazole analogues may have limited brain permeability. Taken together, these results provide the basis for further optimization to develop a suitable agonist to probe GPR88 functions in the brain." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01581"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01581">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01581&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01581&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01581&amp;href=/doi/10.1021/acs.jmedchem.0c01581" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 23</span><span class="cit-fg-pageRange">, 14989-15012</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/23" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01575" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c01607" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, and Structure–Activity Relationship Studies of (4-Alkoxyphenyl)glycinamides and Bioisosteric 1,3,4-Oxadiazoles as GPR88 Agonists</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Md Toufiqur Rahman</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Md Toufiqur Rahman</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Drug Discovery, Research Triangle Institute, Research Triangle Park, North Carolina 27709, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Md+Toufiqur++Rahman">Md Toufiqur Rahman</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ann M. Decker</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ann M. Decker</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Drug Discovery, Research Triangle Institute, Research Triangle Park, North Carolina 27709, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ann+M.++Decker">Ann M. Decker</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tiffany L. Langston</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tiffany L. Langston</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Drug Discovery, Research Triangle Institute, Research Triangle Park, North Carolina 27709, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tiffany+L.++Langston">Tiffany L. Langston</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kelly M. Mathews</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kelly M. Mathews</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Drug Discovery, Research Triangle Institute, Research Triangle Park, North Carolina 27709, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kelly+M.++Mathews">Kelly M. Mathews</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lucas Laudermilk</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lucas Laudermilk</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Drug Discovery, Research Triangle Institute, Research Triangle Park, North Carolina 27709, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lucas++Laudermilk">Lucas Laudermilk</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rangan Maitra</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rangan Maitra</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Drug Discovery, Research Triangle Institute, Research Triangle Park, North Carolina 27709, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rangan++Maitra">Rangan Maitra</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6663-6800" title="Orcid link">http://orcid.org/0000-0001-6663-6800</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Weiya Ma</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Weiya Ma</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Douglas Research Center, Department of Psychiatry, McGill University, Montréal Quebec, H4H 1R3, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Weiya++Ma">Weiya Ma</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Emmanuel Darcq</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Emmanuel Darcq</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Douglas Research Center, Department of Psychiatry, McGill University, Montréal Quebec, H4H 1R3, Canada</div><div class="loa-info-affiliations-info">INSERM U1114, University of Strasbourg, Strasbourg 67085, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Emmanuel++Darcq">Emmanuel Darcq</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8377-8015" title="Orcid link">http://orcid.org/0000-0002-8377-8015</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Brigitte L. Kieffer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Brigitte L. Kieffer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Douglas Research Center, Department of Psychiatry, McGill University, Montréal Quebec, H4H 1R3, Canada</div><div class="loa-info-affiliations-info">INSERM U1114, University of Strasbourg, Strasbourg 67085, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Brigitte+L.++Kieffer">Brigitte L. Kieffer</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Chunyang Jin</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chunyang Jin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Drug Discovery, Research Triangle Institute, Research Triangle Park, North Carolina 27709, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#4e2d2427200e3c3a2760213c29"><span class="__cf_email__" data-cfemail="9ffcf5f6f1dfedebf6b1f0edf8">[email protected]</span></a>. Phone: 919 541-6328. Fax: 919 541-8868.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chunyang++Jin">Chunyang Jin</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6733-3094" title="Orcid link">http://orcid.org/0000-0001-6733-3094</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01581&amp;href=/doi/10.1021%2Facs.jmedchem.0c01581" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 23</span><span class="cit-pageRange">, 14989–15012</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 18, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>9 September 2020</li><li><span class="item_label"><b>Published</b> online</span>18 November 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 December 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01581" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01581</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D14989%26pageCount%3D24%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMd%2BToufiqur%2BRahman%252C%2BAnn%2BM.%2BDecker%252C%2BTiffany%2BL.%2BLangston%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D23%26contentID%3Dacs.jmedchem.0c01581%26title%3DDesign%252C%2BSynthesis%252C%2Band%2BStructure%25E2%2580%2593Activity%2BRelationship%2BStudies%2Bof%2B%25284-Alkoxyphenyl%2529glycinamides%2Band%2BBioisosteric%2B1%252C3%252C4-Oxadiazoles%2Bas%2BGPR88%2BAgonists%26numPages%3D24%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D15012%26publicationDate%3DDecember%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01581"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">973</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01581" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, and Structure–Activity Relationship Studies of (4-Alkoxyphenyl)glycinamides and Bioisosteric 1,3,4-Oxadiazoles as GPR88 Agonists&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Md&quot;,&quot;last_name&quot;:&quot;Toufiqur Rahman&quot;},{&quot;first_name&quot;:&quot;Ann&quot;,&quot;last_name&quot;:&quot;M. Decker&quot;},{&quot;first_name&quot;:&quot;Tiffany&quot;,&quot;last_name&quot;:&quot;L. Langston&quot;},{&quot;first_name&quot;:&quot;Kelly&quot;,&quot;last_name&quot;:&quot;M. Mathews&quot;},{&quot;first_name&quot;:&quot;Lucas&quot;,&quot;last_name&quot;:&quot;Laudermilk&quot;},{&quot;first_name&quot;:&quot;Rangan&quot;,&quot;last_name&quot;:&quot;Maitra&quot;},{&quot;first_name&quot;:&quot;Weiya&quot;,&quot;last_name&quot;:&quot;Ma&quot;},{&quot;first_name&quot;:&quot;Emmanuel&quot;,&quot;last_name&quot;:&quot;Darcq&quot;},{&quot;first_name&quot;:&quot;Brigitte&quot;,&quot;last_name&quot;:&quot;L. Kieffer&quot;},{&quot;first_name&quot;:&quot;Chunyang&quot;,&quot;last_name&quot;:&quot;Jin&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;18&quot;,&quot;issue&quot;:&quot;23&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;14989-15012&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01581&quot;},&quot;abstract&quot;:&quot;Increasing evidence implicates the orphan G protein-coupled receptor 88 (GPR88) in a number of striatal-associated disorders. In this study, we report the design and synthesis of a series of novel (4-alkoxyphenyl)glycinamides (e.g., 31) and the corresponding 1,3,4-oxadiazole bioisosteres derived from the 2-AMPP scaffold (1) as GPR88 agonists. The 5-amino-1,3,4-oxadiazole derivatives (84, 88–90) had significantly improved potency and lower lipophilicity compared to 2-AMPP. Compound 84 had an EC50 of 59 nM in the GPR88 overexpressing cell-based cAMP assay. In addition, 84 had an EC50 of 942 nM in the [35S]GTPγS binding assay using mouse striatal membranes but was inactive in membranes from GPR88 knockout mice, even at a concentration of 100 μM. In vivo pharmacokinetic testing of 90 in rats revealed that the 5-amino-1,3,4-oxadiazole analogues may have limited brain permeability. Taken together, these results provide the basis for further optimization to develop a suitable agonist to probe GPR88 functions in the &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01581&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01581" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01581&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01581" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01581&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01581" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01581&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01581&amp;href=/doi/10.1021/acs.jmedchem.0c01581" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01581" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01581" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01581%26sid%3Dliteratum%253Aachs%26pmid%3D33205975%26genre%3Darticle%26aulast%3DRahman%26date%3D2020%26atitle%3DDesign%252C%2BSynthesis%252C%2Band%2BStructure%25E2%2580%2593Activity%2BRelationship%2BStudies%2Bof%2B%25284-Alkoxyphenyl%2529glycinamides%2Band%2BBioisosteric%2B1%252C3%252C4-Oxadiazoles%2Bas%2BGPR88%2BAgonists%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D23%26spage%3D14989%26epage%3D15012%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=292349" title="Alkyls">Alkyls</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/23" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/jmcmar.2020.63.issue-23/20201210/jmcmar.2020.63.issue-23.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/medium/jm0c01581_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/large/jm0c01581_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01581&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Increasing evidence implicates the orphan G protein-coupled receptor 88 (GPR88) in a number of striatal-associated disorders. In this study, we report the design and synthesis of a series of novel (4-alkoxyphenyl)glycinamides (e.g., <b>31</b>) and the corresponding 1,3,4-oxadiazole bioisosteres derived from the 2-AMPP scaffold (<b>1</b>) as GPR88 agonists. The 5-amino-1,3,4-oxadiazole derivatives (<b>84</b>, <b>88–90</b>) had significantly improved potency and lower lipophilicity compared to 2-AMPP. Compound <b>84</b> had an EC<sub>50</sub> of 59 nM in the GPR88 overexpressing cell-based cAMP assay. In addition, <b>84</b> had an EC<sub>50</sub> of 942 nM in the [<sup>35</sup>S]GTPγS binding assay using mouse striatal membranes but was inactive in membranes from GPR88 knockout mice, even at a concentration of 100 μM. In vivo pharmacokinetic testing of <b>90</b> in rats revealed that the 5-amino-1,3,4-oxadiazole analogues may have limited brain permeability. Taken together, these results provide the basis for further optimization to develop a suitable agonist to probe GPR88 functions in the brain.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16108" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16108" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The orphan G protein-coupled receptor 88 (GPR88) has recently attracted considerable interest in studying its biological functions, mainly through genetic interference. GPR88 is highly expressed in the striatum of the brain and is involved in both the striatonigral and striatopallidal pathways, suggesting that the receptor may play a role in regulating striatal functions.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5">(1−5)</a> Genetic knockout<a onclick="showRef(event, 'ref6 ref7 ref8 ref9 ref10 ref11 ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8 ref9 ref10 ref11 ref12 ref13 ref14 ref15">(6−15)</a> and transcriptional profiling studies<a onclick="showRef(event, 'ref3 ref16 ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref3 ref16 ref17 ref18 ref19 ref20">(3,16−20)</a> in rodents have suggested that GPR88 plays an important role in regulating the dopaminergic system and is implicated in a number of disorders such as Parkinson’s disease, schizophrenia, anxiety, and drug addiction. Additionally, human genetic studies have demonstrated positive associations between the <i>Gpr88</i> gene and schizophrenia<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and evidence that a <i>Gpr88</i> variant was linked to childhood speech delay, learning disabilities, and chorea, indicating the relevance of GPR88 in the genetic risk for these diseases.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Taken together, both animal and human data suggest that GPR88 is a potential novel drug target.</div><div class="NLM_p">To date, the endogenous ligand for GPR88 has not been discovered. GPR88 is most closely related to the biogenic amine receptors and has the highest sequence homology with the 5-HT<sub>1d</sub> receptor and the β<sub>3</sub> adrenergic receptor (27 and 21% identity, respectively).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Chemogenomic analysis, based on the alignment of 30 critical residues predicted to line the binding cavity of G protein-coupled receptors, clustered GPR88 with metabotropic glutamate and GABA<sub>B</sub> receptors.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> In order to characterize GPR88 signaling mechanisms and biological functions, our laboratory, as well as others, has carried out a medicinal chemistry campaign to develop GPR88 synthetic agonist probes.<a onclick="showRef(event, 'ref24 ref25 ref26 ref27 ref28 ref29 ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26 ref27 ref28 ref29 ref30 ref31 ref32">(24−32)</a> We have previously reported that a synthetic small-molecule, 2-PCCA [(1<i>R</i>,2<i>R</i>)-2-(pyridin-2-yl)cyclopropane carboxylic acid ((2<i>S</i>,3<i>S</i>)-2-amino-3-methylpentyl)-(4′-propylbiphenyl-4-yl)amide, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>], was able to activate GPR88 through a Gα<sub>i</sub>-coupled signaling pathway in our time-resolved fluorescence energy transfer (TR-FRET)-based Lance cAMP assay in GPR88 overexpressing CHO cells.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Recently, we have demonstrated that a potent, selective, and brain-penetrant GPR88 agonist RTI-13951-33 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), derived from the 2-PCCA scaffold, significantly reduced alcohol self-administration and alcohol intake in a dose-dependent manner in rats when administered intraperitoneally and at doses that did not affect the locomotor activity and sucrose self-administration.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> These findings support the development and pharmacological validation of GPR88 agonists as a potential therapeutic to treat alcohol addiction.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/medium/jm0c01581_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/large/jm0c01581_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. 2-PCCA scaffold-based GPR88 agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/large/jm0c01581_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01581&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">2-AMPP [(2<i>S</i>)-<i>N</i>-((1<i>R</i>)-2-amino-1-(4-(2-methylpentyloxy)-phenyl)ethyl)-2-phenylpropanamide (<b>1</b>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>)] is another promising GPR88 agonist scaffold for medicinal chemistry optimization.<a onclick="showRef(event, 'ref14 ref28 ref31'); return false;" href="javascript:void(0);" class="ref ref14 ref28 ref31">(14,28,31)</a> Early structure–activity relationship (SAR) studies of <b>1</b> have provided a preliminary understanding of receptor tolerances at three distinct sites for agonist activity (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref28 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref28 ref31 ref32">(28,31,32)</a> For example, the lipophilicity of the alkoxy group on site A is favorable for potency. The amino group on site B can be replaced by other functionalities (e.g., hydroxyl <b>2</b>, ester <b>3</b>, and amide <b>4</b>), all of which have comparable or slightly improved EC<sub>50</sub> values relative to <b>1</b>. Site C, on the other hand, has limited space for structural modifications, possibly involving a sterically defined aromatic stacking interaction with the GPR88 receptor.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/medium/jm0c01581_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/large/jm0c01581_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of 2-AMPP (<b>1</b>) and <b>2–4</b> and preliminary SAR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/large/jm0c01581_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01581&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">2-AMPP was moderately potent with an EC<sub>50</sub> of 414 nM in our TR-FRET-based Lance cAMP assay<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and was reported to have a poor brain penetration because of its high lipophilicity (clog <i>P</i> = 4.53, calculated using Instant JChem 5.4.0, ChemAxon Ltd.).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Recently, 2-AMPP (referring to compound 19 in the literature<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a>) was shown to have an EC<sub>50</sub> of 634 nM in the BRET-based cAMP assay in GPR88 overexpressing HEK293 cells, which is in line with our EC<sub>50</sub> value of this compound. We faced two major challenges for the development of 2-AMPP-based agonists as in vivo probes: (a) potency and (b) brain bioavailability. To address these questions, we planned to further explore the SAR on sites A and B and reasoned that both potency and brain permeability can be improved by fine-tuning the lipophilicity on site A and modifying the functionality on site B. Herein, we report the design, synthesis, and pharmacological evaluation of a series of (4-alkoxyphenyl)glycinols, (4-alkoxyphenyl)glycinamides, and the corresponding bioisosteric 1,3,4-oxadiazoles as GPR88 agonists.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36438" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36438" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">The overall synthetic approach followed the methods detailed in our earlier publication.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> All the synthesized target compounds were characterized by <sup>1</sup>H NMR, <sup>13</sup>C NMR, and high-resolution mass spectra (HRMS) and determined to be >95% pure by high-performance liquid chromatography (HPLC) analyses. The characterization data are in agreement with the assigned structures. The reaction yield is presented in the Experimental Section. Compounds <b>12–28</b> were synthesized following procedures depicted in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Boc-protection of the amino group in (<i>R</i>)-2-phenylglycine methyl ester (<b>5</b>) afforded <b>6</b>. <i>O</i>-Alkylation of <b>6</b> with an appropriate alcohol under Mitsunobu conditions or via S<sub>N</sub>2 substitution with an alkyl <i>p</i>-toluenesulfonate gave ethers <b>7</b>. Reduction of the methyl ester with sodium borohydride in the presence of lithium chloride, followed by the Boc group deprotection with HCl led to amino alcohols <b>8</b>. Boc-removal of <b>7</b>, followed by 2-(1<i>H</i>-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU)-mediated coupling with (<i>S</i>)-2-phenylpropionic acid provided amides <b>11</b>. Alternatively, TIPS-protection of phenol <b>6</b> afforded <b>9</b>, which was subjected to Boc-deprotection, followed by HBTU-mediated coupling with (<i>S</i>)-2-phenylpropionic acid and TIPS-deprotection to furnish phenol <b>10</b>. Subsequent O-alkylation of the phenol group also provided the common intermediate <b>11</b>. Finally, coupling of <b>8</b> with (<i>S</i>)-2-phenylpropionic acid using HBTU or reduction of the ester function in <b>11</b> furnished the target alcohols <b>12–28</b>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/medium/jm0c01581_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/large/jm0c01581_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Target Compounds <b>12–28</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/large/jm0c01581_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01581&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Boc<sub>2</sub>O, DIPEA, DCM, rt, overnight; (b) PPh<sub>3</sub>, DEAD, alcohol, THF, rt, overnight; (c) NaBH<sub>4</sub>, LiCl, THF-EtOH (1:1), rt, 3 h; (d) 4 M HCl in dioxane, DCM, rt, 16 h; or TFA: DCM, rt, 6 h; (e) (<i>S</i>)-2-phenylpropionic acid, HBTU, TEA, MeCN, rt, 5 h; (f) TIPSCl, imidazole, DCM, rt, overnight; (g) TBAF, THF, 0 °C, 3 h; (h) alkyl <i>p</i>-toluenesulfonate, K<sub>2</sub>CO<sub>3</sub> MeCN, 65 °C, overnight.</p></p></figure><div class="NLM_p">Synthesis of amides <b>30–69</b> is outlined in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Briefly, acids <b>29</b>, synthesized according to the procedure in our previous publication,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> were coupled with an appropriate amine using the standard amide coupling reagents, such as Boc anhydride, EDC/HOBt, or by forming an acid chloride to give the target amides <b>30–69</b>.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/medium/jm0c01581_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/large/jm0c01581_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Target Compounds <b>30–69</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/large/jm0c01581_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01581&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: Method A (a) pyridine, dioxane, NH<sub>4</sub>HCO<sub>3</sub>, Boc<sub>2</sub>O, rt, overnight; Method B (a) EDC hydrochloride, HOBt, DIPEA, amine, DMF, rt, overnight; Method C (a) oxalyl chloride, DMF (cat.), DCM, rt; then amine, Et<sub>3</sub>N, rt, overnight.</p></p></figure><div class="NLM_p">Synthesis of 5-alkyl- and 5-amino-1,3,4-oxadiazoles is outlined in <a class="ref internalNav" href="#sch3" aria-label="Schemes 3">Schemes 3</a> and <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. As depicted in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, the reaction of ester <b>3</b> or <b>11h</b>,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> derived from 4-hydroxyphenylacetic acid, with hydrazine hydrate in refluxing ethanol afforded the corresponding hydrazides <b>70a,b</b>. Coupling of <b>70a,b</b> with trimethyl orthoformate or trimethyl orthoacetate in the presence of catalytic acid provided target 1,3,4-oxadiazoles <b>71–74</b>. On the other hand, oxadiazoles derived from 4-hydroxyphenylpropanoic acid were synthesized according to the procedure shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. The reaction of acid <b>75</b> with acetyl chloride in methanol at 65 °C afforded the methyl ester <b>76</b>, which was protected with Boc anhydride to provide the Boc-protected amine <b>77</b>. The Mitsunobu reaction of <b>77</b> with the appropriate alcohol furnished the corresponding alkyl ethers <b>78a–f</b>. The removal of the Boc group from the amine followed by HBTU-mediated coupling with (<i>S</i>)-2-phenylpropionic acid provided amides <b>80a–f</b>. The ester function in <b>80</b> was converted to the corresponding hydrazide by heating the ester with hydrazine hydrate in ethanol. Finally, hydrazides <b>81a–f</b> were condensed with trimethyl orthoformate, trimethyl orthoacetate, or cyanogen bromide to furnish the target 1,3,4-oxadiazoles <b>82–91</b>.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/medium/jm0c01581_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/large/jm0c01581_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Target Compounds <b>71–74</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/large/jm0c01581_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01581&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) hydrazine monohydrate, EtOH, reflux, 3 h; (b) CH(OMe)<sub>3</sub>, PTSA, 85 °C, 2 h or CH<sub>3</sub>C(OMe)<sub>3</sub>, HOAc, <i>m</i>-xylene, reflux, 6 h.</p></p></figure><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/medium/jm0c01581_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/large/jm0c01581_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Target Compounds <b>82–91</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/large/jm0c01581_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01581&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) acetyl chloride, MeOH, reflux, overnight; (b) Boc<sub>2</sub>O, DIPEA, DCM, rt, overnight; (c) PPh<sub>3</sub>, DEAD, alcohol, rt, overnight; or alkyl <i>p</i>-toluenesulfonate, K<sub>2</sub>CO<sub>3</sub>, MeCN, 65 °C, overnight; (d) 4 M HCl in dioxane, DCM, rt, overnight; (e) (<i>S</i>)-2-phenylpropionic acid, HBTU, TEA, MeCN, rt, 5 h; (f) hydrazine monohydrate, EtOH, reflux, 3 h; (g) CH(OMe)<sub>3</sub>, PTSA, 85 °C, 2 h; or CH<sub>3</sub>C(OMe)<sub>3</sub>, HOAc, <i>m</i>-xylene, reflux, 6 h; or CNBr, MeOH, reflux, 3 h.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Pharmacological Evaluation and SAR Study</h3><div class="NLM_p">All synthesized compounds in this study were evaluated for the GPR88 agonist activity in our previously established in vitro GPR88 Lance TR-FRET cAMP assay.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The TR-FRET signal (665 nm) was converted to fmol cAMP by interpolating from the standard cAMP curve. fmol cAMP was plotted against the log of compound concentration, and data were fit to a three-parameter logistic curve to generate the maximum response (<i>E</i><sub>max</sub>) and EC<sub>50</sub> values. In our assay, 2-PCCA had an <i>E</i><sub>max</sub> of 100 ± 2 (mean ± S.E.M.) and RTI-13951-33 had an <i>E</i><sub>max</sub> of 103 ± 2 relative to 2-PCCA. Collectively, all of the active compounds in this study had <i>E</i><sub>max</sub> values comparable to 2-PCCA and RTI-13951-33, except for compounds <b>28</b> and <b>43</b>, which had <i>E</i><sub>max</sub> values of 84 and 83%, respectively. These values might indicate that the compounds are partial agonists; however, it is important to note that <i>E</i><sub>max</sub> was calculated against synthetic agonists because the endogenous ligand for GPR88 has not yet been discovered. <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> displays the concentration–response curves of representative compounds (RTI-13951-33, <b>84</b>, and <b>90</b>). Given the importance of an alkoxy substitution on site A in the 2-AMPP scaffold for GPR88 activity reported earlier, we first examined a series of ether analogues <b>12–28</b> by varying the length, shape, and steric and electronic properties, with the aim of identifying a side chain that can lower the lipophilicity while maintaining the potency of 2-{4-[(2-methylpentyl)oxy]phenyl}glycinol <b>2</b> (clog <i>P</i> = 4.64, EC<sub>50</sub> = 195 nM). As can be seen from <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, the GPR88 agonist activity of this series was sensitive to the branching and length of the alkoxy side chain. First, the position of methyl branching was important for activity, as both 1-methylpentyl <b>12</b> (EC<sub>50</sub> = 380 nM) and 4-methylpentyl <b>13</b> (EC<sub>50</sub> = 282 nM) were less potent than the 2-methylpentyl analogue <b>2</b>. Second, the branched alkyl was more potent than the linear alkyl group, as exemplified by <b>16</b> (EC<sub>50</sub> = 174 nM) relative to <b>14</b> (EC<sub>50</sub> = 295 nM). Third, the length of the alkyl group was important as potency decreased from <i>n</i>-pentyl to <i>n</i>-propyl (<b>14</b>, <b>18</b>, and <b>20</b>). Among the three cyclic alkyl analogues (<b>17</b>, <b>19</b>, and <b>21</b>), only the cyclobutylmethyl <b>19</b> was favored with an EC<sub>50</sub> of 234 nM. Attempts to add an additional oxygen atom into the side chain to reduce clog <i>P</i> resulted in a 10-fold loss of activity (<b>22</b>, <b>23</b>). In general, the GPR88 agonist activity was correlated with the lipophilicity of the compounds. The potency decreased as the clog <i>P</i> of compounds <b>12–23</b> decreased. Compounds <b>16</b> and <b>19</b> with an (<i>S</i>)-2-methylbutyl and a cyclobutylmethyl group, respectively, provided the best balance between potency and lipophilicity. To further explore SAR of the cyclobutylmethyl <b>19</b>, we synthesized and tested a series of substituted analogues <b>24–28</b>. Unfortunately, all of these compounds suffered from loss of potency; in particular, <b>24</b>, <b>26</b>, and <b>27</b> were completely inactive, suggesting that there is a limited steric tolerance in this side-chain position.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/medium/jm0c01581_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/large/jm0c01581_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Concentration–response curves of RTI-13951-33, <b>84</b>, and <b>90</b> in the GPR88 Lance TR-FRET cAMP assay. The TR-FRET signal (665 nm) was converted to fmol cAMP by interpolating from the standard cAMP curve. Percent inhibition of forskolin-induced (300 nM) cAMP levels was plotted against the log of compound concentration, and data were fit to a three-parameter logistic curve to generate EC<sub>50</sub> values. Each data point is the mean ± S.D. of at least three independent experiments performed in duplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/large/jm0c01581_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01581&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Biological Data of 4-Alkoxyphenylglycinols</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/medium/jm0c01581_0010.gif" alt="" id="GRAPHIC-d7e990-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/medium/jm0c01581_0011.gif" alt="" id="gr9" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">clog <i>P</i> was calculated using Instant JChem 5.4.0 (ChemAxon Ltd.).</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">pEC<sub>50</sub> values are means ± standard error of at least three independent experiments performed in duplicate.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last"><i>E</i><sub>max</sub> value is % of 2-PCCA (mean ± standard error).</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last"><i>E</i><sub>max</sub> value is % of RTI-13951-33 (mean ± standard error). N.D., not determined.</p></div></div><div></div></div><div class="NLM_p">We next investigated site B with a rationale that modification of the amide functionality on this site would improve the potency of <b>4</b> (EC<sub>50</sub> = 616 nM, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). In addition, amide formation with a variety of readily available amines can rapidly expand the structural diversity for SAR. To this end, we performed an in-depth examination of the substitution effects on the amide nitrogen by varying the size, lipophilicity, polarity, and electronic properties. The study began with the aliphatic substitutions on the amide nitrogen, as shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. The primary amide <b>30</b> was equipotent to the tertiary <i>N</i>-dimethyl <b>4</b>, whereas a monomethyl group (<b>31</b>) improved the potency by twofold. The agonist activity increased further with an ethyl group (<b>32</b>), decreased with an <i>n</i>-propyl group (<b>33</b>), and then maintained a moderate potency (EC<sub>50</sub> = 200–300 nM) with small-to-large-sized alkyl substitutions (<b>34–42</b>) except for cyclohexyl (<b>43</b>). The <i>N</i>-ethyl analogue <b>32</b> (EC<sub>50</sub> = 120 nM) emerged as the most potent compound in the amide series. Further modifications by adding polar functionalities at the terminal end of <i>N</i>-ethyl, such as ester (<b>44</b>), hydroxyl (<b>45</b>), ether (<b>46</b>, <b>47</b>), carbamate (<b>48</b>, <b>50</b>), and amine (<b>49</b>), led to a significant loss of potency. Interestingly, compounds (<b>49</b>, <b>51–54</b>) with a protonatable nitrogen had the least activity. This SAR trend was also observed in the amide analogues with aromatic substitutions (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Phenyl and benzyl groups (<b>55</b>, <b>56</b>) were favorable with an EC<sub>50</sub> of 245 and 219 nM, respectively, whereas pyridine rings (<b>57–59</b>), capable of forming a salt to improve aqueous solubility, were less active. Other polar five-membered heterocycles (<b>60–69</b>) were also poorly tolerated. It appeared that the activity deteriorated with heterocycles containing more heteroatoms. It should be noted that although two different side chains (2-methylpentyl and cyclobutylmethyl) on site B were used in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, there was little difference in potency contributions between the two groups (<b>60</b> vs <b>61</b>). Overall, the SAR suggested that compounds with a lipophilic alkyl substitution on the amide nitrogen tend to have better potency.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Biological Data of 4-Alkoxyphenylglycinamides</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/medium/jm0c01581_0012.gif" alt="" id="GRAPHIC-d7e1153-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/medium/jm0c01581_0013.gif" alt="" id="gr10" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">pEC<sub>50</sub> values are means ± standard error of at least three independent experiments performed in duplicate.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last"><i>E</i><sub>max</sub> value is % of 2-PCCA (mean ± standard error).</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last"><i>E</i><sub>max</sub> value is % of RTI-13951-33 (mean ± standard error). N.D., not determined.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Biological Data of 4-Alkoxyphenylglycinamides Containing Aromatics</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/medium/jm0c01581_0014.gif" alt="" id="GRAPHIC-d7e1188-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/medium/jm0c01581_0015.gif" alt="" id="gr11" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">pEC<sub>50</sub> values are means ± standard error of at least three independent experiments performed in duplicate.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last"><i>E</i><sub>max</sub> value is % of RTI-13951-33 (mean ± standard error).</p></div></div><div></div></div><div class="NLM_p">Bioisosteric replacement is an essential tool in the SAR study to improve potency, selectivity, and pharmacokinetics (PKs).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The oxadiazole moiety is stable to chemical and enzymatic degradation and capable of forming a hydrogen bond; therefore, it has been broadly used as a nonclassical bioisostere for ester and amide functionalities.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Because the 1,3,4-oxadiazoles have a lower lipophilicity (in general, an order of magnitude of clog <i>P</i>) compared to its 1,2,4-isomers, we selected 1,3,4-oxadiazole as our initial testing set. Replacement of the amide group in <b>4</b> with a 1,3,4-oxadiazole or a 5-methyl-1,3,4-oxadiazole moiety gave analogues <b>71</b> and <b>72</b>, respectively, which were equipotent to <b>4</b> with EC<sub>50</sub> values in the 500–600 nM range (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). There was no difference in potency between the 2-methylpentyl and cyclobutylmethyl side chains (<b>73</b>, <b>74</b> vs <b>71</b>, <b>72</b>). Interestingly, the addition of a methylene linker between the oxadiazole moiety and the benzylic carbon led to a 5-fold increase in potency (<b>82</b>, <b>83</b> vs <b>71</b>, <b>72</b>). Further modification by attaching an amino group to the 5-position gave the most potent compound <b>84</b> (EC<sub>50</sub> = 59 nM) in the series. Attempts to lower the lipophilicity by exchanging the 2-methylpentyl side chain in <b>82–84</b> with the cyclobutylmethyl group, unfortunately, resulted in less active compounds <b>85–87</b>. After identifying a favorable 1,3,4-oxadiazole pharmacophore on site B, we turned our attention back to the side chain on site A, in which we reasoned that the chiral center of the methyl branching might have an impact on the potency. The (<i>S</i>)-isomer <b>88</b> and the (<i>R</i>)-isomer <b>89</b> had equivalent GPR88 activity with EC<sub>50</sub> values of 78 and 74 nM, respectively, in line with the EC<sub>50</sub> value of the racemic mixture <b>84</b>. However, in the case of the 2-methylbutyl side chain, (<i>S</i>)-<b>90</b> was approximately twofold more potent than (<i>R</i>)-<b>91</b>, which is consistent with the observation in the corresponding hydroxyl (on site B) analogues that (<i>S</i>)-2-methylbutyl <b>16</b> is slightly more potent than racemic <b>15</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Biological Data of Bioisosteric 1,3,4-Oxadiazoles</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/medium/jm0c01581_0016.gif" alt="" id="GRAPHIC-d7e1330-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/medium/jm0c01581_0017.gif" alt="" id="gr12" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">clog <i>P</i> was calculated using Instant JChem 5.4.0 (ChemAxon Ltd.).</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">pEC<sub>50</sub> values are means ± standard error of at least three independent experiments performed in duplicate.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last"><i>E</i><sub>max</sub> value is % of RTI-13951-33 (mean ± standard error).</p></div><div class="footnote" id="t4fn4"><sup><sup>d</sup></sup><p class="last"><i>E</i><sub>max</sub> value is % of 2-PCCA (mean ± standard error).</p></div><div class="footnote" id="t4fn5"><sup><sup>e</sup></sup><p class="last">Compounds were tested as the HCl salt.</p></div></div><div></div></div><div class="NLM_p">To further characterize the GPR88 agonist activity, we tested our best compound in the [<sup>35</sup>S]GTPγS binding assay using mouse striatal membrane preparations. RTI-13951-33 (cAMP: EC<sub>50</sub> = 25 nM) increased [<sup>35</sup>S]GTPγS binding with an EC<sub>50</sub> = 535 nM (<i>E</i><sub>max</sub> = 200%).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a><i>E</i><sub>max</sub> is expressed as percentage of activation above the basal binding, which is set as 100%, and the basal binding refers to binding in the absence of the agonist. Compound <b>84</b> also exhibited strong enhancement of the [<sup>35</sup>S]GTPγS binding activity (EC<sub>50</sub> = 942 nM, <i>E</i><sub>max</sub> = 229%) in mouse striatal membranes (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Importantly, the compound was inactive in membranes prepared from GPR88 KO mice at concentrations tested up to 100 μM, indicating that it had a GPR88-specific agonist signaling activity in the striatum. It is worth noting that although the GPR88 agonist activity in the [<sup>35</sup>S]GTPγS binding assay using a native tissue system is approximately 10- to 20-fold less potent than the cAMP assay in a GPR88 overexpressing cell line, the rank order of the potency of compounds is consistent between the two assay systems.</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/medium/jm0c01581_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/large/jm0c01581_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. [<sup>35</sup>S]GTPγS binding of compound <b>84</b> in WT mouse striatal membranes vs GPR88 KO mouse striatal membranes. The data are the means of triplicate measurements with standard deviation shown as error bars.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/large/jm0c01581_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01581&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Solubility and Preliminary PK Studies</h3><div class="NLM_p">One of the major challenges for the development of GPR88 probes is their ability to cross the blood–brain barrier (BBB) and have sufficient brain exposure to modulate receptor functions. Calculated physicochemical properties, such as lipophilicity (clog <i>P</i>) and topological polar surface area (TPSA), are useful indicators of a successful CNS drug. In general, a balance between clog <i>P</i> (2–4)<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> and TPSA (<76 Å<sup>2</sup>)<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> would lead to good solubility and BBB permeability. Therefore, we tested the kinetic aqueous solubility (at pH = 7.4) and PK properties of select compounds to determine their drug-likeness. PK data for the in vivo effective agonist RTI-13951-33 are also presented for comparison.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> As shown in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, both compounds <b>1</b> and <b>84</b> have a poor solubility of <1 μM, which is expected for compounds with a high clog <i>P</i> (4.53 and 4.20, respectively). Compound <b>90</b> (clog <i>P</i> = 3.76) has an increased solubility of 2.9 ± 0.3 μM, which confirms that while solubility is a challenge we still face, lowering lipophilicity does improve solubility. Compound <b>90</b> was further evaluated in a preliminary PK study to assess whether this compound has sufficient brain exposure. Following an intraperitoneal (i.p.) dose of 10 mg/kg in rats, <b>90</b> reached the peak plasma concentration of 270 ng/mL at 30 min (the first time point tested). The brain concentration also peaked at 30 min with a <i>C</i><sub>max</sub> of 39 ng/mL (92 nM), which is slightly above its EC<sub>50</sub> of 71 nM in the cAMP functional assay. The overall brain to plasma AUC ratio (B/P), as determined by AUC<sub>0–inf</sub> ratio, was 0.1, indicating that <b>90</b> has limited brain penetration. As a comparison, RTI-13951-33 has a brain <i>C</i><sub>max</sub> of 287 ng/mL (539 nM) and a B/P ratio of 0.5 in rats (i.p., 10 mg/kg dose).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Compound <b>90</b> has a clog <i>P</i> of 3.76 but a high TPSA of 103 Å<sup>2</sup>, which likely limits its brain permeability. Further optimization of the 1,3,4-oxadiazole analogues is required to improve brain permeability.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Physicochemical, Solubility, and PK Properties of Compounds <b>1</b>, <b>84</b>, and <b>90</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center">rat PK (i.p., 10 mg/kg)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">plasma</th><th class="rowsep1 colsep0" colspan="2" align="center">brain</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">cAMP EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">clog <i>P</i><a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">TPSA<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">kinetic solubility at pH 7.4 (μM)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center">AUC<sub>0–inf</sub> (ng/mL·h)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center">AUC<sub>0–inf</sub> (ng/mL·h)</th><th class="colsep0 rowsep0" align="center">B/P</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">414</td><td class="colsep0 rowsep0" align="char" char=".">4.53</td><td class="colsep0 rowsep0" align="char" char=".">64.3</td><td class="colsep0 rowsep0" align="left"><1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>84</b></td><td class="colsep0 rowsep0" align="char" char=".">59</td><td class="colsep0 rowsep0" align="char" char=".">4.20</td><td class="colsep0 rowsep0" align="char" char=".">103.3</td><td class="colsep0 rowsep0" align="left"><1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>90</b></td><td class="colsep0 rowsep0" align="char" char=".">71</td><td class="colsep0 rowsep0" align="char" char=".">3.76</td><td class="colsep0 rowsep0" align="char" char=".">103.3</td><td class="colsep0 rowsep0" align="left">2.9 ± 0.3</td><td class="colsep0 rowsep0" align="left">270</td><td class="colsep0 rowsep0" align="left">1001</td><td class="colsep0 rowsep0" align="left">39</td><td class="colsep0 rowsep0" align="left">95</td><td class="colsep0 rowsep0" align="left">0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RTI-13951-33<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">3.34</td><td class="colsep0 rowsep0" align="char" char=".">77.7</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">874</td><td class="colsep0 rowsep0" align="left">1510</td><td class="colsep0 rowsep0" align="left">287</td><td class="colsep0 rowsep0" align="left">825</td><td class="colsep0 rowsep0" align="left">0.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">All compounds were tested as the HCl salt.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">clog <i>P</i> and TPSA were calculated using Instant JChem 5.4.0 (ChemAxon Ltd.).</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">Data were obtained from ref <a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a>.</p></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58013" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58013" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The orphan receptor GPR88 plays important roles in mediation of dopaminergic activity and striatal functions. To explore the therapeutic potential of this novel drug target, our group has carried out a medicinal chemistry campaign to develop GPR88 small-molecule agonist probes based on the 2-PCCA and 2-AMPP scaffolds.<a onclick="showRef(event, 'ref25 ref26 ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27 ref28 ref29">(25−29)</a> The present study describes a series of novel (4-alkoxyphenyl)glycinols, (4-alkoxyphenyl)glycinamides and the corresponding bioisosteric 1,3,4-oxadiazoles derived from 2-AMPP and explores their SAR requirements for high potency at the GPR88 receptor. Notably, 5-amino-1,3,4-oxadiazoles <b>84</b> (EC<sub>50</sub> = 59 nM) and <b>90</b> (EC<sub>50</sub> = 71 nM) emerged as the most potent compounds in this study. Compound <b>84</b> exhibited a significant [<sup>35</sup>S]GTPγS binding activity (EC<sub>50</sub> = 942 nM) using the native tissue sample from mouse striatum but was inactive in GPR88 KO mouse striatal membranes, even at a concentration of 100 μM, demonstrating that this type of compound has GPR88-specific agonist activity in the striatum. However, a preliminary PK study of <b>90</b> indicates limited brain permeability. Chemical modifications of 2-AMPP on site B (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) with other five-membered heterocycles, as well as on site C, to further improve potency and ADME properties are currently underway. These studies will facilitate the identification of highly potent and brain-penetrant agonists to probe GPR88 functions in the brain.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70827" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70827" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Chemistry</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> General Methods</h4><div class="NLM_p last">All solvents and chemicals were of reagent grade. Unless otherwise mentioned, all reagents and solvents were purchased from commercial vendors and used as received. Flash column chromatography was carried out on a Teledyne ISCO CombiFlash Rf system using prepacked columns. Solvents used include hexane, ethyl acetate (EtOAc), dichloromethane, and methanol. Purity and characterization of compounds were established by a combination of NMR, mass spectrometry, TLC, and HPLC analyses. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on a Bruker Avance DPX-300 (300 MHz) spectrometer and were determined in CDCl<sub>3</sub>, DMSO-<i>d</i><sub>6</sub>, or CD<sub>3</sub>OD with tetramethylsilane (TMS) (0.00 ppm) or solvent peaks as the internal reference. Chemical shifts are reported in ppm relative to the reference signal and coupling constant (<i>J</i>) values are reported in hertz (Hz). Nominal mass spectra were obtained using an Agilent InfinityLab MSD single quadrupole mass spectrometer system (ESI). HRMS were obtained using Agilent 1290 Infinity UHPLC-6230 TOF mass spectrometer (ESI). Thin-layer chromatography (TLC) was performed on EMD precoated silica gel 60 F254 plates, and spots were visualized with UV light or iodine staining. CMA80 for column chromatography is a mixture of 80:18:2 chloroform/MeOH/NH<sub>4</sub>OH. All final compounds were greater than 95% pure as determined by HPLC on a Waters 2695 Separation Module equipped with a Waters 2996 Photodiode Array Detector and a Phenomenex Synergi 4 mm Hydro-RP 80A C18 250 × 4.6 mm column using a flow rate of 1 mL/min starting with 1 min at 5% solvent B, followed by a 15 min gradient of 5–95% solvent B, followed by 9 min at 95% solvent B (solvent A, water with 0.1% TFA; solvent B, acetonitrile with 0.1% TFA and 5% water; absorbance monitored at 280 nm). All the synthesized target compounds were characterized by <sup>1</sup>H NMR, <sup>13</sup>C NMR, and HRMS and determined to be >95% pure by HPLC analyses.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> Methyl (2<i>R</i>)-2-{[(<i>tert</i>-Butoxy)carbonyl]amino}-2-(4-hydroxyphenyl)acetate (<b>6</b>)</h4><div class="NLM_p last">To a solution of (<i>R</i>)-2-phenylglycine methyl ester hydrochloride (5 g, 23 mmol) in DCM (175 mL) at 0 °C under nitrogen was added DIPEA (12 mL, 69 mmol), followed by di-<i>tert</i>-butyldicarbonate (5.2 g, 23 mmol). The reaction mixture was stirred at room temperature overnight and concentrated under reduced pressure. The residue was dissolved in EtOAc (200 mL), washed with 10% citric acid (3 × 50 mL) and brine (3 × 50 mL), and dried (Na<sub>2</sub>SO<sub>4</sub>). Removal of the solvent under reduced pressure afforded crude <b>6</b> (6.45 g, 100% yield) as a colorless oil. <sup>1</sup>H NMR (300 MHz; CDCl<sub>3</sub>): δ 7.16 (d, <i>J</i> = 9.0 Hz, 2H), 7.13 (d, <i>J</i> = 9.0 Hz, 2H), 6.44 (s, 1H), 5.60 (br d, <i>J</i> = 6.0 Hz, 1H), 5.22 (d, <i>J</i> = 6.0 Hz, 1H), 3.71 (s, 3H), 1.44 (s, 9H); <sup>13</sup>C NMR (75 MHz; CDCl<sub>3</sub>): δ 172.0, 156.3, 155.0, 128.5, 128.4, 115.8, 80.5, 57.1, 52.7, 28.3; MS (ESI) [M + H]<sup>+</sup><i>m</i>/<i>z</i>: 282.3.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Methyl (2<i>R</i>)-2-{[(<i>tert</i>-Butoxy)carbonyl]amino}-2-{4-[(4-methylpentyl)oxy]phenyl}acetate (<b>7b</b>)</h4><div class="NLM_p last">To a solution of <b>6</b> (200 mg, 0.71 mmol), 4-methylpentanol (177 μL, 1.42 mmol), and PPh<sub>3</sub> (316 mg, 1.21 mmol) in THF (10 mL) at room temperature under nitrogen was slowly added DEAD (0.19 mL, 1.21 mmol) dropwise, while keeping the reaction temperature below 35 °C. After addition, the reaction mixture was stirred at room temperature overnight and quenched with H<sub>2</sub>O (10 mL). The layers were separated, and the aqueous layer was extracted with EtOAc (3 × 30 mL). The combined organic layers were washed with brine (3 × 30 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure. The residue was subjected to chromatography on silica gel using 0–20% EtOAc in hexanes to afford <b>7b</b> (130 mg, 50% yield) as a colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.26 (d, <i>J</i> = 9.0 Hz, 2H), 6.85 (d, <i>J</i> = 9.0 Hz, 2H), 5.50 (br d, <i>J</i> = 6.0 Hz, 1H), 5.24 (d, <i>J</i> = 6.0 Hz, 1H), 3.92 (t, <i>J</i> = 6.0 Hz, 2H), 3.71 (s, 3H), 1.86–1.71 (m, 2H), 1.67–1.53 (m, 1H), 1.43 (s, 9H), 1.40–1.25 (m, 2H), 0.91 (d, <i>J</i> = 6.0 Hz, 6H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 171.9, 159.3, 154.8, 128.7, 128.3, 114.8, 80.0, 68.4, 57.1, 52.5, 35.1, 28.3, 27.8, 27.1, 22.5; MS (ESI) <i>m</i>/<i>z</i>: 366.6 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Methyl (2<i>R</i>)-2-{[(<i>tert</i>-Butoxy)carbonyl]amino}-2-[4-(pentyloxy)phenyl]acetate (<b>7c</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>7b</b> was followed starting with <b>6</b> and <i>n</i>-pentanol to give <b>7c</b> (50% yield) as a colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.26 (d, <i>J</i> = 9.0 Hz, 2H), 6.86 (d, <i>J</i> = 9.0 Hz, 2H), 5.50 (br d, <i>J</i> = 6.0 Hz, 1H), 5.25 (d, <i>J</i> = 9.0 Hz, 1H), 3.93 (t, <i>J</i> = 7.5 Hz, 2H), 3.71 (s, 3H), 1.82–1.71 (m, 2H), 1.43 (s, 9H), 1.42–1.25 (m, 4H), 0.92 (t, <i>J</i> = 7.5 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 171.9, 159.3, 154.8, 128.7, 128.3, 114.8, 80.0, 68.0, 57.1, 52.5, 28.9, 28.3, 28.2, 22.4, 14.0; MS (ESI) <i>m</i>/<i>z</i>: 352.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Methyl (2<i>R</i>)-2-{[(<i>tert</i>-Butoxy)carbonyl]amino}-2-[4-(butoxy)phenyl]acetate (<b>7g</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>7b</b> was followed starting with <b>6</b> and <i>n</i>-butanol to give <b>7g</b> (57% yield) as a colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.26 (d, <i>J</i> = 9.0 Hz, 2H), 6.86 (d, <i>J</i> = 9.0 Hz, 2H), 5.53 (br d, <i>J</i> = 9.0 Hz, 1H), 5.25 (d, <i>J</i> = 9.0 Hz, 1H), 3.94 (t, <i>J</i> = 7.5 Hz, 2H), 3.70 (s, 3H), 1.81–1.68 (m, 2H), 1.52–1.44 (m, 2H), 1.43 (s, 9H), 0.96 (t, <i>J</i> = 7.5 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 171.9, 159.3, 154.8, 128.7, 128.3, 114.8, 80.0, 67.7, 57.1, 52.5, 31.3, 28.3, 19.2, 13.8; MS (ESI) <i>m</i>/<i>z</i>: 338.6 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Methyl (2<i>R</i>)-2-{[(<i>tert</i>-Butoxy)carbonyl]amino}-2-[4-(cyclobutylmethoxy)phenyl]acetate (<b>7h</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>7b</b> was followed starting with <b>6</b> and cyclobutylmethanol to give <b>7h</b> (71% yield) as a colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.26 (d, <i>J</i> = 9.0 Hz, 2H), 6.87 (d, <i>J</i> = 9.0 Hz, 2H), 5.50 (br d, <i>J</i> = 6.0 Hz, 1H), 5.25 (d, <i>J</i> = 9.0 Hz, 1H), 3.90 (d, <i>J</i> = 6.0 Hz, 2H), 3.70 (s, 3H), 2.84–1.68 (m, 1H), 2.19–2.06 (m, 2H), 2.01–1.80 (m, 4H), 1.43 (s, 9H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 171.9, 159.4, 154.8, 128.8, 128.3, 114.9, 80.0, 72.1, 57.0, 52.6, 34.6, 28.3, 24.8, 18.6; MS (ESI) <i>m</i>/<i>z</i>: 350.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Methyl (2<i>R</i>)-2-{[(<i>tert</i>-Butoxy)carbonyl]amino}-2-(4-propoxyphenyl)acetate (<b>7i</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>7b</b> was followed starting with <b>6</b> and <i>n</i>-propanol to give <b>7i</b> (57% yield) as a colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.26 (d, <i>J</i> = 9.0 Hz, 2H), 6.86 (d, <i>J</i> = 9.0 Hz, 2H), 5.54 (br d, <i>J</i> = 9.0 Hz, 1H), 5.25 (d, <i>J</i> = 9.0 Hz, 1H), 3.89 (t, <i>J</i> = 7.5 Hz, 2H), 3.70 (s, 3H), 1.85–1.72 (m, 2H), 1.43 (s, 9H), 1.02 (t, <i>J</i> = 7.5 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 171.9, 159.3, 154.8, 128.7, 128.3, 114.8, 80.0, 69.5, 57.1, 52.5, 28.3, 22.5, 10.5; MS (ESI) <i>m</i>/<i>z</i>: 324.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Methyl (2<i>R</i>)-2-{[(<i>tert</i>-Butoxy)carbonyl]amino}-2-[4-(cyclopropylmethoxy)phenyl]acetate (<b>7j</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>7b</b> was followed starting with <b>6</b> and cyclopropylmethanol to give <b>7j</b> (76% yield) as a colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.26 (d, <i>J</i> = 9.0 Hz, 2H), 6.87 (d, <i>J</i> = 9.0 Hz, 2H), 5.54 (br d, <i>J</i> = 9.0 Hz, 1H), 5.25 (d, <i>J</i> = 9.0 Hz, 1H), 3.78 (d, <i>J</i> = 9.0 Hz, 2H), 3.70 (s, 3H), 1.43 (s, 9H), 1.32–1.16 (m, 1H), 0.67–0.58 (m, 2H), 0.39–0.28 (m, 2H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 171.9, 159.1, 154.8, 128.9, 128.4, 114.9, 80.0, 72.8, 57.0, 52.5, 28.3, 10.2, 3.2; MS (ESI) <i>m</i>/<i>z</i>: 336.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Methyl (2<i>R</i>)-2-{[(<i>tert</i>-Butoxy)carbonyl]amino}-2-[4-(4-methoxybutoxy)phenyl]acetate (<b>7k</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>7b</b> was followed starting with <b>6</b> and 4-methoxybutan-1-ol to give <b>7k</b> (63% yield) as a colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.26 (d, <i>J</i> = 9.0 Hz, 2H), 6.86 (d, <i>J</i> = 9.0 Hz, 2H), 5.56 (br d, <i>J</i> = 6.0 Hz, 1H), 5.25 (d, <i>J</i> = 9.0 Hz, 1H), 3.96 (t, <i>J</i> = 6.0 Hz, 2H), 3.70 (s, 3H), 3.43 (t, <i>J</i> = 6.0 Hz, 2H), 3.33 (s, 3H), 1.91–1.68 (m, 4H), 1.43 (s, 9H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 171.9, 159.1, 154.8, 128.8, 128.3, 114.8, 80.0, 72.3, 67.7, 58.5, 57.0, 52.5, 28.3, 26.2, 26.0; MS (ESI) <i>m</i>/<i>z</i>: 368.4 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Methyl (2<i>R</i>)-2-{[(<i>tert</i>-Butoxy)carbonyl]amino}-2-[4-(4-methoxypropoxy)phenyl]acetate (<b>7l</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>7b</b> was followed starting with <b>6</b> and 3-methoxypropan-1-ol to give <b>7l</b> (68% yield) as a colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.26 (d, <i>J</i> = 9.0 Hz, 2H), 6.87 (d, <i>J</i> = 9.0 Hz, 2H), 5.55 (br d, <i>J</i> = 6.0 Hz, 1H), 5.25 (d, <i>J</i> = 9.0 Hz, 1H), 4.03 (t, <i>J</i> = 6.0 Hz, 2H), 3.70 (s, 3H), 3.54 (t, <i>J</i> = 6.0 Hz, 2H), 3.34 (s, 3H), 2.08–1.97 (m, 2H), 1.43 (s, 9H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 171.9, 159.1, 154.8, 128.9, 128.3, 114.8, 80.0, 69.1, 64.9, 58.6, 57.0, 52.5, 29.5, 28.3; MS (ESI) <i>m</i>/<i>z</i>: 354.5 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (2<i>R</i>)-2-Amino-2-{4-[(4-methylpentyl)oxy]phenyl}ethan-1-ol Hydrochloride (<b>8b</b>)</h4><div class="NLM_p last">To a suspension of NaBH<sub>4</sub> (35 mg, 0.93 mmol) in EtOH (1.5 mL) at 0 °C under nitrogen was added LiCl (39 mg, 0.93 mmol). After stirring at 0 °C for 10 min, a solution of <b>7b</b> (130 mg, 0.36 mmol) in THF (1.5 mL) was added. The reaction mixture was stirred at room temperature for 3 h and quenched with saturated NH<sub>4</sub>Cl solution (5 mL), followed by addition of H<sub>2</sub>O (5 mL). The mixture was extracted with EtOAc (3 × 20 mL). The combined organic layers were washed with brine (20 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure to give 125 mg of the crude intermediate alcohol. The Boc group was then deprotected with 4 M HCl in dioxane (2 mL) and DCM (5 mL). The reaction mixture was stirred at room temperature overnight and concentrated to give crude <b>8b</b> (93 mg, 100% over two steps) as an off-white foamy solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.21 (d, <i>J</i> = 9.0 Hz, 2H), 6.87 (d, <i>J</i> = 9.0 Hz, 2H), 4.01–3.84 (m, 3H), 3.74–3.60 (m, 1H), 3.51 (t, <i>J</i> = 9.0 Hz, 1H), 1.84–1.70 (m, 2H), 1.66–1.51 (m, 1H), 1.38–1.21 (m, 3H), 0.92 (d, <i>J</i> = 9.0 Hz, 6H); MS (ESI) free base <i>m</i>/<i>z</i>: 238.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (2<i>R</i>)-2-Amino-2-[4-(pentyloxy)phenyl]ethan-1-ol Hydrochloride (<b>8c</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>8b</b> was followed starting with <b>7c</b> to give crude <b>8c</b> (100% yield over two steps) as an off-white foamy solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.22 (d, <i>J</i> = 9.0 Hz, 2H), 6.87 (d, <i>J</i> = 9.0 Hz, 2H), 4.05–3.84 (m, 3H), 3.75–3.61 (m, 1H), 3.51 (t, <i>J</i> = 9.0 Hz, 1H), 1.84–1.70 (m, 2H), 1.50–1.29 (m, 5H), 0.93 (t, <i>J</i> = 7.5 Hz, 3H); MS (ESI) free base <i>m</i>/<i>z</i>: 224.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (2<i>R</i>)-2-Amino-2-(4-butoxyphenyl)ethan-1-ol Hydrochloride (<b>8g</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>8b</b> was followed starting with <b>7g</b> to give crude <b>8g</b> (100% yield over two steps) as an off-white foamy solid. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD): δ 7.35 (d, <i>J</i> = 9.0 Hz, 2H), 6.98 (d, <i>J</i> = 9.0 Hz, 2H), 4.32–4.21 (m, 1H), 3.99 (t, <i>J</i> = 6.0 Hz, 2H), 3.87–3.72 (m, 2H), 1.82–1.67 (m, 2H), 1.58–1.42 (m, 2H), 0.98 (t, <i>J</i> = 7.5 Hz, 3H); MS (ESI) free base <i>m</i>/<i>z</i>: 210.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (2<i>R</i>)-2-Amino-2-(4-propoxyphenyl)ethan-1-ol Hydrochloride (<b>8i</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>8b</b> was followed starting with <b>7i</b> to give crude <b>8i</b> (100% yield over two steps) as an off-white foamy solid. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD): δ 7.33 (d, <i>J</i> = 9.0 Hz, 2H), 6.95 (d, <i>J</i> = 9.0 Hz, 2H), 4.30–4.14 (m, 1H), 3.97–3.69 (m, 4H), 1.86–1.66 (m, 2H), 1.03 (t, <i>J</i> = 7.5 Hz, 3H); MS (ESI) free base <i>m</i>/<i>z</i>: 196.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (2<i>R</i>)-2-Amino-2-[4-(4-methoxybutoxy)phenyl]ethan-1-ol Hydrochloride (<b>8k</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>8b</b> was followed starting with <b>7k</b> to give crude <b>8k</b> (100% yield over two steps) as an off-white foamy solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.39 (d, <i>J</i> = 9.0 Hz, 2H), 6.83 (d, <i>J</i> = 9.0 Hz, 2H), 5.54–5.28 (m, 1H), 4.53–4.30 (m, 1H), 4.00–3.60 (m, 4H), 3.49–3.36 (m, 2H), 3.32 (s, 3H), 1.86–1.57 (m, 4H); MS (ESI) free base <i>m</i>/<i>z</i>: 240.4 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> (2<i>R</i>)-2-Amino-2-[4-(3-methoxypropoxy)phenyl]ethan-1-ol Hydrochloride (<b>8l</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>8b</b> was followed starting with <b>7l</b> to give crude <b>8l</b> (100% yield over two steps) as an off-white foamy solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.39 (d, <i>J</i> = 9.0 Hz, 2H), 6.83 (d, <i>J</i> = 9.0 Hz, 2H), 5.47–5.36 (m, 1H), 4.47–4.33 (m, 1H), 3.98–3.84 (m, 3H), 3.80–3.68 (m, 1H), 3.49 (t, <i>J</i> = 6.0 Hz, 2H), 3.31 (s, 3H), 2.05–1.91 (m, 2H); MS (ESI) free base <i>m</i>/<i>z</i>: 226.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Methyl (2<i>R</i>)-2-{[(<i>tert</i>-Butoxy)carbonyl]amino}-2-(4-{[tris(propan-2-yl)silyl]oxy}phenyl)acetate (<b>9</b>)</h4><div class="NLM_p last">To a solution of <b>6</b> (1 g, 3.55 mmol) in dry DCM (20 mL) were added imidazole (532 mg, 7.82 mmol) and TIPS–Cl (837 mg, 3.91 mmol) at 0 °C. After stirring at room temperature for 16 h, the reaction was quenched with H<sub>2</sub>O (2 mL), and the layers were separated. The aqueous layer was extracted with additional DCM (3 × 20 mL), and the combined organic layers were washed with brine (3 × 30 mL) and dried (Na<sub>2</sub>SO<sub>4</sub>). The solvent was removed under reduced pressure, and the residue was subjected to chromatography on silica gel using 0–30% EtOAc in hexanes to furnish <b>9</b> (1.47 g, 95% yield) as a thick colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.19 (d, <i>J</i> = 8.5 Hz, 2H), 6.84 (d, <i>J</i> = 8.6 Hz, 2H), 5.42 (d, <i>J</i> = 6.3 Hz, 1H), 5.23 (d, <i>J</i> = 7.3 Hz, 1H), 3.71 (s, 3H), 1.43 (s, 9H), 1.31–1.16 (m, 3H), 1.12–1.05 (m, 18H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 172.0, 156.3, 155.0, 129.1, 128.3, 120.2, 80.1, 57.1, 52.5, 28.3, 17.9, 12.6; MS (ESI) <i>m</i>/<i>z</i>: 460.0 [M + Na]<sup>+</sup>.</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Methyl (2<i>R</i>)-2-(4-Hydroxyphenyl)-2-[(2<i>S</i>)-2-phenylpropanamido]acetate (<b>10</b>)</h4><div class="NLM_p last">To a solution of <b>9</b> (968 mg, 2.25 mmol) in DCM (25 mL) was added TFA (2 mL) at 0 °C. After stirring for 16 h, the reaction was quenched with saturated NaHCO<sub>3</sub> (20 mL) and the layers were separated. The aqueous layer was extracted with additional DCM (3 × 20 mL), and the combined organic layers were washed with brine (3 × 20 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The residue was subjected to chromatography on silica gel using 0–30% EtOAc in hexanes (containing 1.5% Et<sub>3</sub>N) to afford the free amine (650 mg, 85% yield) as a foamy solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.22 (d, <i>J</i> = 8.6 Hz, 2H), 6.84 (d, <i>J</i> = 8.6 Hz, 2H), 4.58 (s, 1H), 3.69 (s, 3H), 2.33 (br s, 2H), 1.35–1.15 (m, 3H), 1.15–0.97 (m, 18H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 174.4, 156.0, 132.2, 127.9, 120.1, 58.1, 52.3, 17.9, 12.6; MS (ESI) <i>m</i>/<i>z</i>: 322.0 [M + H<sup>+</sup> – NH<sub>3</sub>]<sup>+</sup>. To a solution of the amine intermediate (620 mg, 1.84 mmol) in MeCN (20 mL) at room temperature were added TEA (0.77 mL, 5.52 mmol), (<i>S</i>)-2-phenylpropionic acid (0.36 g, 2.39 mmol), and HBTU (1.05 g, 2.76 mmol). After stirring for 5 h, the reaction was quenched by H<sub>2</sub>O (10 mL), followed by addition of EtOAc (50 mL). The layers were separated. The organic layer was washed with saturated NaHCO<sub>3</sub> (10 mL) and brine (2 × 20 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure. The residue was subjected to chromatography on silica gel using 0–30% EtOAc in hexanes to give the corresponding amide as a waxy solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.37–7.16 (m, 5H), 7.02 (d, <i>J</i> = 8.6 Hz, 2H), 6.76 (d, <i>J</i> = 8.6 Hz, 2H), 6.32 (d, <i>J</i> = 7.0 Hz, 1H), 5.46 (d, <i>J</i> = 7.1 Hz, 1H), 3.73–3.52 (m, 4H), 1.49 (d, <i>J</i> = 7.1 Hz, 3H), 1.30–1.14 (m, 3H), 1.11–1.04 (m, 18H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.3, 171.6, 156.2, 141.1, 128.8, 128.6, 128.2, 127.6, 127.2, 120.1, 55.9, 52.6, 46.7, 18.4, 17.9, 12.6; MS (ESI) <i>m</i>/<i>z</i>: 470.0 [M + H]<sup>+</sup>. To a solution of the amide (864 mg, 1.84 mmol) in THF (20 mL) at 0 °C was added TBAF (1.0 M in THF, 2.76 mL, 2.76 mmol) via a syringe. After stirring at 0 °C for 4 h, the reaction was quenched by H<sub>2</sub>O (15 mL) and diluted with EtOAc (20 mL). The layers were separated, and the aqueous layer was extracted with additional EtOAc (2 × 20 mL). The combined organic layers were washed with brine (2 × 2 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure. The residue was subjected to chromatography on silica gel using 0–100% EtOAc in hexanes to furnish <b>10</b> (576 mg, 85% over two steps) as a yellowish waxy solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.48–7.16 (m, 5H), 6.96 (d, <i>J</i> = 8.5 Hz, 2H), 6.78 (br s, 1H), 6.60 (d, <i>J</i> = 8.6 Hz, 2H), 6.48 (d, <i>J</i> = 6.6 Hz, 1H), 5.40 (d, <i>J</i> = 6.7 Hz, 1H), 3.73–3.51 (m, 4H), 1.51 (d, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 171.4, 169.1, 153.9, 138.2, 126.4, 125.7, 125.1, 124.9, 113.3, 53.6, 50.3, 44.3, 15.7; MS (ESI) <i>m</i>/<i>z</i>: 314.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Methyl (2<i>R</i>)-2-[4-(Hexan-2-yloxy)phenyl]-2-[(2<i>S</i>)-2-phenylpropanamido]acetate (<b>11a</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>7b</b> was followed starting with <b>10</b> and 2-hexanol to give <b>11a</b> (46% yield) as a sticky solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.38–7.17 (m, 5H), 7.11–7.00 (m, 2H), 6.83–6.68 (m, 2H), 6.33 (d, <i>J</i> = 6.9 Hz, 1H), 5.44 (d, <i>J</i> = 7.0 Hz, 1H), 4.39–4.23 (m, 1H), 3.67 (s, 3H), 3.66–3.55 (m, 1H), 1.80–1.63 (m, 1H), 1.63–1.52 (m, 1H), 1.50 (d, <i>J</i> = 7.2 Hz, 3H), 1.43–1.28 (m, 4H), 1.25 (d, <i>J</i> = 6.1 Hz, 3H), 0.89 (m, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.4, 171.6, 158.3, 141.1, 128.8, 128.2, 127.9, 127.6, 127.2, 115.9, 73.9, 56.0, 53.0, 46.8, 36.1, 27.7, 22.6, 19.7, 18.4, 14.0; MS (ESI) <i>m</i>/<i>z</i>: 398.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Methyl (2<i>R</i>)-2-[4-(2-Methylbutoxy)phenyl]-2-[(2<i>S</i>)-2-phenylpropanamido]acetate (<b>11d</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>7b</b> was followed starting with <b>10</b> and 2-methyl-1-butanol to give <b>11d</b> (29% yield) as a waxy solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.40–7.20 (m, 5H), 7.19–7.01 (m, 2H), 6.86–6.75 (m, 2H), 6.31 (d, <i>J</i> = 7.0 Hz, 1H), 5.44 (d, <i>J</i> = 6.9 Hz, 1H), 3.82–3.53 (m, 6H), 1.89–1.75 (m, 1H), 1.63–1.42 (m, 4H), 1.37–1.10 (m, 1H), 0.99 (d, <i>J</i> = 6.7 Hz, 3H), 0.93 (t, <i>J</i> = 7.4 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.3, 171.6, 159.4, 128.8, 128.2, 127.6, 127.2, 114.8, 72.9, 56.0, 52.6, 46.8, 34.7, 26.1, 18.4, 16.5, 11.2; MS (ESI) <i>m</i>/<i>z</i>: 384.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Methyl (2<i>R</i>)-2-{4-[(2<i>S</i>)-2-Methylbutoxy]phenyl}-2-[(2S)-2-phenylpropanamido]acetate (<b>11e</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>7b</b> was followed with <b>10</b> and (<i>S</i>)-2-methyl-1-butanol to give <b>11e</b> (41% yield) as a waxy solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.38–7.18 (m, 5H), 7.07 (t, <i>J</i> = 8.7 Hz, 2H), 6.78 (d, <i>J</i> = 8.7 Hz, 2H), 6.34 (d, <i>J</i> = 6.6 Hz, 1H), 5.44 (d, <i>J</i> = 6.9 Hz, 1H), 3.84–3.52 (m, 6H), 1.92–1.70 (m, 1H), 1.64–1.44 (m, 4H), 1.35–1.11 (m, 1H), 0.98 (d, <i>J</i> = 6.7 Hz, 3H), 0.93 (t, <i>J</i> = 7.5 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.3, 171.6, 159.4, 141.1, 128.8, 128.2, 128.1, 127.6, 127.2, 114.8, 72.9, 56.0, 53.0, 46.8, 34.7, 26.1, 18.4, 16.5, 11.2; MS (ESI) <i>m</i>/<i>z</i>: 384.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Methyl (2<i>R</i>)-2-[4-(Cyclopentylmethoxy)phenyl]-2-[(2<i>S</i>)-2-phenylpropanamido]acetate (<b>11f</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>7b</b> was followed with <b>11</b> and (<i>S</i>)-2-methyl-1-butanol to furnish <b>9f</b> (27% yield) as a waxy solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.28 (ddd, <i>J</i> = 9.7, 7.3, 3.1 Hz, 5H), 7.08 (d, <i>J</i> = 8.7 Hz, 2H), 6.78 (d, <i>J</i> = 8.7 Hz, 2H), 6.35 (d, <i>J</i> = 6.9 Hz, 1H), 5.44 (d, <i>J</i> = 6.9 Hz, 1H), 3.77 (d, <i>J</i> = 6.9 Hz, 1H), 3.72–3.52 (m, 4H), 2.41–2.22 (m, 1H), 1.91–1.70 (m, 2H), 1.70–1.51 (m, 4H), 1.49 (d, <i>J</i> = 7.2 Hz, 3H), 1.43–1.14 (m, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.3, 171.6, 159.4, 141.1, 128.8, 128.2, 127.6, 127.2, 114.8, 72.2, 56.0, 52.6, 46.8, 39.0, 29.4, 25.4, 18.4; MS (ESI) <i>m</i>/<i>z</i>: 396.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Methyl (2<i>R</i>)-2-[4-(Cyclobutylmethoxy)phenyl]-2-[(2<i>S</i>)-2-phenylpropanamido]acetate (<b>11h</b>)</h4><div class="NLM_p last">To a solution of <b>7h</b> (175 mg, 0.5 mmol) in DCM (5 mL) at room temperature was added 4 M HCl in dioxane (3 mL). The reaction mixture was stirred at room temperature overnight and concentrated to give crude amine hydrochloride. The crude amine (90 mg, 0.35 mmol) was then dissolved in MeCN (10 mL), followed by addition of TEA (0.16 mL, 1.1 mmol), (<i>S</i>)-2-phenylpropionic acid (56 mg, 0.37 mmol), and HBTU (170 mg, 0.45 mmol). After stirring for 5 h, the reaction was quenched by H<sub>2</sub>O (5 mL), followed by addition of EtOAc (50 mL). The layers were separated. The organic layer was washed with saturated NaHCO<sub>3</sub> (10 mL) and brine (10 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure. The residue was subjected to chromatography on silica gel using 0–30% EtOAc in hexanes to furnish <b>11h</b> (87 mg, 65% yield over two steps) as a colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.38–7.20 (m, 5H), 7.08 (d, <i>J</i> = 9.0 Hz, 2H), 6.79 (d, <i>J</i> = 9.0 Hz, 2H), 6.36 (d, <i>J</i> = 6.0 Hz, 1H), 5.44 (d, <i>J</i> = 6.0 Hz, 1H), 3.87 (d, <i>J</i> = 9.0 Hz, 2H), 3.67 (s, 3H), 3.66–3.56 (m, 1H), 2.81–2.65 (m, 1H), 2.18–2.05 (m, 2H), 2.02–1.72 (m, 4H), 1.49 (d, <i>J</i> = 6.0 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.4, 171.6, 159.4, 141.1, 128.9, 128.2, 127.6, 127.3, 114.9, 101.6, 72.1, 55.1, 52.6, 46.8, 34.6, 24.8, 18.6, 18.5; MS (ESI) <i>m</i>/<i>z</i>: 382.5 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Methyl (2<i>R</i>)-2-[4-(Cyclopropylmethoxy)phenyl]-2-[(2<i>S</i>)-2-phenylpropanamido]acetate (<b>11j</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>11h</b> was followed starting with <b>7j</b> to give <b>11j</b> (63% yield over two steps) as a colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.33–7.20 (m, 5H), 7.08 (d, <i>J</i> = 9.0 Hz, 2H), 6.78 (d, <i>J</i> = 9.0 Hz, 2H), 6.43 (d, <i>J</i> = 6.0 Hz, 1H), 5.44 (d, <i>J</i> = 6.0 Hz, 1H), 4.74 (d, <i>J</i> = 9.0 Hz, 2H), 3.66 (s, 3H), 3.65–3.56 (m, 1H), 1.49 (d, <i>J</i> = 9.0 Hz, 3H), 1.30–1.14 (m, 1H), 0.66–0.57 (m, 2H), 0.34–0.28 (m, 2H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.4, 171.6, 159.1, 141.1, 128.9, 128.3, 127.6, 127.3, 114.8, 72.7, 56.0, 52.7, 46.7, 18.5, 10.2, 3.2; MS (ESI) <i>m</i>/<i>z</i>: 368.5 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Methyl (2<i>R</i>)-2-{4-[(1-Methylcyclobutyl)methoxy]phenyl}-2-[(2<i>S</i>)-2-phenylpropanamido]acetate (<b>11m</b>)</h4><div class="NLM_p last">To a solution of <b>10</b> (200 mg, 0.64 mmol) in anhydrous DMF (15 mL) at room temperature were added (1-methylcyclobutyl)methyl 4-methylbenzene-1-sulfonate (189 mg, 0.7 mmol) and K<sub>2</sub>CO<sub>3</sub> (264 mg, 1.92 mmol). After stirring for 16 h at 60 °C, the reaction was quenched by H<sub>2</sub>O (10 mL), followed by addition of EtOAc (15 mL). The layers were separated, and the aqueous layer was extracted with additional EtOAc (2 × 10 mL). The combined organic layers were washed with brine (4 × 15 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure. The residue was subjected to column chromatography on silica gel using 0–50% EtOAc in hexanes to furnish <b>11m</b> (15 mg, 6% yield) as a waxy solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.41–7.23 (m, 5H), 7.17 (d, <i>J</i> = 8.7 Hz, 2H), 6.86 (d, <i>J</i> = 8.7 Hz, 2H), 6.30 (d, <i>J</i> = 6.7 Hz, 1H), 5.43 (d, <i>J</i> = 6.9 Hz, 1H), 3.73 (s, 2H), 3.66 (s, 3H), 3.59 (q, <i>J</i> = 7.2 Hz, 1H), 2.12–1.82 (m, 4H), 1.82–1.66 (m, 2H), 1.51 (d, <i>J</i> = 7.2 Hz, 3H), 1.21 (s, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.4, 171.5, 159.8, 140.9, 128.9, 128.3, 127.7, 127.3, 114.9, 75.6, 56.0, 52.6, 46.9, 38.7, 30.1, 24.5, 18.4, 15.0; MS (ESI) <i>m</i>/<i>z</i>: 396.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Methyl (2<i>R</i>)-2-{4-[(3-Methylcyclobutyl)methoxy]phenyl}-2-[(2<i>S</i>)-2-phenylpropanamido]acetate (<b>11n</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>7b</b> was followed starting with <b>10</b> and (3-methylcyclobutyl)methanol to give <b>11n</b> (27% yield) as a waxy solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.37–7.19 (m, 5H), 7.08 (dd, <i>J</i> = 8.7, 2.2 Hz, 2H), 6.85–6.70 (m, 2H), 6.32 (d, <i>J</i> = 6.6 Hz, 1H), 5.44 (d, <i>J</i> = 6.9 Hz, 1H), 3.91 (d, <i>J</i> = 7.1 Hz, 1H), 3.80 (d, <i>J</i> = 6.3 Hz, 1H), 3.71–3.54 (m, 4H), 2.85–2.12 (m, 3H), 2.04–1.92 (m, 1H), 1.84–1.67 (m, 1H), 1.49 (d, <i>J</i> = 7.2 Hz, 3H), 1.45–1.35 (m, 1H), 1.12 (d, <i>J</i> = 6.9 Hz, 1.4 H), 1.04 (d, <i>J</i> = 6.1 Hz, 1.6 H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.3, 171.6, 159.3, 141.1, 128.8, 128.2, 127.6, 1272, 114.8, 72.7, 72.2, 56.0, 52.6, 46.8, 31.2, 31.5, 30.6, 30.3, 27.0, 26.8, 22.3, 22.1, 18.4; MS (ESI) <i>m</i>/<i>z</i>: 396.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Methyl (2<i>R</i>)-2-{4-[(3,3-Dimethylcyclobutyl)methoxy]phenyl}-2-[(2<i>S</i>)-2-phenylpropanami do]acetate (<b>11o</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>11m</b> was followed starting with <b>10</b> and (3,3-dimethylcyclobutyl)methyl-4-methylbenzene-1-sulfonate to give <b>11o</b> (21% yield) as a waxy solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.40–7.23 (m, 5H), 7.16 (d, <i>J</i> = 8.7 Hz, 2H), 6.82 (d, <i>J</i> = 8.7 Hz, 2H), 6.34 (d, <i>J</i> = 6.8 Hz, 1H), 5.43 (d, <i>J</i> = 6.9 Hz, 1H), 3.86 (d, <i>J</i> = 6.6 Hz, 2H), 3.65 (s, 3H), 3.59 (q, <i>J</i> = 7.2 Hz, 1H), 2.75–2.50 (m, 1H), 1.96–1.81 (m, 2H), 1.68–1.54 (m, 2H), 1.50 (d, <i>J</i> = 7.2 Hz, 3H), 1.17 (s, 3H), 1.08 (s, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.4, 171.4, 159.4, 140.9, 128.9, 128.3, 127.7, 127.3, 114.9, 73.0, 56.0, 52.6, 46.9, 37.7, 31.9, 30.9, 28.9, 27.2, 18.4; MS (ESI) <i>m</i>/<i>z</i>: 410.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> Methyl (2<i>R</i>)-2-[(2<i>S</i>)-2-Phenylpropanamido]-2-[4-({spiro[2.3]hexan-5-yl}methoxy)phenyl]acetate (<b>11p</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>11m</b> (except, MeCN was used instead of DMF) was followed starting with <b>10</b> and (3-methylidenecyclobutyl)methyl 4-methylbenzene-1-sulfonate to give the corresponding olefin intermediate methyl (2<i>R</i>)-2-{4-[(3-methylidenecyclobutyl)methoxy]phenyl}-2-[(2<i>S</i>)-2-phenylpropanamido] acetate (12% yield) as a waxy solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.43–7.21 (m, 5H), 7.16 (d, <i>J</i> = 8.6 Hz, 2H), 6.83 (d, <i>J</i> = 8.6 Hz, 2H), 6.39 (d, <i>J</i> = 6.7 Hz, 1H), 5.42 (d, <i>J</i> = 6.9 Hz, 1H), 4.88–4.68 (m, 2H), 3.93 (d, <i>J</i> = 6.7 Hz, 2H), 3.64 (s, 3H), 3.58 (q, <i>J</i> = 7.2 Hz, 1H), 2.92–2.78 (m, 2H), 2.78–2.62 (m, 1H), 2.56–2.44 (m, 2H), 1.49 (d, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.4, 171.4, 159.2, 146.3, 140.9, 128.9, 128.6, 128.4, 127.7, 127.3, 114.9, 106.7, 71.6, 56.0, 52.6, 46.8, 34.6, 29.2, 18.5; MS (ESI) <i>m</i>/<i>z</i>: 394.0 [M + H]<sup>+</sup>. The olefin function of this material was transformed into the corresponding cyclopropyl function under Shi<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> modified Simmons–Smith<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> reaction. To a solution of Et<sub>2</sub>Zn (171.5 μL, 0.17 mmol) in DCM (1 mL) at 0 °C was added TFA (13.1 μL, 0.17 mmol). After stirring at 0 °C for 1 h, diiodomethane (13.8 μL, 0.17 mmol) was added and stirred for another 40 min at 0 °C. At that time, the olefin intermediate (27 mg, 0.07 mmol) was dissolved in DCM (1 mL) and added slowly to the above reaction via a syringe at 0 °C. The reaction, which resulted, was stirred under N<sub>2</sub> at room temperature for 2 h. After that, the reaction was quenched by cold saturated NH<sub>4</sub>Cl (2 mL) and diluted with EtOAc (5 mL). The layers were separated, and the aqueous layer was extracted with additional EtOAc (2 × 10 mL). The combined organic layers were washed with saturated NaHCO<sub>3</sub> (5 mL) and brine (3 × 10 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure. The residue was subjected to column chromatography on silica gel using 0–25% EtOAc in hexanes to furnish <b>11p</b> (20 mg, 72% yield) as a waxy solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.41–7.22 (m, 5H), 7.17 (d, <i>J</i> = 8.6 Hz, 2H), 6.85 (d, <i>J</i> = 8.7 Hz, 2H), 6.30 (d, <i>J</i> = 6.7 Hz, 1H), 5.43 (d, <i>J</i> = 6.9 Hz, 1H), 4.01 (d, <i>J</i> = 7.1 Hz, 2H), 3.66 (s, 3H), 3.59 (q, <i>J</i> = 7.2 Hz, 1H), 2.92–2.73 (m, 1H), 2.37–2.14 (m, 2H), 1.93 (dd, <i>J</i> = 12.3, 5.8 Hz, 2H), 1.51 (d, <i>J</i> = 7.2 Hz, 3H), 0.41 (s, 4H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.4, 171.4, 159.4, 140.9, 128.9, 128.4, 128.3, 127.7, 127.3, 115.0, 72.5, 56.0, 52.6, 46.9, 33.4, 29.8, 18.4, 16.9, 12.1, 11.7; MS (ESI) <i>m</i>/<i>z</i>: 408.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> Methyl (2<i>R</i>)-2-{4-[(3,3-Difluorocyclobutyl)methoxy]phenyl}-2-[(2<i>S</i>)-2-phenylpropanamido]acetate (<b>11q</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>11m</b> was followed starting with <b>10</b> and (3,3-difluorocyclobutyl)methyl 4-methylbenzene-1-sulfonate to give <b>11q</b> (8% yield) as a waxy solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.38–7.21 (m, 5H), 7.09 (d, <i>J</i> = 8.6 Hz, 2H), 6.78 (d, <i>J</i> = 8.7 Hz, 2H), 6.34 (d, <i>J</i> = 6.8 Hz, 1H), 5.45 (d, <i>J</i> = 6.9 Hz, 1H), 3.94 (d, <i>J</i> = 5.8 Hz, 2H), 3.72–3.54 (m, 4H), 2.84–2.34 (m, 5H), 1.49 (d, <i>J</i> = 7.1 Hz, 3H); MS (ESI) <i>m</i>/<i>z</i>: 418.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> (2<i>S</i>)-<i>N</i>-[(1<i>R</i>)-1-[4-(Hexan-2-yloxy)phenyl]-2-hydroxyethyl]-2-phenylpropanamide (<b>12</b>)</h4><div class="NLM_p last">To a suspension of NaBH<sub>4</sub> (20.9 mg, 0.55 mmol) in EtOH (6 mL) at 0 °C under nitrogen was added LiCl (23.4 mg, 0.55 mmol). After stirring at 0 °C for 10 min, a solution of <b>11a</b> (88 mg, 0.22 mmol) in THF (6 mL) was added. The reaction mixture was stirred at room temperature for 3 h and quenched with saturated NH<sub>4</sub>Cl solution (5 mL), followed by the addition of H<sub>2</sub>O (10 mL). The mixture was extracted with EtOAc (3 × 20 mL). The combined organic layers were washed with brine (20 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure. The residue was subjected to column chromatography on silica gel using 0–30% EtOAc in hexanes to furnish <b>12</b> (45 mg, 55% yield) as a white waxy solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.44–7.20 (m, 5H), 6.93 (d, <i>J</i> = 8.7 Hz, 2H), 6.74 (d, <i>J</i> = 8.7 Hz, 2H), 6.14 (d, <i>J</i> = 7.1 Hz, 1H), 4.94 (dd, <i>J</i> = 11.2, 6.0 Hz, 1H), 4.42–4.04 (m, 1H), 3.73 (d, <i>J</i> = 5.5 Hz, 2H), 3.62 (q, <i>J</i> = 7.1 Hz, 1H), 2.98 (br s, 1H), 1.79–1.61 (m, 1H), 1.61–1.46 (m, 4H), 1.46–1.28 (m, 4H), 1.25 (d, <i>J</i> = 6.1 Hz, 3H), 0.90 (t, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 174.6, 157.7, 141.3, 130.6, 128.9, 127.6, 127.3, 116.0, 73.9, 66.5, 55.3, 47.0, 36.2, 27.7, 22.6, 19.7, 18.5, 14.0; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>23</sub>H<sub>31</sub>NO<sub>3</sub> [M + H]<sup>+</sup>, 370.2377, <i>m</i>/<i>z</i>: found, 370.2371.</div></div><div id="sec4_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> (2<i>S</i>)-<i>N</i>-[(1<i>R</i>)-2-Hydroxy-1-{4-[(4-methylpentyl)oxy]phenyl}ethyl]-2-phenylpropanamide (<b>13</b>)</h4><div class="NLM_p last">To a solution of <b>8b</b> (96 mg, 0.35 mmol) in MeCN (10 mL) at room temperature were added TEA (0.16 mL, 1.1 mmol), (<i>S</i>)-2-phenylpropionic acid (56 mg, 0.37 mmol), and HBTU (170 mg, 0.45 mmol). After stirring for 5 h, the reaction was quenched by H<sub>2</sub>O (5 mL), followed by addition of EtOAc (50 mL). The layers were separated. The organic layer was washed with saturated NaHCO<sub>3</sub> (10 mL) and brine (10 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure. The residue was subjected to chromatography on silica gel using 0–30% EtOAc in hexanes to provide <b>13</b> (55 mg, 43% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.38–7.20 (m, 5H), 6.95 (d, <i>J</i> = 9.0 Hz, 2H), 6.78 (d, <i>J</i> = 9.0 Hz, 2H), 6.08 (d, <i>J</i> = 9.0 Hz, 1H), 4.99–4.90 (m, 1H), 3.88 (t, <i>J</i> = 7.5 Hz, 2H), 3.75 (br s, 2H), 3.68–3.56 (m, 1H), 2.83 (br s, 1H), 1.81–1.69 (m, 2H), 1.64–1.54 (m, 1H), 1.51 (d, <i>J</i> = 9.0 Hz, 3H), 1.36–1.23 (m, 2H), 0.91 (d, <i>J</i> = 6.0 Hz, 6H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 174.6, 158.6, 141.2, 130.6, 128.9, 127.5, 127.3, 114.7, 68.3, 66.6, 55.3, 47.0, 35.1, 27.8, 27.1, 22.5, 18.4; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>23</sub>H<sub>31</sub>NO<sub>3</sub> [M + H]<sup>+</sup>, 370.2377; <i>m</i>/<i>z</i>: found, 370.2375.</div></div><div id="sec4_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> (2<i>S</i>)-<i>N</i>-{(1<i>R</i>)-2-Hydroxy-1-[4-(pentyloxy)phenyl]ethyl}-2-phenylpropanamide (<b>14</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>13</b> was followed starting with <b>8c</b> to give <b>14</b> (43% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.40–7.20 (m, 5H), 6.95 (d, <i>J</i> = 9.0 Hz, 2H), 6.77 (d, <i>J</i> = 9.0 Hz, 2H), 6.03 (d, <i>J</i> = 6.0 Hz, 1H), 5.00–4.89 (m, 1H), 3.89 (t, <i>J</i> = 6.0 Hz, 2H), 3.76 (d, <i>J</i> = 6.0 Hz, 2H), 3.68–3.55 (m, 1H), 2.73 (br s, 1H), 1.85–1.67 (m, 2H), 1.51 (d, <i>J</i> = 6.0 Hz, 3H), 1.46–1.25 (m, 4H), 0.92 (t, <i>J</i> = 7.5 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 174.6, 158.7, 141.2, 130.6, 128.9, 127.6, 127.5, 127.3, 114.7, 68.0, 66.7, 55.4, 47.1, 28.9, 28.2, 22.4, 18.4, 14.0; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>22</sub>H<sub>29</sub>NO<sub>3</sub> [M + H]<sup>+</sup>, 356.2220; <i>m</i>/<i>z</i>: found, 356.2219.</div></div><div id="sec4_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> (2<i>S</i>)-<i>N</i>-[(1<i>R</i>)-2-Hydroxy-1-[4-(2-methylbutoxy)phenyl]ethyl]-2-phenylpropanamide (<b>15</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>12</b> was followed starting with <b>11d</b> to give <b>15</b> (67% yield) as a white waxy solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.43–7.16 (m, 5H), 6.95 (d, <i>J</i> = 8.6 Hz, 2H), 6.78 (d, <i>J</i> = 8.6 Hz, 2H), 5.98 (d, <i>J</i> = 6.9 Hz, 1H), 4.95 (dd, <i>J</i> = 11.8, 5.0 Hz, 1H), 3.81–3.72 (m, 3H), 3.71–3.57 (m, 2H), 2.61 (t, <i>J</i> = 5.7 Hz, 1H), 1.94–1.73 (m, 1H), 1.64–1.44 (m, 4H), 1.37–1.12 (m, 1H), 0.99 (d, <i>J</i> = 6.7 Hz, 3H), 0.93 (t, <i>J</i> = 7.4 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 174.6, 158.9, 141.2, 130.5, 128.9, 127.6, 127.5, 127.3, 114.8, 72.9, 66.8, 55.4, 47.1, 34.7, 26.1, 18.4, 16.5, 11.2; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>22</sub>H<sub>29</sub>NO<sub>3</sub> [M + H]<sup>+</sup>, 356.2220; <i>m</i>/<i>z</i>: found, 356.2213.</div></div><div id="sec4_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> (2<i>S</i>)-<i>N</i>-[(1<i>R</i>)-2-Hydroxy-1-{4-[(2<i>S</i>)-2-methylbutoxy]phenyl}ethyl]-2-phenylpropanamide (<b>16</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>12</b> was followed starting with <b>11e</b> to give <b>16</b> (69% yield) as a white waxy solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.43–7.19 (m, 5H), 6.94 (d, <i>J</i> = 8.6 Hz, 2H), 6.76 (d, <i>J</i> = 8.7 Hz, 2H), 6.11 (d, <i>J</i> = 7.1 Hz, 1H), 4.93 (dd, <i>J</i> = 11.9, 5.3 Hz, 1H), 3.82–3.51 (m, 5H), 2.90 (br s, 1H), 1.94–1.72 (m, 1H), 1.61–1.43 (m, 4H), 1.33–1.14 (m, 1H), 0.99 (d, <i>J</i> = 6.7 Hz, 3H), 0.93 (t, <i>J</i> = 7.4 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 174.6, 158.8, 141.3, 130.6, 128.9, 127.6, 127.5, 127.3, 114.7, 72.9, 66.6, 55.3, 47.0, 34.7, 26.1, 18.4, 16.5, 11.3; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>22</sub>H<sub>29</sub>NO<sub>3</sub> [M + H]<sup>+</sup>, 356.2220; <i>m</i>/<i>z</i>: found, 356.2214.</div></div><div id="sec4_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> (2<i>S</i>)-<i>N</i>-[(1<i>R</i>)-1-[4-(Cyclopentylmethoxy)phenyl]-2-hydroxyethyl]-2-phenylpropanamide (<b>17</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>12</b> was followed starting with <b>11f</b> to give <b>17</b> (58% yield) as a white waxy solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.44–7.17 (m, 5H), 6.95 (d, <i>J</i> = 8.7 Hz, 2H), 6.77 (d, <i>J</i> = 8.7 Hz, 2H), 6.01 (d, <i>J</i> = 6.9 Hz, 1H), 4.95 (dd, <i>J</i> = 11.9, 5.0 Hz, 1H), 3.76 (dd, <i>J</i> = 6.0, 3.2 Hz, 4H), 3.62 (q, <i>J</i> = 7.1 Hz, 1H), 2.67 (t, <i>J</i> = 6.0 Hz, 1H), 2.45–2.20 (m, 1H), 1.90–1.69 (m, 3H), 1.69–1.55 (m, 3H), 1.52 (t, <i>J</i> = 6.2 Hz, 3H), 1.34 (dt, <i>J</i> = 11.6, 7.2 Hz, 2H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 174.6, 158.8, 141.2, 130.6, 128.9, 127.6, 127.5, 127.3, 114.8, 72.3, 66.7, 55.4, 47.1, 39.0, 29.4, 25.4, 18.4; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>23</sub>H<sub>29</sub>NO<sub>3</sub> [M + H]<sup>+</sup>, 368.2220; <i>m</i>/<i>z</i>: found, 368.2215.</div></div><div id="sec4_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> (2<i>S</i>)-<i>N</i>-[(1<i>R</i>)-1-(4-Butoxyphenyl)-2-hydroxyethyl]-2-phenylpropanamide (<b>18</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>13</b> was followed starting with <b>8g</b> to give <b>18</b> (33% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.36–7.23 (m, 5H), 6.96 (d, <i>J</i> = 9.0 Hz, 2H), 6.78 (d, <i>J</i> = 9.0 Hz, 2H), 5.99 (d, <i>J</i> = 6.0 Hz, 1H), 5.00–4.89 (m, 1H), 3.91 (t, <i>J</i> = 7.5 Hz, 2H), 3.76 (d, <i>J</i> = 3.0 Hz, 2H), 3.69–3.57 (m, 1H), 2.62 (br s, 1H), 1.82–1.66 (m, 2H), 1.52 (d, <i>J</i> = 6.0 Hz, 3H), 1.51–1.37 (m, 2H), 0.96 (t, <i>J</i> = 7.5 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 174.6, 158.7, 141.2, 130.6, 128.9, 127.6, 127.5, 127.3, 114.8, 67.7, 66.8, 55.4, 47.1, 31.3, 19.2, 18.4, 13.8; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>21</sub>H<sub>27</sub>NO<sub>3</sub> [M + H]<sup>+</sup>, 342.2064; <i>m</i>/<i>z</i>: found, 342.2071.</div></div><div id="sec4_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> (2<i>S</i>)-<i>N</i>-{(1<i>R</i>)-1-[4-(Cyclobutylmethoxy)phenyl]-2-hydroxyethyl}-2-phenylpropanamide (<b>19</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>12</b> was followed starting with <b>11h</b> to give <b>19</b> (83% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.37–7.22 (m, 5H), 6.95 (d, <i>J</i> = 9.0 Hz, 2H), 6.77 (d, <i>J</i> = 9.0 Hz, 2H), 6.09 (d, <i>J</i> = 6.0 Hz, 1H), 4.98–4.88 (m, 1H), 3.86 (d, <i>J</i> = 6.0 Hz, 2H), 3.74 (br s, 2H), 3.68–3.56 (m, 1H), 2.86 (br t, <i>J</i> = 6.0 Hz, 1H), 2.81–2.65 (m, 2H), 2.20–2.04 (m, 2H), 2.20–1.75 (m, 4H), 1.51 (d, <i>J</i> = 9.0 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 174.6, 158.8, 141.2, 130.7, 128.9, 127.5, 127.3, 114.8, 72.1, 66.6, 55.3, 47.0, 34.6, 24.8, 18.5, 18.4; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>22</sub>H<sub>27</sub>NO<sub>3</sub> [M + H]<sup>+</sup>, 354.2064; <i>m</i>/<i>z</i>: found, 354.2064.</div></div><div id="sec4_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> (2<i>S</i>)-<i>N</i>-[(1<i>R</i>)-2-Hydroxy-1-(4-propoxyphenyl)ethyl]-2-phenylpropanamide (<b>20</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>13</b> was followed starting with <b>8i</b> to give <b>20</b> (32% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.39–7.22 (m, 5H), 6.95 (d, <i>J</i> = 9.0 Hz, 2H), 6.77 (d, <i>J</i> = 9.0 Hz, 2H), 6.08 (d, <i>J</i> = 6.0 Hz, 1H), 4.99–4.90 (m, 1H), 3.96 (t, <i>J</i> = 7.5 Hz, 2H), 3.75 (br s, 2H), 3.67–3.56 (m, 1H), 2.83 (br t, <i>J</i> = 4.5 Hz, 1H), 1.83–1.68 (m, 2H), 1.51 (d, <i>J</i> = 9.0 Hz, 3H), 1.01 (t, <i>J</i> = 7.5 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 174.6, 158.6, 141.2, 130.6, 128.9, 127.5, 127.3, 114.7, 69.5, 66.6, 55.3, 47.0, 22.5, 18.4, 10.4; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>20</sub>H<sub>25</sub>NO<sub>3</sub> [M + H]<sup>+</sup>, 328.1907; <i>m</i>/<i>z</i>: found, 328.1911.</div></div><div id="sec4_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> (2<i>S</i>)-<i>N</i>-{(1<i>R</i>)-1-[4-(Cyclopropylmethoxy)phenyl]-2-hydroxyethyl}-2-phenylpropanamide (<b>21</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>12</b> was followed starting with <b>11j</b> to give <b>21</b> (82% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.38–7.19 (m, 5H), 6.94 (d, <i>J</i> = 9.0 Hz, 2H), 6.77 (d, <i>J</i> = 9.0 Hz, 2H), 6.11 (d, <i>J</i> = 6.0 Hz, 1H), 4.99–4.88 (m, 1H), 3.73 (d, <i>J</i> = 6.0 Hz, 3H), 3.68–3.54 (m, 1H), 2.89 (br t, <i>J</i> = 6.0 Hz, 1H), 1.50 (d, <i>J</i> = 6.0 Hz, 4H), 1.32–1.14 (m, 1H), 0.69–0.56 (m, 2H), 0.36–0.26 (m, 2H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 174.5, 158.5, 141.2, 130.8, 128.9, 127.5, 127.3, 114.8, 72.7, 66.5, 55.2, 47.0, 18.4, 10.2, 3.1; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>21</sub>H<sub>25</sub>NO<sub>3</sub> [M + H]<sup>+</sup>, 340.1907; <i>m</i>/<i>z</i>: found, 340.1910.</div></div><div id="sec4_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> (2<i>S</i>)-<i>N</i>-[(1<i>R</i>)-2-Hydroxy-1-[4-(4-methoxybutoxy)phenyl]ethyl}-2-phenylpropanamide (<b>22</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>13</b> was followed starting with <b>8k</b> to give <b>22</b> (82% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.36–7.20 (m, 5H), 6.94 (d, <i>J</i> = 9.0 Hz, 2H), 6.74 (d, <i>J</i> = 9.0 Hz, 2H), 6.29 (d, <i>J</i> = 6.0 Hz, 1H), 4.97–4.86 (m, 1H), 3.90 (t, <i>J</i> = 6.0 Hz, 2H), 3.70 (br s, 2H), 3.66–3.55 (m, 1H), 3.41 (t, <i>J</i> = 6.0 Hz, 2H), 3.32 (s, 3H), 3.27 (br s, 1H), 1.86–1.63 (m, 4H), 1.48 (d, <i>J</i> = 9.0 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 174.5, 158.3, 141.2, 130.8, 128.8, 127.4, 127.1, 114.5, 72.2, 67.5, 66.2, 58.4, 55.1, 46.8, 26.1, 25.9, 18.4; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>22</sub>H<sub>29</sub>NO<sub>4</sub> [M + H]<sup>+</sup>, 372.2169; <i>m</i>/<i>z</i>: found, 372.2173.</div></div><div id="sec4_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> (2<i>S</i>)-<i>N</i>-[(1<i>R</i>)-2-Hydroxy-1-[4-(3-methoxypropoxy)phenyl]ethyl}-2-phenylpropanamide (<b>23</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>13</b> was followed starting with <b>8l</b> to give <b>23</b> (73% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.34–7.20 (m, 5H), 6.93 (d, <i>J</i> = 9.0 Hz, 2H), 6.75 (d, <i>J</i> = 9.0 Hz, 2H), 6.36 (d, <i>J</i> = 6.0 Hz, 1H), 4.96–4.87 (m, 1H), 3.97 (t, <i>J</i> = 6.0 Hz, 2H), 3.76–3.55 (m, 3H), 3.51 (t, <i>J</i> = 6.0 Hz, 2H), 3.45 (br s, 1H), 3.32 (s, 3H), 2.05–1.93 (m, 2H), 1.47 (d, <i>J</i> = 6.0 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 174.5, 158.2, 141.2, 130.9, 128.7, 127.4, 127.1, 114.5, 69.1, 66.0, 64.7, 58.5, 55.0, 48.8, 29.4, 18.3; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>21</sub>H<sub>27</sub>NO<sub>4</sub> [M + H]<sup>+</sup>, 358.2013; <i>m</i>/<i>z</i>: found, 358.2017.</div></div><div id="sec4_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> (2<i>S</i>)-<i>N</i>-[(1<i>R</i>)-2-Hydroxy-1-{4-[(1-methylcyclobutyl)methoxy]phenyl}ethyl]-2-phenylpropanamide (<b>24</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>12</b> was followed starting with <b>11m</b> to give <b>24</b> (83% yield) as a white waxy solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.46–7.21 (m, 5H), 7.08 (d, <i>J</i> = 8.6 Hz, 2H), 6.86 (d, <i>J</i> = 8.6 Hz, 2H), 5.91 (d, <i>J</i> = 6.5 Hz, 1H), 4.96 (dd, <i>J</i> = 11.1, 5.9 Hz, 1H), 3.86–3.67 (m, 4H), 3.60 (q, <i>J</i> = 7.2 Hz, 1H), 2.58 (t, <i>J</i> = 6.0 Hz, 1H), 2.09–1.81 (m, 4H), 1.81–1.68 (m, 2H), 1.54 (d, <i>J</i> = 7.2 Hz, 3H), 1.22 (s, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 174.8, 159.4, 141.2, 130.6, 129.0, 127.6, 127.5, 127.4, 114.9, 75.7, 66.8, 55.7, 47.2, 38.7, 30.1, 24.5, 18.5, 15.0; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>23</sub>H<sub>29</sub>NO<sub>3</sub> [M + H]<sup>+</sup>, 368.2220; <i>m</i>/<i>z</i>: found, 368.2214.</div></div><div id="sec4_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> (2<i>S</i>)-<i>N</i>-[(1<i>R</i>)-2-Hydroxy-1-{4-[(3-methylcyclobutyl)methoxy]phenyl}ethyl]-2-phenylpropanamide (<b>25</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>12</b> was followed starting with <b>11n</b> to give <b>25</b> (65% yield) as a white waxy solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.39–7.09 (m, 5H), 6.94 (dd, <i>J</i> = 8.6, 2.0 Hz, 2H), 6.81–6.72 (m, 2H), 6.08 (d, <i>J</i> = 6.5 Hz, 1H), 4.94 (dd, <i>J</i> = 11.3, 5.5 Hz, 1H), 3.90 (d, <i>J</i> = 7.1 Hz, 1H), 3.80 (d, <i>J</i> = 6.4 Hz, 1H), 3.74 (br s, 2H), 3.61 (q, <i>J</i> = 7.1 Hz, 1H), 2.90–2.80 (m, 1H), 2.78–2.60 (m, 0.5 H), 2.60–2.35 (m, 1H), 2.35–2.14 (m, 1.5 H), 2.07–1.91 (m, 1H), 1.82–1.67 (m, 1H), 1.50 (d, <i>J</i> = 7.1 Hz, 3H), 1.46–1.31 (m, 1H), 1.12 (d, <i>J</i> = 6.8 Hz, 1.4H), 1.04 (d, <i>J</i> = 6.1 Hz, 1.6H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 174.6, 158.8, 158.8, 141.3, 130.7, 130.7, 128.9, 127.6, 127.5, 127.3, 114.8, 72.8, 72.2, 66.6, 55.3, 47.1, 33.2, 31.5, 30.6, 30.3, 27.0, 26.8, 22.3, 22.1, 18.4; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>23</sub>H<sub>29</sub>NO<sub>3</sub> [M + H]<sup>+</sup>, 368.2220; <i>m</i>/<i>z</i>: found, 368.2213.</div></div><div id="sec4_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> (2<i>S</i>)-<i>N</i>-[(1<i>R</i>)-1-{4-[(3,3-Dimethylcyclobutyl)methoxy]phenyl}-2-hydroxyethyl]-2-phenylpropanamide (<b>26</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>12</b> was followed starting with <b>11o</b> to give <b>26</b> (75% yield) as a white waxy solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.44–7.20 (m, 5H), 7.06 (d, <i>J</i> = 8.6 Hz, 2H), 6.82 (d, <i>J</i> = 8.6 Hz, 2H), 5.95 (d, <i>J</i> = 6.7 Hz, 1H), 4.94 (dd, <i>J</i> = 11.4, 5.5 Hz, 1H), 3.86 (d, <i>J</i> = 6.6 Hz, 2H), 3.80–3.65 (m, 2H), 3.58 (q, <i>J</i> = 7.2 Hz, 1H), 2.75–2.44 (m, 2H), 1.98–1.76 (m, 2H), 1.67–1.57 (m, 2H), 1.52 (d, <i>J</i> = 7.2 Hz, 3H), 1.17 (s, 3H), 1.08 (s, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 174.8, 158.9, 141.2, 130.7, 129.0, 127.6, 127.5, 127.4, 114.9, 73.1, 66.7, 55.6, 47.2, 37.7, 31.9, 30.9, 28.9, 27.2, 18.5; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>24</sub>H<sub>31</sub>NO<sub>3</sub> [M + H]<sup>+</sup>, 382.2377; <i>m</i>/<i>z</i>: found, 382.2368.</div></div><div id="sec4_1_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> (2<i>S</i>)-<i>N</i>-[(1<i>R</i>)-2-Hydroxy-1-[4-({spiro[2.3]hexan-5-yl}methoxy)phenyl]ethyl]-2-phenylpropanamide (<b>27</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>12</b> was followed starting with <b>11p</b> to give <b>27</b> (80% yield) as a white waxy solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.44–7.22 (m, 5H), 7.08 (d, <i>J</i> = 8.6 Hz, 2H), 6.86 (d, <i>J</i> = 8.6 Hz, 2H), 5.93 (d, <i>J</i> = 6.7 Hz, 1H), 4.96 (dd, <i>J</i> = 11.4, 5.5 Hz, 1H), 4.01 (d, <i>J</i> = 7.1 Hz, 2H), 3.86–3.67 (m, 2H), 3.60 (q, <i>J</i> = 7.1 Hz, 1H), 2.93–2.71 (m, 1H), 2.56 (t, <i>J</i> = 6.0 Hz, 1H), 2.32–2.11 (m, 2H), 2.04–1.81 (m, 2H), 1.54 (d, <i>J</i> = 7.2 Hz, 3H), 0.58–0.30 (m, 4H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 174.8, 159.0, 141.2, 130.7, 129.0, 127.7, 127.5, 127.4, 115.0, 72.6, 66.7, 55.7, 47.2, 33.4, 29.8, 18.5, 16.9, 12.1, 11.7; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>24</sub>H<sub>29</sub>NO<sub>3</sub> [M + H]<sup>+</sup>, 380.2220; <i>m</i>/<i>z</i>: found, 380.2214.</div></div><div id="sec4_1_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> (2<i>S</i>)-<i>N</i>-[(1<i>R</i>)-1-{4-[(3,3-Difluorocyclobutyl)methoxy]phenyl}-2-hydroxyethyl]-2-phenylpropanamide (<b>28</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>12</b> was followed starting with <b>11q</b> to give <b>28</b> (50% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.41–7.22 (m, 5H), 6.97 (d, <i>J</i> = 8.6 Hz, 2H), 6.78 (d, <i>J</i> = 8.7 Hz, 2H), 6.00 (d, <i>J</i> = 7.0 Hz, 1H), 4.96 (dd, <i>J</i> = 11.8, 4.9 Hz, 1H), 3.94 (d, <i>J</i> = 5.9 Hz, 2H), 3.77 (d, <i>J</i> = 5.1 Hz, 2H), 3.63 (q, <i>J</i> = 7.1 Hz, 1H), 2.82–2.61 (m, 2H), 2.61–2.33 (m, 4H), 1.52 (d, <i>J</i> = 7.1 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 174.5, 158.2, 141.2, 131.4, 128.9, 127.6, 127.6, 127.3, 114.8, 70.1 (m), 55.2, 47.1, 37.7 (t, <i>J</i> = 23.0 Hz), 22.5 (dd, <i>J</i> = 12.0, 7.4 Hz), 18.4; <sup>19</sup>F NMR (282 MHz, CDCl<sub>3</sub>): δ −83.8 (d, <i>J</i> = 193 Hz), −93.2 (d, <i>J</i> = 196 Hz); HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>22</sub>H<sub>25</sub>F<sub>2</sub>NO<sub>3</sub> [M + H]<sup>+</sup>, 390.1875; <i>m</i>/<i>z</i>: found, 390.1867.</div></div><div id="sec4_1_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> (2<i>R</i>)-2-{4-[(2-Methylpentyl)oxy]phenyl}-2-[(2<i>S</i>)-2-phenylpropanamido]acetic Acid (<b>29a</b>)<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></h4><div class="NLM_p last">To a solution of <b>3</b> (1.2 g, 3.02 mmol) in THF/H<sub>2</sub>O (10 mL, 1:1, v/v) was added 1 N NaOH (6.04 mL, 6.04 mmol) at room temperature. After stirring for 1 h, the reaction was cooled (ice bath) and acidified (pH = ∼4) with 1 N HCl and extracted with EtOAc (3 × 20 mL). The combined EtOAc layers were washed with brine (3 × 20 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure to furnish <b>29a</b> (1.06 g, 92%) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.40–7.17 (m, 5H), 7.11 (d, <i>J</i> = 8.1 Hz, 2H), 6.79 (d, <i>J</i> = 8.2 Hz, 2H), 6.21 (d, <i>J</i> = 6.1 Hz, 1H), 5.43 (d, <i>J</i> = 6.3 Hz, 1H), 3.82–3.72 (m, 1H), 3.71–3.57 (m, 2H), 2.01–1.78 (m, 1H), 1.49 (d, <i>J</i> = 7.1 Hz, 3H), 1.45–1.07 (m, 4H), 0.99 (d, <i>J</i> = 6.6 Hz, 3H), 0.91 (t, <i>J</i> = 6.7 Hz, 3H); MS (ESI) <i>m</i>/<i>z</i>: 384.4 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> (2<i>R</i>)-2-[4-(Cyclobutylmethoxy)phenyl]-2-[(2<i>S</i>)-2-phenylpropanamido]acetic Acid (<b>29b</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>29a</b> was followed starting with <b>11h</b> to give <b>29b</b> (100% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.32–7.20 (m, 6H), 7.10 (d, <i>J</i> = 8.7 Hz, 2H), 6.79 (d, <i>J</i> = 8.7 Hz, 2H), 6.25 (d, <i>J</i> = 6.6 Hz, 1H), 5.43 (d, <i>J</i> = 6.7 Hz, 1H), 3.87 (d, <i>J</i> = 6.7 Hz, 2H), 3.63 (q, <i>J</i> = 7.1 Hz, 1H), 2.82–2.62 (m, 1H), 2.22–2.03 (m, 2H), 2.03–1.73 (m, 4H), 1.49 (d, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 174.3, 174.1, 159.5, 140.7, 128.9, 128.3, 127.6, 127.4, 127.4, 114.9, 72.1, 56.1, 46.7, 34.5, 24.8, 18.5, 18.2; MS (ESI) <i>m</i>/<i>z</i>: 368.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-Carbamoyl({4-[(2-methylpentyl)oxy]phenyl})methyl]-2-phenylpropanamide (<b>30</b>)</h4><div class="NLM_p last">To a solution of <b>29a</b> (230 mg, 0.6 mmol) in dioxane (10 mL) at room temperature were added pyridine (0.1 mL, 1.2 mmol), NH<sub>4</sub>HCO<sub>3</sub> (95 mg, 1.2 mmol), and Boc anhydride (262 mg, 1.2 mmol). The reaction mixture was stirred for 4 h. Another portion of NH<sub>4</sub>HCO<sub>3</sub> (95 mg, 1.2 mmol) and Boc anhydride (262 mg, 1.2 mmol) was added, and the mixture was stirred overnight. The reaction was quenched by 10% citric acid (10 mL) and extracted with EtOAc (3 × 30 mL). The combined extracts were washed with 10% citric acid (10 mL), NaHCO<sub>3</sub> (2 × 10 mL), and brine (10 mL), dried (NaSO<sub>4</sub>), and concentrated under reduced pressure. The residue was subjected to column chromatography on silica gel using 0–3% MeOH in DCM to provide <b>30</b> (100 mg, 44% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.37–7.15 (m, 5H), 7.09 (d, <i>J</i> = 9.0 Hz, 2H), 6.96 (d, <i>J</i> = 9.0 Hz, 1H), 6.72 (d, <i>J</i> = 9.0 Hz, 2H), 6.61 (s, 1H), 5.85 (s, 1H), 5.54 (d, <i>J</i> = 6.0 Hz, 1H), 3.84–3.54 (m, 3H), 1.98–1.81 (m, 1H), 1.44 (d, <i>J</i> = 9.0 Hz, 3H), 1.41–1.08 (m, 4H), 0.98 (d, <i>J</i> = 9.0 Hz, 3H), 0.91 (t, <i>J</i> = 7.5 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.7, 172.8, 159.2, 141.1, 129.4, 128.7, 128.1, 127.5, 127.1, 114.7, 73.2, 56.0, 46.6, 35.7, 32.8, 20.0, 18.3, 16.9, 14.3; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>23</sub>H<sub>30</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 383.2329; <i>m</i>/<i>z</i>: found, 383.2332.</div></div><div id="sec4_1_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-(Methylcarbamoyl)({4-[(2-methylpentyl)oxy]phenyl})methyl]-2-phenylpropanamide (<b>31</b>)</h4><div class="NLM_p last">To a solution of <b>29a</b> (115 mg, 0.3 mmol) in DMF (5 mL) under nitrogen were added EDC hydrochloride (63 mg, 0.33 mmol), HOBt (45 mg, 0.33 mmol), and DIPEA (0.16 mL, 0.9 mmol). After cooling to 0 °C, methylamine hydrochloride (22 mg, 0.33 mmol) was added and the reaction mixture was stirred at room temperature overnight. The reaction was quenched with 10% citric acid solution (5 mL) and extracted with EtOAc (3 × 20 mL). The combined organic layers were washed with saturated NaHCO<sub>3</sub> (10 mL) and brine (10 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure. The residue was subjected to column chromatography on silica gel using 0–100% EtOAc in hexanes to furnish <b>31</b> (56 mg, 47% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.38–7.18 (m, 5H), 7.17–6.96 (m, 4H), 6.68 (d, <i>J</i> = 9.0 Hz, 2H), 5.62 (d, <i>J</i> = 9.0 Hz, 1H), 3.79–3.54 (m, 3H), 2.70 (d, <i>J</i> = 6.0 Hz, 2H), 1.99–1.81 (m, 1H), 1.55–1.12 (m, 5H), 1.48 (d, <i>J</i> = 9.0 Hz, 3H), 0.99 (d, <i>J</i> = 6.0 Hz, 3H), 0.91 (t, <i>J</i> = 7.5 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.6, 171.0, 159.0, 141.2, 129.9, 128.7, 128.0, 127.5, 127.1, 114.6, 73.1, 56.2, 46.6, 35.7, 32.8, 26.3, 20.0, 18.4, 16.9, 14.2; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>24</sub>H<sub>32</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 397.2486; <i>m</i>/<i>z</i>: found, 397.2482.</div></div><div id="sec4_1_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> (2<i>S</i>)-<i>N</i>-((1R)-2-(Ethylamino)-1-(4-((2-methylpentyl)oxy)phenyl)-2-oxoethyl)-2-phenylpropanamide (<b>32</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>31</b> was followed starting with <b>29a</b> and ethylamine to give <b>32</b> (53% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.36–7.17 (m, 5H), 7.08 (d, <i>J</i> = 8.7 Hz, 2H), 6.77 (d, <i>J</i> = 8.7 Hz, 2H), 6.73 (d, <i>J</i> = 6.5 Hz, 1H), 5.64 (br s, 1H), 5.28 (d, <i>J</i> = 6.6 Hz, 1H), 3.76 (dd, <i>J</i> = 8.8, 5.8 Hz, 1H), 3.70–3.54 (m, 2H), 3.35–3.08 (m, 2H), 2.03–1.77 (m, 1H), 1.53–1.11 (m, 7H), 1.05 (t, <i>J</i> = 7.3 Hz, 3H), 0.99 (d, <i>J</i> = 6.7 Hz, 3H), 0.91 (t, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.5, 170.2, 159.0, 141.2, 130.0, 128.8, 128.1, 127.5, 127.1, 114.7, 73.2, 56.4, 46.7, 35.7, 34.6, 32.9, 20.0, 18.4, 17.0, 14.5, 14.3; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>25</sub>H<sub>34</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 411.2642; <i>m</i>/<i>z</i>: found, 411.2639.</div></div><div id="sec4_1_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-{4-[(2-Methylpentyl)oxy]phenyl}(propylcarbamoyl)methyl]-2-phenylpropanamide (<b>33</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>31</b> was followed starting with <b>29a</b> and propylamine hydrochloride to give <b>33</b> (39% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.39–7.17 (m, 5H), 7.06 (d, <i>J</i> = 9.0 Hz, 2H), 6.98 (d, <i>J</i> = 6.0 Hz, 1H), 6.70 (d, <i>J</i> = 9.0 Hz, 2H), 6.68–6.55 (m, 1H), 5.63 (d, <i>J</i> = 9.0 Hz, 1H), 3.78–3.55 (m, 3H), 3.23–3.03 (m, 2H), 1.98–1.81 (m, 1H), 1.55–1.10 (m, 6H), 1.48 (d, <i>J</i> = 9.0 Hz, 3H), 0.99 (d, <i>J</i> = 6.0 Hz, 3H), 0.91 (t, <i>J</i> = 7.5 Hz, 3H), 0.79 (t, <i>J</i> = 7.5 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.4, 170.3, 159.0, 141.2, 130.0, 128.7, 128.0, 127.5, 127.1, 114.6, 73.2, 56.4, 46.7, 41.4, 35.7, 32.8, 22.6, 20.0, 18.4, 16.9, 14.2, 11.2; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>26</sub>H<sub>36</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 425.2799; <i>m</i>/<i>z</i>: found, 425.2798.</div></div><div id="sec4_1_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-{4-[(2-Methylpentyl)oxy]phenyl}[(propan-2-yl)carbamoyl]methyl]-2-phenylpropanamide (<b>34</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>31</b> was followed starting with <b>29a</b> and isopropylamine to give <b>34</b> (41% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.38–7.16 (m, 5H), 7.03 (d, <i>J</i> = 9.0 Hz, 2H), 6.94 (d, <i>J</i> = 9.0 Hz, 1H), 6.68 (d, <i>J</i> = 9.0 Hz, 2H), 6.39 (d, <i>J</i> = 9.0 Hz, 1H), 5.49 (d, <i>J</i> = 6.0 Hz, 1H), 4.07–3.90 (m, 1H), 3.80–3.57 (m, 3H), 1.98–1.81 (m, 1H), 1.52–1.14 (m, 4H), 1.48 (d, <i>J</i> = 9.0 Hz, 3H), 1.12 (d, <i>J</i> = 6.0 Hz, 3H), 1.00 (d, <i>J</i> = 6.0 Hz, 3H), 0.99 (d, <i>J</i> = 6.0 Hz, 3H), 0.91 (t, <i>J</i> = 7.5 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.4, 169.4, 158.9, 141.2, 130.0, 128.7, 128.0, 127.5, 127.1, 114.6, 73.2, 56.3, 46.7, 41.7, 35.7, 32.9, 22.5, 22.3, 20.0, 18.5, 16.9, 14.2; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>26</sub>H<sub>36</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 425.2799; <i>m</i>/<i>z</i>: found, 425.2804.</div></div><div id="sec4_1_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> (2<i>S</i>)-<i>N</i>-((1<i>R</i>)-2-(<i>tert</i>-Butylamino)-1-(4-((2-methylpentyl)oxy)phenyl)-2-oxoethyl)-2-phenylpropanamide (<b>35</b>)</h4><div class="NLM_p last">To a solution of <b>29a</b> (50 mg, 0.13 mmol) in THF (2 mL) were added 2-chloro-4,6-dimethoxy-1,3,5-triazine (22.9 mg, 0.13 mmol) and <i>N</i>-methylmorpholine (15 μL, 13.5 mmol). The reaction that resulted was stirred at room temperature. After 1 h, <i>tert</i>-butylamine (21 μL, 0.2 mmol) was added to the above cloudy solution, and the reaction that resulted was stirred overnight at room temperature. The solvent was evaporated, and the residue was subjected to column chromatography on silica gel using 0–50% EtOAc in hexanes to furnish <b>35</b> (28 mg, 49% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.35–7.13 (m, 5H), 7.08 (d, <i>J</i> = 8.7 Hz, 2H), 6.77 (d, <i>J</i> = 8.7 Hz, 2H), 6.70 (d, <i>J</i> = 6.6 Hz, 1H), 5.30 (br s, 1H), 5.19 (d, <i>J</i> = 6.7 Hz, 1H), 3.82–3.71 (m, 1H), 3.71–3.50 (m, 2H), 2.05–1.72 (m, 1H), 1.46 (d, <i>J</i> = 7.1 Hz, 3H), 1.44–1.13 (m, 13H), 1.00 (d, <i>J</i> = 6.7 Hz, 3H), 0.92 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.2, 169.2, 159.1, 141.4, 130.3, 128.7, 128.2, 127.5, 127.0, 114.8, 73.2, 56.9, 51.7, 46.8, 35.8, 32.9, 28.6, 20.0, 18.5, 17.0, 14.3; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>27</sub>H<sub>38</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 439.2955; <i>m</i>/<i>z</i>: found, 439.2957.</div></div><div id="sec4_1_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-[(Butan-2-yl)carbamoyl]({4-[(2-methylpentyl)oxy]phenyl})methyl]-2-phenylpropanamide (<b>36</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>31</b> was followed starting with <b>29a</b> and butan-2-amine to give <b>36</b> (42% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.36–7.16 (m, 5H), 7.07 (d, <i>J</i> = 9.0 Hz, 2H), 6.86 (d, <i>J</i> = 9.0 Hz, 1H), 6.72 (d, <i>J</i> = 9.0 Hz, 2H), 5.94–5.83 (m, 1H), 5.40 (d, <i>J</i> = 6.0 Hz, 1H), 3.90–3.55 (m, 4H), 1.99–1.83 (m, 1H), 1.53–1.12 (m, 6H), 1.48 (d, <i>J</i> = 6.0 Hz, 3H), 1.09 (d, <i>J</i> = 6.0 Hz, 3H), 0.99 (d, <i>J</i> = 6.0 Hz, 3H), 0.91 (t, <i>J</i> = 7.5 Hz, 3H), 0.84 (t, <i>J</i> = 7.5 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.3, 169.6, 159.0, 141.2, 130.2, 128.8, 128.1, 127.5, 127.1, 114.7, 73.2, 56.6, 47.0, 46.8, 35.7, 32.9, 29.4, 20.4, 20.0, 18.5, 17.0, 14.3, 10.0; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>27</sub>H<sub>38</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 439.2955; <i>m</i>/<i>z</i>: found, 439.2952.</div></div><div id="sec4_1_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> (2<i>S</i>)-<i>N</i>-((1<i>R</i>)-2-((3-Methylbutan-2-yl)amino)-1-(4-((2-methylpentyl)oxy)phenyl)-2-oxoethyl)-2-phenylpropanamide (<b>37</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>31</b> was followed starting with <b>29a</b> and 1,2-dimethylpropylamine to give <b>37</b> (44% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.37–7.16 (m, 5H), 7.08 (d, <i>J</i> = 8.6 Hz, 2H), 6.82 (d, <i>J</i> = 6.5 Hz, 1H), 6.76 (d, <i>J</i> = 8.7 Hz, 2H), 5.53 (d, <i>J</i> = 9.0 Hz, 1H), 5.30 (d, <i>J</i> = 6.5 Hz, 1H), 3.87–3.69 (m, 2H), 3.69–3.41 (m, 2H), 2.04–1.75 (m, 1H), 1.73–1.10 (m, 8H), 1.01 (dd, <i>J</i> = 13.6, 6.7 Hz, 6H), 0.91 (t, <i>J</i> = 7.0 Hz, 3H), 0.69–0.58 (m, 6H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.3, 169.4, 159.1, 141.2, 130.3, 128.8, 128.1, 127.5, 127.1, 114.8, 73.3, 56.8, 50.4, 46.9, 35.7, 32.9, 32.9, 20.0, 18.4, 18.3, 18.0, 17.6, 16.9, 14.3; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>28</sub>H<sub>40</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 453.3112; <i>m</i>/<i>z</i>: found, 453.3110.</div></div><div id="sec4_1_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-(Cyclopropylcarbamoyl)({4-[(2-methylpentyl)oxy]phenyl})methyl]-2-phenylpropanamide (<b>38</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>31</b> was followed starting with <b>29a</b> and cyclopropylamine to give <b>38</b> (35% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.36–7.16 (m, 5H), 7.06–6.93 (m, 3H), 6.86 (d, <i>J</i> = 6.0 Hz, 1H), 6.88 (d, <i>J</i> = 9.0 Hz, 2H), 5.49 (d, <i>J</i> = 6.0 Hz, 1H), 3.79–3.56 (m, 3H), 2.68–2.57 (m, 1H), 1.98–1.85 (m, 1H), 1.51–1.10 (m, 4H), 1.48 (d, <i>J</i> = 6.0 Hz, 3H), 0.99 (d, <i>J</i> = 6.0 Hz, 3H), 0.91 (t, <i>J</i> = 7.5 Hz, 3H), 0.76–0.57 (m, 2H), 0.52–0.29 (m, 2H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.5, 171.7, 159.0, 141.1, 129.7, 128.8, 128.0, 127.5, 127.1, 114.6, 73.2, 56.1, 46.7, 35.7, 32.9, 22.7, 20.0, 18.4, 17.0, 14.2, 6.4, 6.2; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>26</sub>H<sub>34</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 423.2642; <i>m</i>/<i>z</i>: found, 423.2647.</div></div><div id="sec4_1_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> (2<i>S</i>)-<i>N</i>-((1<i>R</i>)-2-((Cyclopropylmethyl)amino)-1-(4-((2-methylpentyl)oxy)phenyl)-2-oxoethyl)-2-phenylpropanamide (<b>39</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>31</b> was followed starting with <b>29a</b> and cyclopropylmethylamine hydrochloride to give <b>39</b> (49% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.35–7.18 (m, 5H), 7.07 (d, <i>J</i> = 8.7 Hz, 2H), 6.93 (d, <i>J</i> = 7.2 Hz, 1H), 6.70 (d, <i>J</i> = 8.7 Hz, 2H), 6.57 (t, <i>J</i> = 5.4 Hz, 1H), 5.53 (d, <i>J</i> = 7.2 Hz, 1H), 3.82–3.52 (m, 3H), 3.15–2.92 (m, 2H), 2.04–1.78 (m, 1H), 1.48 (d, <i>J</i> = 7.1 Hz, 3H), 1.45–1.11 (m, 4H), 0.99 (d, <i>J</i> = 6.7 Hz, 3H), 0.91 (t, <i>J</i> = 7.0 Hz, 3H), 0.88–0.77 (m, 1H), 0.47–0.35 (m, 2H), 0.15–0.05 (m, 2H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.4, 170.3, 159.1, 141.3, 130.0, 128.8, 128.1, 127.5, 127.1, 114.7, 73.2, 56.4, 46.8, 44.3, 35.7, 32.9, 20.0, 18.5, 17.0, 14.3, 10.5, 3.3, 3.2; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>27</sub>H<sub>36</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 437.2799; <i>m</i>/<i>z</i>: found, 437.2793.</div></div><div id="sec4_1_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-(Cyclobutylcarbamoyl)({4-[(2-methylpentyl)oxy]phenyl})methyl]-2-phenylpropanamide (<b>40</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>31</b> was followed starting with <b>29a</b> and cyclobutylamine to give <b>40</b> (35% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.36–7.17 (m, 5H), 7.04 (d, <i>J</i> = 9.0 Hz, 2H), 6.86 (d, <i>J</i> = 6.0 Hz, 1H), 6.70 (d, <i>J</i> = 9.0 Hz, 2H), 6.59 (d, <i>J</i> = 9.0 Hz, 1H), 5.45 (d, <i>J</i> = 6.0 Hz, 1H), 4.36–4.20 (m, 1H), 3.80–3.56 (m, 3H), 2.35–2.13 (m, 2H), 1.97–1.57 (m, 5H), 1.54–1.10 (m, 4H), 1.49 (d, <i>J</i> = 6.0 Hz, 3H), 0.99 (d, <i>J</i> = 6.0 Hz, 3H), 0.91 (t, <i>J</i> = 7.5 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.4, 169.3, 159.0, 141.2, 129.9, 128.8, 128.1, 127.5, 127.1, 114.7, 73.2, 58.3, 46.8, 45.0, 35.7, 32.9, 30.8, 30.7, 20.0, 18.4, 17.0, 15.0, 14.3; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>27</sub>H<sub>36</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 437.2799; <i>m</i>/<i>z</i>: found, 437.2806.</div></div><div id="sec4_1_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> (2<i>S</i>)-<i>N</i>-((1<i>R</i>)-2-((1-Methylcyclobutyl)amino)-1-(4-((2-methylpentyl)oxy)phenyl)-2-oxoethyl)-2-phenylpropanamide (<b>41</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>31</b> was followed starting with <b>29a</b> and 1-methylcyclobutylamine to give <b>41</b> (48% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.35–7.13 (m, 5H), 7.07 (d, <i>J</i> = 8.7 Hz, 2H), 6.75 (d, <i>J</i> = 8.7 Hz, 2H), 5.89 (s, 1H), 5.29 (d, <i>J</i> = 6.8 Hz, 1H), 3.76 (dd, <i>J</i> = 8.9, 5.8 Hz, 1H), 3.71–3.54 (m, 2H), 2.26–2.03 (m, 2H), 2.03–1.85 (m, 3H), 1.83–1.67 (m, 2H), 1.54–1.10 (m, 10H), 1.00 (d, <i>J</i> = 6.7 Hz, 3H), 0.92 (t, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.2, 168.9, 159.1, 141.3, 130.2, 128.8, 128.2, 127.5, 127.1, 114.8, 73.2, 56.6, 54.5, 46.8, 35.7, 34.4, 34.3, 32.9, 25.0, 20.0, 18.5, 17.0, 14.5, 14.3; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>28</sub>H<sub>38</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 451.2955; <i>m</i>/<i>z</i>: found, 451.2950.</div></div><div id="sec4_1_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-(Cyclopentylcarbamoyl)({4-[(2-methylpentyl)oxy]phenyl})methyl]-2-phenylpropanamide (<b>42</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>31</b> was followed starting with <b>29a</b> and cyclopentylamine to give <b>42</b> (33% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.38–7.15 (m, 5H), 7.06 (d, <i>J</i> = 8.6 Hz, 2H), 6.87–6.64 (m, 3H), 5.90 (d, <i>J</i> = 7.3 Hz, 1H), 5.35 (d, <i>J</i> = 6.9 Hz, 1H), 4.28–4.02 (m, 1H), 3.75 (dd, <i>J</i> = 8.9, 5.8 Hz, 1H), 3.70–3.55 (m, 2H), 2.04–1.76 (m, 3H), 1.66–1.28 (m, 11H), 1.27–1.10 (m, 2H), 0.99 (d, <i>J</i> = 6.7 Hz, 3H), 0.91 (t, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.3, 169.7, 159.1, 141.2, 130.0, 128.8, 128.1, 127.5, 127.1, 114.8, 73.2, 56.5, 51.5, 46.8, 35.7, 32.9, 32.8, 32.8, 23.7, 23.6, 20.0, 18.4, 17.0, 14.3; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>28</sub>H<sub>38</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 451.2955; <i>m</i>/<i>z</i>: found, 451.2952.</div></div><div id="sec4_1_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-(Cyclohexylcarbamoyl)({4-[(2-methylpentyl)oxy]phenyl})methyl]-2-phenylpropanamide (<b>43</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>31</b> was followed starting with <b>29a</b> and cyclohexylamine to give <b>43</b> (54% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.39–7.15 (m, 5H), 7.06 (d, <i>J</i> = 8.7 Hz, 2H), 6.85–6.64 (m, 3H), 5.75 (d, <i>J</i> = 7.6 Hz, 1H), 5.33 (d, <i>J</i> = 6.9 Hz, 1H), 3.83–3.53 (m, 4H), 2.01–1.77 (m, 2H), 1.76–1.51 (m, 5H), 1.48 (d, <i>J</i> = 7.1 Hz, 3H), 1.46–1.03 (m, 8H), 0.99 (d, <i>J</i> = 6.7 Hz, 3H), 0.91 (t, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.3, 169.2, 159.1, 141.2, 130.1, 128.8, 128.2, 127.5, 127.1, 114.8, 73.2, 56.6, 48.6, 46.9, 35.7, 32.9, 32.8, 32.6, 25.4, 24.7, 24.6, 20.0, 18.4, 17.0, 14.3; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>29</sub>H<sub>40</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 465.3122; <i>m</i>/<i>z</i>: found, 465.3111.</div></div><div id="sec4_1_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> Methyl 2-[(2<i>R</i>)-2-{4-[(2-Methylpentyl)oxy]phenyl}-2-[(2<i>S</i>)-2-phenylpropanamido]acetamido]acetate (<b>44</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>31</b> was followed starting with <b>29a</b> and methyl 2-aminoacetate hydrochloride to give <b>44</b> (46% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.35–7.16 (m, 5H), 7.10 (d, <i>J</i> = 9.0 Hz, 2H), 6.88 (t, <i>J</i> = 4.5 Hz, 1H), 6.82–6.67 (m, 3H), 5.54 (d, <i>J</i> = 6.0 Hz, 1H), 3.93 (t, <i>J</i> = 6.0 Hz, 2H), 3.79–3.58 (m, 6H), 1.97–1.85 (m, 1H), 1.54–1.13 (m, 4H), 1.47 (d, <i>J</i> = 9.0 Hz, 3H), 0.99 (d, <i>J</i> = 6.0 Hz, 3H), 0.91 (t, <i>J</i> = 7.5 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.5, 170.6, 169.8, 159.2, 141.1, 129.3, 128.8, 128.2, 127.5, 127.1, 114.7, 73.2, 56.4, 52.3, 46.7, 41.3, 35.7, 32.8, 20.0, 18.4, 16.9, 14.3; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>26</sub>H<sub>34</sub>N<sub>2</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 455.2540; <i>m</i>/<i>z</i>: found, 455.2541.</div></div><div id="sec4_1_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-[(2-Hydroxyethyl)carbamoyl]({4-[(2-methylpentyl)oxy]phenyl})methyl]-2-phenylpropanamide (<b>45</b>)</h4><div class="NLM_p last">To a suspension of NaBH<sub>4</sub> (11 mg, 0.29 mmol) in EtOH (2 mL) at 0 °C under nitrogen was added LiCl (12 mg, 0.29 mmol). After stirring at 0 °C for 10 min, a solution of <b>44</b> (50 mg, 0.11 mmol) in THF (2 mL) was added. The reaction mixture was stirred at room temperature for 3 h and quenched with saturated NH<sub>4</sub>Cl solution (5 mL), followed by addition of H<sub>2</sub>O (10 mL). The mixture was extracted with EtOAc (3 × 20 mL). The combined organic layers were washed with brine (20 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure. The residue was subjected to column chromatography on silica gel using 20–70% EtOAc in hexanes to afford <b>45</b> (38 mg, 81% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.28–7.08 (m, 5H), 7.07–6.88 (m, 3H), 6.76 (d, <i>J</i> = 6.0 Hz, 1H), 6.65 (d, <i>J</i> = 9.0 Hz, 2H), 5.39 (d, <i>J</i> = 6.0 Hz, 1H), 3.71–3.44 (m, 4H), 3.44–3.26 (m, 1H), 3.20–3.04 (m, 1H), 1.92–1.74 (m, 1H), 1.46–1.01 (m, 6H), 1.40 (d, <i>J</i> = 9.0 Hz, 3H), 0.92 (d, <i>J</i> = 9.0 Hz, 3H), 0.84 (t, <i>J</i> = 7.5 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 174.1, 171.2, 159.2, 141.0, 129.2, 128.8, 128.1, 127.5, 127.2, 114.8, 73.2, 61.6, 56.7, 46.7, 42.5, 35.7, 32.9, 20.0, 18.4, 17.0, 14.3; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>25</sub>H<sub>34</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 427.2591; <i>m</i>/<i>z</i>: found, 427.2589.</div></div><div id="sec4_1_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-[(2-Methoxyethyl)carbamoyl]({4-[(2-methylpentyl)oxy]phenyl})methyl]-2-phenylpropanamide (<b>46</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>31</b> was followed starting with <b>29a</b> and 2-methoxyethan-1-amine to give <b>46</b> (42% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.29–7.09 (m, 5H), 7.00 (d, <i>J</i> = 9.0 Hz, 2H), 6.74 (d, <i>J</i> = 6.0 Hz, 1H), 6.66 (d, <i>J</i> = 9.0 Hz, 2H), 6.37 (br s, 1H), 5.35 (d, <i>J</i> = 6.0 Hz, 1H), 3.73–3.62 (m, 1H), 3.61–3.50 (m, 2H), 3.42–3.18 (m, 4H), 3.17 (s, 3H), 1.91–1.74 (m, 1H), 1.49–1.05 (m, 4H), 1.40 (d, <i>J</i> = 6.0 Hz, 3H), 0.91 (d, <i>J</i> = 6.0 Hz, 3H), 0.84 (t, <i>J</i> = 7.5 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.3, 170.3, 159.1, 141.2, 129.8, 128.7, 128.1, 127.5, 127.1, 114.7, 73.2, 70.8, 58.7, 56.5, 46.7, 39.4, 35.7, 32.8, 20.0, 18.4, 16.9, 14.2; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>26</sub>H<sub>36</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 441.2748; <i>m</i>/<i>z</i>: found, 441.2743.</div></div><div id="sec4_1_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-{4-[(2-Methylpentyl)oxy]phenyl}({[(oxolan-2-yl)methyl]carbamoyl})methyl]-2-phenylpropanamide (<b>47</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>31</b> was followed starting with <b>29a</b> and tetrahydrofurfurylamine to give <b>47</b> (88% yield) as a waxy solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.35–7.18 (m, 5H), 7.08 (d, <i>J</i> = 8.6 Hz, 2H), 6.82–6.66 (m, 3H), 6.19–6.03 (m, 1H), 5.35 (t, <i>J</i> = 7.2 Hz, 1H), 3.95–3.49 (m, 6H), 3.50–3.32 (m, 1H), 3.32–3.06 (m, 1H), 2.01–1.64 (m, 3H), 1.64–1.08 (m, 8H), 0.99 (d, <i>J</i> = 6.7 Hz, 3H), 0.91 (t, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.3, 173.2, 170.4, 170.3, 159.2, 159.2, 141.3, 141.2, 130.2, 129.8, 128.8, 128.2, 128.1, 127.6, 127.1, 114.8, 77.3, 73.3, 73.2, 68.1, 68.1, 56.8, 56.7, 46.8, 43.2, 42.9, 35.7, 32.9, 28.5, 28.2, 25.8, 20.0, 18.4, 17.0, 14.3; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>28</sub>H<sub>38</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 467.2904; <i>m</i>/<i>z</i>: found, 467.2905.</div></div><div id="sec4_1_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> <i>tert</i>-Butyl <i>N</i>-{2-[(2<i>R</i>)-2-{4-[(2-Methylpentyl)oxy]phenyl}-2-[(2<i>S</i>)-2-phenylpropanamido]acetamido]ethyl}carbamate (<b>48</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>31</b> was followed starting with <b>29a</b> and <i>N</i>-Boc-ethylenediamine hydrochloride to give <b>48</b> (55% yield) as a colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.36–7.17 (m, 5H), 7.06 (d, <i>J</i> = 8.7 Hz, 2H), 6.84–6.65 (m, 4H), 5.35 (d, <i>J</i> = 6.7 Hz, 1H), 4.92 (d, <i>J</i> = 5.5 Hz, 1H), 3.74 (dd, <i>J</i> = 8.9, 5.8 Hz, 1H), 3.69–3.55 (m, 2H), 3.40–3.04 (m, 4H), 2.05–1.73 (m, 1H), 1.47 (d, <i>J</i> = 7.1 Hz, 3H), 1.45–1.11 (m, 13H), 0.99 (d, <i>J</i> = 6.7 Hz, 3H), 0.91 (t, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.5, 170.8, 159.2, 141.2, 129.6, 128.8, 128.1, 127.5, 127.2, 114.8, 79.7, 73.2, 56.8, 46.8, 40.8, 40.0, 35.7, 32.9, 28.3, 20.0, 18.4, 17.0, 14.3; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>30</sub>H<sub>43</sub>N<sub>3</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 526.3275; <i>m</i>/<i>z</i>: found, 526.3267.</div></div><div id="sec4_1_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-[(2-Aminoethyl)carbamoyl]({4-[(2-methylpentyl)oxy]phenyl})methyl]-2-phenylpropanamide Hydrochloride (<b>49</b>)</h4><div class="NLM_p last">To a solution of <b>48</b> (14.1 mg, 0.03 mmol) in DCM, HCl (4 M in dioxane, 67 μL, 0.27 mmol) was added at 0 °C. The reaction that resulted was warmed to room temperature and stirred until completion. After the completion of the reaction, the solvent was evaporated, and the residue was redissolved in DCM and evaporated under reduced pressure (three times). The residue was dried <i>in vacuo</i> to furnish <b>49</b> as hydrochloride salt (9.7 mg, 78%) as a thick colorless oil. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD): δ 7.36–7.15 (m, 7H), 6.86 (d, <i>J</i> = 8.7 Hz, 2H), 5.11 (s, 1H), 3.84–3.53 (m, 4H), 3.37–3.22 (m, 1H), 3.19–2.94 (m, 2H), 2.00–1.76 (m, 1H), 1.57–1.14 (m, 7H), 1.00 (d, <i>J</i> = 6.7 Hz, 3H), 0.92 (t, <i>J</i> = 7.1 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CD<sub>3</sub>OD): δ 177.3, 174.4, 161.0, 142.8, 130.2, 129.5, 129.1, 128.5, 128.0, 115.8, 74.3, 59.4, 48.4, 41.0, 38.3, 36.9, 34.1, 21.1, 18.9, 17.3, 14.6; HRMS (ESI) free base <i>m</i>/<i>z</i>: calcd for C<sub>25</sub>H<sub>35</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 426.2751; <i>m</i>/<i>z</i>: found, 426.2750.</div></div><div id="sec4_1_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> <i>tert</i>-Butyl <i>N</i>-Methyl-<i>N</i>-{2-[(2<i>R</i>)-2-{4-[(2-methylpentyl)oxy]phenyl}-2-[(2<i>S</i>)-2-phenylpropanamido]acetamido]ethyl}carbamate (<b>50</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>31</b> was followed starting with <b>29a</b> and <i>N</i>-Boc-<i>N</i>-methylethylenediamine to give <b>50</b> (32% yield) as a colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.39–7.15 (m, 5H), 7.06 (d, <i>J</i> = 8.6 Hz, 2H), 6.97 (br s, 1H), 6.84 (d, <i>J</i> = 6.7 Hz, 1H), 6.72 (d, <i>J</i> = 8.6 Hz, 2H), 5.62–4.88 (m, 1H), 3.80–3.57 (m, 3H), 3.27 (br s, 4H), 2.74 (br s, 3H), 2.01–1.78 (m, 1H), 1.46 (d, <i>J</i> = 7.2 Hz, 3H), 1.44–1.10 (m, 13H), 0.99 (d, <i>J</i> = 6.7 Hz, 3H), 0.91 (t, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.2, 170.6, 159.1, 156.8, 141.3, 129.9, 128.8, 128.1, 127.5, 127.1, 114.7, 79.9, 73.2, 56.6, 47.6, 46.7, 39.1, 35.7, 35.0, 32.9, 28.4, 20.0, 18.4, 17.0, 14.3; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>31</sub>H<sub>45</sub>N<sub>3</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 540.3432; <i>m</i>/<i>z</i>: found, 540.3424.</div></div><div id="sec4_1_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-{[2-(Methylamino)ethyl]carbamoyl}({4-[(2-methylpentyl)oxy]phenyl})methyl]-2-phenylpropanamide Hydrochloride (<b>51</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>49</b> was followed starting with <b>50</b> to give <b>51</b> as hydrochloride salt (94%) as a thick colorless oil. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD): δ 8.62–8.38 (m, 1H), 7.37–7.12 (m, 7H), 6.85 (d, <i>J</i> = 8.7 Hz, 2H), 5.17–5.06 (m, 1H), 3.89–3.61 (m, 4H), 3.40–3.32 (m, 1H), 3.26–3.03 (m, 2H), 2.73 (s, 3H), 2.05–1.75 (m, 1H), 1.57–1.13 (m, 7H), 0.99 (d, <i>J</i> = 6.7 Hz, 3H), 0.92 (t, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CD<sub>3</sub>OD): δ 179.9, 176.9, 163.6, 145.3, 132.7, 132.1, 131.6, 131.0, 130.5, 118.3, 76.9, 62.0, 53.0, 49.3, 39.6, 39.4, 36.6, 36.4, 23.6, 21.4, 19.8, 17.2; HRMS (ESI) free base <i>m</i>/<i>z</i>: calcd for C<sub>26</sub>H<sub>37</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 440.2908; <i>m</i>/<i>z</i>: found, 440.2923.</div></div><div id="sec4_1_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-{[2-(Dimethylamino)ethyl]carbamoyl}({4-[(2-methylpentyl)oxy]phenyl})methyl]-2-phenylpropanamide (<b>52</b>)</h4><div class="NLM_p last">A solution of <b>29a</b> (77 mg, 0.20 mmol) in DCM (5 mL) was cooled to 0 °C. To that above solution oxalyl chloride (0.4 mmol, 34 μL) and DMF (catalytic) were added sequentially. The reaction that resulted was stirred at room temperature for 2 h. At that time, the solvent was removed, and the residue was dried <i>in vacuo</i> for 1 h. The yellow color residue was redissolved in DCM (5 mL) and DIPEA (350 μL, 2.0 mmol), and <i>N</i>,<i>N</i>-dimethylethylenediamine (88.5 mg, 1.0 mmol) was added. The reaction that resulted was stirred at room temperature for 14 h. The solvent was evaporated under reduced pressure. The residue was subjected to column chromatography on silica gel using 0–50% CMA80 in DCM to furnish the amide <b>52</b> (37 mg, 41%) as a colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.40–7.08 (m, 6H), 6.95 (d, <i>J</i> = 6.7 Hz, 1H), 6.79 (dd, <i>J</i> = 18.1, 8.7 Hz, 2H), 6.69 (s, 1H), 5.33 (d, <i>J</i> = 6.7 Hz, 1H), 3.82–3.52 (m, 3H), 3.47–3.28 (m, 1H), 3.28–2.97 (m, 1H), 2.56–2.32 (m, 2H), 2.32–2.16 (m, 6H), 2.03–1.78 (m, 1H), 1.62–1.09 (m, 8H), 0.99 (d, <i>J</i> = 6.7 Hz, 3H), 0.91 (t, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.1, 170.0, 158.8, 140.7, 129.5, 128.3, 128.0, 127.3, 126.7, 114.4, 72.8, 57.0, 56.4, 46.5, 44.2, 36.0, 35.3, 32.4, 19.6, 18.1, 16.5, 13.8; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>27</sub>H<sub>39</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 454.3064; <i>m</i>/<i>z</i>: found, 454.3059.</div></div><div id="sec4_1_72" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-{4-[(2-Methylpentyl)oxy]phenyl}({[(pyrrolidin-2-yl)methyl]carbamoyl})methyl]-2-phenylpropanamide (<b>53</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>31</b> was followed starting with <b>29a</b> and 1-Boc-2-(aminomethyl)pyrrolidine to give <i>N</i>-Boc-<b>53</b> (68% yield). The <i>N</i>-Boc compound (100.0 mg, 0.18 mmol) was dissolved in DCM (2 mL) and cooled to 0 °C. To that above solution, HCl (4 M in dioxane, 440 μL, 1.77 mmol) was added, and the reaction that resulted was stirred at room temperature until complete conversion. After that, the reaction was diluted with DCM (10 mL) and basified with saturated NaHCO<sub>3</sub> (10 mL). The organic layer was separated, and the aqueous layer was extracted with additional DCM (2 × 10 mL). The combined organic layers were washed with brine, dried (K<sub>2</sub>CO<sub>3</sub>), and evaporated to furnish the free base <b>53</b> (72 mg, 87%) as a colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.35–7.18 (m, 5H), 7.08 (d, <i>J</i> = 8.6 Hz, 2H), 6.96 (dd, <i>J</i> = 6.8, 2.3 Hz, 1H), 6.90–6.81 (m, 1H), 6.72 (d, <i>J</i> = 8.6 Hz, 2H), 5.42 (dd, <i>J</i> = 6.9, 2.0 Hz, 1H), 3.82–3.53 (m, 3H), 3.37–2.90 (m, 3H), 2.90–2.57 (m, 2H), 2.32 (br s, 1H), 2.07–1.82 (m, 1H), 1.79–1.06 (m, 11H), 0.99 (d, <i>J</i> = 6.7 Hz, 3H), 0.91 (t, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.4, 173.4, 170.5, 170.4, 159.1, 141.3, 130.1, 130.1, 128.7, 128.1, 127.5, 127.1, 114.7, 73.2, 57.4, 57.4, 56.6, 46.7, 46.4, 46.3, 44.0, 43.8, 35.7, 32.9, 29.0, 28.8, 25.6, 25.6, 20.0, 18.4, 17.0, 14.3; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>28</sub>H<sub>39</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 466.3064; <i>m</i>/<i>z</i>: found, 464.3077.</div></div><div id="sec4_1_73" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-{[(Azetidin-3-yl)methyl]carbamoyl}({4-[(2-methylpentyl)oxy]phenyl})methyl]-2-phenylpropanamide (<b>54</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>53</b> was followed starting with <b>29a</b> and 1-Boc-3-(aminomethyl)azetidine to furnish <b><i>N</i>-Boc-54</b> (88% yield) as a colorless oil. The amide, <b><i>N</i>-Boc-54</b> (75 mg, 0.13 mmol) was dissolved in DCM (6 mL) and cooled to 0 °C. To that above solution, TFA (0.4 mL) was added dropwise with a syringe, and the reaction, which resulted, was stirred at 0 °C for 30 min. At that time, the reaction was diluted with DCM (10 mL) and basified with saturated aqueous NaHCO<sub>3</sub> (15 mL). The organic layer was separated, and the aqueous layer was extracted with additional DCM (2 × 5 mL). The combined organic layers were dried with K<sub>2</sub>CO<sub>3</sub>, and the residue was subjected to column chromatography on silica gel using 0–40% CMA80/DCM to furnish <b>54</b> (38 mg, 62%) as a free base. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 9.68–8.74 (br s, 2H), 8.53 (s, 1H), 7.40–7.08 (m, 6H), 6.95 (d, <i>J</i> = 6.6 Hz, 1H), 6.76 (dd, <i>J</i> = 26.9, 8.7 Hz, 2H), 5.59 (d, <i>J</i> = 6.6 Hz, 1H), 4.22–3.82 (m, 3H), 3.77–3.47 (m, 4H), 3.27–3.04 (m, 1H), 3.03–2.84 (m, 1H), 2.72–2.24 (m, 1H), 1.96–1.78 (m, 1H), 1.59–1.05 (m, 7H), 0.96 (d, <i>J</i> = 6.7 Hz, 3H), 0.90 (t, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 174.6, 171.8, 159.3, 140.9, 128.8, 128.1, 127.5, 127.3, 114.8, 73.2, 57.0, 48.7, 46.5, 40.1, 35.7, 32.8, 32.0, 20.0, 18.2, 16.9, 14.3; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>27</sub>H<sub>37</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 452.2908; <i>m</i>/<i>z</i>: found, 452.2908.</div></div><div id="sec4_1_74" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-{4-[(2-Methylpentyl)oxy]phenyl}(phenylcarbamoyl)methyl]-2-phenylpropanamide (<b>55</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>35</b> was followed starting with <b>29a</b> and aniline to give <b>55</b> (65% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.22 (br s, 1H), 7.41 (d, <i>J</i> = 7.9 Hz, 2H), 7.37–7.19 (m, 7H), 7.15 (d, <i>J</i> = 8.7 Hz, 2H), 7.06 (t, <i>J</i> = 7.4 Hz, 1H), 6.81 (d, <i>J</i> = 7.2 Hz, 1H), 6.75 (d, <i>J</i> = 8.7 Hz, 2H), 5.67 (d, <i>J</i> = 7.0 Hz, 1H), 3.83–3.52 (m, 3H), 2.01–1.78 (m, 1H), 1.51 (d, <i>J</i> = 7.1 Hz, 3H), 1.47–1.07 (m, 4H), 0.99 (d, <i>J</i> = 6.7 Hz, 3H), 0.91 (t, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.9, 168.5, 159.4, 141.0, 137.4, 129.0, 128.9, 128.3, 127.6, 127.3, 124.5, 120.0, 115.0, 73.3, 57.3, 46.9, 35.7, 32.8, 20.0, 18.4, 17.0, 14.3; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>29</sub>H<sub>34</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 459.2642; <i>m</i>/<i>z</i>: found, 459.2642.</div></div><div id="sec4_1_75" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-(Benzylcarbamoyl)({4-[(2-methylpentyl)oxy]phenyl})methyl]-2-phenylpropanamide (<b>56</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>31</b> was followed starting with <b>29a</b> and benzylamine to give <b>56</b> (45% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.37–7.15 (m, 8H), 7.09 (d, <i>J</i> = 8.8 Hz, 4H), 6.80–6.68 (m, 3H), 6.12 (t, <i>J</i> = 5.6 Hz, 1H), 5.39 (d, <i>J</i> = 6.7 Hz, 1H), 4.51–4.13 (m, 2H), 3.88–3.44 (m, 3H), 2.06–1.63 (m, 1H), 1.60–1.08 (m, 7H), 0.99 (d, <i>J</i> = 6.7 Hz, 3H), 0.92 (t, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.4, 170.2, 159.3, 141.2, 137.6, 129.7, 128.8, 128.6, 128.3, 127.5, 127.4, 127.1, 114.9, 73.3, 56.8, 46.8, 43.7, 35.7, 32.9, 20.0, 18.4, 17.0, 14.3; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>30</sub>H<sub>36</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 473.2799; <i>m</i>/<i>z</i>: found, 473.2797.</div></div><div id="sec4_1_76" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-{4-[(2-Methylpentyl)oxy]phenyl}({[(pyridin-2-yl)methyl]carbamoyl})methyl]-2-phenylpropanamide (<b>57</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>31</b> was followed starting with <b>29a</b> and 2-picolylamine to give <b>57</b> (75% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.47 (d, <i>J</i> = 4.3 Hz, 1H), 7.61 (td, <i>J</i> = 7.7, 1.8 Hz, 1H), 7.36–7.19 (m, 5H), 7.19–7.06 (m, 4H), 6.93 (d, <i>J</i> = 4.4 Hz, 1H), 6.78 (d, <i>J</i> = 8.7 Hz, 2H), 6.71 (d, <i>J</i> = 6.6 Hz, 1H), 5.43 (d, <i>J</i> = 6.6 Hz, 1H), 4.63–4.36 (m, 2H), 3.79–3.71 (m, 1H), 3.70–3.48 (m, 2H), 1.94–1.82 (m, 1H), 1.47 (d, <i>J</i> = 7.1 Hz, 3H), 1.45–1.09 (m, 4H), 0.99 (d, <i>J</i> = 6.7 Hz, 3H), 0.91 (t, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.3, 170.2, 159.2, 155.7, 149.0, 141.2, 136.7, 129.8, 128.8, 128.2, 127.6, 127.1, 122.4, 121.7, 114.9, 73.2, 56.8, 46.9, 44.5, 35.7, 32.9, 20.0, 18.4, 17.0, 14.3; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>29</sub>H<sub>35</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 474.2751; <i>m</i>/<i>z</i>: found, 474.2749.</div></div><div id="sec4_1_77" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-{4-[(2-Methylpentyl)oxy]phenyl}({[(pyridin-3-yl)methyl]carbamoyl})methyl]-2-phenylpropanamide (<b>58</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>31</b> was followed starting with <b>29a</b> and 3-picolylamine to give <b>58</b> (71% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.46 (dd, <i>J</i> = 4.8, 1.5 Hz, 1H), 8.39 (d, <i>J</i> = 1.8 Hz, 1H), 7.45–7.38 (m, 1H), 7.34–7.22 (m, 3H), 7.22–7.10 (m, 3H), 7.05 (d, <i>J</i> = 8.7 Hz, 2H), 7.02–6.94 (m, 1H), 6.79–6.68 (m, 3H), 5.54 (d, <i>J</i> = 7.0 Hz, 1H), 4.48–4.19 (m, 2H), 3.74 (dd, <i>J</i> = 8.9, 5.8 Hz, 1H), 3.69–3.53 (m, 2H), 1.98–1.84 (m, 1H), 1.58–1.07 (m, 7H), 0.99 (d, <i>J</i> = 6.7 Hz, 3H), 0.92 (t, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.6, 170.6, 159.3, 148.9, 148.8, 141.0, 135.1, 133.5, 129.3, 128.8, 128.1, 127.5, 127.2, 123.4, 114.8, 73.3, 56.6, 46.8, 41.1, 35.7, 32.9, 20.0, 18.3, 17.0, 14.3; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>29</sub>H<sub>35</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 474.2751; <i>m</i>/<i>z</i>: found, 474.2744.</div></div><div id="sec4_1_78" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-{4-[(2-Methylpentyl)oxy]phenyl}({[(pyridin-4-yl)methyl]carbamoyl})methyl]-2-phenylpropanamide (<b>59</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>31</b> was followed starting with <b>29a</b> and 4-picolylamine to give <b>59</b> (74% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.43 (d, <i>J</i> = 5.8 Hz, 2H), 7.39–7.20 (m, 4H), 7.19–7.13 (m, 2H), 7.08 (d, <i>J</i> = 8.6 Hz, 2H), 6.95 (d, <i>J</i> = 5.7 Hz, 2H), 6.85 (d, <i>J</i> = 7.1 Hz, 1H), 6.73 (d, <i>J</i> = 8.5 Hz, 2H), 5.66 (d, <i>J</i> = 7.2 Hz, 1H), 4.33 (ddd, <i>J</i> = 48.7, 16.1, 6.0 Hz, 2H), 3.81–3.70 (m, 1H), 3.70–3.50 (m, 2H), 2.09–1.72 (m, 1H), 1.57–1.08 (m, 7H), 1.00 (d, <i>J</i> = 6.7 Hz, 3H), 0.90 (t, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.8, 170.8, 159.4, 149.9, 147.0, 140.9, 129.3, 128.9, 128.1, 127.5, 127.3, 121.9, 114.8, 73.3, 56.5, 46.7, 42.3, 35.7, 32.9, 20.0, 18.3, 17.0, 14.3; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>29</sub>H<sub>35</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 474.2751; <i>m</i>/<i>z</i>: found, 474.2750.</div></div><div id="sec4_1_79" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-{[(Furan-2-yl)methyl]carbamoyl}({4-[(2-methylpentyl)oxy]phenyl})methyl]-2-phenylpropanamide (<b>60</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>31</b> was followed starting with <b>29a</b> and furfurylamine to give <b>60</b> (75% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.41–7.12 (m, 6H), 7.06 (d, <i>J</i> = 8.6 Hz, 2H), 6.74 (d, <i>J</i> = 8.6 Hz, 3H), 6.46–6.15 (m, 2H), 6.09 (d, <i>J</i> = 3.1 Hz, 1H), 5.43 (d, <i>J</i> = 6.9 Hz, 1H), 4.56–4.20 (m, 2H), 3.86–3.49 (m, 3H), 1.99–1.81 (m, 1H), 1.54–1.09 (m, 7H), 0.99 (d, <i>J</i> = 6.7 Hz, 3H), 0.90 (t, <i>J</i> = 7.0, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.4, 170.1, 159.2, 150.7, 142.2, 141.1, 129.5, 128.8, 128.3, 127.5, 127.2, 114.8, 110.4, 107.4, 73.2, 56.6, 46.8, 36.8, 35.7, 32.9, 20.0, 18.4, 17.0, 14.3; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>28</sub>H<sub>34</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 463.2591; <i>m</i>/<i>z</i>: found, 463.2585.</div></div><div id="sec4_1_80" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-[4-(Cyclobutylmethoxy)phenyl]({[(furan-2-yl)methyl]carbamoyl})methyl]-2-phenylpropanamide (<b>61</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>31</b> was followed starting with <b>29b</b> and furfurylamine to give <b>61</b> (73% yield) as a waxy solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.44–7.12 (m, 6H), 7.04 (d, <i>J</i> = 8.7 Hz, 2H), 6.82 (d, <i>J</i> = 7.1 Hz, 1H), 6.76 (t, <i>J</i> = 5.6 Hz, 1H), 6.70 (d, <i>J</i> = 8.7 Hz, 2H), 6.25 (dd, <i>J</i> = 3.1, 1.9 Hz, 1H), 6.08 (d, <i>J</i> = 2.7 Hz, 1H), 5.54 (d, <i>J</i> = 7.1 Hz, 1H), 4.35 (qd, <i>J</i> = 15.6, 5.6 Hz, 2H), 3.85 (d, <i>J</i> = 6.7 Hz, 2H), 3.61 (q, <i>J</i> = 7.1 Hz, 1H), 2.82–2.64 (m, 1H), 2.20–2.04 (m, 2H), 2.02–1.66 (m, 4H), 1.43 (d, <i>J</i> = 7.1 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.5, 170.2, 159.1, 150.8, 142.1, 141.1, 129.7, 128.8, 128.2, 127.5, 127.2, 114.8, 110.4, 107.3, 72.1, 56.4, 46.8, 36.7, 34.6, 24.8, 18.5, 18.3; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>27</sub>H<sub>30</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 447.2278; <i>m</i>/<i>z</i>: found, 447.2277.</div></div><div id="sec4_1_81" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-[4-(Cyclobutylmethoxy)phenyl]({[(thiophen-2-yl)methyl]carbamoyl})methyl]-2-phenylpropanamide (<b>62</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>31</b> was followed starting with <b>29b</b> and 2-thiophenemethylamine to give <b>62</b> (80% yield) as a white waxy solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.35–7.23 (m, 3H), 7.23–7.14 (m, 3H), 7.07 (d, <i>J</i> = 8.7 Hz, 2H), 6.89 (dd, <i>J</i> = 5.1, 3.5 Hz, 1H), 6.86–6.80 (m, 1H), 6.76 (d, <i>J</i> = 8.7 Hz, 2H), 6.70 (d, <i>J</i> = 6.8 Hz, 1H), 6.26–6.17 (m, 1H), 5.38 (d, <i>J</i> = 6.7 Hz, 1H), 4.67–4.36 (m, 2H), 3.87 (d, <i>J</i> = 6.7 Hz, 2H), 3.61 (q, <i>J</i> = 7.1 Hz, 1H), 2.88–2.52 (m, 1H), 2.20–2.04 (m, 2H), 2.03–1.73 (m, 4H), 1.45 (d, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.4, 169.9, 159.2, 141.1, 140.2, 129.5, 128.8, 128.3, 127.5, 127.2, 126.8, 125.9, 125.2, 114.9, 72.1, 56.7, 46.8, 38.6, 34.6, 24.8, 18.5, 18.4; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>27</sub>H<sub>30</sub>N<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup>, 463.2050; <i>m</i>/<i>z</i>: found, 463.2046.</div></div><div id="sec4_1_82" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-[4-(Cyclobutylmethoxy)phenyl]({[(1<i>H</i>-pyrrol-2-yl)methyl]carbamoyl})methyl]-2-phenylpropanamide (<b>63</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>31</b> was followed starting with <b>29b</b> and (1<i>H</i>-pyrrol-2-yl)methanamine to give <b>63</b> (58% yield) as a waxy solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.87 (br s, 1H), 7.45–7.15 (m, 5H), 7.11 (t, <i>J</i> = 5.7 Hz, 1H), 7.01 (d, <i>J</i> = 8.7 Hz, 2H), 6.79–6.55 (m, 4H), 6.04 (dd, <i>J</i> = 5.8, 2.8 Hz, 1H), 5.97–5.92 (m, 1H), 5.45 (d, <i>J</i> = 7.1 Hz, 1H), 4.33 (dd, <i>J</i> = 15.1, 6.0 Hz, 1H), 4.21–4.08 (m, 1H), 3.84 (d, <i>J</i> = 6.7 Hz, 2H), 3.60 (q, <i>J</i> = 7.1 Hz, 1H), 2.81–2.61 (m, 1H), 2.20–2.04 (m, 2H), 2.00–1.73 (m, 4H), 1.44 (d, <i>J</i> = 7.1 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.8, 171.3, 159.2, 141.0, 129.3, 128.9, 128.5, 128.1, 127.5, 127.3, 118.2, 114.9, 107.7, 106.8, 72.1, 56.6, 46.7, 37.1, 34.6, 24.8, 18.5, 18.4, HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>27</sub>H<sub>31</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 446.2438; <i>m</i>/<i>z</i>: found, 446.2437.</div></div><div id="sec4_1_83" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-[4-(Cyclobutylmethoxy)phenyl]({[(5-methyl-1,3-oxazol-2-yl)methyl]carbamoyl})methyl]-2-phenylpropanamide (<b>64</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>31</b> was followed starting with <b>29b</b> and (5-methyloxazol-2-yl)methanamine to give <b>64</b> (46% yield) as a waxy solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.36–7.15 (m, 5H), 7.09 (d, <i>J</i> = 8.7 Hz, 2H), 6.87 (t, <i>J</i> = 5.4 Hz, 1H), 6.81–6.67 (m, 3H), 6.59 (d, <i>J</i> = 1.2 Hz, 1H), 5.50 (d, <i>J</i> = 7.0 Hz, 1H), 4.51 (dd, <i>J</i> = 16.4, 5.8 Hz, 1H), 4.32 (dd, <i>J</i> = 16.4, 5.1 Hz, 1H), 3.86 (d, <i>J</i> = 6.7 Hz, 2H), 3.62 (q, <i>J</i> = 7.1 Hz, 1H), 2.84–2.52 (m, 1H), 2.24 (d, <i>J</i> = 1.1 Hz, 3H), 2.19–2.03 (m, 2H), 2.03–1.70 (m, 4H), 1.45 (d, <i>J</i> = 7.1 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.4, 170.4, 159.2, 158.8, 149.4, 141.2, 129.5, 128.8, 128.3, 127.6, 127.2, 122.7, 114.8, 72.1, 56.5, 46.8, 37.0, 34.6, 24.8, 18.5, 18.4, 10.7; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>27</sub>H<sub>31</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 462.2387; <i>m</i>/<i>z</i>: found, 462.2385.</div></div><div id="sec4_1_84" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-[4-(Cyclobutylmethoxy)phenyl]({[(1,2-oxazol-3-yl)methyl]carbamoyl})methyl]-2-phenylpropanamide (<b>65</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>31</b> was followed starting with <b>29b</b> and isoxazol-3-ylmethanamine hydrochloride to give <b>65</b> (60% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.25 (d, <i>J</i> = 1.6 Hz, 1H), 7.50–7.36 (m, 1H), 7.35–7.12 (m, 5H), 7.04 (d, <i>J</i> = 8.7 Hz, 2H), 6.84 (d, <i>J</i> = 7.2 Hz, 1H), 6.69 (d, <i>J</i> = 8.7 Hz, 2H), 6.13 (d, <i>J</i> = 1.6 Hz, 1H), 5.60 (d, <i>J</i> = 7.2 Hz, 1H), 4.51–4.31 (m, 2H), 3.84 (d, <i>J</i> = 6.7 Hz, 2H), 3.64 (q, <i>J</i> = 7.1 Hz, 1H), 2.84–2.60 (m, 1H), 2.23–2.02 (m, 2H), 2.02–1.69 (m, 4H), 1.43 (d, <i>J</i> = 7.1 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.8, 170.8, 160.0, 159.2, 158.7, 141.0, 129.3, 128.8, 128.1, 127.5, 127.2, 114.8, 103.6, 72.1, 56.4, 46.7, 35.2, 34.6, 24.8, 18.5, 18.3; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>26</sub>H<sub>29</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 448.2231; <i>m</i>/<i>z</i>: found, 448.2229.</div></div><div id="sec4_1_85" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-[4-(Cyclobutylmethoxy)phenyl]({[(1,3-thiazol-2-yl)methyl]carbamoyl})methyl]-2-phenylpropanamide (<b>66</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>31</b> was followed starting with <b>29b</b> and 1,3-thiazol-2-ylmethylamine hydrochloride to give <b>66</b> (65% yield) as a waxy solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.63 (d, <i>J</i> = 3.3 Hz, 1H), 7.49–7.14 (m, 6H), 7.07 (d, <i>J</i> = 8.7 Hz, 2H), 6.81 (d, <i>J</i> = 7.1 Hz, 1H), 6.72 (d, <i>J</i> = 8.7 Hz, 2H), 5.58 (d, <i>J</i> = 7.1 Hz, 1H), 4.66 (d, <i>J</i> = 5.9 Hz, 2H), 3.85 (d, <i>J</i> = 6.7 Hz, 2H), 3.62 (q, <i>J</i> = 7.1 Hz, 1H), 2.95–2.50 (m, 1H), 2.23–2.03 (m, 2H), 2.03–1.64 (m, 4H), 1.43 (d, <i>J</i> = 7.1 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 170.5, 167.0, 159.2, 142.4, 141.1, 129.3, 128.8, 128.3, 127.5, 127.2, 126.2, 119.5, 114.9, 72.1, 56.5, 46.7, 41.2, 34.6, 24.8, 18.5, 18.4; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>26</sub>H<sub>29</sub>N<sub>3</sub>O<sub>3</sub>S [M + H]<sup>+</sup>, 464.2002; <i>m</i>/<i>z</i>: found, 448.2000.</div></div><div id="sec4_1_86" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-[4-(Cyclobutylmethoxy)phenyl]({[(1<i>H</i>-imidazol-2-yl)methyl]carbamoyl})methyl]-2-phenylpropanamide (<b>67</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>31</b> was followed starting with <b>29b</b> and (1<i>H</i>-imidazol-2-yl)methanamine hydrochloride to give <b>67</b> (53% yield) as a waxy solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.35 (t, <i>J</i> = 5.7 Hz, 1H), 7.38–7.15 (m, 6H), 7.02 (d, <i>J</i> = 8.7 Hz, 2H), 6.89–6.82 (m, 3H), 6.70 (d, <i>J</i> = 8.7 Hz, 2H), 5.41 (d, <i>J</i> = 6.8 Hz, 1H), 4.42 (dd, <i>J</i> = 15.3, 6.3 Hz, 1H), 4.22 (dd, <i>J</i> = 15.3, 5.5 Hz, 1H), 3.83 (d, <i>J</i> = 6.7 Hz, 2H), 3.66 (q, <i>J</i> = 7.1 Hz, 1H), 2.81–2.52 (m, 1H), 2.18–1.66 (m, 6H), 1.46 (d, <i>J</i> = 7.1 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 229.0, 174.1, 171.9, 159.3, 145.2, 141.1, 128.8, 128.2, 127.5, 127.2, 122.0, 114.9, 72.1, 57.0, 46.6, 37.4, 34.6, 24.8, 18.5, 18.4; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>26</sub>H<sub>30</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 447.2391; <i>m</i>/<i>z</i>: found, 447.2387.</div></div><div id="sec4_1_87" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-[4-(Cyclobutylmethoxy)phenyl]({[(5-methyl-1,3,4-oxadiazol-2-yl)methyl]carbamoyl})methyl]-2-phenylpropanamide (<b>68</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>31</b> was followed starting with <b>29b</b> and (5-methyl-1,3,4-oxadiazol-2-yl)methanamine oxalate to give <b>68</b> (55% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.39–7.16 (m, 5H), 7.10 (d, <i>J</i> = 8.7 Hz, 2H), 6.78 (d, <i>J</i> = 8.7 Hz, 2H), 6.59 (d, <i>J</i> = 6.4 Hz, 2H), 5.44 (d, <i>J</i> = 6.7 Hz, 1H), 4.57 (ddd, <i>J</i> = 38.1, 16.6, 5.8 Hz, 2H), 3.87 (d, <i>J</i> = 6.6 Hz, 2H), 3.63 (q, <i>J</i> = 7.1 Hz, 1H), 2.81–2.65 (m, 1H), 2.48 (s, 3H), 2.21–2.02 (m, 2H), 2.02–1.73 (m, 4H), 1.47 (d, <i>J</i> = 7.1 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 229.0, 173.6, 170.6, 164.4, 163.0, 159.4, 141.0, 128.9, 128.4, 127.5, 127.2, 115.0, 77.2, 72.1, 56.7, 46.8, 34.6, 34.5, 24.8, 18.5, 18.4, 10.9; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>26</sub>H<sub>30</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 463.2340; <i>m</i>/<i>z</i>: found, 463.2337.</div></div><div id="sec4_1_88" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-[4-(Cyclobutylmethoxy)phenyl]({[(1<i>H</i>-1,2,4-triazol-3-yl)methyl]carbamoyl})methyl]-2-phenylpropanamide (<b>69</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>31</b> was followed starting with <b>29b</b> and (4<i>H</i>-1,2,4-triazol-3-yl)methanamine hydrochloride to give <b>69</b> (47% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD): δ 8.20 (s, 1H), 7.39–7.06 (m, 7H), 6.80 (d, <i>J</i> = 8.7 Hz, 2H), 5.37 (s, 1H), 4.52 (dd, <i>J</i> = 52.1, 15.8 Hz, 2H), 3.89 (d, <i>J</i> = 6.6 Hz, 2H), 3.80 (q, <i>J</i> = 7.0 Hz, 1H), 2.85–2.58 (m, 1H), 2.19–2.03 (m, 2H), 2.03–1.75 (m, 4H), 1.46 (d, <i>J</i> = 7.1 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CD<sub>3</sub>OD): δ 176.6, 173.1, 160.7, 158.4, 148.1, 142.9, 130.3, 129.9, 129.6, 128.5, 128.0, 115.7, 73.2, 58.4, 47.0, 37.2, 36.1, 25.7, 19.4, 18.8; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>25</sub>H<sub>29</sub>N<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 448.2343; <i>m</i>/<i>z</i>: found, 448.2342.</div></div><div id="sec4_1_89" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-(Hydrazinecarbonyl)({4-[(2-methylpentyl)oxy]phenyl})methyl]-2-phenylpropanamide (<b>70a</b>)</h4><div class="NLM_p last">A mixture of <b>3</b> (596 mg, 1.5 mmol) and hydrazine hydrate (2 mL) in EtOH (10 mL) was refluxed for 3 h. After cooling to room temperature, the mixture was concentrated under reduced pressure. The residue was crystallized from MeOH/hexanes to give <b>70a</b> (572 mg, 96% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.55 (s, 1H), 7.42–7.16 (m, 5H), 7.07 (d, <i>J</i> = 9.0 Hz, 2H), 6.76 (d, <i>J</i> = 9.0 Hz, 2H), 6.61 (d, <i>J</i> = 6.0 Hz, 1H), 5.43 (d, <i>J</i> = 6.0 Hz, 1H), 3.81 (s, 2H), 3.80–3.69 (m, 1H), 3.69–3.55 (m, 2H), 2.01–1.81 (m, 1H), 1.56–1.12 (m, 4H), 1.50 (d, <i>J</i> = 9.0 Hz, 3H), 0.99 (d, <i>J</i> = 6.0 Hz, 3H), 0.91 (t, <i>J</i> = 7.5 Hz, 3H); MS (ESI) <i>m</i>/<i>z</i>: 398.4 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_90" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-[4-(Cyclobutylmethoxy)phenyl](hydrazinecarbonyl)methyl]-2-phenylpropanamide (<b>70b</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>70a</b> was followed starting with <b>11h</b> to give <b>70b</b> (90% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD): δ 7.33–7.19 (m, 5H), 7.16 (d, <i>J</i> = 8.6 Hz, 2H), 6.79 (d, <i>J</i> = 8.7 Hz, 2H), 5.28 (s, 1H), 3.87 (d, <i>J</i> = 6.6 Hz, 2H), 3.78 (q, <i>J</i> = 7.1 Hz, 1H), 2.85–2.63 (m, 1H), 2.19–2.02 (m, 2H), 2.02–1.77 (m, 4H), 1.44 (d, <i>J</i> = 7.1 Hz, 3H); <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD): δ 176.5, 172.2, 160.7, 142.9, 130.4, 129.6, 129.6, 128.5, 128.0, 115.7, 73.2, 56.8, 47.0, 36.1, 25.7, 19.3, 18.8; MS (ESI) <i>m</i>/<i>z</i>: 382.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_91" class="NLM_sec NLM_sec_level_3"><div id="ac_i109" class="anchor-spacer"></div><h4 class="article-section__title" id="_i109"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-{4-[(2-Methylpentyl)oxy]phenyl}(1,3,4-oxadiazol-2-yl)methyl]-2-phenylpropanamide (<b>71</b>)</h4><div class="NLM_p last">A mixture of <b>70a</b> (70 mg, 0.18 mmol), trimethyl orthoformate (5 mL), and PTSA (45 mg, 0.23 mmol) was heated at 80 °C for 2 h. After cooling to room temperature, the mixture was diluted with EtOAc (50 mL), washed with NaHCO<sub>3</sub> (3 × 10 mL) and brine (10 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure. The residue was subjected to column chromatography on silica gel using 0–20% CMA80 in DCM to furnish <b>71</b> (40 mg, 56% yield) as an off-white solid. <sup>1</sup>H NMR (300 MHz; CDCl<sub>3</sub>): δ 8.31 (s, 1H), 7.43–7.19 (m, 5H), 7.05 (d, <i>J</i> = 9.0 Hz, 2H), 6.79 (d, <i>J</i> = 9.0 Hz, 2H), 6.54 (d, <i>J</i> = 9.0 Hz, 1H), 6.33 (d, <i>J</i> = 6.0 Hz, 1H), 3.80–3.60 (m, 3H), 1.98–1.81 (m, 1H), 1.56–1.09 (m, 4H), 1.51 (d, <i>J</i> = 6.0 Hz, 3H), 0.98 (d, <i>J</i> = 6.0 Hz, 3H), 0.91 (t, <i>J</i> = 7.5 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.4, 165.9, 159.9, 163.2, 140.8, 128.9, 128.2, 127.7, 127.6, 127.4, 115.0, 73.3, 49.5, 46.7, 35.7, 32.8, 20.0, 18.4, 16.9, 14.2; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>24</sub>H<sub>29</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 408.2282; <i>m</i>/<i>z</i>: found, 408.2278.</div></div><div id="sec4_1_92" class="NLM_sec NLM_sec_level_3"><div id="ac_i110" class="anchor-spacer"></div><h4 class="article-section__title" id="_i110"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-(5-Methyl-1,3,4-oxadiazol-2-yl)({4-[(2-methylpentyl)oxy]phenyl})-2-phenylpropanamide (<b>72</b>)</h4><div class="NLM_p last">A mixture of <b>70a</b> (100 mg, 0.25 mmol), trimethyl orthoacetate (0.065 mL, 0.5 mmol), and acetic acid (0.1 mL) in <i>m</i>-xylene (5 mL) was refluxed for 6 h. After cooling to room temperature, the mixture was diluted with EtOAc (50 mL), washed with NaHCO<sub>3</sub> (3 × 10 mL) and brine (10 mL), dried (NaSO<sub>4</sub>), and concentrated under reduced pressure. The residue was subjected to column chromatography on silica gel using 0–20% CMA80 in DCM to provide <b>72</b> (60 mg, 57% yield) as an off-white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.38–7.21 (m, 5H), 7.06 (d, <i>J</i> = 9.0 Hz, 2H), 6.78 (d, <i>J</i> = 9.0 Hz, 2H), 6.60 (d, <i>J</i> = 9.0 Hz, 1H), 6.25 (d, <i>J</i> = 6.0 Hz, 1H), 3.79–3.60 (m, 3H), 2.44 (s, 3H), 1.95–1.83 (m, 1H), 1.53–1.12 (m, 4H), 1.50 (d, <i>J</i> = 6.0 Hz, 3H), 0.98 (d, <i>J</i> = 9.0 Hz, 3H), 0.91 (t, <i>J</i> = 7.5 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.2, 165.8, 164.2, 159.5, 140.8, 128.8, 128.2, 127.5, 127.2, 114.8, 73.1, 49.4, 46.8, 35.6, 32.7, 20.0, 18.4, 16.8, 14.2, 10.8; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>25</sub>H<sub>31</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 422.2438; <i>m</i>/<i>z</i>: found, 422.2440.</div></div><div id="sec4_1_93" class="NLM_sec NLM_sec_level_3"><div id="ac_i111" class="anchor-spacer"></div><h4 class="article-section__title" id="_i111"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-[4-(Cyclobutylmethoxy)phenyl](1,3,4-oxadiazol-2-yl)methyl]-2-phenylpropanamide (<b>73</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>71</b> was followed starting with <b>70b</b> and trimethyl orthoformate to give <b>73</b> (65% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.31 (s, 1H), 7.43–7.18 (m, 5H), 7.05 (d, <i>J</i> = 8.7 Hz, 2H), 6.79 (d, <i>J</i> = 8.7 Hz, 2H), 6.52 (d, <i>J</i> = 7.6 Hz, 1H), 6.33 (d, <i>J</i> = 7.7 Hz, 1H), 3.86 (d, <i>J</i> = 6.6 Hz, 2H), 3.67 (q, <i>J</i> = 7.1 Hz, 1H), 2.90–2.53 (m, 1H), 2.22–2.02 (m, 2H), 2.02–1.66 (m, 4H), 1.51 (d, <i>J</i> = 7.1 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.4, 165.9, 159.7, 153.2, 140.8, 128.9, 128.2, 127.8, 127.6, 127.4, 115.1, 72.1, 49.5, 46.8, 34.5, 24.8, 18.5, 18.4; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>23</sub>H<sub>25</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 392.1969; <i>m</i>/<i>z</i>: found, 392.1967.</div></div><div id="sec4_1_94" class="NLM_sec NLM_sec_level_3"><div id="ac_i112" class="anchor-spacer"></div><h4 class="article-section__title" id="_i112"> (2<i>S</i>)-<i>N</i>-[(<i>R</i>)-[4-(Cyclobutylmethoxy)phenyl](5-methyl-1,3,4-oxadiazol-2-yl)methyl]-2-phenylpropanamide (<b>74</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>72</b> was followed starting with <b>70b</b> and trimethyl orthoacetate to give <b>74</b> (72% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.43–7.18 (m, 5H), 7.06 (d, <i>J</i> = 8.7 Hz, 2H), 6.78 (d, <i>J</i> = 8.7 Hz, 2H), 6.55 (d, <i>J</i> = 7.7 Hz, 1H), 6.24 (d, <i>J</i> = 7.7 Hz, 1H), 3.87 (d, <i>J</i> = 6.6 Hz, 2H), 3.66 (q, <i>J</i> = 7.1 Hz, 1H), 2.86–2.61 (m, 1H), 2.45 (s, 3H), 2.20–2.04 (m, 2H), 2.04–1.68 (m, 4H), 1.50 (d, <i>J</i> = 7.1 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.3, 165.8, 164.3, 159.5, 140.9, 128.9, 128.3, 128.2, 127.6, 127.3, 115.0, 72.1, 49.5, 46.8, 34.5, 24.8, 18.5, 18.5, 10.9; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>24</sub>H<sub>27</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 406.2125; <i>m</i>/<i>z</i>: found, 406.2123.</div></div><div id="sec4_1_95" class="NLM_sec NLM_sec_level_3"><div id="ac_i113" class="anchor-spacer"></div><h4 class="article-section__title" id="_i113"> Methyl (3<i>S</i>)-3-Amino-3-(4-hydroxyphenyl)propanoate (<b>76</b>)</h4><div class="NLM_p last">(<i>S</i>)-3-Amino-3-(4-hydroxyphenyl)propanoic acid (<b>75</b>) (6.0 g, 33.15 mmol) was dissolved in dry MeOH (60 mL). Acetyl chloride (5 mL) was added to that above solution slowly via a syringe. The reaction that resulted was stirred at 65 °C for 12 h. After that, the solvent was evaporated under reduced pressure, and the residue was dried <i>in vacuo</i> to furnish the methyl ester <b>76</b> as hydrochloride salt (8.63 g, 115% crude yield) as a foamy solid which was used for the next transformation without purification. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD): δ 7.35–7.24 (m, 2H), 6.84 (d, <i>J</i> = 8.6 Hz, 2H), 4.63 (t, <i>J</i> = 7.2 Hz, 1H), 3.68 (s, 3H), 3.12 (ddd, <i>J</i> = 16.8, 7.9, 1.6 Hz, 1H), 2.98 (dd, <i>J</i> = 16.8, 6.6 Hz, 1H); <sup>13</sup>C NMR (75 MHz, CD<sub>3</sub>OD): δ 171.8, 159.8, 129.8, 127.8, 117.0, 52.8, 52.7, 39.2; MS (ESI) <i>m</i>/<i>z</i>: 196.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_96" class="NLM_sec NLM_sec_level_3"><div id="ac_i114" class="anchor-spacer"></div><h4 class="article-section__title" id="_i114"> Methyl (3<i>S</i>)-3-{[(<i>tert</i>-Butoxy)carbonyl]amino}-3-(4-hydroxyphenyl)propanoate (<b>77</b>)</h4><div class="NLM_p last">To a solution of <b>76</b> (8.6 g, 37.1 mmol) in DCM (200 mL), DIPEA (38.8 mL, 0.22 mol) was added slowly via a syringe at 0 °C. To that above solution, Boc<sub>2</sub>O (8.09 g, 37.1 mmol) was added, and the reaction which resulted was stirred at room temperature under nitrogen for 12 h. At that time, water (100 mL) was added to the reaction and the organic layer was separated. The aqueous layer was extracted with additional DCM (2 × 50 mL) and the combined organic layers were washed with brine and dried (Na<sub>2</sub>SO<sub>4</sub>). The solvent was evaporated under reduced pressure, and the residue was crystallized with DCM/hexanes to furnish <b>77</b> (11.5 g, 78%) as an off-white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.04 (t, <i>J</i> = 9.2 Hz, 3H), 6.67 (d, <i>J</i> = 8.1 Hz, 2H), 5.54 (br s, 1H), 5.00 (br s, 1H), 3.61 (s, 3H), 2.96–2.60 (m, 2H), 1.43 (s, 9H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 171.7, 155.7, 155.4, 132.4, 127.3, 115.6, 80.0, 51.8, 50.9, 40.9, 28.3; MS (ESI) <i>m</i>/<i>z</i>: 318.0 [M + Na]<sup>+</sup>.</div></div><div id="sec4_1_97" class="NLM_sec NLM_sec_level_3"><div id="ac_i115" class="anchor-spacer"></div><h4 class="article-section__title" id="_i115"> Methyl (3<i>S</i>)-3-{[(<i>tert</i>-Butoxy)carbonyl]amino}-3-{4-[(2-methylpentyl)oxy]phenyl}propanoate (<b>78a</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>7b</b> was followed starting with <b>77</b> and 2-methylpentanol to give <b>78a</b> (87% yield) as a colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.19 (d, <i>J</i> = 8.6 Hz, 2H), 6.84 (d, <i>J</i> = 8.7 Hz, 2H), 5.32 (br s, 1H), 5.04 (br s, 1H), 3.79 (dd, <i>J</i> = 9.0, 5.8 Hz, 1H), 3.69 (dd, <i>J</i> = 8.9, 6.7 Hz, 1H), 3.61 (s, 3H), 2.82 (qd, <i>J</i> = 15.3, 6.2 Hz, 2H), 2.07–1.78 (m, 1H), 1.55–1.11 (m, 13H), 1.00 (d, <i>J</i> = 6.7 Hz, 3H), 0.91 (t, <i>J</i> = 7.1 Hz, 3H); MS (ESI) <i>m</i>/<i>z</i>: 402.0 [M + Na]<sup>+</sup>.</div></div><div id="sec4_1_98" class="NLM_sec NLM_sec_level_3"><div id="ac_i116" class="anchor-spacer"></div><h4 class="article-section__title" id="_i116"> Methyl (3<i>S</i>)-3-{[(<i>tert</i>-Butoxy)carbonyl]amino}-3-[4-(cyclobutylmethoxy)phenyl]propanoate (<b>78b</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>7b</b> was followed starting with <b>77</b> and cyclobutylmethanol to give <b>78b</b> (87% yield) as a colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.19 (d, <i>J</i> = 8.6 Hz, 2H), 6.90–6.77 (m, 2H), 5.36 (s, 1H), 5.04 (d, <i>J</i> = 5.0 Hz, 1H), 3.90 (d, <i>J</i> = 6.7 Hz, 2H), 3.61 (s, 3H), 2.94–2.59 (m, 3H), 2.23–2.04 (m, 2H), 2.01–1.78 (m, 4H), 1.42 (s, 9H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 171.4, 158.7, 155.0, 133.1, 127.2, 114.7, 79.6, 72.1, 51.7, 50.9, 40.9, 34.6, 28.3, 24.8, 18.5; MS (ESI) <i>m</i>/<i>z</i>: 386.0 [M + Na]<sup>+</sup>.</div></div><div id="sec4_1_99" class="NLM_sec NLM_sec_level_3"><div id="ac_i117" class="anchor-spacer"></div><h4 class="article-section__title" id="_i117"> Methyl (3<i>S</i>)-3-{[(<i>tert</i>-Butoxy)carbonyl]amino}-3-(4-{[(2<i>S</i>)-2-methylpentyl]oxy}phenyl)propanoate (<b>78c</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>7b</b> was followed starting with <b>77</b> and (<i>S</i>)-2-methylpentanol to give <b>78c</b> (30% yield) as a colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.19 (d, <i>J</i> = 8.6 Hz, 2H), 6.84 (d, <i>J</i> = 8.7 Hz, 2H), 5.35 (br s, 1H), 5.04 (br s, 1H), 3.79 (dd, <i>J</i> = 9.0, 5.8 Hz, 1H), 3.69 (dd, <i>J</i> = 8.9, 6.7 Hz, 1H), 3.61 (s, 3H), 2.82 (qd, <i>J</i> = 15.3, 6.2 Hz, 2H), 2.01–1.77 (m, 1H), 1.55–1.09 (m, 13H), 1.00 (d, <i>J</i> = 6.7 Hz, 3H), 0.91 (t, <i>J</i> = 7.1 Hz, 3H); MS (ESI) <i>m</i>/<i>z</i>: 402.0 [M + Na]<sup>+</sup>.</div></div><div id="sec4_1_100" class="NLM_sec NLM_sec_level_3"><div id="ac_i118" class="anchor-spacer"></div><h4 class="article-section__title" id="_i118"> Methyl (3<i>S</i>)-3-{[(<i>tert</i>-Butoxy)carbonyl]amino}-3-(4-{[(2<i>R</i>)-2-methylpentyl]oxy}phenyl)propanoate (<b>78d</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>11m</b> was followed starting with <b>77</b> and (<i>2R</i>)-2-methylpentyl 4-methylbenzene-1-sulfonate to give <b>78d</b> (35% yield) as a colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.19 (d, <i>J</i> = 8.6 Hz, 2H), 6.84 (d, <i>J</i> = 8.7 Hz, 2H), 5.38 (br s, 1H), 5.03 (br s, <i>J</i> = 5.4 Hz, 1H), 3.78 (dd, <i>J</i> = 9.0, 5.8 Hz, 1H), 3.68 (dd, <i>J</i> = 9.0, 6.7 Hz, 1H), 3.61 (s, 3H), 2.82 (qd, <i>J</i> = 15.3, 6.3 Hz, 2H), 2.00–1.76 (m, 1H), 1.56–1.11 (m, 13H), 1.00 (d, <i>J</i> = 6.7 Hz, 3H), 0.91 (t, <i>J</i> = 7.1 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 171.4, 158.7, 155.0, 133.1, 127.2, 114.6, 79.6, 73.2, 51.6, 50.9, 40.9, 35.7, 32.9, 28.3, 20.0, 17.0, 14.3; MS (ESI) <i>m</i>/<i>z</i>: 402.0 [M + Na]<sup>+</sup>.</div></div><div id="sec4_1_101" class="NLM_sec NLM_sec_level_3"><div id="ac_i119" class="anchor-spacer"></div><h4 class="article-section__title" id="_i119"> Methyl (3<i>S</i>)-3-{[(<i>tert</i>-Butoxy)carbonyl]amino}-3-{4-[(2<i>S</i>)-2-methylbutoxy]phenyl}propanoate (<b>78e</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>7b</b> was followed starting with <b>77</b> and (<i>S</i>)-2-methylbutanol to give <b>78e</b> (95% yield) as a colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.20 (d, <i>J</i> = 8.7 Hz, 2H), 6.84 (d, <i>J</i> = 8.7 Hz, 2H), 5.42 (br s, 1H), 5.03 (br s, 1H), 3.79 (dd, <i>J</i> = 9.0, 6.0 Hz, 1H), 3.70 (dd, <i>J</i> = 9.0, 6.6 Hz, 1H), 3.61 (s, 3H), 2.82 (qd, <i>J</i> = 15.3, 6.3 Hz, 2H), 1.90–1.75 (m, 1H), 1.564–1.48 (m, 1H), 1.42 (s, 9H), 1.33–1.15 (m, 4H), 1.00 (d, <i>J</i> = 6.7 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 171.3, 158.7, 155.0, 133.1, 127.2, 114.6, 79.5, 72.8, 51.6, 50.9, 40.9, 34.7, 28.3, 26.1, 16.5, 11.2; MS (ESI) <i>m</i>/<i>z</i>: 388 [M + Na]<sup>+</sup>.</div></div><div id="sec4_1_102" class="NLM_sec NLM_sec_level_3"><div id="ac_i120" class="anchor-spacer"></div><h4 class="article-section__title" id="_i120"> Methyl (3<i>S</i>)-3-{[(<i>tert</i>-Butoxy)carbonyl]amino}-3-{4-[(2<i>R</i>)-2-methylbutoxy]phenyl}propanoate (<b>78f</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>11m</b> was followed starting with <b>77</b> and (<i>2R</i>)-2-methylbutyl 4-methylbenzene-1-sulfonate to give <b>78f</b> as a colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.19 (d, <i>J</i> = 8.7 Hz, 2H), 6.85 (d, <i>J</i> = 8.7 Hz, 2H), 5.34 (br s, 1H), 5.04 (br s, 1H), 3.83–3.66 (m, 2H), 3.61 (s, 3H), 2.82 (qd, <i>J</i> = 15.3, 6.2 Hz, 2H), 1.96–1.71 (m, 1H), 1.65–1.48 (m, 1H), 1.42 (br s, 9H), 1.33–1.16 (m, 1H), 1.00 (d, <i>J</i> = 6.7 Hz, 3H), 0.94 (t, <i>J</i> = 7.4 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 171.4, 158.7, 155.0, 133.0, 127.3, 114.6, 79.6, 72.9, 51.7, 50.9, 40.9, 34.7, 28.3, 26.1, 16.5, 11.3; MS (ESI) <i>m</i>/<i>z</i>: 388 [M + Na]<sup>+</sup>.</div></div><div id="sec4_1_103" class="NLM_sec NLM_sec_level_3"><div id="ac_i121" class="anchor-spacer"></div><h4 class="article-section__title" id="_i121"> Methyl (3<i>S</i>)-3-Amino-3-{4-[(2-methylpentyl)oxy]phenyl}propanoate Hydrochloride (<b>79a</b>)</h4><div class="NLM_p last">A solution of <b>78a</b> (1.63 g, 4.29 mmol) in DCM (20 mL) was cooled to 0 °C. To that above solution, HCl (4 M in dioxane, 10.74 mL, 42.95 mmol) was added via a syringe. The reaction which resulted was stirred at room temperature for overnight. At that time, the solvent was removed under reduced pressure, and the residue was redissolved in DCM and evaporated (repeated three times). The residue was dried in vacuo to furnish <b>79a</b> (1.35 g, 99%) as a foamy solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.72 (br s, 3H), 7.42 (d, <i>J</i> = 8.3 Hz, 2H), 6.86 (d, <i>J</i> = 8.1 Hz, 2H), 4.64 (br s, 1H), 3.87–3.64 (m, 2H), 3.60 (s, 3H), 3.35–3.15 (m, 1H), 3.00 (dd, <i>J</i> = 16.4, 6.5 Hz, 1H), 2.00–1.82 (m, 1H), 1.55–1.09 (m, 4H), 1.00 (d, <i>J</i> = 6.7 Hz, 3H), 0.91 (t, <i>J</i> = 7.0 Hz, 3H); MS (ESI) free base <i>m</i>/<i>z</i>: 263.0 [M + H<sup>+</sup> – NH<sub>3</sub>]<sup>+</sup>.</div></div><div id="sec4_1_104" class="NLM_sec NLM_sec_level_3"><div id="ac_i122" class="anchor-spacer"></div><h4 class="article-section__title" id="_i122"> Methyl (3<i>S</i>)-3-Amino-3-[4-(cyclobutylmethoxy)phenyl]propanoate Hydrochloride (<b>79b</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>79a</b> was followed starting with <b>78b</b> to give <b>79b</b> as a waxy solid. MS (ESI) free base <i>m</i>/<i>z</i>: 247.0 [M + H<sup>+</sup> – NH<sub>3</sub>]<sup>+</sup>. This material was used for the next transformation without further characterization.</div></div><div id="sec4_1_105" class="NLM_sec NLM_sec_level_3"><div id="ac_i123" class="anchor-spacer"></div><h4 class="article-section__title" id="_i123"> Methyl (3<i>S</i>)-3-Amino-3-(4-{[(2<i>S</i>)-2-methylpentyl]oxy}phenyl)propanoate Hydrochloride (<b>79c</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>79a</b> was followed starting with <b>78c</b> to give <b>79c</b> as a waxy solid. MS (ESI) free base <i>m</i>/<i>z</i>: 263.0 [M + H<sup>+</sup> – NH<sub>3</sub>]<sup>+</sup>. This material was used for the next transformation without further characterization.</div></div><div id="sec4_1_106" class="NLM_sec NLM_sec_level_3"><div id="ac_i124" class="anchor-spacer"></div><h4 class="article-section__title" id="_i124"> Methyl (3<i>S</i>)-3-Amino-3-(4-{[(2<i>R</i>)-2-methylpentyl]oxy}phenyl)propanoate Hydrochloride (<b>79d</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>79a</b> was followed starting with <b>78d</b> to give <b>79d</b> as a waxy solid. MS (ESI) free base <i>m</i>/<i>z</i>: 263.0 [M + H<sup>+</sup> – NH<sub>3</sub>]<sup>+</sup>. This material was used for the next transformation without further characterization.</div></div><div id="sec4_1_107" class="NLM_sec NLM_sec_level_3"><div id="ac_i125" class="anchor-spacer"></div><h4 class="article-section__title" id="_i125"> Methyl (3<i>S</i>)-3-Amino-3-{4-[(2<i>S</i>)-2-methylbutoxy]phenyl}propanoate Hydrochloride (<b>79e</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>79a</b> was followed starting with <b>78e</b> to give <b>79e</b> as a waxy solid. MS (ESI) free base <i>m</i>/<i>z</i>: 249.0 [M + H<sup>+</sup> – NH<sub>3</sub>]<sup>+</sup>. This material was used for the next transformation without further characterization.</div></div><div id="sec4_1_108" class="NLM_sec NLM_sec_level_3"><div id="ac_i126" class="anchor-spacer"></div><h4 class="article-section__title" id="_i126"> Methyl (3<i>S</i>)-3-Amino-3-{4-[(2<i>R</i>)-2-methylbutoxy]phenyl}propanoate Hydrochloride (<b>79f</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>79a</b> was followed starting with <b>78f</b> to give <b>79f</b> as a waxy solid. MS (ESI) free base <i>m</i>/<i>z</i>: 249.0 [M + H<sup>+</sup> – NH<sub>3</sub>]<sup>+</sup>.</div></div><div id="sec4_1_109" class="NLM_sec NLM_sec_level_3"><div id="ac_i127" class="anchor-spacer"></div><h4 class="article-section__title" id="_i127"> Methyl (3<i>S</i>)-3-{4-[(2-Methylpentyl)oxy]phenyl}-3-[(2<i>S</i>)-2-phenylpropanamido]propanoate (<b>80a</b>)</h4><div class="NLM_p last">To a solution of <b>79a</b> (1.35 g, 4.27 mmol) in MeCN (50 mL), HBTU (2.43 g, 6.41 mmol), Et<sub>3</sub>N (1.80 mL, 12.82 mmol), and (<i>S</i>)-(+)-2-phenylpropionic acid (642 mg, 4.27 mmol) were added, and the reaction that resulted was stirred at room temperature 5 h. After the completion of the reaction, EtOAC (20 mL) and saturated NaHCO<sub>3</sub> (20 mL) were added, and the organic layer was separated. The aqueous layer was extracted with additional EtOAc, and the combined organic layers were washed with brine and dried (Na<sub>2</sub>SO<sub>4</sub>). The solvent was evaporated under reduced pressure. The residue was subjected to column chromatography on silica gel using 0–50% EtOAc in hexanes to furnish <b>80a</b> (1.60 g, 91%) as a colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.39–7.19 (m, 5H), 6.95 (d, <i>J</i> = 8.7 Hz, 2H), 6.74 (d, <i>J</i> = 8.7 Hz, 2H), 6.38 (d, <i>J</i> = 8.4 Hz, 1H), 5.31 (dt, <i>J</i> = 8.3, 5.9 Hz, 1H), 3.75 (dd, <i>J</i> = 8.9, 5.8 Hz, 1H), 3.69–3.57 (m, 2H), 3.55 (s, 3H), 2.77 (qd, <i>J</i> = 15.5, 5.9 Hz, 2H), 2.00–1.77 (m, 1H), 1.51 (d, <i>J</i> = 57.2 Hz, 3H), 1.48–1.09 (m, 4H), 0.98 (d, <i>J</i> = 6.7 Hz, 3H), 0.91 (t, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.2, 171.5, 158.6, 141.3, 132.3, 128.9, 127.6, 127.2, 127.0, 114.5, 73.2, 51.7, 49.0, 47.1, 40.0, 35.7, 32.9, 20.0, 18.3, 17.0, 14.3; MS (ESI) <i>m</i>/<i>z</i>: 412.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_110" class="NLM_sec NLM_sec_level_3"><div id="ac_i128" class="anchor-spacer"></div><h4 class="article-section__title" id="_i128"> Methyl (3<i>S</i>)-3-[4-(Cyclobutylmethoxy)phenyl]-3-[(2<i>S</i>)-2-phenylpropanamido]propanoate (<b>80b</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>80a</b> was followed starting with <b>79b</b> to give <b>80b</b> (65% yield over 2 steps) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.29 (dd, <i>J</i> = 13.5, 6.6 Hz, 5H), 6.95 (d, <i>J</i> = 8.7 Hz, 2H), 6.74 (d, <i>J</i> = 8.7 Hz, 2H), 6.50 (d, <i>J</i> = 8.4 Hz, 1H), 5.31 (dt, <i>J</i> = 8.3, 6.0 Hz, 1H), 3.85 (d, <i>J</i> = 6.7 Hz, 2H), 3.59 (q, <i>J</i> = 7.1 Hz, 1H), 3.54 (s, 3H), 2.91–2.64 (m, 3H), 2.18–2.00 (m, 2H), 1.96–1.63 (m, 4H), 1.50 (d, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 13.2, 171.5, 158.5, 141.3, 132.4, 128.9, 127.6, 127.2, 127.0, 114.6, 72.1, 51.7, 49.0, 47.1, 40.0, 34.6, 24.8, 18.5, 18.3; MS (ESI) <i>m</i>/<i>z</i>: 396.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_111" class="NLM_sec NLM_sec_level_3"><div id="ac_i129" class="anchor-spacer"></div><h4 class="article-section__title" id="_i129"> Methyl (3<i>S</i>)-3-(4-{[(2<i>S</i>)-2-Methylpentyl]oxy}phenyl)-3-[(2<i>S</i>)-2-phenylpropanamido]propanoate (<b>80c</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>80a</b> was followed starting with <b>79c</b> to give <b>80c</b> (61% yield) as a sticky solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.38–7.21 (m, 5H), 6.95 (d, <i>J</i> = 8.7 Hz, 2H), 6.73 (d, <i>J</i> = 8.7 Hz, 2H), 6.46 (d, <i>J</i> = 8.4 Hz, 1H), 5.32 (dt, <i>J</i> = 8.2, 5.9 Hz, 1H), 3.74 (dd, <i>J</i> = 8.9, 5.8 Hz, 1H), 3.69–3.58 (m 2H), 3.55 (s, 3H), 2.78 (qd, <i>J</i> = 15.5, 5.9 Hz, 2H), 2.01–1.80 (m, 1H), 1.52 (d, <i>J</i> = 7.2 Hz, 3H), 1.49–1.02 (m, 4H), 0.98 (d, <i>J</i> = 6.7 Hz, 3H), 0.91 (t, <i>J</i> = 7.1 Hz, 3H); MS (ESI) <i>m</i>/<i>z</i>: 412.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_112" class="NLM_sec NLM_sec_level_3"><div id="ac_i130" class="anchor-spacer"></div><h4 class="article-section__title" id="_i130"> Methyl (3<i>S</i>)-3-(4-{[(2<i>R</i>)-2-Methylpentyl]oxy}phenyl)-3-[(2<i>S</i>)-2-phenylpropanamido]propanoate (<b>80d</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>80a</b> was followed starting with <b>79d</b> to give <b>80d</b> (63% yield over two steps) as a sticky solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.40–7.15 (m, 5H), 6.95 (d, <i>J</i> = 8.6 Hz, 2H), 6.74 (d, <i>J</i> = 8.7 Hz, 2H), 6.43 (d, <i>J</i> = 8.4 Hz, 1H), 5.36–5.25 (m, 1H), 3.79–3.70 (m, 1H), 3.69–3.56 (m, 2H), 3.54 (s, 3H), 2.77 (qd, <i>J</i> = 15.5, 5.9 Hz, 2H), 1.98–1.81 (m, 1H), 1.51 (d, <i>J</i> = 7.2 Hz, 3H), 1.49–1.11 (m, 4H), 0.98 (d, <i>J</i> = 6.7 Hz, 3H), 0.91 (t, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.3, 171.5, 158.6, 141.3, 132.3, 128.9, 127.6, 127.2, 127.0, 114.5, 73.2, 51.7, 49.0, 47.1, 40.0, 35.7, 32.9, 20.0, 18.3, 17.0, 14.3; MS (ESI) <i>m</i>/<i>z</i>: 412.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_113" class="NLM_sec NLM_sec_level_3"><div id="ac_i131" class="anchor-spacer"></div><h4 class="article-section__title" id="_i131"> Methyl (3<i>S</i>)-3-{4-[(2<i>S</i>)-2-Methylbutoxy]phenyl}-3-[(2<i>S</i>)-2-phenylpropanamido]propanoate (<b>80e</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>80a</b> was followed starting with <b>79e</b> to give <b>80e</b> (64% yield over two steps) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.48–7.03 (m, 5H), 6.95 (d, <i>J</i> = 8.7 Hz, 2H), 6.74 (d, <i>J</i> = 8.7 Hz, 2H), 6.43 (d, <i>J</i> = 8.4 Hz, 1H), 5.30 (dd, <i>J</i> = 14.2, 6.0 Hz, 1H), 3.79–3.66 (m, 3H), 3.54 (s, 3H), 2.77 (qd, <i>J</i> = 15.5, 6.0 Hz, 2H), 1.90–1.75 (m, 1H), 1.64–1.37 (m, 4H), 1.36–1.08 (m, 1H), 0.98 (d, <i>J</i> = 6.7 Hz, 3H), 0.92 (t, <i>J</i> = 7.4 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.2, 171.5, 158.6, 141.3, 132.3, 128.8, 127.6, 127.2, 127.1, 114.5, 72.8, 51.7, 49.0, 47.1, 40.0, 34.7, 26.1, 18.3, 16.5, 11.3; MS (ESI) <i>m</i>/<i>z</i>: 398.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_114" class="NLM_sec NLM_sec_level_3"><div id="ac_i132" class="anchor-spacer"></div><h4 class="article-section__title" id="_i132"> Methyl (3<i>S</i>)-3-{4-[(2<i>R</i>)-2-Methylbutoxy]phenyl}-3-[(2<i>S</i>)-2-phenylpropanamido]propanoate (<b>80f</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>80a</b> was followed starting with <b>79f</b> to give <b>80f</b> (54% yield over two steps) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.40–7.20 (m, 5H), 6.99–6.88 (m, 2H), 6.80–6.69 (m, 2H), 6.38 (d, <i>J</i> = 8.4 Hz, 1H), 5.35–5.25 (m, 1H), 3.79–3.71 (m, 1H), 3.70–3.56 (m, 2H), 3.55 (s, 6H), 2.77 (qd, <i>J</i> = 15.5, 5.9 Hz, 2H), 1.89–1.72 (m, 1H), 1.62–1.45 (m, 4H), 1.32–1.13 (m, 1H), 0.98 (d, <i>J</i> = 6.7 Hz, 3H), 0.93 (t, <i>J</i> = 7.4 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.2, 171.5, 158.6, 141.3, 132.3, 128.9, 127.6, 127.2, 127.0, 114.5, 72.9, 51.7, 49.0, 47.1, 40.0, 34.7, 26.1, 18.3, 16.5, 11.3; MS (ESI) <i>m</i>/<i>z</i>: 398.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_115" class="NLM_sec NLM_sec_level_3"><div id="ac_i133" class="anchor-spacer"></div><h4 class="article-section__title" id="_i133"> (2<i>S</i>)-<i>N</i>-[(1<i>S</i>)-2-(Hydrazinecarbonyl)-1-{4-[(2-methylpentyl)oxy]phenyl}ethyl]-2-phenylpropanamide (<b>81a</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>70a</b> was followed starting with <b>80a</b> to give <b>81a</b> (92% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.39–7.21 (m, 5H), 6.93 (d, <i>J</i> = 8.7 Hz, 2H), 6.73 (d, <i>J</i> = 8.7 Hz, 2H), 6.68 (br s, 1H), 5.27–5.14 (m, 1H), 3.79–3.57 (m, 3H), 2.59 (qd, <i>J</i> = 14.6, 5.5 Hz, 2H), 1.99–1.82 (m, 1H), 1.65–1.09 (m, 9H), 0.99 (d, <i>J</i> = 6.7 Hz, 3H), 0.91 (t, <i>J</i> = 7.0 Hz, 3H); MS (ESI) <i>m</i>/<i>z</i>: 412.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_116" class="NLM_sec NLM_sec_level_3"><div id="ac_i134" class="anchor-spacer"></div><h4 class="article-section__title" id="_i134"> (2<i>S</i>)-<i>N</i>-[(1<i>S</i>)-1-[4-(Cyclobutylmethoxy)phenyl]-2-(hydrazinecarbonyl)ethyl]-2-phenylpropanamide (<b>81b</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>70a</b> was followed starting with <b>80b</b> to give <b>81b</b> (90% yield) as a white solid. MS (ESI) <i>m</i>/<i>z</i>: 396.0 [M + H]<sup>+</sup>. This material was used for the next transformation without further characterization.</div></div><div id="sec4_1_117" class="NLM_sec NLM_sec_level_3"><div id="ac_i135" class="anchor-spacer"></div><h4 class="article-section__title" id="_i135"> (2<i>S</i>)-<i>N</i>-[(1<i>S</i>)-2-(Hydrazinecarbonyl)-1-(4-{[(2<i>S</i>)-2-methylpentyl]oxy}phenyl)ethyl]-2-phenylpropanamide (<b>81c</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>70a</b> was followed starting with <b>80c</b> to give <b>81c</b> (67% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD): δ 7.30–7.06 (m, 5H), 6.94 (d, <i>J</i> = 8.6 Hz, 2H), 6.63 (d, <i>J</i> = 8.7 Hz, 2H), 5.15 (t, <i>J</i> = 7.1 Hz, 1H), 3.72–3.49 (m, 3H), 2.58–2.39 (m, 2H), 1.87–1.62 (m, 1H), 1.44–0.93 (m, 7H), 0.88 (d, <i>J</i> = 6.7 Hz, 3H), 0.82 (t, <i>J</i> = 7.1 Hz, 3H); MS (ESI) <i>m</i>/<i>z</i>: 412.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_118" class="NLM_sec NLM_sec_level_3"><div id="ac_i136" class="anchor-spacer"></div><h4 class="article-section__title" id="_i136"> (2<i>S</i>)-<i>N</i>-[((1<i>S</i>)-2-Hydrazinecarbonyl)-1-(4-{[(2<i>R</i>)-2-methylpentyl]oxy}phenyl)ethyl]-2-phenylpropanamide (<b>81d</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>70a</b> was followed starting with <b>80d</b> to give <b>81d</b> (75% yield) as a white solid. MS (ESI) <i>m</i>/<i>z</i>: 412.0 [M + H]<sup>+</sup>. This material was used for the next transformation without further characterization.</div></div><div id="sec4_1_119" class="NLM_sec NLM_sec_level_3"><div id="ac_i137" class="anchor-spacer"></div><h4 class="article-section__title" id="_i137"> (2<i>S</i>)-<i>N</i>-[(1<i>S</i>)-2-(Hydrazinecarbonyl)-1-{4-[(2<i>S</i>)-2-methylbutoxy]phenyl}ethyl]-2-phenylpropanamide (<b>81e</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>70a</b> was followed starting with <b>80e</b> to give <b>81e</b> (97% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.43–7.17 (m, 5H), 6.95 (m, 4H), 6.73 (d, <i>J</i> = 8.7 Hz, 2H), 5.26–5.15 (m, 1H), 3.80–3.45 (m, 4H), 2.58 (qd, <i>J</i> = 14.6, 5.6 Hz, 2H), 1.91–1.41 (m, 6H), 1.34–1.12 (m, 1H), 0.98 (d, <i>J</i> = 6.7 Hz, 3H), 0.93 (t, <i>J</i> = 7.4 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.5, 171.2, 158.6, 141.3, 132.3, 128.8, 127.6, 127.2, 126.9, 114.6, 72.9, 49.9, 47.2, 40.1, 34.7, 26.1, 18.2, 16.5, 11.3; (ESI) <i>m</i>/<i>z</i>: 398.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_120" class="NLM_sec NLM_sec_level_3"><div id="ac_i138" class="anchor-spacer"></div><h4 class="article-section__title" id="_i138"> (2<i>S</i>)-<i>N</i>-[(1<i>S</i>)-2-(Hydrazinecarbonyl)-1-{4-[(2<i>R</i>)-2-methylbutoxy]phenyl}ethyl]-2-phenylpropanamide (<b>81f</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>70a</b> was followed starting with <b>80f</b> to give <b>81f</b> (90% yield) as a white solid. MS (ESI) <i>m</i>/<i>z</i>: 398.0 [M + H]<sup>+</sup>. This material was used for the next transformation without further characterization.</div></div><div id="sec4_1_121" class="NLM_sec NLM_sec_level_3"><div id="ac_i139" class="anchor-spacer"></div><h4 class="article-section__title" id="_i139"> (2<i>S</i>)-<i>N</i>-[(1<i>S</i>)-1-{4-[(2-Methylpentyl)oxy]phenyl}-2-(1,3,4-oxadiazol-2-yl)ethyl]-2-phenylpropanamide (<b>82</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>71</b> was followed starting with <b>81a</b> and trimethyl orthoformate to give <b>82</b> (35% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.27 (s, 1H), 7.28 (m, 5H), 6.96 (d, <i>J</i> = 8.6 Hz, 2H), 6.74 (d, <i>J</i> = 8.6 Hz, 2H), 6.29 (d, <i>J</i> = 8.3 Hz, 1H), 5.42 (dd, <i>J</i> = 14.1, 7.3 Hz, 1H), 3.78–3.69 (m, 1H), 3.68–3.51 (m, 2H), 3.43–3.15 (m, 2H), 1.99–1.80 (m, 1H), 1.46 (d, <i>J</i> = 7.2 Hz, 3H), 1.43–1.07 (m, 4H), 0.98 (d, <i>J</i> = 6.7 Hz, 3H), 0.91 (t, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.5, 164.0, 158.9, 153.0, 141.0, 131.2, 128.9, 127.6, 127.2, 127.1, 114.7, 73.2, 50.0, 47.0, 35.7, 32.8, 31.7, 20.0, 18.3, 17.0, 14.3; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>25</sub>H<sub>31</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 422.2438; <i>m</i>/<i>z</i>: found, 422.2432.</div></div><div id="sec4_1_122" class="NLM_sec NLM_sec_level_3"><div id="ac_i140" class="anchor-spacer"></div><h4 class="article-section__title" id="_i140"> (2<i>S</i>)-<i>N</i>-[(1<i>S</i>)-2-(5-Methyl-1,3,4-oxadiazol-2-yl)-1-{4-[(2-methylpentyl)oxy]phenyl}ethyl]-2-phenylpropanamide (<b>83</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>72</b> was followed starting with <b>81a</b> and trimethyl orthoacetate to give <b>83</b> (93% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.38–7.16 (m, 5H), 6.97 (d, <i>J</i> = 8.6 Hz, 2H), 6.73 (d, <i>J</i> = 8.7 Hz, 2H), 6.41 (d, <i>J</i> = 8.4 Hz, 1H), 5.46–5.29 (m, 1H), 3.78–3.69 (m, 1H), 3.68–3.48 (m, 2H), 3.35–3.07 (m, 2H), 2.42 (s, 3H), 1.98–1.79 (m, 1H), 1.52–1.10 (m, 7H), 0.98 (d, <i>J</i> = 6.7 Hz, 3H), 0.91 (t, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.5, 164.0, 163.9, 158.8, 141.1, 131.6, 128.8, 127.6, 127.2, 127.2, 114.7, 73.2, 49.9, 47.0, 35.7, 32.8, 31.8, 20.0, 18.3, 17.0, 14.3, 10.8; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>26</sub>H<sub>33</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 436.2595; <i>m</i>/<i>z</i>: found, 436.2609.</div></div><div id="sec4_1_123" class="NLM_sec NLM_sec_level_3"><div id="ac_i141" class="anchor-spacer"></div><h4 class="article-section__title" id="_i141"> (2<i>S</i>)-<i>N</i>-[(1<i>S</i>)-2-(5-Amino-1,3,4-oxadiazol-2-yl)-1-{4-[(2-methylpentyl)oxy]phenyl}ethyl]-2-phenylpropanamide Hydrochloride (<b>84</b>)</h4><div class="NLM_p last">To a solution of <b>81a</b> (28 mg, 0.07 mmol) in dry MeOH (2.5 mL), cyanogen bromide (8 mg, 0.075 mmol) was added, and the reaction that resulted was heated to reflux under nitrogen for 4 h. The reaction was cooled to room temperature and quenched with saturated NaHCO<sub>3</sub> (5 mL) and extracted with EtOAc (3 × 10 mL). The combined organic layers were washed with brine (2 × 10 mL) and dried (Na<sub>2</sub>SO<sub>4</sub>). The solvent was evaporated, and the residue was subjected to column chromatography on silica gel using 0–50% CMA80 in DCM to furnish <b>84</b> (free base, 22 mg, 75% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.34–7.17 (m, 5H), 6.99 (d, <i>J</i> = 8.6 Hz, 2H), 6.74 (d, <i>J</i> = 8.7 Hz, 2H), 6.51 (d, <i>J</i> = 8.5 Hz, 1H), 5.45 (br s, 2H), 5.37 (dd, <i>J</i> = 14.4, 7.6 Hz, 1H), 3.73 (dd, <i>J</i> = 8.9, 5.8 Hz, 1H), 3.68–3.48 (m, 2H), 3.26–3.01 (m, 2H), 1.96–1.80 (m, 1H), 1.52–1.05 (m, 7H), 0.98 (d, <i>J</i> = 6.7 Hz, 3H), 0.90 (t, <i>J</i> = 7.0 Hz, 3H). The above solid was suspended in DCM (2 mL) and cooled to 0 °C. To that above suspension, HCl (126 μL, 2.0 M in diethyl ether) was added dropwise. The solution that resulted was stirred for 30 min at 0 °C. The solvent was evaporated, and the solid was triturated with MeOH and hexanes to furnish the hydrochloride salt <b>84</b> as a white solid. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD): δ 8.52 (d, <i>J</i> = 8.3 Hz, 1H), 7.34–7.19 (m, 5H), 7.16 (d, <i>J</i> = 8.6 Hz, 2H), 6.83 (d, <i>J</i> = 8.7 Hz, 2H), 5.37–5.18 (m, 1H), 3.86–3.59 (m, 3H), 3.24 (d, <i>J</i> = 7.3 Hz, 2H), 2.05–1.78 (m, 1H), 1.61–1.30 (m, 6H), 1.30–1.11 (m, 1H), 1.01 (d, <i>J</i> = 6.7 Hz, 3H), 0.97–0.87 (m, 3H); <sup>13</sup>C NMR (75 MHz, CD<sub>3</sub>OD): δ 176.5, 163.3, 160.4, 159.4, 142.7, 133.0, 129.5, 128.7, 128.4, 127.9, 115.7, 74.3, 51.4, 47.3, 36.9, 34.1, 32.8, 21.1, 18.8, 17.3, 14.6; HRMS (ESI) free base <i>m</i>/<i>z</i>: calcd for C<sub>25</sub>H<sub>32</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 437.2547; <i>m</i>/<i>z</i>: found, 437.2546.</div></div><div id="sec4_1_124" class="NLM_sec NLM_sec_level_3"><div id="ac_i142" class="anchor-spacer"></div><h4 class="article-section__title" id="_i142"> (2<i>S</i>)-<i>N</i>-[(1<i>S</i>)-1-[4-(Cyclobutylmethoxy)phenyl]-2-(1,3,4-oxadiazol-2-yl)ethyl]-2-phenylpropanamide (<b>85</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>71</b> was followed starting with <b>81b</b> and trimethyl orthoformate to give <b>85</b> (57% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.27 (s, 1H), 7.39–7.17 (m, 5H), 6.96 (d, <i>J</i> = 8.7 Hz, 2H), 6.75 (d, <i>J</i> = 8.7 Hz, 2H), 6.17 (d, <i>J</i> = 8.3 Hz, 1H), 5.42 (dd, <i>J</i> = 14.0, 7.3 Hz, 1H), 3.85 (d, <i>J</i> = 6.6 Hz, 2H), 3.56 (q, <i>J</i> = 7.1 Hz, 1H), 3.45–3.22 (m, 2H), 2.79–2.63 (m, 1H), 2.24–1.98 (m, 2H), 1.97–1.70 (m, 4H), 1.47 (d, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.6, 164.0, 158.9, 153.0, 141.0, 131.3, 128.9, 127.6, 127.3, 127.1, 114.8, 72.1, 50.0, 47.0, 34.6, 31.7, 24.8, 24.5, 18.6, 18.3; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>24</sub>H<sub>27</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 406.2125; <i>m</i>/<i>z</i>: found, 406.2122.</div></div><div id="sec4_1_125" class="NLM_sec NLM_sec_level_3"><div id="ac_i143" class="anchor-spacer"></div><h4 class="article-section__title" id="_i143"> (2<i>S</i>)-<i>N</i>-[(1<i>S</i>)-1-[4-(Cyclobutylmethoxy)phenyl]-2-(5-methyl-1,3,4-oxadiazol-2-yl)ethyl]-2-phenylpropanamide (<b>86</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>72</b> was followed starting with <b>81b</b> and trimethyl orthoacetate to give <b>86</b> (88% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.39–7.17 (m, 5H), 6.96 (d, <i>J</i> = 8.6 Hz, 2H), 6.83–6.65 (m, 2H), 6.25 (d, <i>J</i> = 8.3 Hz, 1H), 5.39 (dd, <i>J</i> = 14.7, 6.6 Hz, 1H), 3.85 (d, <i>J</i> = 6.6 Hz, 2H), 3.57 (q, <i>J</i> = 7.1 Hz, 1H), 3.39–3.09 (m, 2H), 2.80–2.63 (m, 1H), 2.44 (s, 3H), 2.20–2.02 (m, 2H), 2.02–1.65 (m, 4H), 1.47 (d, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.5, 163.9, 158.8, 141.1, 131.6, 128.9, 127.6, 127.2, 127.1, 114.7, 72.1, 49.9, 47.0, 34.6, 31.9, 24.8, 18.5, 18.3, 10.8; HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>25</sub>H<sub>29</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 420.2282; <i>m</i>/<i>z</i>: found, 420.2281.</div></div><div id="sec4_1_126" class="NLM_sec NLM_sec_level_3"><div id="ac_i144" class="anchor-spacer"></div><h4 class="article-section__title" id="_i144"> (2<i>S</i>)-<i>N</i>-[(1<i>S</i>)-2-(5-Amino-1,3,4-oxadiazol-2-yl)-1-[4-(cyclobutylmethoxy)phenyl]ethyl]-2-phenylpropanamide Hydrochloride (<b>87</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>84</b> was followed starting with <b>81b</b> and cyanogen bromide to give <b>87</b> (80% yield) as a white solid. <sup>1</sup>H NMR [free base] (300 MHz, CD<sub>3</sub>OD): δ 7.36–7.14 (m, 5H), 7.10 (d, <i>J</i> = 8.7 Hz, 2H), 6.78 (d, <i>J</i> = 8.7 Hz, 2H), 5.28 (t, <i>J</i> = 7.6 Hz, 1H), 3.87 (d, <i>J</i> = 6.6 Hz, 2H), 3.65 (q, <i>J</i> = 7.0 Hz, 1H), 3.16 (d, <i>J</i> = 7.6 Hz, 2H), 2.84–2.46 (m, 1H), 2.19–2.03 (m, 2H), 2.03–1.64 (m, 4H), 1.39 (d, <i>J</i> = 7.1 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CD<sub>3</sub>OD): δ 176.3, 165.8, 160.2, 159.3, 142.8, 133.6, 129.5, 128.6, 128.4, 127.9, 115.6, 73.2, 51.6, 47.4, 36.1, 32.9, 25.7, 19.3, 18.9; HRMS (ESI) free base <i>m</i>/<i>z</i>: calcd for C<sub>24</sub>H<sub>28</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 421.2234; <i>m</i>/<i>z</i>: found, 421.2231.</div></div><div id="sec4_1_127" class="NLM_sec NLM_sec_level_3"><div id="ac_i145" class="anchor-spacer"></div><h4 class="article-section__title" id="_i145"> (2<i>S</i>)-<i>N</i>-[(1<i>S</i>)-2-(5-Amino-1,3,4-oxadiazol-2-yl)-1-(4-{[(2<i>S</i>)-2-methylpentyl]oxy}phenyl)ethyl]-2-phenylpropanamide Hydrochloride (<b>88</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>84</b> was followed starting with <b>81c</b> and cyanogen bromide to give <b>88</b> (60% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.40–7.16 (m, 5H), 6.98 (d, <i>J</i> = 8.7 Hz, 2H), 6.75 (d, <i>J</i> = 8.6 Hz, 2H), 6.30 (d, <i>J</i> = 8.4 Hz, 1H), 5.35 (dd, <i>J</i> = 14.8, 6.8 Hz, 1H), 5.06 (br s, 2H), 3.81–3.45 (m, 3H), 3.13 (d, <i>J</i> = 6.7 Hz, 2H), 1.95–1.76 (m, 1H), 1.46 (d, <i>J</i> = 7.2 Hz, 3H), 1.43–1.10 (m, 4H), 0.98 (d, <i>J</i> = 6.7 Hz, 3H), 0.91 (t, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.6, 162.8, 158.8, 158.2, 141.1, 131.7, 128.8, 127.6, 127.2, 127.1, 114.7, 73.2, 49.9, 47.0, 35.7, 32.8, 32.0, 20.0, 18.3, 17.0, 14.3; HRMS (ESI) free base <i>m</i>/<i>z</i>: calcd for C<sub>25</sub>H<sub>32</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 437.2547; <i>m</i>/<i>z</i>: found, 437.2537.</div></div><div id="sec4_1_128" class="NLM_sec NLM_sec_level_3"><div id="ac_i146" class="anchor-spacer"></div><h4 class="article-section__title" id="_i146"> (2<i>S</i>)-<i>N</i>-[(1<i>S</i>)-2-(5-Amino-1,3,4-oxadiazol-2-yl)-1-(4-{[(2<i>R</i>)-2-methylpentyl]oxy}phenyl)ethyl]-2-phenylpropanamide Hydrochloride (<b>89</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>84</b> was followed starting with <b>81d</b> and cyanogen bromide to give <b>89</b> (75% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD): δ 7.33–7.16 (m, 5H), 7.12 (d, <i>J</i> = 8.7 Hz, 2H), 6.80 (d, <i>J</i> = 8.6 Hz, 2H), 5.30 (t, <i>J</i> = 7.6 Hz, 1H), 3.84–3.60 (m, 3H), 3.18 (d, <i>J</i> = 7.5 Hz, 2H), 1.97–1.88 (m, 1H), 1.57–1.12 (m, 7H), 1.01 (d, <i>J</i> = 6.7 Hz, 3H), 0.94 (t, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CD<sub>3</sub>OD): δ 176.3, 165.8, 160.2, 159.3, 142.8, 133.5, 129.5, 128.6, 128.4, 127.9, 115.6, 74.3, 51.6, 47.0, 36.9, 34.1, 32.9, 21.1, 18.9, 17.3, 14.6; HRMS (ESI) free base <i>m</i>/<i>z</i>: calcd for C<sub>25</sub>H<sub>32</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 437.2547; <i>m</i>/<i>z</i>: found, 437.2539.</div></div><div id="sec4_1_129" class="NLM_sec NLM_sec_level_3"><div id="ac_i147" class="anchor-spacer"></div><h4 class="article-section__title" id="_i147"> (2<i>S</i>)-<i>N</i>-[(1<i>S</i>)-2-(5-Amino-1,3,4-oxadiazol-2-yl)-1-{4-[(2<i>S</i>)-2-methylbutoxy]phenyl}ethyl]-2-phenylpropanamide Hydrochloride (<b>90</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>84</b> was followed starting with <b>81e</b> and cyanogen bromide to give <b>90</b> (94% yield) as a white solid. <sup>1</sup>H NMR [free base] (300 MHz, CDCl<sub>3</sub>): δ 7.36–7.11 (m, 5H), 7.10–6.97 (m, 3H), 6.71 (d, <i>J</i> = 8.6 Hz, 2H), 6.20 (br s, 2H), 5.41 (dt, <i>J</i> = 14.2, 7.2 Hz, 1H), 3.71 (dd, <i>J</i> = 9.0, 6.0 Hz, 1H), 3.58 (ddd, <i>J</i> = 21.3, 11.5, 6.8 Hz, 2H), 3.16 (qd, <i>J</i> = 15.2, 7.2 Hz, 2H), 1.89–1.71 (m, 1H), 1.63–1.44 (m, 1H), 1.39 (d, <i>J</i> = 7.1 Hz, 3H), 1.30–1.11 (m, 1H), 0.97 (d, <i>J</i> = 6.7 Hz, 3H), 0.92 (t, <i>J</i> = 7.4 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.9, 163.7, 158.8, 157.9, 141.2, 132.0, 128.7, 127.6, 127.2, 127.0, 114.7, 72.9, 49.9, 46.8, 34.7, 32.1, 26.1, 18.4, 16.5, 11.3; HRMS (ESI) free base <i>m</i>/<i>z</i>: calcd for C<sub>24</sub>H<sub>30</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 423.2391; <i>m</i>/<i>z</i>: found, 423.2388.</div></div><div id="sec4_1_130" class="NLM_sec NLM_sec_level_3"><div id="ac_i148" class="anchor-spacer"></div><h4 class="article-section__title" id="_i148"> (2<i>S</i>)-<i>N</i>-[(1<i>S</i>)-2-(5-Amino-1,3,4-oxadiazol-2-yl)-1-{4-[(2<i>R</i>)-2-methylbutoxy]phenyl}ethyl]-2-phenylpropanamide Hydrochloride (<b>91</b>)</h4><div class="NLM_p last">The procedure for the synthesis of <b>84</b> was followed starting with <b>81f</b> and cyanogen bromide to give <b>91</b> (59% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD): δ 7.32–7.02 (m, 5H), 6.93 (d, <i>J</i> = 8.6 Hz, 2H), 6.63 (d, <i>J</i> = 8.7 Hz, 2H), 5.14 (t, <i>J</i> = 7.1 Hz, 1H), 3.77–3.48 (m, 3H), 2.50 (d, <i>J</i> = 7.1 Hz, 2H), 1.76–1.60 (m, 1H), 1.53–1.37 (m, 1H), 1.32 (d, <i>J</i> = 7.1 Hz, 3H), 1.23–1.06 (m, 1H), 0.88 (d, <i>J</i> = 6.7 Hz, 3H), 0.83 (t, <i>J</i> = 7.5 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CD<sub>3</sub>OD): δ 175.9, 172.0, 160.0, 142.9, 134.4, 129.5, 128.5, 128.5, 127.9, 115.4, 73.9, 51.4, 47.5, 41.3, 36.0, 27.2, 18.8, 16.8, 11.6; HRMS (ESI) free base <i>m</i>/<i>z</i>: calcd for C<sub>24</sub>H<sub>30</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 423.2391; <i>m</i>/<i>z</i>: found, 423.2383.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i149" class="anchor-spacer"></div><h3 class="article-section__title" id="_i149"> Pharmacology</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i150" class="anchor-spacer"></div><h4 class="article-section__title" id="_i150"> Materials</h4><div class="NLM_p last">Cell culture materials were purchased from Fisher SSI. Forskolin was purchased from Sigma-Aldrich. The Lance Ultra kit (TRF0262) was purchased from PerkinElmer.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i151" class="anchor-spacer"></div><h4 class="article-section__title" id="_i151"> Lance Ultra cAMP Assay Using Stable PPLS-HA-GPR88 CHO Cells</h4><div class="NLM_p last">All cAMP assays were performed using our previously published methods.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Stimulation buffer containing 1× Hank’s balanced salt solution, 5 mM HEPES, 0.1% BSA stabilizer, and 0.5 mM final IBMX was prepared and titrated to pH 7.4 at room temperature. Serial dilutions of the test compounds (5 μL) and 300 nM forskolin (5 μL), both prepared at 4× the desired final concentration in 2% DMSO/stimulation buffer, were added to a 96-well white 1/2 area microplate (PerkinElmer). A cAMP standard curve was prepared at 4× the desired final concentration in stimulation buffer and 5 μL was added to the assay plate. Stable PPLS-HA-GPR88 CHO cells were lifted with versene and spun at 270<i>g</i> for 10 min. The cell pellet was resuspended in stimulation buffer and 4000 cells (10 μL) were added to each well except for wells containing the cAMP standard curve. After incubating for 30 min at room temperature, Eu-cAMP tracer and uLIGHT-anti-cAMP working solutions were added per the manufacturer’s instructions. After incubation at room temperature for 1 h, the TR-FRET signal (ex 337 nm) was read on a CLARIOstar multimode plate reader (BMG Biotech, Cary, NC).</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i152" class="anchor-spacer"></div><h4 class="article-section__title" id="_i152"> Data Analysis</h4><div class="NLM_p last">The TR-FRET signal (665 nm) was converted to fmol cAMP by interpolating from the standard cAMP curve. fmol cAMP was plotted against the log of compound concentration, and data were fit to a three-parameter logistic curve to generate EC<sub>50</sub> values (Prism, version 6.0, GraphPad Software, Inc., San Diego, CA). The <i>E</i><sub>max</sub> value for each test compound relative to the control compounds RTI-13951-33 or 2-PCCA was calculated using the equation % control <i>E</i><sub>max</sub> = (maximal test compound signal/maximal control signal) × 100.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i153" class="anchor-spacer"></div><h4 class="article-section__title" id="_i153"> [<sup>35</sup>S]GTPγS Binding Assay</h4><div class="NLM_p last">[<sup>35</sup>S]GTPγS binding assays were performed on membrane preparations from wild-type (WT) mice or GPR88 KO mice, following our previously published methods.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> To assess [<sup>35</sup>S]GTPγS binding in the whole striatal region, brains were quickly removed after cervical dislocation and the whole striatal region was dissected out, frozen, and stored at −80 °C until use. Membranes were prepared by homogenizing brain samples in ice-cold 0.25 M sucrose solution 10 vol (mL/g wet weight of tissue). The obtained suspensions were then centrifuged at 2500<i>g</i> for 10 min. Supernatants were collected and diluted 10 times in buffer containing 50 mM Tris HCl (pH 7.4), 3 mM MgCl<sub>2</sub>, 100 mM NaCl, and 0.2 mM EGTA and then centrifuged at 23,000<i>g</i> for 30 min. The pellets were homogenized in 800 μL ice-cold sucrose solution (0.32 M), aliquoted, and kept at −80 °C. For [<sup>35</sup>S]GTPγS binding assays, 2 μg of protein was used per well. Samples were incubated with and without the test compound for 1 h at 25 °C in an assay buffer containing 30 mM GDP and 0.1 nM [<sup>35</sup>S]GTPγS. Bound radioactivity was quantified using a liquid scintillation counter. Nonspecific binding was defined as binding in the presence of 10 μM GTPγS; basal binding refers to binding in the absence of the agonist. Data were expressed as a mean percentage of activation above the basal binding. GTPγS binding by the agonist was plotted with <i>X</i>-axis representing concentration and <i>Y</i>-axis representing the percentage of activation against background. EC<sub>50</sub> values were calculated using GraphPad Prism software.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i154" class="anchor-spacer"></div><h3 class="article-section__title" id="_i154"> Solubility Determination</h3><div class="NLM_p last">For kinetic solubility experiments, 10 mM DMSO stocks of compounds were directly diluted into 10 mM phosphate buffer at pH 7.4 and shaken for 90 min at room temperature. The final concentration of DMSO was 1%. After the incubation, samples were filtered through a 0.4 μm filter plate (Millipore). Filtrates were carefully collected. On each experimental occasion, tamoxifen and caffeine were assessed as reference compounds for low and high solubilities, respectively. All samples were assessed in triplicate and analyzed by LC–MS/MS using electrospray ionization against standards prepared in the same matrix.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i155" class="anchor-spacer"></div><h3 class="article-section__title" id="_i155"> PK Analysis</h3><div class="NLM_p last">PK study of <b>90</b> was performed using male Long-Evans rats (Paraza Pharma Inc., Montreal, Canada). Doses were formulated in 5% dimethylacetamide in sesame oil. On the morning of the PK study, animals were weighed, and dosing formulation volumes were calculated accordingly. The compound was injected intraperitoneally to all animals. At selected time points (0.5, 1, 2, 4, and 8 h postdose), animals were anesthetized to perform a cardiac puncture to collect blood for pooled plasma analysis, followed by whole-body perfusion with phosphate saline buffer (pH 7.4) to wash out any remaining blood from the organs. Brains were harvested and homogenized by polytron 1:4 (w/v) in 25% isopropanol in water. Brain homogenates were further pooled per corresponding time point and extracted for drug quantification of LC–MS/MS. Samples were prepared and analyzed as follows: Plasma (10 μL) was mixed with 10 μL of 0.5% formic acid in water and 100 μL of internal standard working solution (0.1 μM Glyburide/Labetalol in 0.5% ammonium formate in methanol/acetonitrile), vortexed, and centrifuged at 10,000<i>g</i> for 10 min at 4 °C. The supernatant (100 μL) was transferred to a 2 mL deepwell plate and diluted with 200 μL of 30% acetonitrile/water. Brain homogenate (25 μL) was mixed with 25 μL of 0.5% formic acid in water and 150 μL of internal standard working solution (0.1 μM Glyburide/Labetalol in methanol/acetonitrile), vortexed, and centrifuged at 10,000<i>g</i> for 10 min at 4 °C. The supernatant (100 μL) was transferred to a 2 mL deepwell plate and diluted with 100 μL of water. LC–MS/MS was conducted using an Applied Biosystems API 4000 HPLC system. Chromatography was performed with an Xbridge BEH C18 (2.1 × 30 mm, 2.5 μm) column. Mobile phases were 0.1% formic acid in water (A), and 0.1% formic acid in 25% isopropanol/acetonitrile (B). Initial conditions were 5% B and held for 0.5 min, followed by a linear gradient to 95% B over 1.8 min. 95% B was held for 2.6 min before returning to initial conditions.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i156"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01581" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08803" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08803" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01581?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01581</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline"><sup>1</sup>H NMR, <sup>13</sup>C NMR, and HPLC analysis results of target compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01581/suppl_file/jm0c01581_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings with biological data (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01581/suppl_file/jm0c01581_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01581/suppl_file/jm0c01581_si_001.pdf">jm0c01581_si_001.pdf (19.92 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01581/suppl_file/jm0c01581_si_002.csv">jm0c01581_si_002.csv (5.6 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01581" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37437" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37437" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chunyang Jin</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Discovery, Research Triangle Institute, Research Triangle Park, North Carolina 27709, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6733-3094" title="Orcid link">http://orcid.org/0000-0001-6733-3094</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#197a737077596b6d7037766b7e"><span class="__cf_email__" data-cfemail="cdaea7a4a38dbfb9a4e3a2bfaa">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Md Toufiqur Rahman</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Discovery, Research Triangle Institute, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ann M. Decker</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Discovery, Research Triangle Institute, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tiffany L. Langston</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Discovery, Research Triangle Institute, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kelly M. Mathews</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Discovery, Research Triangle Institute, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lucas Laudermilk</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Discovery, Research Triangle Institute, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rangan Maitra</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Discovery, Research Triangle Institute, Research Triangle Park, North Carolina 27709, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6663-6800" title="Orcid link">http://orcid.org/0000-0001-6663-6800</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Weiya Ma</span> - <span class="hlFld-Affiliation affiliation">Douglas
Research Center, Department of Psychiatry, McGill University, Montréal Quebec, H4H 1R3, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emmanuel Darcq</span> - <span class="hlFld-Affiliation affiliation">Douglas
Research Center, Department of Psychiatry, McGill University, Montréal Quebec, H4H 1R3, Canada</span>; 
    <span class="hlFld-Affiliation affiliation">INSERM
U1114, University of Strasbourg, Strasbourg 67085, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8377-8015" title="Orcid link">http://orcid.org/0000-0002-8377-8015</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brigitte L. Kieffer</span> - <span class="hlFld-Affiliation affiliation">Douglas
Research Center, Department of Psychiatry, McGill University, Montréal Quebec, H4H 1R3, Canada</span>; 
    <span class="hlFld-Affiliation affiliation">INSERM
U1114, University of Strasbourg, Strasbourg 67085, France</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li><span class="author-information-subsection-header">Funding</span><p>This work was supported by the National Institute of Mental Health (NIMH, grant MH103708 to C.J.) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA, grant AA026820 to C.J. and B.K.), National Institutes of Health, US.</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, and excretion</p></td></tr><tr><td class="NLM_term">2-AMPP</td><td class="NLM_def"><p class="first last">(2<i>S</i>)-<i>N</i>-((1<i>R</i>)-2-amino-1-(4-(2-methyl-pentyloxy)phenyl)ethyl)-2-phenylpropanamide</p></td></tr><tr><td class="NLM_term">cAMP</td><td class="NLM_def"><p class="first last">cyclic adenosine monophosphate</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">BRET</td><td class="NLM_def"><p class="first last">bioluminescence resonance energy transfer</p></td></tr><tr><td class="NLM_term">CHO cells</td><td class="NLM_def"><p class="first last">Chinese hamster ovary cells</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DEAD</td><td class="NLM_def"><p class="first last">diethyl azodicarboxylate</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">EDC</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-dimethylaminopropyl)carbodiimide</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G protein-coupled receptor</p></td></tr><tr><td class="NLM_term">HA</td><td class="NLM_def"><p class="first last">human influenza hemagglutinin</p></td></tr><tr><td class="NLM_term">HBTU</td><td class="NLM_def"><p class="first last">2-(1<i>H</i>-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">HEK293 cells</td><td class="NLM_def"><p class="first last">human embryonic kidney cells</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">KO</td><td class="NLM_def"><p class="first last">knockout</p></td></tr><tr><td class="NLM_term">MS</td><td class="NLM_def"><p class="first last">mass spectroscopy</p></td></tr><tr><td class="NLM_term">2-PCCA</td><td class="NLM_def"><p class="first last">(1<i>R</i>,2<i>R</i>)-2-(pyridin-2-yl)cyclopropane carboxylic acid((2<i>S</i>,3<i>S</i>)-2-amino-3-methylpentyl)-(4′-propylbiphenyl-4-yl)amide</p></td></tr><tr><td class="NLM_term">Pgp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">PPLS</td><td class="NLM_def"><p class="first last">pre-prolactin leader sequence</p></td></tr><tr><td class="NLM_term">PTSA</td><td class="NLM_def"><p class="first last"><i>p</i>-toluenesulfonic acid</p></td></tr><tr><td class="NLM_term">TBAF</td><td class="NLM_def"><p class="first last">tetrabutylammonium fluoride</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TIPS</td><td class="NLM_def"><p class="first last">triisopropylsilyl</p></td></tr><tr><td class="NLM_term">TIPSCl</td><td class="NLM_def"><p class="first last">triisopropylsilyl chloride</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin-layer chromatography</p></td></tr><tr><td class="NLM_term">TPSA</td><td class="NLM_def"><p class="first last">topological polar surface area</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i159">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03616" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03616" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 39 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mizushima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukahara, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, T.</span></span> <span> </span><span class="NLM_article-title">A novel G-protein-coupled receptor gene expressed in striatum</span>. <i>Genomics</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">314</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1006/geno.2000.6340</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1006%2Fgeno.2000.6340" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=11056049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosVCqsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2000&pages=314-321&author=K.+Mizushimaauthor=Y.+Miyamotoauthor=F.+Tsukaharaauthor=M.+Hiraiauthor=Y.+Sakakiauthor=T.+Ito&title=A+novel+G-protein-coupled+receptor+gene+expressed+in+striatum&doi=10.1006%2Fgeno.2000.6340"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">A novel G-protein-coupled receptor gene expressed in striatum</span></div><div class="casAuthors">Mizushima, Kazuyuki; Miyamoto, Yasuhide; Tsukahara, Fujiko; Hirai, Momoki; Sakaki, Yoshiyuki; Ito, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Genomics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">314-321</span>CODEN:
                <span class="NLM_cas:coden">GNMCEP</span>;
        ISSN:<span class="NLM_cas:issn">0888-7543</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Differential display screening for region-specific transcripts in rat brain revealed a novel striatum-specific transcript encoding an orphan G-protein-coupled receptor (GPCR) designated Strg/Gpr88 for striatum-specific GPCR.  We isolated its homologues from human (HGMW-approved symbol GPR88) and mouse and mapped them to chromosomes 1p21.3 and 3G1, resp.  These loci are syntenic to each other, thereby suggesting their orthol.  The predicted primary sequences of Strg/Gpr88 proteins are highly conserved between human and rodents and show the highest level of homol. to receptors for biogenic amines.  However, Strg/Gpr88 lacks some residues conserved in all known biogenic amine receptors and hence may represent a novel subtype of GPCR.  Northern blot and in situ hybridization analyses revealed that Strg/Gpr88 transcripts are expressed almost exclusively in striatum in both human and rodents.  Remarkable conservation in primary structure and a unique expression pattern may indicate a role for Strg/Gpr88 in the fundamental functions of striatum such as the control of motor behavior.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonYGGyr1F_rLVg90H21EOLACvtfcHk0lg3BgBql6qOpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosVCqsr4%253D&md5=083f323e1b3596d57d622aad487e371b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1006%2Fgeno.2000.6340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fgeno.2000.6340%26sid%3Dliteratum%253Aachs%26aulast%3DMizushima%26aufirst%3DK.%26aulast%3DMiyamoto%26aufirst%3DY.%26aulast%3DTsukahara%26aufirst%3DF.%26aulast%3DHirai%26aufirst%3DM.%26aulast%3DSakaki%26aufirst%3DY.%26aulast%3DIto%26aufirst%3DT.%26atitle%3DA%2520novel%2520G-protein-coupled%2520receptor%2520gene%2520expressed%2520in%2520striatum%26jtitle%3DGenomics%26date%3D2000%26volume%3D69%26spage%3D314%26epage%3D321%26doi%3D10.1006%2Fgeno.2000.6340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghate, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Befort, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, J. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filliol, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bole-Feysot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demebele, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jost, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieffer, B. L.</span></span> <span> </span><span class="NLM_article-title">Identification of novel striatal genes by expression profiling in adult mouse brain</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>146</i></span>,  <span class="NLM_fpage">1182</span>– <span class="NLM_lpage">1192</span>, <span class="refDoi"> DOI: 10.1016/j.neuroscience.2007.02.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1016%2Fj.neuroscience.2007.02.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=17395390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1Sjtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2007&pages=1182-1192&author=A.+Ghateauthor=K.+Befortauthor=J.+A.+J.+Beckerauthor=D.+Filliolauthor=C.+Bole-Feysotauthor=D.+Demebeleauthor=B.+Jostauthor=M.+Kochauthor=B.+L.+Kieffer&title=Identification+of+novel+striatal+genes+by+expression+profiling+in+adult+mouse+brain&doi=10.1016%2Fj.neuroscience.2007.02.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of novel striatal genes by expression profiling in adult mouse brain</span></div><div class="casAuthors">Ghate, A.; Befort, K.; Becker, J. A. J.; Filliol, D.; Bole-Feysot, C.; Demebele, D.; Jost, B.; Koch, M.; Kieffer, B. L.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">146</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1182-1192</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Large-scale transcriptome anal. in the brain is a powerful approach to identify novel genes of potential interest toward understanding cerebral organization and function.  We utilized the microarray technol. to measure expression levels of about 24,000 genes and expressed sequence tags in mouse hippocampus, frontal cortex and striatum.  Using expression profile obtained from whole brain as a ref., we categorized the genes into groups of genes either enriched in, or restricted to, one of the three areas of interest.  We found enriched genes for each target area.  Further, we identified 14 genes in the category of genes restricted to the striatum, among which were the orphan G protein-coupled receptor GPR88 and retinoic acid receptor-beta.  These two genes were already reported to be selectively expressed in the striatum, thus validating our exptl. approach.  We selected 6 striatal-restricted genes, as well as 10 striatal-enriched candidates, that were previously undescribed.  We analyzed their expression by in situ hybridization anal. in the brain, and quant. RT-PCR in both brain and peripheral organs.  Two of these unknown genes displayed a notable expression pattern.  The striatal-restricted gene H3076B11 shows uniform expression throughout and uniquely in the striatum, representing a genuine striatal marker.  The striatal-enriched gene 4833421E05Rik is preferentially expressed in the rostral striatum, and is also abundant in kidney, liver and lung.  These two genes may contribute to some of the many striatal-controlled behaviors, including initiation of movement, habit formation, or reward and motivation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphf3vUv0FcfbVg90H21EOLACvtfcHk0lgFuBKH-g1lNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1Sjtr4%253D&md5=2c5b56fbbc6ea93e9ed698f90b0db3dc</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2007.02.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2007.02.040%26sid%3Dliteratum%253Aachs%26aulast%3DGhate%26aufirst%3DA.%26aulast%3DBefort%26aufirst%3DK.%26aulast%3DBecker%26aufirst%3DJ.%2BA.%2BJ.%26aulast%3DFilliol%26aufirst%3DD.%26aulast%3DBole-Feysot%26aufirst%3DC.%26aulast%3DDemebele%26aufirst%3DD.%26aulast%3DJost%26aufirst%3DB.%26aulast%3DKoch%26aufirst%3DM.%26aulast%3DKieffer%26aufirst%3DB.%2BL.%26atitle%3DIdentification%2520of%2520novel%2520striatal%2520genes%2520by%2520expression%2520profiling%2520in%2520adult%2520mouse%2520brain%26jtitle%3DNeuroscience%26date%3D2007%26volume%3D146%26spage%3D1182%26epage%3D1192%26doi%3D10.1016%2Fj.neuroscience.2007.02.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Massart, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guilloux, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mignon, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sokoloff, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, J.</span></span> <span> </span><span class="NLM_article-title">Striatal GPR88 expression is confined to the whole projection neuron population and is regulated by dopaminergic and glutamatergic afferents</span>. <i>Eur. J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">397</span>– <span class="NLM_lpage">414</span>, <span class="refDoi"> DOI: 10.1111/j.1460-9568.2009.06842.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1111%2Fj.1460-9568.2009.06842.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=19656174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A280%3ADC%252BD1MrmtVWgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=397-414&author=R.+Massartauthor=J.-P.+Guillouxauthor=V.+Mignonauthor=P.+Sokoloffauthor=J.+Diaz&title=Striatal+GPR88+expression+is+confined+to+the+whole+projection+neuron+population+and+is+regulated+by+dopaminergic+and+glutamatergic+afferents&doi=10.1111%2Fj.1460-9568.2009.06842.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Striatal GPR88 expression is confined to the whole projection neuron population and is regulated by dopaminergic and glutamatergic afferents</span></div><div class="casAuthors">Massart Renaud; Guilloux Jean-Philippe; Mignon Virginie; Sokoloff Pierre; Diaz Jorge</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">397-414</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">GPR88, an orphan G protein-coupled receptor, was designated Strg/GPR88 for striatum-specific G protein-coupled receptor (K.  Mizushima et al. (2000)Genomics, 69, 314-321).  In this study, we focused on striatal GPR88 protein localization using a polyclonal antibody.  We established that the distribution of immunoreactivity in rat brain matched that of GPR88 transcripts and provided evidence for its exclusive neuronal expression.  GPR88 protein is abundant throughout the striatum of rat and primate, with expression limited to the two subsets of striatal projection medium spiny neurons (MSNs) expressing preprotachykinin-substance P or preproenkephalin mRNAs.  Ultrastructural immunolabelling revealed the GPR88 concentration at post-synaptic sites along the somatodendritic compartments of MSNs, with pronounced preference for dendrites and dendritic spines.  The GPR88-rich expression, in both striatal output pathways, designates this receptor as a potential therapeutic target for diseases involving dysfunction of the basal ganglia, such as Parkinson's disease.  Hence, we investigated changes of GPR88 expression in a model of Parkinson's disease (unilateral 6-hydroxydopamine-lesioned rats) following repeated L-DOPA treatment.  In dopamine-depleted striatum, GPR88 expression was differentially regulated, i.e. decreased in striatopallidal and increased in striatonigral MSNs.  L-DOPA treatment led to a normalization of GPR88 levels through dopamine D1 and D2 receptor-mediated mechanisms in striatopallidal and striatonigral MSNs, respectively.  Moreover, the removal of corticostriatal inputs, by ibotenate infusion, downregulated GPR88 in striatopallidal MSNs.  These findings provide the first evidence that GPR88 is confined to striatal MSNs and indicate that L-DOPA-mediated behavioural effects in hemiparkinsonian rats may involve normalization of striatal GPR88 levels probably through dopamine receptor-mediated mechanisms and modulations of corticostriatal pathway activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT7FouKlwBWEftos8R3JUhXfW6udTcc2eayT8cb7nKUSLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MrmtVWgtQ%253D%253D&md5=a1d34c936414e98d4ae80d5670038d8a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fj.1460-9568.2009.06842.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1460-9568.2009.06842.x%26sid%3Dliteratum%253Aachs%26aulast%3DMassart%26aufirst%3DR.%26aulast%3DGuilloux%26aufirst%3DJ.-P.%26aulast%3DMignon%26aufirst%3DV.%26aulast%3DSokoloff%26aufirst%3DP.%26aulast%3DDiaz%26aufirst%3DJ.%26atitle%3DStriatal%2520GPR88%2520expression%2520is%2520confined%2520to%2520the%2520whole%2520projection%2520neuron%2520population%2520and%2520is%2520regulated%2520by%2520dopaminergic%2520and%2520glutamatergic%2520afferents%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2009%26volume%3D30%26spage%3D397%26epage%3D414%26doi%3D10.1111%2Fj.1460-9568.2009.06842.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
Waes, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, H.</span></span> <span> </span><span class="NLM_article-title">GPR88: A putative signaling molecule predominantly expressed in the striatum: Cellular localization and developmental regulation</span>. <i>Basal Ganglia</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">89</span>, <span class="refDoi"> DOI: 10.1016/j.baga.2011.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1016%2Fj.baga.2011.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=21804954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A280%3ADC%252BC2srisVClsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=83-89&author=V.+Van%0AWaesauthor=K.+Y.+Tsengauthor=H.+Steiner&title=GPR88%3A+A+putative+signaling+molecule+predominantly+expressed+in+the+striatum%3A+Cellular+localization+and+developmental+regulation&doi=10.1016%2Fj.baga.2011.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">GPR88 - a putative signaling molecule predominantly expressed in the striatum: Cellular localization and developmental regulation</span></div><div class="casAuthors">Van Waes Vincent; Tseng Kuei Y; Steiner Heinz</div><div class="citationInfo"><span class="NLM_cas:title">Basal ganglia</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">83-89</span>
        ISSN:<span class="NLM_cas:issn">2210-5336</span>.
    </div><div class="casAbstract">GPR88 is a putative G-protein-coupled receptor that is highly and almost exclusively expressed in the striatum.  Its function remains unknown.  We investigated GPR88 cellular localization and expression levels across development in different functional domains of the striatum in juvenile (P25), adolescent (P40), and adult (P70) rats, by in situ hybridization histochemistry.  At all ages, GPR88 mRNA expression was most robust in the sensorimotor (lateral) striatum and was detected in virtually every neuron.  Expression was highest in juveniles and decreased thereafter with regionally distinct trajectories.  Thus, in the dorsal striatum, there was a progressive decrease from juveniles to adolescents to adults.  In contrast, in the nucleus accumbens, the only (modest) decrease occurred between juveniles and adolescents.  These findings indicate that GPR88 is expressed in all striatal neurons, but is differentially regulated across development in different striatal regions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQlTwP-2_q2SJggzHGM8X5CfW6udTcc2eayT8cb7nKUSLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2srisVClsA%253D%253D&md5=48eeca69729ca864b85f65198413f101</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.baga.2011.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.baga.2011.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BWaes%26aufirst%3DV.%26aulast%3DTseng%26aufirst%3DK.%2BY.%26aulast%3DSteiner%26aufirst%3DH.%26atitle%3DGPR88%253A%2520A%2520putative%2520signaling%2520molecule%2520predominantly%2520expressed%2520in%2520the%2520striatum%253A%2520Cellular%2520localization%2520and%2520developmental%2520regulation%26jtitle%3DBasal%2520Ganglia%26date%3D2011%26volume%3D1%26spage%3D83%26epage%3D89%26doi%3D10.1016%2Fj.baga.2011.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becker, J. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Befort, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blad, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filliol, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghate, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dembele, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thibault, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lardenois, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poch, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieffer, B. L.</span></span> <span> </span><span class="NLM_article-title">Transcriptome analysis identifies genes with enriched expression in the mouse central extended amygdala</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>156</i></span>,  <span class="NLM_fpage">950</span>– <span class="NLM_lpage">965</span>, <span class="refDoi"> DOI: 10.1016/j.neuroscience.2008.07.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1016%2Fj.neuroscience.2008.07.070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=18786617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlSgsrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2008&pages=950-965&author=J.+A.+J.+Beckerauthor=K.+Befortauthor=C.+Bladauthor=D.+Filliolauthor=A.+Ghateauthor=D.+Dembeleauthor=C.+Thibaultauthor=M.+Kochauthor=J.+Mullerauthor=A.+Lardenoisauthor=O.+Pochauthor=B.+L.+Kieffer&title=Transcriptome+analysis+identifies+genes+with+enriched+expression+in+the+mouse+central+extended+amygdala&doi=10.1016%2Fj.neuroscience.2008.07.070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Transcriptome analysis identifies genes with enriched expression in the mouse central extended amygdala</span></div><div class="casAuthors">Becker, J. A. J.; Befort, K.; Blad, C.; Filliol, D.; Ghate, A.; Dembele, D.; Thibault, C.; Koch, M.; Muller, J.; Lardenois, A.; Poch, O.; Kieffer, B. L.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">950-965</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The central extended amygdala (EAc) is an ensemble of highly interconnected limbic structures of the anterior brain, and forms a cellular continuum including the bed nucleus of the stria terminalis (BNST), the central nucleus of the amygdala (CeA) and the nucleus accumbens shell (AcbSh).  This neural network is a key site for interactions between brain reward and stress systems, and has been implicated in several aspects of drug abuse.  In order to increase our understanding of EAc function at the mol. level, we undertook a genome-wide screen (Affymetrix) to identify genes whose expression is enriched in the mouse EAc.  We focused on the less-well known BNST-CeA areas of the EAc, and identified 121 genes that exhibit more than twofold higher expression level in the EAc compared with whole brain.  Among these, 43 genes have never been described to be expressed in the EAc.  We mapped these genes throughout the brain, using non-radioactive in situ hybridization, and identified eight genes with a unique and distinct rostro-caudal expression pattern along AcbSh, BNST and CeA.  Q-PCR anal. performed in brain and peripheral organ tissues indicated that, with the exception of one (Spata13), all these genes are predominantly expressed in brain.  These genes encode signaling proteins (Adora2, GPR88, Arpp21 and Rem2), a transcription factor (Limh6) or proteins of unknown function (Rik130, Spata13 and Wfs1).  The identification of genes with enriched expression expands our knowledge of EAc at a mol. level, and provides useful information to toward genetic manipulations within the EAc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxgJBYmSPX1bVg90H21EOLACvtfcHk0liCV849mjpYUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlSgsrbJ&md5=acddb2e181359ad30074a67401b23b63</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2008.07.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2008.07.070%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DJ.%2BA.%2BJ.%26aulast%3DBefort%26aufirst%3DK.%26aulast%3DBlad%26aufirst%3DC.%26aulast%3DFilliol%26aufirst%3DD.%26aulast%3DGhate%26aufirst%3DA.%26aulast%3DDembele%26aufirst%3DD.%26aulast%3DThibault%26aufirst%3DC.%26aulast%3DKoch%26aufirst%3DM.%26aulast%3DMuller%26aufirst%3DJ.%26aulast%3DLardenois%26aufirst%3DA.%26aulast%3DPoch%26aufirst%3DO.%26aulast%3DKieffer%26aufirst%3DB.%2BL.%26atitle%3DTranscriptome%2520analysis%2520identifies%2520genes%2520with%2520enriched%2520expression%2520in%2520the%2520mouse%2520central%2520extended%2520amygdala%26jtitle%3DNeuroscience%26date%3D2008%26volume%3D156%26spage%3D950%26epage%3D965%26doi%3D10.1016%2Fj.neuroscience.2008.07.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bates, B.</span>; <span class="NLM_string-name">Logue, S. F.</span>; <span class="NLM_string-name">Pausch, M.</span></span> <span> </span><span class="NLM_article-title">Methods of Identifying Agents for Treatment of Schizophrenia and Related Disorders</span>. U.S. Patent <span class="NLM_patent">0,040,819 A1</span>, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=B.+Bates&author=S.+F.+Logue&author=M.+Pausch&title=Methods+of+Identifying+Agents+for+Treatment+of+Schizophrenia+and+Related+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBates%26aufirst%3DB.%26atitle%3DMethods%2520of%2520Identifying%2520Agents%2520for%2520Treatment%2520of%2520Schizophrenia%2520and%2520Related%2520Disorders%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Logue, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grauer, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulsen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graf, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sung, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pulito, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig-Lipson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandon, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pausch, M.</span></span> <span> </span><span class="NLM_article-title">The orphan GPCR, GPR88, modulates function of the striatal dopamine system: a possible therapeutic target for psychiatric disorders?</span>. <i>Mol. Cell. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">438</span>– <span class="NLM_lpage">447</span>, <span class="refDoi"> DOI: 10.1016/j.mcn.2009.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1016%2Fj.mcn.2009.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=19796684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVaju73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2009&pages=438-447&author=S.+F.+Logueauthor=S.+M.+Grauerauthor=J.+Paulsenauthor=R.+Grafauthor=N.+Taylorauthor=M.+A.+Sungauthor=L.+Zhangauthor=Z.+Hughesauthor=V.+L.+Pulitoauthor=F.+Liuauthor=S.+Rosenzweig-Lipsonauthor=N.+J.+Brandonauthor=K.+L.+Marquisauthor=B.+Batesauthor=M.+Pausch&title=The+orphan+GPCR%2C+GPR88%2C+modulates+function+of+the+striatal+dopamine+system%3A+a+possible+therapeutic+target+for+psychiatric+disorders%3F&doi=10.1016%2Fj.mcn.2009.09.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The orphan GPCR, GPR88, modulates function of the striatal dopamine system: A possible therapeutic target for psychiatric disorders?</span></div><div class="casAuthors">Logue, Sheree F.; Grauer, Steven M.; Paulsen, Janet; Graf, Radka; Taylor, Noel; Sung, M. Amy; Zhang, Lynn; Hughes, Zoe; Pulito, Virginia L.; Liu, Feng; Rosenzweig-Lipson, Sharon; Brandon, Nicholas J.; Marquis, Karen L.; Bates, Brian; Pausch, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">438-447</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In rodents, the orphan G protein-coupled receptor, Gpr88, is highly expressed in brain regions implicated in the pathophysiol. of and is modulated by treatments for schizophrenia.  We compared striatal function of Gpr88 knockout mice (Gpr88KOs) to wild-type mice using mol., neurochem. and behavioral tests.  Gpr88KOs lacked expression of Gpr88 in striatum, nucleus accumbens and layer IV of cortex.  Gpr88KOs had normal striatal dopamine D2 receptor d. and affinity and DARPP-32 expression but Gpr88KOs had higher basal striatal phosphorylated DARPP-32 Thr-34.  In vivo microdialysis detected lower basal dopamine in Gpr88KOs while amphetamine-induced dopamine release was normal.  Behaviorally, Gpr88KOs demonstrated disrupted prepulse inhibition of startle (PPI) and increased sensitivity to apomorphine-induced climbing and stereotypy (AICS) and amphetamine-stimulated locomotor activity.  Antipsychotic administration to Gpr88KOs normalized the PPI deficit and blocked AICS.  The modulatory role of Gpr88 in striatal dopamine function suggests it may be a new target for treatments for psychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVBeUcz-AbdbVg90H21EOLACvtfcHk0liCV849mjpYUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVaju73I&md5=ffccbf40b5a945696b0ea10ebc19c39a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.mcn.2009.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mcn.2009.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DLogue%26aufirst%3DS.%2BF.%26aulast%3DGrauer%26aufirst%3DS.%2BM.%26aulast%3DPaulsen%26aufirst%3DJ.%26aulast%3DGraf%26aufirst%3DR.%26aulast%3DTaylor%26aufirst%3DN.%26aulast%3DSung%26aufirst%3DM.%2BA.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DHughes%26aufirst%3DZ.%26aulast%3DPulito%26aufirst%3DV.%2BL.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26aulast%3DBrandon%26aufirst%3DN.%2BJ.%26aulast%3DMarquis%26aufirst%3DK.%2BL.%26aulast%3DBates%26aufirst%3DB.%26aulast%3DPausch%26aufirst%3DM.%26atitle%3DThe%2520orphan%2520GPCR%252C%2520GPR88%252C%2520modulates%2520function%2520of%2520the%2520striatal%2520dopamine%2520system%253A%2520a%2520possible%2520therapeutic%2520target%2520for%2520psychiatric%2520disorders%253F%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D2009%26volume%3D42%26spage%3D438%26epage%3D447%26doi%3D10.1016%2Fj.mcn.2009.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quintana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storey, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Güler, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanat, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roller, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Torre, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amieux, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKnight, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bamford, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmiter, R. D.</span></span> <span> </span><span class="NLM_article-title">Lack of GPR88 enhances medium spiny neuron activity and alters motor- and cue-dependent behaviors</span>. <i>Nat. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1547</span>– <span class="NLM_lpage">1555</span>, <span class="refDoi"> DOI: 10.1038/nn.3239</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1038%2Fnn.3239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=23064379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsV2rsbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2012&pages=1547-1555&author=A.+Quintanaauthor=E.+Sanzauthor=W.+Wangauthor=G.+P.+Storeyauthor=A.+D.+G%C3%BClerauthor=M.+J.+Wanatauthor=B.+A.+Rollerauthor=A.+La+Torreauthor=P.+S.+Amieuxauthor=G.+S.+McKnightauthor=N.+S.+Bamfordauthor=R.+D.+Palmiter&title=Lack+of+GPR88+enhances+medium+spiny+neuron+activity+and+alters+motor-+and+cue-dependent+behaviors&doi=10.1038%2Fnn.3239"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Lack of GPR88 enhances medium spiny neuron activity and alters motor- and cue-dependent behaviors</span></div><div class="casAuthors">Quintana, Albert; Sanz, Elisenda; Wang, Wengang; Storey, Granville P.; Gueler, Ali D.; Wanat, Matthew J.; Roller, Bryan A.; La Torre, Anna; Amieux, Paul S.; McKnight, G. Stanley; Bamford, Nigel S.; Palmiter, Richard D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1547-1555</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The striatum regulates motor control, reward and learning.  Abnormal function of striatal GABAergic medium spiny neurons (MSNs) is believed to contribute to the deficits in these processes that are obsd. in many neuropsychiatric diseases.  The orphan G protein-coupled receptor GPR88 is robustly expressed in MSNs and is regulated by neuropharmacol. drugs, but its contribution to MSN physiol. and behavior is unclear.  We found that, in the absence of GPR88, MSNs showed increased glutamatergic excitation and reduced GABAergic inhibition, which promoted enhanced firing rates in vivo, resulting in hyperactivity, poor motor coordination and impaired cue-based learning in mice.  Targeted viral expression of GPR88 in MSNs rescued the mol. and electrophysiol. properties and normalized behavior, suggesting that aberrant MSN activation in the absence of GPR88 underlies behavioral deficits and its dysfunction may contribute to behaviors obsd. in neuropsychiatric disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgZhWCHnaKlrVg90H21EOLACvtfcHk0lhGIcb795KcwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsV2rsbbF&md5=8241862c3f7a1a411d56b172e1aff36c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnn.3239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.3239%26sid%3Dliteratum%253Aachs%26aulast%3DQuintana%26aufirst%3DA.%26aulast%3DSanz%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DStorey%26aufirst%3DG.%2BP.%26aulast%3DG%25C3%25BCler%26aufirst%3DA.%2BD.%26aulast%3DWanat%26aufirst%3DM.%2BJ.%26aulast%3DRoller%26aufirst%3DB.%2BA.%26aulast%3DLa%2BTorre%26aufirst%3DA.%26aulast%3DAmieux%26aufirst%3DP.%2BS.%26aulast%3DMcKnight%26aufirst%3DG.%2BS.%26aulast%3DBamford%26aufirst%3DN.%2BS.%26aulast%3DPalmiter%26aufirst%3DR.%2BD.%26atitle%3DLack%2520of%2520GPR88%2520enhances%2520medium%2520spiny%2520neuron%2520activity%2520and%2520alters%2520motor-%2520and%2520cue-dependent%2520behaviors%26jtitle%3DNat.%2520Neurosci.%26date%3D2012%26volume%3D15%26spage%3D1547%26epage%3D1555%26doi%3D10.1038%2Fnn.3239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arefin, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mechling, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meirsman, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bienert, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben Hamida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehrlich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roquet, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennig, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Elverfeldt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieffer, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harsan, L.-A.</span></span> <span> </span><span class="NLM_article-title">Remodeling of sensorimotor brain connectivity in Gpr88-deficient mice</span>. <i>Brain Connect.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">526</span>– <span class="NLM_lpage">540</span>, <span class="refDoi"> DOI: 10.1089/brain.2017.0486</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1089%2Fbrain.2017.0486" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=28882062" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A280%3ADC%252BC1cblslWquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=526-540&author=T.+M.+Arefinauthor=A.+E.+Mechlingauthor=A.+C.+Meirsmanauthor=T.+Bienertauthor=N.+S.+H%C3%BCbnerauthor=H.-L.+Leeauthor=S.+Ben+Hamidaauthor=A.+Ehrlichauthor=D.+Roquetauthor=J.+Hennigauthor=D.+von+Elverfeldtauthor=B.+L.+Kiefferauthor=L.-A.+Harsan&title=Remodeling+of+sensorimotor+brain+connectivity+in+Gpr88-deficient+mice&doi=10.1089%2Fbrain.2017.0486"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Remodeling of Sensorimotor Brain Connectivity in Gpr88-Deficient Mice</span></div><div class="casAuthors">Arefin Tanzil Mahmud; Mechling Anna E; Bienert Thomas; Hubner Neele Saskia; Lee Hsu-Lei; Hennig Jurgen; von Elverfeldt Dominik; Harsan Laura-Adela; Arefin Tanzil Mahmud; Mechling Anna E; Hubner Neele Saskia; Arefin Tanzil Mahmud; Arefin Tanzil Mahmud; Meirsman Aura Carole; Ben Hamida Sami; Ehrlich Aliza; Kieffer Brigitte Lina; Meirsman Aura Carole; Ben Hamida Sami; Ehrlich Aliza; Kieffer Brigitte Lina; Roquet Dan; Harsan Laura-Adela; Harsan Laura-Adela</div><div class="citationInfo"><span class="NLM_cas:title">Brain connectivity</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">526-540</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Recent studies have demonstrated that orchestrated gene activity and expression support synchronous activity of brain networks.  However, there is a paucity of information on the consequences of single gene function on overall brain functional organization and connectivity and how this translates at the behavioral level.  In this study, we combined mouse mutagenesis with functional and structural magnetic resonance imaging (MRI) to determine whether targeted inactivation of a single gene would modify whole-brain connectivity in live animals.  The targeted gene encodes GPR88 (G protein-coupled receptor 88), an orphan G protein-coupled receptor enriched in the striatum and previously linked to behavioral traits relevant to neuropsychiatric disorders.  Connectivity analysis of Gpr88-deficient mice revealed extensive remodeling of intracortical and cortico-subcortical networks.  Most prominent modifications were observed at the level of retrosplenial cortex connectivity, central to the default mode network (DMN) whose alteration is considered a hallmark of many psychiatric conditions.  Next, somatosensory and motor cortical networks were most affected.  These modifications directly relate to sensorimotor gating deficiency reported in mutant animals and also likely underlie their hyperactivity phenotype.  Finally, we identified alterations within hippocampal and dorsal striatum functional connectivity, most relevant to a specific learning deficit that we previously reported in Gpr88(-/-) animals.  In addition, amygdala connectivity with cortex and striatum was weakened, perhaps underlying the risk-taking behavior of these animals.  This is the first evidence demonstrating that GPR88 activity shapes the mouse brain functional and structural connectome.  The concordance between connectivity alterations and behavior deficits observed in Gpr88-deficient mice suggests a role for GPR88 in brain communication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRh_DRjxLxXkvEeosoOnpOLfW6udTcc2eaJjZjfqwYUh7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cblslWquw%253D%253D&md5=4eceb22496981306c73fec973b9987d1</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1089%2Fbrain.2017.0486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fbrain.2017.0486%26sid%3Dliteratum%253Aachs%26aulast%3DArefin%26aufirst%3DT.%2BM.%26aulast%3DMechling%26aufirst%3DA.%2BE.%26aulast%3DMeirsman%26aufirst%3DA.%2BC.%26aulast%3DBienert%26aufirst%3DT.%26aulast%3DH%25C3%25BCbner%26aufirst%3DN.%2BS.%26aulast%3DLee%26aufirst%3DH.-L.%26aulast%3DBen%2BHamida%26aufirst%3DS.%26aulast%3DEhrlich%26aufirst%3DA.%26aulast%3DRoquet%26aufirst%3DD.%26aulast%3DHennig%26aufirst%3DJ.%26aulast%3Dvon%2BElverfeldt%26aufirst%3DD.%26aulast%3DKieffer%26aufirst%3DB.%2BL.%26aulast%3DHarsan%26aufirst%3DL.-A.%26atitle%3DRemodeling%2520of%2520sensorimotor%2520brain%2520connectivity%2520in%2520Gpr88-deficient%2520mice%26jtitle%3DBrain%2520Connect.%26date%3D2017%26volume%3D7%26spage%3D526%26epage%3D540%26doi%3D10.1089%2Fbrain.2017.0486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ben
Hamida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendonça-Netto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arefin, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasseef, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boulos, L.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNicholas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehrlich, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moquin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gratton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darcq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harsan, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maldonado, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieffer, B. L.</span></span> <span> </span><span class="NLM_article-title">Increased alcohol seeking in mice lacking Gpr88 involves dysfunctional mesocorticolimbic networks</span>. <i>Biol. Psychiatr.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1016/j.biopsych.2018.01.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1016%2Fj.biopsych.2018.01.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=29580570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmtVWqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2018&pages=202-212&author=S.+Ben%0AHamidaauthor=S.+Mendon%C3%A7a-Nettoauthor=T.+M.+Arefinauthor=M.+T.+Nasseefauthor=L.-J.+Boulosauthor=M.+McNicholasauthor=A.+T.+Ehrlichauthor=E.+Clarkeauthor=L.+Moquinauthor=A.+Grattonauthor=E.+Darcqauthor=L.+A.+Harsanauthor=R.+Maldonadoauthor=B.+L.+Kieffer&title=Increased+alcohol+seeking+in+mice+lacking+Gpr88+involves+dysfunctional+mesocorticolimbic+networks&doi=10.1016%2Fj.biopsych.2018.01.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Increased Alcohol Seeking in Mice Lacking Gpr88 Involves Dysfunctional Mesocorticolimbic Networks</span></div><div class="casAuthors">Ben Hamida, Sami; Mendonca-Netto, Sueli; Arefin, Tanzil Mahmud; Nasseef, Md. Taufiq; Boulos, Laura-Joy; McNicholas, Michael; Ehrlich, Aliza Toby; Clarke, Eleanor; Moquin, Luc; Gratton, Alain; Darcq, Emmanuel; Harsan, Laura Adela; Maldonado, Rafael; Kieffer, Brigitte Lina</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">202-212</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Alc. use disorder (AUD) is devastating and poorly treated, and innovative targets are actively sought for prevention and treatment.  The orphan G protein-coupled receptor GPR88 is enriched in mesocorticolimbic pathways, and Gpr88 knockout mice show hyperactivity and risk-taking behavior, but a potential role for this receptor in drug abuse has not been examd.  We tested Gpr88 knockout mice for alc.-drinking and -seeking behaviors.  To gain system-level understanding of their alc. endophenotype, we also analyzed whole-brain functional connectivity in naive mice using resting-state functional magnetic resonance imaging.  Gpr88 knockout mice showed increased voluntary alc. drinking at both moderate and excessive levels, with intact alc. sedation and metab.  Mutant mice also showed increased operant responding and motivation for alc., while food and chocolate operant self-administration were unchanged.  Alc. place conditioning and alc.-induced dopamine release in the nucleus accumbens were decreased, suggesting reduced alc. reward in mutant mice that may partly explain enhanced alc. drinking.  Seed-based voxelwise functional connectivity anal. revealed significant remodeling of mesocorticolimbic centers, whose hallmark was predominant weakening of prefrontal cortex, ventral tegmental area, and amygdala connectional patterns.  Also, effective connectivity from the ventral tegmental area to the nucleus accumbens and amygdala was reduced.  Gpr88 deletion disrupts executive, reward, and emotional networks in a configuration that reduces alc. reward and promotes alc. seeking and drinking.  The functional connectivity signature is reminiscent of alterations obsd. in individuals at risk for AUD.  The Gpr88 gene, therefore, may represent a vulnerability/resilience factor for AUD, and a potential drug target for AUD treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOfRTmTEAe5bVg90H21EOLACvtfcHk0lhGIcb795KcwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmtVWqsbo%253D&md5=42c6ef0992d27ea61bb85cbdbc73e787</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2018.01.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2018.01.026%26sid%3Dliteratum%253Aachs%26aulast%3DBen%2BHamida%26aufirst%3DS.%26aulast%3DMendon%25C3%25A7a-Netto%26aufirst%3DS.%26aulast%3DArefin%26aufirst%3DT.%2BM.%26aulast%3DNasseef%26aufirst%3DM.%2BT.%26aulast%3DBoulos%26aufirst%3DL.-J.%26aulast%3DMcNicholas%26aufirst%3DM.%26aulast%3DEhrlich%26aufirst%3DA.%2BT.%26aulast%3DClarke%26aufirst%3DE.%26aulast%3DMoquin%26aufirst%3DL.%26aulast%3DGratton%26aufirst%3DA.%26aulast%3DDarcq%26aufirst%3DE.%26aulast%3DHarsan%26aufirst%3DL.%2BA.%26aulast%3DMaldonado%26aufirst%3DR.%26aulast%3DKieffer%26aufirst%3DB.%2BL.%26atitle%3DIncreased%2520alcohol%2520seeking%2520in%2520mice%2520lacking%2520Gpr88%2520involves%2520dysfunctional%2520mesocorticolimbic%2520networks%26jtitle%3DBiol.%2520Psychiatr.%26date%3D2018%26volume%3D84%26spage%3D202%26epage%3D212%26doi%3D10.1016%2Fj.biopsych.2018.01.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maroteaux, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arefin, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harsan, L.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darcq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben Hamida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieffer, B. L.</span></span> <span> </span><span class="NLM_article-title">Lack of anticipatory behavior in Gpr88 knockout mice showed by automatized home cage phenotyping</span>. <i>Genes, Brain Behav.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>, <span class="NLM_elocation-id">e12473</span> <span class="refDoi"> DOI: 10.1111/gbb.12473</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1111%2Fgbb.12473" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=29575471" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&author=G.+Maroteauxauthor=T.+M.+Arefinauthor=L.-A.+Harsanauthor=E.+Darcqauthor=S.+Ben+Hamidaauthor=B.+L.+Kieffer&title=Lack+of+anticipatory+behavior+in+Gpr88+knockout+mice+showed+by+automatized+home+cage+phenotyping&doi=10.1111%2Fgbb.12473"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1111%2Fgbb.12473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fgbb.12473%26sid%3Dliteratum%253Aachs%26aulast%3DMaroteaux%26aufirst%3DG.%26aulast%3DArefin%26aufirst%3DT.%2BM.%26aulast%3DHarsan%26aufirst%3DL.-A.%26aulast%3DDarcq%26aufirst%3DE.%26aulast%3DBen%2BHamida%26aufirst%3DS.%26aulast%3DKieffer%26aufirst%3DB.%2BL.%26atitle%3DLack%2520of%2520anticipatory%2520behavior%2520in%2520Gpr88%2520knockout%2520mice%2520showed%2520by%2520automatized%2520home%2520cage%2520phenotyping%26jtitle%3DGenes%252C%2520Brain%2520Behav.%26date%3D2018%26volume%3D17%26doi%3D10.1111%2Fgbb.12473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meirsman, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben Hamida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Kerchove d’Exaerde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darcq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieffer, B. L.</span></span> <span> </span><span class="NLM_article-title">GPR88 in D1R-type and D2R-type medium spiny neurons differentially regulates affective and motor behavior</span>. <i>eNeuro</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">ENEURO.0035-19.2019</span> <span class="refDoi"> DOI: 10.1523/eneuro.0035-19.2019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1523%2FENEURO.0035-19.2019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2019&author=A.+C.+Meirsmanauthor=S.+Ben+Hamidaauthor=E.+Clarkeauthor=A.+de+Kerchove+d%E2%80%99Exaerdeauthor=E.+Darcqauthor=B.+L.+Kieffer&title=GPR88+in+D1R-type+and+D2R-type+medium+spiny+neurons+differentially+regulates+affective+and+motor+behavior&doi=10.1523%2Feneuro.0035-19.2019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1523%2FENEURO.0035-19.2019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FENEURO.0035-19.2019%26sid%3Dliteratum%253Aachs%26aulast%3DMeirsman%26aufirst%3DA.%2BC.%26aulast%3DBen%2BHamida%26aufirst%3DS.%26aulast%3DClarke%26aufirst%3DE.%26aulast%3Dde%2BKerchove%2Bd%25E2%2580%2599Exaerde%26aufirst%3DA.%26aulast%3DDarcq%26aufirst%3DE.%26aulast%3DKieffer%26aufirst%3DB.%2BL.%26atitle%3DGPR88%2520in%2520D1R-type%2520and%2520D2R-type%2520medium%2520spiny%2520neurons%2520differentially%2520regulates%2520affective%2520and%2520motor%2520behavior%26jtitle%3DeNeuro%26date%3D2019%26volume%3D6%26doi%3D10.1523%2Feneuro.0035-19.2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meirsman, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Kerchove d’Exaerde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieffer, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouagazzal, A.-M.</span></span> <span> </span><span class="NLM_article-title">GPR88 in A2A receptor-expressing neurons modulates locomotor response to dopamine agonists but not sensorimotor gating</span>. <i>Eur. J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">2026</span>– <span class="NLM_lpage">2034</span>, <span class="refDoi"> DOI: 10.1111/ejn.13646</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1111%2Fejn.13646" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=28700108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A280%3ADC%252BC1cjmvVWjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2017&pages=2026-2034&author=A.+C.+Meirsmanauthor=A.+de+Kerchove+d%E2%80%99Exaerdeauthor=B.+L.+Kiefferauthor=A.-M.+Ouagazzal&title=GPR88+in+A2A+receptor-expressing+neurons+modulates+locomotor+response+to+dopamine+agonists+but+not+sensorimotor+gating&doi=10.1111%2Fejn.13646"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">GPR88 in A2A receptor-expressing neurons modulates locomotor response to dopamine agonists but not sensorimotor gating</span></div><div class="casAuthors">Meirsman A C; Kieffer B L; Ouagazzal A-M; Meirsman A C; de Kerchove d'Exaerde A; Kieffer B L; Ouagazzal A-M</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2026-2034</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The orphan receptor, GPR88, is emerging as a key player in the pathophysiology of several neuropsychiatric diseases, including psychotic disorders.  Knockout (KO) mice lacking GPR88 throughout the brain exhibit many abnormalities relevant to schizophrenia including locomotor hyperactivity, behavioural hypersensitivity to dopaminergic psychostimulants and deficient sensorimotor gating.  Here, we used conditional knockout (cKO) mice lacking GPR88 selectively in striatal medium spiny neurons expressing A2A receptor to determine neuronal circuits underlying these phenotypes.  We first studied locomotor responses of A2A R-Gpr88 KO mice and their control littermates to psychotomimetic, amphetamine, and to selective D1 and D2 receptor agonists, SKF-81297 and quinpirole, respectively.  To assess sensorimotor gating performance, mice were submitted to acoustic and visual prepulse inhibition (PPI) paradigms.  Total knockout GPR88 mice were also studied for comparison.  Like total GPR88 KO mice, A2A R-Gpr88 KO mice displayed a heightened sensitivity to locomotor stimulant effects of amphetamine and SKF-81297.  They also exhibited enhanced locomotor activity to quinpirole, which tended to suppress locomotion in control mice.  By contrast, they had normal acoustic and visual PPI, unlike total GPR88 KO mice that show impairments across different sensory modalities.  Finally, none of the genetic manipulations altered central auditory temporal processing assessed by gap-PPI.  Together, these findings support the role of GPR88 in the pathophysiology of schizophrenia and show that GPR88 in A2A receptor-expressing neurons modulates psychomotor behaviour but not sensorimotor gating.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4gdqrBWdvB1HFYivNCdPRfW6udTcc2eadEOeFgSQKrrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cjmvVWjug%253D%253D&md5=42056f84558b350f0a6c7ee6f2a86ac2</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1111%2Fejn.13646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fejn.13646%26sid%3Dliteratum%253Aachs%26aulast%3DMeirsman%26aufirst%3DA.%2BC.%26aulast%3Dde%2BKerchove%2Bd%25E2%2580%2599Exaerde%26aufirst%3DA.%26aulast%3DKieffer%26aufirst%3DB.%2BL.%26aulast%3DOuagazzal%26aufirst%3DA.-M.%26atitle%3DGPR88%2520in%2520A2A%2520receptor-expressing%2520neurons%2520modulates%2520locomotor%2520response%2520to%2520dopamine%2520agonists%2520but%2520not%2520sensorimotor%2520gating%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2017%26volume%3D46%26spage%3D2026%26epage%3D2034%26doi%3D10.1111%2Fejn.13646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meirsman, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Merrer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellissier, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clesse, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieffer, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, J. A. J.</span></span> <span> </span><span class="NLM_article-title">Mice lacking GPR88 show motor deficit, improved spatial learning, and low anxiety reversed by delta opioid antagonist</span>. <i>Biol. Psychiatr.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">917</span>– <span class="NLM_lpage">927</span>, <span class="refDoi"> DOI: 10.1016/j.biopsych.2015.05.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1016%2Fj.biopsych.2015.05.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=26188600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtF2itbjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2016&pages=917-927&author=A.+C.+Meirsmanauthor=J.+Le+Merrerauthor=L.+P.+Pellissierauthor=J.+Diazauthor=D.+Clesseauthor=B.+L.+Kiefferauthor=J.+A.+J.+Becker&title=Mice+lacking+GPR88+show+motor+deficit%2C+improved+spatial+learning%2C+and+low+anxiety+reversed+by+delta+opioid+antagonist&doi=10.1016%2Fj.biopsych.2015.05.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Mice Lacking GPR88 Show Motor Deficit, Improved Spatial Learning, and Low Anxiety Reversed by Delta Opioid Antagonist</span></div><div class="casAuthors">Meirsman, Aura C.; Le Merrer, Julie; Pellissier, Lucie P.; Diaz, Jorge; Clesse, Daniel; Kieffer, Brigitte L.; Becker, Jerome A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">917-927</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">GPR88 is an orphan G protein coupled receptor highly enriched in the striatum, and previous studies have focused on GPR88 function in striatal physiol.  The receptor is also expressed in other brain areas, and here we examd. whether GPR88 function extends beyond striatal-mediated responses.  We created Gpr88 knockout mice and examd. both striatal and extrastriatal regions at mol. and cellular levels.  We also tested striatum-, hippocampus-, and amygdala-dependent behaviors in Gpr88-/- mice using extensive behavioral testing.  We found increased G protein coupling for delta opioid receptor (DOR) and mu opioid, but not other Gi/o coupled receptors, in the striatum of Gpr88 knockout mice.  We also found modifications in gene transcription, dopamine and serotonin contents, and dendritic morphol. inside and outside the striatum.  Behavioral testing confirmed striatal deficits (hyperactivity, stereotypies, motor impairment in rotarod).  In addn., mutant mice performed better in spatial tasks dependent on hippocampus (Y-maze, novel object recognition, dual soln. cross-maze) and also showed markedly reduced levels of anxiety (elevated plus maze, marble burying, novelty suppressed feeding).  Strikingly, chronic blockade of DOR using naltrindole partially improved motor coordination and normalized spatial navigation and anxiety of Gpr88-/- mice.  We demonstrate that GPR88 is implicated in a large repertoire of behavioral responses that engage motor activity, spatial learning, and emotional processing.  Our data also reveal functional antagonism between GPR88 and DOR activities in vivo.  The therapeutic potential of GPR88 therefore extends to cognitive and anxiety disorders, possibly in interaction with other receptor systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAlo6_6eKZqrVg90H21EOLACvtfcHk0lgsnpEM0MaXJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtF2itbjO&md5=6fd7b2f2d75066fd97668c7bf9b69786</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2015.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2015.05.020%26sid%3Dliteratum%253Aachs%26aulast%3DMeirsman%26aufirst%3DA.%2BC.%26aulast%3DLe%2BMerrer%26aufirst%3DJ.%26aulast%3DPellissier%26aufirst%3DL.%2BP.%26aulast%3DDiaz%26aufirst%3DJ.%26aulast%3DClesse%26aufirst%3DD.%26aulast%3DKieffer%26aufirst%3DB.%2BL.%26aulast%3DBecker%26aufirst%3DJ.%2BA.%2BJ.%26atitle%3DMice%2520lacking%2520GPR88%2520show%2520motor%2520deficit%252C%2520improved%2520spatial%2520learning%252C%2520and%2520low%2520anxiety%2520reversed%2520by%2520delta%2520opioid%2520antagonist%26jtitle%3DBiol.%2520Psychiatr.%26date%3D2016%26volume%3D79%26spage%3D917%26epage%3D927%26doi%3D10.1016%2Fj.biopsych.2015.05.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meirsman, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Kerchove
d’Exaerde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieffer, B. L.</span></span> <span> </span><span class="NLM_article-title">GPR88 in A2AR neurons enhances anxiety-like behaviors</span>. <i>eNeuro</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>3</i></span>, <span class="NLM_elocation-id">ENEURO.0202-16.2016</span> <span class="refDoi"> DOI: 10.1523/eneuro.0202-16.2016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1523%2FENEURO.0202-16.2016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2016&author=A.+C.+Meirsmanauthor=A.+Robeauthor=A.+de+Kerchove%0Ad%E2%80%99Exaerdeauthor=B.+L.+Kieffer&title=GPR88+in+A2AR+neurons+enhances+anxiety-like+behaviors&doi=10.1523%2Feneuro.0202-16.2016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1523%2FENEURO.0202-16.2016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FENEURO.0202-16.2016%26sid%3Dliteratum%253Aachs%26aulast%3DMeirsman%26aufirst%3DA.%2BC.%26aulast%3DRobe%26aufirst%3DA.%26aulast%3Dde%2BKerchove%2Bd%25E2%2580%2599Exaerde%26aufirst%3DA.%26aulast%3DKieffer%26aufirst%3DB.%2BL.%26atitle%3DGPR88%2520in%2520A2AR%2520neurons%2520enhances%2520anxiety-like%2520behaviors%26jtitle%3DeNeuro%26date%3D2016%26volume%3D3%26doi%3D10.1523%2Feneuro.0202-16.2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsunoda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumiyoshi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takasaki, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabuchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uehara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurachi, M.</span></span> <span> </span><span class="NLM_article-title">Effect of MK-801 on gene expressions in the amygdala of rats</span>. <i>Synapse</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">7</span>, <span class="refDoi"> DOI: 10.1002/syn.20455</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1002%2Fsyn.20455" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=17948890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A280%3ADC%252BD2snlvVKrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2008&pages=1-7&author=T.+Matsuokaauthor=M.+Tsunodaauthor=T.+Sumiyoshiauthor=I.+Takasakiauthor=Y.+Tabuchiauthor=T.+Seoauthor=K.+Tanakaauthor=T.+Ueharaauthor=H.+Itohauthor=M.+Suzukiauthor=M.+Kurachi&title=Effect+of+MK-801+on+gene+expressions+in+the+amygdala+of+rats&doi=10.1002%2Fsyn.20455"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of MK-801 on gene expressions in the amygdala of rats</span></div><div class="casAuthors">Matsuoka Tadasu; Tsunoda Masahiko; Sumiyoshi Tomiki; Takasaki Ichiro; Tabuchi Yoshiaki; Seo Tomonori; Tanaka Kodai; Uehara Takashi; Itoh Hiroko; Suzuki Michio; Kurachi Masayoshi</div><div class="citationInfo"><span class="NLM_cas:title">Synapse (New York, N.Y.)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-7</span>
        ISSN:<span class="NLM_cas:issn">0887-4476</span>.
    </div><div class="casAbstract">Rodents treated with N-methyl-D-aspartate (NMDA) antagonists have been thought to be an animal model of schizophrenia.  In this study, we examined gene expression in the amygdala of rats chronically treated with MK-801, as well as behavioral changes, such as social behavior, in these animals.  The social interaction test, a measure of social behavior, and locomotor activity was performed in male Wistar rats injected with MK-801 (0.13 mg/kg i.p.) or saline for 14 days.  Changes in mRNA levels were analyzed using a GeneChip microarray system.  Real-time quantitative PCR (RT-qPCR) assay was subsequently conducted to confirm the results of the microarray analysis.  MK-801 decreased social interaction and increased locomotor activity in rats, consistent with previous reports.  We found 23 downregulated genes and 16 upregulated genes, with the gene encoding arginine-vasopressin (AVP) being most downregulated, and that for transthyretin (Ttr) most upregulated. mRNA levels, quantified by RT-qPCR assay, were altered for genes related to neuropeptides (AVP, Sstr2), the arachidonic cascade (Ptgds), myelination (Mobp, Enpp2), neurotrophic factors (Igfbp2), and hormonal milieu (Ttr).  Downregulation of the AVP gene in the amygdala of MK-801-treated rats may provide a basis for the ability of AVP-analogues to ameliorate the behavioral disturbances caused by blockade of the NMDA receptor.  The results of this study provide an insight into the neural substrates responsible for the generation of psychotic symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS-X1qC28tJg7BItaL1WaVAfW6udTcc2eZCErwR7T7bErntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2snlvVKrtg%253D%253D&md5=b3e4474289bd3772bf4b1b3931bcf472</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fsyn.20455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsyn.20455%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuoka%26aufirst%3DT.%26aulast%3DTsunoda%26aufirst%3DM.%26aulast%3DSumiyoshi%26aufirst%3DT.%26aulast%3DTakasaki%26aufirst%3DI.%26aulast%3DTabuchi%26aufirst%3DY.%26aulast%3DSeo%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DUehara%26aufirst%3DT.%26aulast%3DItoh%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DKurachi%26aufirst%3DM.%26atitle%3DEffect%2520of%2520MK-801%2520on%2520gene%2520expressions%2520in%2520the%2520amygdala%2520of%2520rats%26jtitle%3DSynapse%26date%3D2008%26volume%3D62%26spage%3D1%26epage%3D7%26doi%3D10.1002%2Fsyn.20455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogden, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rich, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schork, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulus, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geyer, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohr, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuczenski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niculescu, A. B.</span></span> <span> </span><span class="NLM_article-title">Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach</span>. <i>Mol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1007</span>– <span class="NLM_lpage">1029</span>, <span class="refDoi"> DOI: 10.1038/sj.mp.4001547</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1038%2Fsj.mp.4001547" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=15314610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovVGit7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=1007-1029&author=C.+A.+Ogdenauthor=M.+E.+Richauthor=N.+J.+Schorkauthor=M.+P.+Paulusauthor=M.+A.+Geyerauthor=J.+B.+Lohrauthor=R.+Kuczenskiauthor=A.+B.+Niculescu&title=Candidate+genes%2C+pathways+and+mechanisms+for+bipolar+%28manic-depressive%29+and+related+disorders%3A+an+expanded+convergent+functional+genomics+approach&doi=10.1038%2Fsj.mp.4001547"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach</span></div><div class="casAuthors">Ogden, C. A.; Rich, M. E.; Schork, N. J.; Paulus, M. P.; Geyer, M. A.; Lohr, J. B.; Kuczenski, R.; Niculescu, A. B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1007-1029</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Identifying genes for bipolar mood disorders through classic genetics has proven difficult.  Here, we present a comprehensive convergent approach that translationally integrates brain gene expression data from a relevant pharmacogenomic mouse model (involving treatments with a stimulant-methamphetamine, and a mood stabilizer-valproate), with human data (linkage loci from human genetic studies, changes in postmortem brains from patients), as a bayesian strategy of crossvalidating findings.  Topping the list of candidate genes, we have DARPP-32 (dopamine- and cAMP-regulated phosphoprotein of 32 kDa) located at 17q12, PENK (preproenkephalin) located at 8q12.1, and TAC1 (tachykinin 1, substance P) located at 7q21.3.  These data suggest that more primitive mol. mechanisms involved in pleasure and pain may have been recruited by evolution to play a role in higher mental functions such as mood.  The anal. also revealed other high-probability candidates genes (neurogenesis, neurotrophic, neurotransmitter, signal transduction, circadian, synaptic, and myelin related), pathways and mechanisms of likely importance in pathophysiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeYC9brrU5L7Vg90H21EOLACvtfcHk0lhs5I2ibwBm_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovVGit7s%253D&md5=42dd287af0bb5a71f8384f0d4ed5a314</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fsj.mp.4001547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.mp.4001547%26sid%3Dliteratum%253Aachs%26aulast%3DOgden%26aufirst%3DC.%2BA.%26aulast%3DRich%26aufirst%3DM.%2BE.%26aulast%3DSchork%26aufirst%3DN.%2BJ.%26aulast%3DPaulus%26aufirst%3DM.%2BP.%26aulast%3DGeyer%26aufirst%3DM.%2BA.%26aulast%3DLohr%26aufirst%3DJ.%2BB.%26aulast%3DKuczenski%26aufirst%3DR.%26aulast%3DNiculescu%26aufirst%3DA.%2BB.%26atitle%3DCandidate%2520genes%252C%2520pathways%2520and%2520mechanisms%2520for%2520bipolar%2520%2528manic-depressive%2529%2520and%2520related%2520disorders%253A%2520an%2520expanded%2520convergent%2520functional%2520genomics%2520approach%26jtitle%3DMol.%2520Psychiatry%26date%3D2004%26volume%3D9%26spage%3D1007%26epage%3D1029%26doi%3D10.1038%2Fsj.mp.4001547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brandish, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holder, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodor, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szumiloski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleinhanz, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forbes, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McWhorter, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duenwald, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parrish, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Na, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renger, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sankaranarayanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scolnick, E. M.</span></span> <span> </span><span class="NLM_article-title">Regulation of gene expression by lithium and depletion of inositol in slices of adult rat cortex</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">861</span>– <span class="NLM_lpage">872</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2005.02.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1016%2Fj.neuron.2005.02.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=15797548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjt1Oitb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2005&pages=861-872&author=P.+E.+Brandishauthor=M.+Suauthor=D.+J.+Holderauthor=P.+Hodorauthor=J.+Szumiloskiauthor=R.+R.+Kleinhanzauthor=J.+E.+Forbesauthor=M.+E.+McWhorterauthor=S.+J.+Duenwaldauthor=M.+L.+Parrishauthor=S.+Naauthor=Y.+Liuauthor=R.+L.+Phillipsauthor=J.+J.+Rengerauthor=S.+Sankaranarayananauthor=A.+J.+Simonauthor=E.+M.+Scolnick&title=Regulation+of+gene+expression+by+lithium+and+depletion+of+inositol+in+slices+of+adult+rat+cortex&doi=10.1016%2Fj.neuron.2005.02.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of gene expression by lithium and depletion of inositol in slices of adult rat cortex</span></div><div class="casAuthors">Brandish, Philip E.; Su, Ming; Holder, Daniel J.; Hodor, Paul; Szumiloski, John; Kleinhanz, Robert R.; Forbes, Jaime E.; McWhorter, Mollie E.; Duenwald, Sven J.; Parrish, Mark L.; Na, Sang; Liu, Yuan; Phillips, Robert L.; Renger, John J.; Sankaranarayanan, Sethu; Simon, Adam J.; Scolnick, Edward M.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">861-872</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Lithium inhibits inositol monophosphatase at therapeutically effective concns., and it has been hypothesized that depletion of brain inositol levels is an important chem. alteration for lithium's therapeutic efficacy in bipolar disorder.  We have employed adult rat cortical slices as a model to investigate the gene regulatory consequences of inositol depletion effected by lithium using cytidine diphosphoryl-diacylglycerol as a functionally relevant biochem. marker to define treatment conditions.  Genes coding for the neuropeptide hormone pituitary adenylate cyclase activating polypeptide (PACAP) and the enzyme that processes PACAP's precursor to the mature form, peptidylglycine α-amidating monooxygenase, were upregulated by inositol depletion.  Previous work has shown that PACAP can increase tyrosine hydroxylase (TH) activity and dopamine release, and we found that the gene for GTP cyclohydrolase, which effectively regulates TH through synthesis of tetrahydrobiopterin, was also upregulated by inositol depletion.  We propose that modulation of brain PACAP signaling might represent a new opportunity in the treatment of bipolar disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZgClt5tNV7rVg90H21EOLACvtfcHk0lhzrV7pMDPtxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjt1Oitb8%253D&md5=d7d4d9b9a5295137c34bbb4497c3626b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2005.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2005.02.006%26sid%3Dliteratum%253Aachs%26aulast%3DBrandish%26aufirst%3DP.%2BE.%26aulast%3DSu%26aufirst%3DM.%26aulast%3DHolder%26aufirst%3DD.%2BJ.%26aulast%3DHodor%26aufirst%3DP.%26aulast%3DSzumiloski%26aufirst%3DJ.%26aulast%3DKleinhanz%26aufirst%3DR.%2BR.%26aulast%3DForbes%26aufirst%3DJ.%2BE.%26aulast%3DMcWhorter%26aufirst%3DM.%2BE.%26aulast%3DDuenwald%26aufirst%3DS.%2BJ.%26aulast%3DParrish%26aufirst%3DM.%2BL.%26aulast%3DNa%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DPhillips%26aufirst%3DR.%2BL.%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26aulast%3DSankaranarayanan%26aufirst%3DS.%26aulast%3DSimon%26aufirst%3DA.%2BJ.%26aulast%3DScolnick%26aufirst%3DE.%2BM.%26atitle%3DRegulation%2520of%2520gene%2520expression%2520by%2520lithium%2520and%2520depletion%2520of%2520inositol%2520in%2520slices%2520of%2520adult%2520rat%2520cortex%26jtitle%3DNeuron%26date%3D2005%26volume%3D45%26spage%3D861%26epage%3D872%26doi%3D10.1016%2Fj.neuron.2005.02.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maier, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barr, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morale, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanna, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilbe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartfai, T.</span></span> <span> </span><span class="NLM_article-title">Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine</span>. <i>Mol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">167</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.1038/sj.mp.4001897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1038%2Fsj.mp.4001897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=17033635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BD2sXoslSjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=167-189&author=B.+Contiauthor=R.+Maierauthor=A.+M.+Barrauthor=M.+C.+Moraleauthor=X.+Luauthor=P.+P.+Sannaauthor=G.+Bilbeauthor=D.+Hoyerauthor=T.+Bartfai&title=Region-specific+transcriptional+changes+following+the+three+antidepressant+treatments+electro+convulsive+therapy%2C+sleep+deprivation+and+fluoxetine&doi=10.1038%2Fsj.mp.4001897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Region-specific transcriptional changes following the three antidepressant treatments: electro convulsive therapy, sleep deprivation and fluoxetine</span></div><div class="casAuthors">Conti, B.; Maier, R.; Barr, A. M.; Morale, M. C.; Lu, X.; Sanna, P. P.; Bilbe, G.; Hoyer, D.; Bartfai, T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">167-189</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The significant proportion of depressed patients that are resistant to monoaminergic drug therapy and the slow onset of therapeutic effects of the selective serotonin reuptake inhibitors (SSRIs)/serotonin/noradrenaline reuptake inhibitors (SNRIs) are two major reasons for the sustained search for new antidepressants.  In an attempt to identify common underlying mechanisms for fast- and slow-acting antidepressant modalities, we have examd. the transcriptional changes in seven different brain regions of the rat brain induced by three clin. effective antidepressant treatments: electro convulsive therapy (ECT), sleep deprivation (SD), and fluoxetine (FLX), the most commonly used slow-onset antidepressant.  Each of these antidepressant treatments was applied with the same regimen known to have clin. efficacy: 2 days of ECT (four sessions per day), 24 h of SD, and 14 days of daily treatment of FLX, resp.  Transcriptional changes were evaluated on RNA extd. from seven different brain regions using the Affymetrix rat genome microarray 230 2.0.  The gene chip data were validated using in situ hybridization or autoradiog. for selected genes.  The transcriptional changes induced by SD, ECT and SSRI display a regionally specific distribution distinct to each treatment.  The fast-onset, short-lived antidepressant treatments ECT and SD evoked transcriptional changes primarily in the catecholaminergic system, whereas the slow-onset antidepressant FLX treatment evoked transcriptional changes in the serotonergic system.  ECT and SD affect in a similar manner the same brain regions, primarily the locus coeruleus, whereas the effects of FLX were primarily in the dorsal raphe and hypothalamus, suggesting that both different regions and pathways account for fast onset but short lasting effects as compared to slow-onset but long-lasting effects.  However, the similarity between effects of ECT and SD is somewhat confounded by the fact that the two treatments appear to regulate a no. of transcripts in an opposite manner.  Multiple transcripts (e.g. brain-derived neurotrophic factor (BDNF), serum/glucocorticoid-regulated kinase (Sgk1)), whose level was reported to be affected by antidepressants or behavioral manipulations, were also found to be regulated by the treatments used in the present study.  Several novel findings of transcriptional regulation upon one, two or all three treatments were made, for the latter we highlight homer, erg2, HSP27, the proto oncogene ret, sulfotransferase family 1A (Sult1a1), glycerol 3-phosphate dehydrogenase (GPD3), the orphan receptor G protein-coupled receptor 88 (GPR88) and a large no. of expressed sequence tags (ESTs).  Transcripts encoding proteins involved in synaptic plasticity in the hippocampus were strongly affected by ECT and SD, but not by FLX.  The novel transcripts, concomitantly regulated by several antidepressant treatments, may represent novel targets for fast onset, long-duration antidepressants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor-zqFvP0pHbVg90H21EOLACvtfcHk0lhzrV7pMDPtxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXoslSjug%253D%253D&md5=7717a8f9e52b3e6197fd081e02ee388e</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fsj.mp.4001897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.mp.4001897%26sid%3Dliteratum%253Aachs%26aulast%3DConti%26aufirst%3DB.%26aulast%3DMaier%26aufirst%3DR.%26aulast%3DBarr%26aufirst%3DA.%2BM.%26aulast%3DMorale%26aufirst%3DM.%2BC.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DSanna%26aufirst%3DP.%2BP.%26aulast%3DBilbe%26aufirst%3DG.%26aulast%3DHoyer%26aufirst%3DD.%26aulast%3DBartfai%26aufirst%3DT.%26atitle%3DRegion-specific%2520transcriptional%2520changes%2520following%2520the%2520three%2520antidepressant%2520treatments%2520electro%2520convulsive%2520therapy%252C%2520sleep%2520deprivation%2520and%2520fluoxetine%26jtitle%3DMol.%2520Psychiatry%26date%3D2007%26volume%3D12%26spage%3D167%26epage%3D189%26doi%3D10.1038%2Fsj.mp.4001897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Befort, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filliol, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghate, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darcq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matifas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lardenois, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thibault, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dembele, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Merrer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, J. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poch, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieffer, B. L.</span></span> <span> </span><span class="NLM_article-title">Mu-opioid receptor activation induces transcriptional plasticity in the central extended amygdala</span>. <i>Eur. J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2973</span>– <span class="NLM_lpage">2984</span>, <span class="refDoi"> DOI: 10.1111/j.1460-9568.2008.06273.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1111%2Fj.1460-9568.2008.06273.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=18588537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A280%3ADC%252BD1cvhvVOltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=2973-2984&author=K.+Befortauthor=D.+Filliolauthor=A.+Ghateauthor=E.+Darcqauthor=A.+Matifasauthor=J.+Mullerauthor=A.+Lardenoisauthor=C.+Thibaultauthor=D.+Dembeleauthor=J.+Le+Merrerauthor=J.+A.+J.+Beckerauthor=O.+Pochauthor=B.+L.+Kieffer&title=Mu-opioid+receptor+activation+induces+transcriptional+plasticity+in+the+central+extended+amygdala&doi=10.1111%2Fj.1460-9568.2008.06273.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Mu-opioid receptor activation induces transcriptional plasticity in the central extended amygdala</span></div><div class="casAuthors">Befort K; Filliol D; Ghate A; Darcq E; Matifas A; Muller J; Lardenois A; Thibault C; Dembele D; Le Merrer J; Becker J A J; Poch O; Kieffer B L</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2973-84</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Addiction develops from the gradual adaptation of the brain to chronic drug exposure, and involves genetic reprogramming of neuronal function.  The central extended amygdala (EAc) is a network formed by the central amygdala and the bed nucleus of the stria terminalis.  This key site controls drug craving and seeking behaviors, and has not been investigated at the gene regulation level.  We used Affymetrix microarrays to analyze transcriptional activity in the murine EAc, with a focus on mu-opioid receptor-associated events because these receptors mediate drug reward and dependence.  We identified 132 genes whose expression is regulated by a chronic escalating morphine regimen in the EAc from wild-type but not mu-opioid receptor knockout mice.  These modifications are mostly EAc-specific.  Gene ontology analysis reveals an overrepresentation of neurogenesis, cell growth and signaling protein categories.  A separate quantitative PCR analysis of genes in the last of these groups confirms the dysregulation of both orphan (Gpr88) and known (DrD1A, Adora2A, Cnr1, Grm5, Gpr6) G protein-coupled receptors, scaffolding (PSD95, Homer1) and signaling (Sgk, Cap1) proteins, and neuropeptides (CCK, galanin).  These transcriptional modifications do not occur following a single morphine injection, and hence result from long-term adaptation to excessive mu receptor activation.  Proteins encoded by these genes are classically associated with spine modules function in other brain areas, and therefore our data suggest a remodeling of EAc circuits at sites where glutamatergic and monoaminergic afferences interact.  Together, mu receptor-dependent genes identified in this study potentially contribute to drug-induced neural plasticity, and provide a unique molecular repertoire towards understanding drug craving and relapse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTbQoHVgtNR9jEC-75aqa5AfW6udTcc2eYZXAs1T5RRXLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cvhvVOltA%253D%253D&md5=d5b56f1be18d7ba5ea95ae37f452ff0f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1111%2Fj.1460-9568.2008.06273.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1460-9568.2008.06273.x%26sid%3Dliteratum%253Aachs%26aulast%3DBefort%26aufirst%3DK.%26aulast%3DFilliol%26aufirst%3DD.%26aulast%3DGhate%26aufirst%3DA.%26aulast%3DDarcq%26aufirst%3DE.%26aulast%3DMatifas%26aufirst%3DA.%26aulast%3DMuller%26aufirst%3DJ.%26aulast%3DLardenois%26aufirst%3DA.%26aulast%3DThibault%26aufirst%3DC.%26aulast%3DDembele%26aufirst%3DD.%26aulast%3DLe%2BMerrer%26aufirst%3DJ.%26aulast%3DBecker%26aufirst%3DJ.%2BA.%2BJ.%26aulast%3DPoch%26aufirst%3DO.%26aulast%3DKieffer%26aufirst%3DB.%2BL.%26atitle%3DMu-opioid%2520receptor%2520activation%2520induces%2520transcriptional%2520plasticity%2520in%2520the%2520central%2520extended%2520amygdala%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2008%26volume%3D27%26spage%3D2973%26epage%3D2984%26doi%3D10.1111%2Fj.1460-9568.2008.06273.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Del
Zompo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deleuze, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chillotti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cousin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niehaus, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebstein, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ardau, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macé, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warnich, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mujahed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Severino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dib, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordaan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murad, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soubigou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannoura, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocher, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurent, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derock, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faucon Biguet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meloni, R.</span></span> <span> </span><span class="NLM_article-title">Association study in three different populations between the GPR88 gene and major psychoses</span>. <i>Mol. Genet. Genomic Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">152</span>– <span class="NLM_lpage">159</span>, <span class="refDoi"> DOI: 10.1002/mgg3.54</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1002%2Fmgg3.54" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=24689078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVOgtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=152-159&author=M.+Del%0AZompoauthor=J.+F.+Deleuzeauthor=C.+Chillottiauthor=E.+Cousinauthor=D.+Niehausauthor=R.+P.+Ebsteinauthor=R.+Ardauauthor=S.+Mac%C3%A9author=L.+Warnichauthor=M.+Mujahedauthor=G.+Severinoauthor=C.+Dibauthor=E.+Jordaanauthor=I.+Muradauthor=S.+Soubigouauthor=L.+Koenauthor=I.+Bannouraauthor=C.+Rocherauthor=C.+Laurentauthor=M.+Derockauthor=N.+Faucon+Biguetauthor=J.+Malletauthor=R.+Meloni&title=Association+study+in+three+different+populations+between+the+GPR88+gene+and+major+psychoses&doi=10.1002%2Fmgg3.54"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Association study in three different populations between the GPR88 gene and major psychoses</span></div><div class="casAuthors">Del Zompo, Maria; Deleuze, Jean-Francois; Chillotti, Caterina; Cousin, Emmanuelle; Niehaus, Dana; Ebstein, Richard P.; Ardau, Raffaella; Mace, Sandrine; Warnich, Louise; Mujahed, Mustafa; Severino, Giovanni; Dib, Colette; Jordaan, Esme; Murad, Ibrahim; Soubigou, Stephane; Koen, Liezl; Bannoura, Issam; Rocher, Corinne; Laurent, Claudine; Derock, Murielle; Biguet, Nicole Faucon; Mallet, Jacques; Meloni, Rolando</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Genetics & Genomic Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">152-159, 8 pp.</span>CODEN:
                <span class="NLM_cas:coden">MGGMC6</span>;
        ISSN:<span class="NLM_cas:issn">2324-9269</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">GPR88, coding for a G protein-coupled orphan receptor that is highly represented in the striatum, is a strong functional candidate gene for neuropsychiatric disorders and is located at 1p22-p21, a chromosomal region that we have previously linked to bipolar disorder (BD) in the Sardinian population.  In order to ascertain the relevance of GPR88 as a risk factor for psychiatric diseases, we performed a genetic assocn. anal. between GPR88 and BD in a sample of triads (patient and both parents) recruited in the Sardinian and the Palestinian population as well as between GPR88 and schizophrenia (SZ) in triads from the Xhosa population in South Africa.  We found a pos. assocn. between GPR88 and BD in the Sardinian and Palestinian triads.  Moreover, we found a pos. assocn. between GPR88 and SZ in triads from the Xhosa population in South Africa.  When these results were cor. for multiple testing, the assocn. between GPR88 and BD was maintained in the Palestinian population.  Thus, these results suggest that GPR88 deserves consideration as a candidate gene for psychiatric diseases and requires to be further investigated in other populations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOk2Vftt3xZbVg90H21EOLACvtfcHk0ljs01kaotREqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVOgtLs%253D&md5=2f29002cf8b9e4e565151a4f1f5c36e9</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fmgg3.54&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmgg3.54%26sid%3Dliteratum%253Aachs%26aulast%3DDel%2BZompo%26aufirst%3DM.%26aulast%3DDeleuze%26aufirst%3DJ.%2BF.%26aulast%3DChillotti%26aufirst%3DC.%26aulast%3DCousin%26aufirst%3DE.%26aulast%3DNiehaus%26aufirst%3DD.%26aulast%3DEbstein%26aufirst%3DR.%2BP.%26aulast%3DArdau%26aufirst%3DR.%26aulast%3DMac%25C3%25A9%26aufirst%3DS.%26aulast%3DWarnich%26aufirst%3DL.%26aulast%3DMujahed%26aufirst%3DM.%26aulast%3DSeverino%26aufirst%3DG.%26aulast%3DDib%26aufirst%3DC.%26aulast%3DJordaan%26aufirst%3DE.%26aulast%3DMurad%26aufirst%3DI.%26aulast%3DSoubigou%26aufirst%3DS.%26aulast%3DKoen%26aufirst%3DL.%26aulast%3DBannoura%26aufirst%3DI.%26aulast%3DRocher%26aufirst%3DC.%26aulast%3DLaurent%26aufirst%3DC.%26aulast%3DDerock%26aufirst%3DM.%26aulast%3DFaucon%2BBiguet%26aufirst%3DN.%26aulast%3DMallet%26aufirst%3DJ.%26aulast%3DMeloni%26aufirst%3DR.%26atitle%3DAssociation%2520study%2520in%2520three%2520different%2520populations%2520between%2520the%2520GPR88%2520gene%2520and%2520major%2520psychoses%26jtitle%3DMol.%2520Genet.%2520Genomic%2520Med.%26date%3D2014%26volume%3D2%26spage%3D152%26epage%3D159%26doi%3D10.1002%2Fmgg3.54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alkufri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaag, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abu-Libdeh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elpeleg, O.</span></span> <span> </span><span class="NLM_article-title">Deleterious mutation in GPR88 is associated with chorea, speech delay, and learning disabilities</span>. <i>Neurol.: Genet.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2</i></span>, <span class="NLM_elocation-id">e64</span> <span class="refDoi"> DOI: 10.1212/nxg.0000000000000064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1212%2FNXG.0000000000000064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=27123486" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&author=F.+Alkufriauthor=A.+Shaagauthor=B.+Abu-Libdehauthor=O.+Elpeleg&title=Deleterious+mutation+in+GPR88+is+associated+with+chorea%2C+speech+delay%2C+and+learning+disabilities&doi=10.1212%2Fnxg.0000000000000064"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1212%2FNXG.0000000000000064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FNXG.0000000000000064%26sid%3Dliteratum%253Aachs%26aulast%3DAlkufri%26aufirst%3DF.%26aulast%3DShaag%26aufirst%3DA.%26aulast%3DAbu-Libdeh%26aufirst%3DB.%26aulast%3DElpeleg%26aufirst%3DO.%26atitle%3DDeleterious%2520mutation%2520in%2520GPR88%2520is%2520associated%2520with%2520chorea%252C%2520speech%2520delay%252C%2520and%2520learning%2520disabilities%26jtitle%3DNeurol.%253A%2520Genet.%26date%3D2016%26volume%3D2%26doi%3D10.1212%2Fnxg.0000000000000064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Surgand, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellenberger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rognan, D.</span></span> <span> </span><span class="NLM_article-title">A chemogenomic analysis of the transmembrane binding cavity of human G-protein-coupled receptors</span>. <i>Proteins</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">509</span>– <span class="NLM_lpage">538</span>, <span class="refDoi"> DOI: 10.1002/prot.20768</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1002%2Fprot.20768" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=16294340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A280%3ADC%252BD2MnovFyrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=509-538&author=J.+S.+Surgandauthor=J.+Rodrigoauthor=E.+Kellenbergerauthor=D.+Rognan&title=A+chemogenomic+analysis+of+the+transmembrane+binding+cavity+of+human+G-protein-coupled+receptors&doi=10.1002%2Fprot.20768"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A chemogenomic analysis of the transmembrane binding cavity of human G-protein-coupled receptors</span></div><div class="casAuthors">Surgand Jean-Sebastien; Rodrigo Jordi; Kellenberger Esther; Rognan Didier</div><div class="citationInfo"><span class="NLM_cas:title">Proteins</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">509-38</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The amino acid sequences of 369 human nonolfactory G-protein-coupled receptors (GPCRs) have been aligned at the seven transmembrane domain (TM) and used to extract the nature of 30 critical residues supposed--from the X-ray structure of bovine rhodopsin bound to retinal--to line the TM binding cavity of ground-state receptors.  Interestingly, the clustering of human GPCRs from these 30 residues mirrors the recently described phylogenetic tree of full-sequence human GPCRs (Fredriksson et al., Mol Pharmacol 2003;63:1256-1272) with few exceptions.  A TM cavity could be found for all investigated GPCRs with physicochemical properties matching that of their cognate ligands.  The current approach allows a very fast comparison of most human GPCRs from the focused perspective of the predicted TM cavity and permits to easily detect key residues that drive ligand selectivity or promiscuity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTH-6l-CmE2uXWEEzDrymxmfW6udTcc2ea6w3e5t6LWU7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MnovFyrtw%253D%253D&md5=5f60612975dbffa52e440cd2d7ab080c</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fprot.20768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.20768%26sid%3Dliteratum%253Aachs%26aulast%3DSurgand%26aufirst%3DJ.%2BS.%26aulast%3DRodrigo%26aufirst%3DJ.%26aulast%3DKellenberger%26aufirst%3DE.%26aulast%3DRognan%26aufirst%3DD.%26atitle%3DA%2520chemogenomic%2520analysis%2520of%2520the%2520transmembrane%2520binding%2520cavity%2520of%2520human%2520G-protein-coupled%2520receptors%26jtitle%3DProteins%26date%3D2006%26volume%3D62%26spage%3D509%26epage%3D538%26doi%3D10.1002%2Fprot.20768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorn, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, C.</span></span> <span> </span><span class="NLM_article-title">The GPR88 receptor agonist 2-PCCA does not alter the behavioral effects of methamphetamine in rats</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>698</i></span>,  <span class="NLM_fpage">272</span>– <span class="NLM_lpage">277</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2012.10.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1016%2Fj.ejphar.2012.10.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=23123351" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslSlsrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=698&publication_year=2013&pages=272-277&author=J.-X.+Liauthor=D.+A.+Thornauthor=C.+Jin&title=The+GPR88+receptor+agonist+2-PCCA+does+not+alter+the+behavioral+effects+of+methamphetamine+in+rats&doi=10.1016%2Fj.ejphar.2012.10.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The GPR88 receptor agonist 2-PCCA does not alter the behavioral effects of methamphetamine in rats</span></div><div class="casAuthors">Li, Jun-Xu; Thorn, David A.; Jin, Chunyang</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">698</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">272-277</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">GPR88 is a novel orphan G protein-coupled receptor that is primarily located at the striatum.  Genetic knockout studies reveal phenotypes of increased dopamine D2 receptor sensitivity in mice, suggesting that GPR88 receptors may be involved in the modulation of dopaminergic system.  However, there is no study that examines the pharmacol. effects of GPR88 receptor ligands in in vivo prepns.  This study examd. the effects of a GPR88 receptor agonist, (1R, 2R)-2-pyridin-2-yl-cyclopropane carboxylic acid ((2S, 3S)-2-amino-3-methyl-pentyl)-(4'-propylbiphenyl-4-yl)-amide (2-PCCA), on the motor activity in rats and on methamphetamine-induced hyperactivity and discriminative stimulus effects.  2-PCCA (0.1-3.2 mg/kg) dose-dependently decreased the locomotor activity in rats and, when studied in combination with 1.0 mg/kg methamphetamine, also dose-dependently decreased methamphetamine-induced hyperactivity.  However, the dose of 2-PCCA that significantly attenuated methamphetamine-induced hyperactivity was also the dose that by itself markedly decreased the baseline locomotor activity.  In rats discriminating 0.32 mg/kg methamphetamine, 2-PCCA (1-3.2 mg/kg) itself did not produce methamphetamine-like discriminative stimulus effects and, when studied in combination, did not alter the discriminative stimulus effects of methamphetamine.  Together, these data have provided the first line of evidence that activation of GPR88 receptors does not alter the behavioral effects of methamphetamine.  The potential implications of these findings are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTSCwsmccgk7Vg90H21EOLACvtfcHk0lgMfPUmg2bWoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslSlsrvL&md5=ed2554d727a15175af0f5f40310e3b9f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2012.10.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2012.10.037%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.-X.%26aulast%3DThorn%26aufirst%3DD.%2BA.%26aulast%3DJin%26aufirst%3DC.%26atitle%3DThe%2520GPR88%2520receptor%2520agonist%25202-PCCA%2520does%2520not%2520alter%2520the%2520behavioral%2520effects%2520of%2520methamphetamine%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D698%26spage%3D272%26epage%3D277%26doi%3D10.1016%2Fj.ejphar.2012.10.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilmour, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blough, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. P.</span></span> <span> </span><span class="NLM_article-title">Synthesis, pharmacological characterization, and structure-activity relationship studies of small molecular agonists for the orphan GPR88 receptor</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">576</span>– <span class="NLM_lpage">587</span>, <span class="refDoi"> DOI: 10.1021/cn500082p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn500082p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntlGju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=576-587&author=C.+Jinauthor=A.+M.+Deckerauthor=X.-P.+Huangauthor=B.+P.+Gilmourauthor=B.+E.+Bloughauthor=B.+L.+Rothauthor=Y.+Huauthor=J.+B.+Gillauthor=X.+P.+Zhang&title=Synthesis%2C+pharmacological+characterization%2C+and+structure-activity+relationship+studies+of+small+molecular+agonists+for+the+orphan+GPR88+receptor&doi=10.1021%2Fcn500082p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Pharmacological Characterization, and Structure-Activity Relationship Studies of Small Molecular Agonists for the Orphan GPR88 Receptor</span></div><div class="casAuthors">Jin, Chunyang; Decker, Ann M.; Huang, Xi-Ping; Gilmour, Brian P.; Blough, Bruce E.; Roth, Bryan L.; Hu, Yang; Gill, Joseph B.; Zhang, X. Peter</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">576-587</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">GPR88 is an orphan G-protein-coupled receptor (GPCR) enriched in the striatum.  Genetic deletion and gene expression studies have suggested that GPR88 plays an important role in the regulation of striatal functions and is implicated in psychiatric disorders.  The signal transduction pathway and receptor functions of GPR88, however, are still largely unknown due to the lack of endogenous and synthetic ligands.  In this paper, we report the synthesis of a GPR88 agonist 2-PCCA (I) and its pure diastereomers, which were functionally characterized in both transiently and stably expressing GPR88 HEK293 cells.  I inhibited isoproterenol-stimulated cAMP accumulation in a concn.-dependent manner in cells expressing GPR88 but not in the control cells, suggesting that the obsd. cAMP inhibition is mediated through GPR88 and that GPR88 is coupled to Gαi.  I did not induce calcium mobilization in GPR88 cells, indicating no Gαq-mediated response.  A structure-activity relation (SAR) study of I was also conducted to explore the key structural features for GPR88 agonist activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKep9SfTAK_LVg90H21EOLACvtfcHk0lgMfPUmg2bWoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntlGju7Y%253D&md5=ae1adf5b99e8309aca2660406fde88f4</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fcn500082p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn500082p%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DC.%26aulast%3DDecker%26aufirst%3DA.%2BM.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DGilmour%26aufirst%3DB.%2BP.%26aulast%3DBlough%26aufirst%3DB.%2BE.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DGill%26aufirst%3DJ.%2BB.%26aulast%3DZhang%26aufirst%3DX.%2BP.%26atitle%3DSynthesis%252C%2520pharmacological%2520characterization%252C%2520and%2520structure-activity%2520relationship%2520studies%2520of%2520small%2520molecular%2520agonists%2520for%2520the%2520orphan%2520GPR88%2520receptor%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2014%26volume%3D5%26spage%3D576%26epage%3D587%26doi%3D10.1021%2Fcn500082p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blough, B. E.</span></span> <span> </span><span class="NLM_article-title">Effect of substitution on the aniline moiety of the GPR88 agonist 2-PCCA: Synthesis, structure-activity relationships, and molecular modeling studies</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1418</span>– <span class="NLM_lpage">1432</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.6b00182</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.6b00182" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht12jsbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=1418-1432&author=C.+Jinauthor=A.+M.+Deckerauthor=D.+L.+Harrisauthor=B.+E.+Blough&title=Effect+of+substitution+on+the+aniline+moiety+of+the+GPR88+agonist+2-PCCA%3A+Synthesis%2C+structure-activity+relationships%2C+and+molecular+modeling+studies&doi=10.1021%2Facschemneuro.6b00182"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of Substitution on the Aniline Moiety of the GPR88 Agonist 2-PCCA: Synthesis, Structure-Activity Relationships, and Molecular Modeling Studies</span></div><div class="casAuthors">Jin, Chunyang; Decker, Ann M.; Harris, Danni L.; Blough, Bruce E.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1418-1432</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">GPR88, an orphan receptor richly expressed in the striatum, is implicated in a no. of basal ganglia-assocd. disorders.  In order to elucidate the functions of GPR88, an in vivo probe appropriate for CNS investigation is required.  We previously reported that 2-PCCA was able to modulate GPR88-mediated cAMP prodn. through a Gαi-coupled pathway.  Early structure-activity relationship (SAR) studies suggested that the aniline moiety of 2-PCCA is a suitable site for diverse modifications.  Aimed at elucidating structural requirements in this region, we have designed and synthesized a series of analogs bearing a variety of substituents at the Ph ring of the aniline moiety.  Several compds. (e.g., 5j, 5o) showed improved or comparable potency, but have lower lipophilicity than 2-PCCA (clogP 6.19).  These compds. provide the basis for further optimization to probe GPR88 in vivo functions.  Computational studies confirmed the SAR trends and supported the notion that 4'-substituents on the biphenyl ring exit through a largely hydrophobic binding site to the extracellular loop.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6kqs-lCWWirVg90H21EOLACvtfcHk0lgMfPUmg2bWoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht12jsbbJ&md5=3923e7fbf09828f0435edd9269219458</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.6b00182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.6b00182%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DC.%26aulast%3DDecker%26aufirst%3DA.%2BM.%26aulast%3DHarris%26aufirst%3DD.%2BL.%26aulast%3DBlough%26aufirst%3DB.%2BE.%26atitle%3DEffect%2520of%2520substitution%2520on%2520the%2520aniline%2520moiety%2520of%2520the%2520GPR88%2520agonist%25202-PCCA%253A%2520Synthesis%252C%2520structure-activity%2520relationships%252C%2520and%2520molecular%2520modeling%2520studies%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26spage%3D1418%26epage%3D1432%26doi%3D10.1021%2Facschemneuro.6b00182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Decker, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gay, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathews, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosa, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langston, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maitra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, C.</span></span> <span> </span><span class="NLM_article-title">Development and validation of a high-throughput calcium mobilization assay for the orphan receptor GPR88</span>. <i>J. Biomed. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">23</span>, <span class="refDoi"> DOI: 10.1186/s12929-017-0330-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1186%2Fs12929-017-0330-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=28347302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A280%3ADC%252BC1cvhs1aitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=23&author=A.+M.+Deckerauthor=E.+A.+Gayauthor=K.+M.+Mathewsauthor=T.+C.+Rosaauthor=T.+L.+Langstonauthor=R.+Maitraauthor=C.+Jin&title=Development+and+validation+of+a+high-throughput+calcium+mobilization+assay+for+the+orphan+receptor+GPR88&doi=10.1186%2Fs12929-017-0330-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a high-throughput calcium mobilization assay for the orphan receptor GPR88</span></div><div class="casAuthors">Decker Ann M; Gay Elaine A; Mathews Kelly M; Rosa Taylor C; Langston Tiffany L; Maitra Rangan; Jin Chunyang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomedical science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  GPR88 is an orphan G protein-coupled receptor highly expressed in the striatum and is implicated in basal ganglia-associated disorders.  However, the receptor functions of GPR88 are still largely unknown due to the lack of potent and selective ligands appropriate for central nervous system investigation.  Development of a high-throughput screening assay for GPR88 should facilitate the discovery of novel ligands to probe GPR88 functions.  METHODS:  In this paper, we describe the development of a CHO-Gαqi5-GPR88 cell-based calcium mobilization assay.  The assay takes advantage of functional coupling of GPR88 with the promiscuous Gαqi5 protein and consequent mobilization of intracellular calcium, which can be measured in a 384-well format with a Fluorescent Imaging Plate Reader.  RESULTS:  The CHO-Gαqi5-GPR88 cell-based calcium mobilization assay was validated by the structure-activity relationship study of known GPR88 agonist (1R,2R)-2-PCCA analogues.  The assay was automated and miniaturized to a 384-well format, and was deemed robust and reproducible with a Z'-factor of 0.72 and tolerated dimethyl sulfoxide to a final concentration of 2%.  Screening a pilot neurotransmitter library consisting of 228 compounds yielded 10 hits, but none of the hits were confirmed as GPR88 agonists in follow-up assays.  CONCLUSIONS:  We have developed a high-throughput calcium mobilization assay for the orphan receptor GPR88.  This calcium mobilization assay can be used to identify several different types of GPR88 ligands including agonists, competitive and noncompetitive antagonists, inverse agonists, and allosteric modulators.  These ligands will serve as valuable tools to probe signaling mechanisms and in vivo functions of GPR88, and could expedite development of novel therapies for diseases potentially mediated by GPR88.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQP05P7u3hXiSSm0e6ZOaemfW6udTcc2eao2YhM0-gKn7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cvhs1aitQ%253D%253D&md5=d7861bf0e7d6962d0c133563fee99ac7</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1186%2Fs12929-017-0330-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12929-017-0330-3%26sid%3Dliteratum%253Aachs%26aulast%3DDecker%26aufirst%3DA.%2BM.%26aulast%3DGay%26aufirst%3DE.%2BA.%26aulast%3DMathews%26aufirst%3DK.%2BM.%26aulast%3DRosa%26aufirst%3DT.%2BC.%26aulast%3DLangston%26aufirst%3DT.%2BL.%26aulast%3DMaitra%26aufirst%3DR.%26aulast%3DJin%26aufirst%3DC.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%2520high-throughput%2520calcium%2520mobilization%2520assay%2520for%2520the%2520orphan%2520receptor%2520GPR88%26jtitle%3DJ.%2520Biomed.%2520Sci.%26date%3D2017%26volume%3D24%26spage%3D23%26doi%3D10.1186%2Fs12929-017-0330-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langston, T. L.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and pharmacological evaluation of 4-hydroxyphenylglycine and 4-hydroxyphenylglycinol derivatives as GPR88 agonists</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">805</span>– <span class="NLM_lpage">812</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.11.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1016%2Fj.bmc.2016.11.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=27956039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVyjur%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=805-812&author=C.+Jinauthor=A.+M.+Deckerauthor=T.+L.+Langston&title=Design%2C+synthesis+and+pharmacological+evaluation+of+4-hydroxyphenylglycine+and+4-hydroxyphenylglycinol+derivatives+as+GPR88+agonists&doi=10.1016%2Fj.bmc.2016.11.058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and pharmacological evaluation of 4-hydroxyphenylglycine and 4-hydroxyphenylglycinol derivatives as GPR88 agonists</span></div><div class="casAuthors">Jin, Chunyang; Decker, Ann M.; Langston, Tiffany L.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">805-812</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The orphan receptor GPR88 is an attractive therapeutic target because of its implications in a no. of basal ganglia-assocd. disorders.  To date, pharmacol. characterization of GPR88 has been limited due to the lack of potent and selective agonists and antagonists appropriate for CNS investigations.  We have previously reported that GPR88 couples to Gαi proteins and modulates cAMP levels upon treatment with a small mol. agonist 2-PCCA.  Recently, another chemotype of GPR88 agonist, represented by 2-AMPP [(2S)-N-((1R)-2-amino-1-(4-(2-methylpentyloxy)-phenyl)ethyl)-2-phenylpropanamide], has also been discovered.  In this report, a new series of 2-AMPP structurally related 4-hydroxyphenylglycine and 4-hydroxyphenylglycinol derivs. have been designed and evaluated for agonist activity at GPR88.  The structure-activity relationship (SAR) studies suggest that the amine group in 2-AMPP can be replaced by hydroxyl, ester and amide groups, resulting in analogs with good to moderate potency, whereas the Ph group on the amide cap is essential for activity and has limited size, shape and electronic tolerance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQTVDfiQIu2LVg90H21EOLACvtfcHk0ljZBOlgx7QncA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVyjur%252FK&md5=08b74fc125213c2ac52846704d2e8661</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.11.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.11.058%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DC.%26aulast%3DDecker%26aufirst%3DA.%2BM.%26aulast%3DLangston%26aufirst%3DT.%2BL.%26atitle%3DDesign%252C%2520synthesis%2520and%2520pharmacological%2520evaluation%2520of%25204-hydroxyphenylglycine%2520and%25204-hydroxyphenylglycinol%2520derivatives%2520as%2520GPR88%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D805%26epage%3D812%26doi%3D10.1016%2Fj.bmc.2016.11.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makhijani, V. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besheer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darcq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieffer, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maitra, R.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Potent, selective, and brain-penetrant small molecule that activates the orphan receptor GPR88 and reduces alcohol intake</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">6748</span>– <span class="NLM_lpage">6758</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00566</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00566" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlWrtLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6748-6758&author=C.+Jinauthor=A.+M.+Deckerauthor=V.+H.+Makhijaniauthor=J.+Besheerauthor=E.+Darcqauthor=B.+L.+Kiefferauthor=R.+Maitra&title=Discovery+of+a+Potent%2C+selective%2C+and+brain-penetrant+small+molecule+that+activates+the+orphan+receptor+GPR88+and+reduces+alcohol+intake&doi=10.1021%2Facs.jmedchem.8b00566"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent, Selective, and Brain-Penetrant Small Molecule that Activates the Orphan Receptor GPR88 and Reduces Alcohol Intake</span></div><div class="casAuthors">Jin, Chunyang; Decker, Ann M.; Makhijani, Viren H.; Besheer, Joyce; Darcq, Emmanuel; Kieffer, Brigitte L.; Maitra, Rangan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6748-6758</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The orphan G-protein-coupled receptor GPR88 is highly expressed in the striatum.  Studies using GPR88 knockout mice have suggested that the receptor is implicated in alc. seeking and drinking behaviors.  To date, the biol. effects of GPR88 activation are still unknown due to the lack of a potent and selective agonist appropriate for in vivo investigation.  In this study, we report the discovery of the first potent, selective, and brain-penetrant GPR88 agonist RTI-13951-33 (6).  RTI-13951-33 exhibited an EC50 of 25 nM in an in vitro cAMP functional assay and had no significant off-target activity at 38 GPCRs, ion channels, and neurotransmitter transporters that were tested.  RTI-13951-33 displayed enhanced aq. soly. compared to (1R,2R)-2-PCCA (2) and had favorable pharmacokinetic properties for behavioral assessment.  Finally, RTI-13951-33 significantly reduced alc. self-administration and alc. intake in a dose-dependent manner without effects on locomotion and sucrose self-administration in rats when administered i.p.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoU1feawI2n0LVg90H21EOLACvtfcHk0ljZBOlgx7QncA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlWrtLrK&md5=1e9b99b4fda0398302cf52a5710c2707</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00566%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DC.%26aulast%3DDecker%26aufirst%3DA.%2BM.%26aulast%3DMakhijani%26aufirst%3DV.%2BH.%26aulast%3DBesheer%26aufirst%3DJ.%26aulast%3DDarcq%26aufirst%3DE.%26aulast%3DKieffer%26aufirst%3DB.%2BL.%26aulast%3DMaitra%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520a%2520Potent%252C%2520selective%252C%2520and%2520brain-penetrant%2520small%2520molecule%2520that%2520activates%2520the%2520orphan%2520receptor%2520GPR88%2520and%2520reduces%2520alcohol%2520intake%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D6748%26epage%3D6758%26doi%3D10.1021%2Facs.jmedchem.8b00566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzierba, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zipp, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burford, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrante, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertekap, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cacace, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westphal, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimball, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronson, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macor, J. E.</span></span> <span> </span><span class="NLM_article-title">The discovery of potent agonists for GPR88, an orphan GPCR, for the potential treatment of CNS disorders</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1443</span>– <span class="NLM_lpage">1447</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.02.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1016%2Fj.bmcl.2015.02.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=25754495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjsFCqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=1443-1447&author=Y.+Biauthor=C.+D.+Dzierbaauthor=C.+Finkauthor=Y.+Garciaauthor=M.+Greenauthor=J.+Hanauthor=S.+Kwonauthor=G.+Kumiauthor=Z.+Liangauthor=Y.+Liuauthor=Y.+Qiaoauthor=Y.+Zhangauthor=G.+Zippauthor=N.+Burfordauthor=M.+Ferranteauthor=R.+Bertekapauthor=M.+Lewisauthor=A.+Cacaceauthor=R.+S.+Westphalauthor=D.+Kimballauthor=J.+J.+Bronsonauthor=J.+E.+Macor&title=The+discovery+of+potent+agonists+for+GPR88%2C+an+orphan+GPCR%2C+for+the+potential+treatment+of+CNS+disorders&doi=10.1016%2Fj.bmcl.2015.02.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of potent agonists for GPR88, an orphan GPCR, for the potential treatment of CNS disorders</span></div><div class="casAuthors">Bi, Yingzhi; Dzierba, Carolyn D.; Fink, Cynthia; Garcia, Yudith; Green, Michael; Han, Jianxin; Kwon, Soojin; Kumi, Godwin; Liang, Zhi; Liu, Ying; Qiao, Ying; Zhang, Yulian; Zipp, Greg; Burford, Neil; Ferrante, Meredith; Bertekap, Robert; Lewis, Martin; Cacace, Angela; Westphal, Ryan S.; Kimball, David; Bronson, Joanne J.; Macor, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1443-1447</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Modulating GPR88 activity is suggested to have therapeutic utility in the treatment of CNS disorders, such as schizophrenia.  This Letter will describe the discovery and SAR development of a class of potent GPR88 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquM7yMUlK40LVg90H21EOLACvtfcHk0ljtva6Nqu6WvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjsFCqsL4%253D&md5=ec62482f43cf71b6f7f2153b6535089f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.02.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.02.038%26sid%3Dliteratum%253Aachs%26aulast%3DBi%26aufirst%3DY.%26aulast%3DDzierba%26aufirst%3DC.%2BD.%26aulast%3DFink%26aufirst%3DC.%26aulast%3DGarcia%26aufirst%3DY.%26aulast%3DGreen%26aufirst%3DM.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DKwon%26aufirst%3DS.%26aulast%3DKumi%26aufirst%3DG.%26aulast%3DLiang%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DQiao%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZipp%26aufirst%3DG.%26aulast%3DBurford%26aufirst%3DN.%26aulast%3DFerrante%26aufirst%3DM.%26aulast%3DBertekap%26aufirst%3DR.%26aulast%3DLewis%26aufirst%3DM.%26aulast%3DCacace%26aufirst%3DA.%26aulast%3DWestphal%26aufirst%3DR.%2BS.%26aulast%3DKimball%26aufirst%3DD.%26aulast%3DBronson%26aufirst%3DJ.%2BJ.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26atitle%3DThe%2520discovery%2520of%2520potent%2520agonists%2520for%2520GPR88%252C%2520an%2520orphan%2520GPCR%252C%2520for%2520the%2520potential%2520treatment%2520of%2520CNS%2520disorders%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D1443%26epage%3D1447%26doi%3D10.1016%2Fj.bmcl.2015.02.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dzierba, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dasgupta, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartz, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahuja, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianchetta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aleem, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zipp, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burford, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrante, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertekap, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cacace, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grace, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nouraldeen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westphal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimball, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronson, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macor, J. E.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of phenylglycinols and phenyl amines as agonists of GPR88</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1448</span>– <span class="NLM_lpage">1452</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.01.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1016%2Fj.bmcl.2015.01.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=25690789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslSnur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=1448-1452&author=C.+D.+Dzierbaauthor=Y.+Biauthor=B.+Dasguptaauthor=R.+A.+Hartzauthor=V.+Ahujaauthor=G.+Cianchettaauthor=G.+Kumiauthor=L.+Dongauthor=S.+Aleemauthor=C.+Finkauthor=Y.+Garciaauthor=M.+Greenauthor=J.+Hanauthor=S.+Kwonauthor=Y.+Qiaoauthor=J.+Wangauthor=Y.+Zhangauthor=Y.+Liuauthor=G.+Zippauthor=Z.+Liangauthor=N.+Burfordauthor=M.+Ferranteauthor=R.+Bertekapauthor=M.+Lewisauthor=A.+Cacaceauthor=J.+Graceauthor=A.+Wilsonauthor=A.+Nouraldeenauthor=R.+Westphalauthor=D.+Kimballauthor=K.+Carsonauthor=J.+J.+Bronsonauthor=J.+E.+Macor&title=Design%2C+synthesis%2C+and+evaluation+of+phenylglycinols+and+phenyl+amines+as+agonists+of+GPR88&doi=10.1016%2Fj.bmcl.2015.01.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and evaluation of phenylglycinols and phenylamines as agonists of GPR88</span></div><div class="casAuthors">Dzierba, Carolyn D.; Bi, Yingzhi; Dasgupta, Bireshwar; Hartz, Richard A.; Ahuja, Vijay; Cianchetta, Giovanni; Kumi, Godwin; Dong, Li; Aleem, Saadat; Fink, Cynthia; Garcia, Yudith; Green, Michael; Han, Jianxin; Kwon, Soojin; Qiao, Ying; Wang, Jiancheng; Zhang, Yulian; Liu, Ying; Zipp, Greg; Liang, Zhi; Burford, Neil; Ferrante, Meredith; Bertekap, Robert; Lewis, Martin; Cacace, Angela; Grace, James; Wilson, Alan; Nouraldeen, Amr; Westphal, Ryan; Kimball, David; Carson, Kenneth; Bronson, Joanne J.; Macor, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1448-1452</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Small mol. modulators of GPR88 activity (agonists, antagonists, or modulators) are of interest as potential agents for the treatment of a variety of psychiatric disorders including schizophrenia.  A series of phenylglycinol and phenylamine analogs, e.g., I [R1 = iso-Bu, (S)-2-methylbutyl, 2-methylpentyl, (oxetan-2-yl)methyl, (S)-2-methoxypropyl, 1-methoxy-2-propyl] and II [R2 = R3 = H, Me; NR2R3 = (4-methylpiperazin-1-yl), morpholin-4-yl, pyrrolidin-1-yl], resp., have been prepd. and evaluated for their GPR88 agonist activity and pharmacokinetic (PK) properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohypcmQcdKqLVg90H21EOLACvtfcHk0ljtva6Nqu6WvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslSnur0%253D&md5=003075f447e1c76b56b885fe8cd21f4e</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.01.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.01.036%26sid%3Dliteratum%253Aachs%26aulast%3DDzierba%26aufirst%3DC.%2BD.%26aulast%3DBi%26aufirst%3DY.%26aulast%3DDasgupta%26aufirst%3DB.%26aulast%3DHartz%26aufirst%3DR.%2BA.%26aulast%3DAhuja%26aufirst%3DV.%26aulast%3DCianchetta%26aufirst%3DG.%26aulast%3DKumi%26aufirst%3DG.%26aulast%3DDong%26aufirst%3DL.%26aulast%3DAleem%26aufirst%3DS.%26aulast%3DFink%26aufirst%3DC.%26aulast%3DGarcia%26aufirst%3DY.%26aulast%3DGreen%26aufirst%3DM.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DKwon%26aufirst%3DS.%26aulast%3DQiao%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZipp%26aufirst%3DG.%26aulast%3DLiang%26aufirst%3DZ.%26aulast%3DBurford%26aufirst%3DN.%26aulast%3DFerrante%26aufirst%3DM.%26aulast%3DBertekap%26aufirst%3DR.%26aulast%3DLewis%26aufirst%3DM.%26aulast%3DCacace%26aufirst%3DA.%26aulast%3DGrace%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DA.%26aulast%3DNouraldeen%26aufirst%3DA.%26aulast%3DWestphal%26aufirst%3DR.%26aulast%3DKimball%26aufirst%3DD.%26aulast%3DCarson%26aufirst%3DK.%26aulast%3DBronson%26aufirst%3DJ.%2BJ.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520phenylglycinols%2520and%2520phenyl%2520amines%2520as%2520agonists%2520of%2520GPR88%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D1448%26epage%3D1452%26doi%3D10.1016%2Fj.bmcl.2015.01.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wold, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Orphan receptor GPR88 as an emerging neurotherapeutic target</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">190</span>– <span class="NLM_lpage">200</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.8b00572</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.8b00572" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVyhs7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=190-200&author=N.+Yeauthor=B.+Liauthor=Q.+Maoauthor=E.+A.+Woldauthor=S.+Tianauthor=J.+A.+Allenauthor=J.+Zhou&title=Orphan+receptor+GPR88+as+an+emerging+neurotherapeutic+target&doi=10.1021%2Facschemneuro.8b00572"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Orphan Receptor GPR88 as an Emerging Neurotherapeutic Target</span></div><div class="casAuthors">Ye, Na; Li, Bang; Mao, Qi; Wold, Eric A.; Tian, Sheng; Allen, John A.; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">190-200</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Although G protein-coupled receptors (GPCRs) are recognized as pivotal drug targets involved in multiple physiol. and pathol. processes, the majority of GPCRs including orphan GPCRs (oGPCRs) are unexploited.  GPR88, a brain-specific oGPCR with particularly robust expression in the striatum, regulates diverse brain and behavioral functions, including cognition, mood, movement control, and reward-based learning, and is thus emerging as a novel drug target for central nervous system disorders including schizophrenia, Parkinson's disease, anxiety, and addiction.  Nevertheless, no effective GPR88 synthetic ligands have yet entered into clin. trials, and GPR88 endogenous ligands remain unknown.  Despite the recent discovery and early stage study of several GPR88 agonists, such as 2-PCCA, RTI-13951-33, and phenylglycinol derivs., further research into GPR88 pharmacol., medicinal chem., and chem. biol. is urgently needed to yield structurally diversified GPR88-specific ligands.  Drug-like pharmacol. tool function and relevant signaling elucidation will also accelerate the evaluation of this receptor as a viable neurotherapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoP8O0djL7NL7Vg90H21EOLACvtfcHk0ljtva6Nqu6WvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVyhs7fO&md5=0511e92dd00711cb2b4f83a6e5b82818</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.8b00572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.8b00572%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DMao%26aufirst%3DQ.%26aulast%3DWold%26aufirst%3DE.%2BA.%26aulast%3DTian%26aufirst%3DS.%26aulast%3DAllen%26aufirst%3DJ.%2BA.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DOrphan%2520receptor%2520GPR88%2520as%2520an%2520emerging%2520neurotherapeutic%2520target%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2019%26volume%3D10%26spage%3D190%26epage%3D200%26doi%3D10.1021%2Facschemneuro.8b00572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laboute, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellissier, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corde, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebeillard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauthier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leaute, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poupon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieffer, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Merrer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, J. A.</span></span> <span> </span><span class="NLM_article-title">The orphan receptor GPR88 blunts the signaling of opioid receptors and multiple striatal GPCRs</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e50519</span> <span class="refDoi"> DOI: 10.7554/elife.50519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.7554%2FeLife.50519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=32003745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtlarsLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2020&author=T.+Labouteauthor=J.+Gandiaauthor=L.+P.+Pellissierauthor=Y.+Cordeauthor=F.+Rebeillardauthor=M.+Galloauthor=C.+Gauthierauthor=A.+Leauteauthor=J.+Diazauthor=A.+Pouponauthor=B.+L.+Kiefferauthor=J.+Le+Merrerauthor=J.+A.+Becker&title=The+orphan+receptor+GPR88+blunts+the+signaling+of+opioid+receptors+and+multiple+striatal+GPCRs&doi=10.7554%2Felife.50519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The orphan receptor GPR88 blunts the signaling of opioid receptors and multiple striatal GPCRs</span></div><div class="casAuthors">Laboute, Thibaut; Gandia, Jorge; Pellissier, Lucie P.; Corde, Yannick; Rebeillard, Florian; Gallo, Maria; Gauthier, Christophe; Leaute, Audrey; Diaz, Jorge; Poupon, Anne; Kieffer, Brigitte L.; Le Merrer, Julie; Becker, Jerome A. J.</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e50519</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">GPR88 is an orphan G protein-coupled receptor (GPCR) considered as a promising therapeutic target for neuropsychiatric disorders; its pharmacol., however, remains scarcely understood.  Based on our previous report of increased delta opioid receptor activity in Gpr88 null mice, we investigated the impact of GPR88 co-expression on the signaling of opioid receptors in vitro and revealed that GPR88 inhibits the activation of both their G protein- and β-arrestindependent signaling pathways.  In Gpr88 knockout mice, morphine-induced locomotor sensitization, withdrawal and supra-spinal analgesia were facilitated, consistent with a tonic inhibitory action of GPR88 on μOR signaling.  We then explored GPR88 interactions with more striatal vs. nonneuronal GPCRs, and revealed that GPR88 can decrease the G protein-dependent signaling of most receptors in close proximity, but impedes β-arrestin recruitment by all receptors tested.  Our study unravels an unsuspected buffering role of GPR88 expression on GPCR signaling, with intriguing consequences for opioid and striatal functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9Wb2Oy7Vz1bVg90H21EOLACvtfcHk0lgtmL48lUuLuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtlarsLbP&md5=5ff9500c552a41fd51dc26aa318f9d08</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.7554%2FeLife.50519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.50519%26sid%3Dliteratum%253Aachs%26aulast%3DLaboute%26aufirst%3DT.%26aulast%3DGandia%26aufirst%3DJ.%26aulast%3DPellissier%26aufirst%3DL.%2BP.%26aulast%3DCorde%26aufirst%3DY.%26aulast%3DRebeillard%26aufirst%3DF.%26aulast%3DGallo%26aufirst%3DM.%26aulast%3DGauthier%26aufirst%3DC.%26aulast%3DLeaute%26aufirst%3DA.%26aulast%3DDiaz%26aufirst%3DJ.%26aulast%3DPoupon%26aufirst%3DA.%26aulast%3DKieffer%26aufirst%3DB.%2BL.%26aulast%3DLe%2BMerrer%26aufirst%3DJ.%26aulast%3DBecker%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520orphan%2520receptor%2520GPR88%2520blunts%2520the%2520signaling%2520of%2520opioid%2520receptors%2520and%2520multiple%2520striatal%2520GPCRs%26jtitle%3DeLife%26date%3D2020%26volume%3D9%26doi%3D10.7554%2Felife.50519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Synopsis of some recent tactical application of bioisosteres in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2529</span>– <span class="NLM_lpage">2591</span>, <span class="refDoi"> DOI: 10.1021/jm1013693</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&author=N.+A.+Meanwell&title=Synopsis+of+some+recent+tactical+application+of+bioisosteres+in+drug+design&doi=10.1021%2Fjm1013693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0lgtmL48lUuLuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520some%2520recent%2520tactical%2520application%2520of%2520bioisosteres%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2529%26epage%3D2591%26doi%3D10.1021%2Fjm1013693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boström, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llinàs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wellner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plowright, A. T.</span></span> <span> </span><span class="NLM_article-title">Oxadiazoles in medicinal chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1817</span>– <span class="NLM_lpage">1830</span>, <span class="refDoi"> DOI: 10.1021/jm2013248</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2013248" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A280%3ADC%252BC383pt1Oisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1817-1830&author=J.+Bostr%C3%B6mauthor=A.+Hognerauthor=A.+Llin%C3%A0sauthor=E.+Wellnerauthor=A.+T.+Plowright&title=Oxadiazoles+in+medicinal+chemistry&doi=10.1021%2Fjm2013248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Oxadiazoles in medicinal chemistry</span></div><div class="casAuthors">Bostrom Jonas; Hogner Anders; Llinas Antonio; Wellner Eric; Plowright Alleyn T</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1817-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Oxadiazoles are five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom, and they exist in different regioisomeric forms.  Oxadiazoles are frequently occurring motifs in druglike molecules, and they are often used with the intention of being bioisosteric replacements for ester and amide functionalities.  The current study presents a systematic comparison of 1,2,4- and 1,3,4-oxadiazole matched pairs in the AstraZeneca compound collection.  In virtually all cases, the 1,3,4-oxadiazole isomer shows an order of magnitude lower lipophilicity (log D), as compared to its isomeric partner.  Significant differences are also observed with respect to metabolic stability, hERG inhibition, and aqueous solubility, favoring the 1,3,4-oxadiazole isomers.  The difference in profile between the 1,2,4 and 1,3,4 regioisomers can be rationalized by their intrinsically different charge distributions (e.g., dipole moments).  To facilitate the use of these heteroaromatic rings, novel synthetic routes for ready access of a broad spectrum of 1,3,4-oxadiazoles, under mild conditions, are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSO9RQiG9xFS2Zyxfu64m4ffW6udTcc2ebCdeSNXlB4YLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC383pt1Oisw%253D%253D&md5=b934995431ced1be297e6f126262f3cb</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm2013248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2013248%26sid%3Dliteratum%253Aachs%26aulast%3DBostr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DHogner%26aufirst%3DA.%26aulast%3DLlin%25C3%25A0s%26aufirst%3DA.%26aulast%3DWellner%26aufirst%3DE.%26aulast%3DPlowright%26aufirst%3DA.%2BT.%26atitle%3DOxadiazoles%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1817%26epage%3D1830%26doi%3D10.1021%2Fjm2013248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Summerfield, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Begley, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obradovic, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hidalgo, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coggon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, P.</span></span> <span> </span><span class="NLM_article-title">Central nervous system drug disposition: the relationship between in situ brain permeability and brain free fraction</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>322</i></span>,  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">213</span>, <span class="refDoi"> DOI: 10.1124/jpet.107.121525</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1124%2Fjpet.107.121525" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=17405866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntl2jt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=2007&pages=205-213&author=S.+G.+Summerfieldauthor=K.+Readauthor=D.+J.+Begleyauthor=T.+Obradovicauthor=I.+J.+Hidalgoauthor=S.+Coggonauthor=A.+V.+Lewisauthor=R.+A.+Porterauthor=P.+Jeffrey&title=Central+nervous+system+drug+disposition%3A+the+relationship+between+in+situ+brain+permeability+and+brain+free+fraction&doi=10.1124%2Fjpet.107.121525"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Central nervous system drug disposition: the relationship between in situ brain permeability and brain free fraction</span></div><div class="casAuthors">Summerfield, Scott G.; Read, Kevin; Begley, David J.; Obradovic, Tanja; Hidalgo, Ismael J.; Coggon, Sara; Lewis, Ann V.; Porter, Rod A.; Jeffrey, Phil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">322</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">205-213</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The dispositions of 50 marketed central nervous system (CNS) drugs into the brain have been examd. in terms of their rat in situ (P) and in vitro apparent membrane permeability (Papp) alongside lipophilicity and free fraction in rat brain tissue.  The inter-relation between these parameters highlights that both permeability and brain tissue binding influence the uptake of drugs into the CNS.  Hydrophilic compds. characterized by low brain tissue binding display a strong correlation (R2 = 0.82) between P and Papp, whereas the uptake of more lipophilic compds. seems to be influenced by both Papp and brain free fraction.  A nonlinear relation is obsd. between logPoct and P over the 6 orders of magnitude range in lipophilicity studied.  These findings corroborate recent reports in the literature that brain penetration is a function of both rate and extent of drug uptake into the CNS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYr8NNFNDFz7Vg90H21EOLACvtfcHk0ljcEOEPLqtGOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntl2jt7g%253D&md5=006fd227474b6d404de1c44cf76289ba</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.121525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.121525%26sid%3Dliteratum%253Aachs%26aulast%3DSummerfield%26aufirst%3DS.%2BG.%26aulast%3DRead%26aufirst%3DK.%26aulast%3DBegley%26aufirst%3DD.%2BJ.%26aulast%3DObradovic%26aufirst%3DT.%26aulast%3DHidalgo%26aufirst%3DI.%2BJ.%26aulast%3DCoggon%26aufirst%3DS.%26aulast%3DLewis%26aufirst%3DA.%2BV.%26aulast%3DPorter%26aufirst%3DR.%2BA.%26aulast%3DJeffrey%26aufirst%3DP.%26atitle%3DCentral%2520nervous%2520system%2520drug%2520disposition%253A%2520the%2520relationship%2520between%2520in%2520situ%2520brain%2520permeability%2520and%2520brain%2520free%2520fraction%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D322%26spage%3D205%26epage%3D213%26doi%3D10.1124%2Fjpet.107.121525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghose, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbertz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudkins, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsey, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallamo, J. P.</span></span> <span> </span><span class="NLM_article-title">Knowledge-based, central nervous system (CNS) lead selection and lead optimization for CNS drug discovery</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1021/cn200100h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn200100h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSit7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=50-68&author=A.+K.+Ghoseauthor=T.+Herbertzauthor=R.+L.+Hudkinsauthor=B.+D.+Dorseyauthor=J.+P.+Mallamo&title=Knowledge-based%2C+central+nervous+system+%28CNS%29+lead+selection+and+lead+optimization+for+CNS+drug+discovery&doi=10.1021%2Fcn200100h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery</span></div><div class="casAuthors">Ghose, Arup K.; Herbertz, Torsten; Hudkins, Robert L.; Dorsey, Bruce D.; Mallamo, John P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-68</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The central nervous system (CNS) is the major area that is affected by aging.  Alzheimer's disease (AD), Parkinson's disease (PD), brain cancer, and stroke are the CNS diseases that will cost trillions of dollars for their treatment.  Achievement of appropriate blood-brain barrier (BBB) penetration is often considered a significant hurdle in the CNS drug discovery process.  On the other hand, BBB penetration may be a liability for many of the non-CNS drug targets, and a clear understanding of the physicochem. and structural differences between CNS and non-CNS drugs may assist both research areas.  Because of the numerous and challenging issues in CNS drug discovery and the low success rates, pharmaceutical companies are beginning to deprioritize their drug discovery efforts in the CNS arena.  Prompted by these challenges and to aid in the design of high-quality, efficacious CNS compds., we analyzed the physicochem. property and the chem. structural profiles of 317 CNS and 626 non-CNS oral drugs.  The conclusions derived provide an ideal property profile for lead selection and the property modification strategy during the lead optimization process.  A list of substructural units that may be useful for CNS drug design was also provided here.  A classification tree was also developed to differentiate between CNS drugs and non-CNS oral drugs.  The combined anal. provided the following guidelines for designing high-quality CNS drugs: (i) topol. mol. polar surface area of <76 Å2 (25-60 Å2), (ii) at least one (one or two, including one aliph. amine) nitrogen, (iii) fewer than seven (two to four) linear chains outside of rings, (iv) fewer than three (zero or one) polar hydrogen atoms, (v) vol. of 740-970 Å3, (vi) solvent accessible surface area of 460-580 Å2, and (vii) pos. QikProp parameter CNS.  The ranges within parentheses may be used during lead optimization.  One violation to this proposed profile may be acceptable.  The chemoinformatics approaches for graphically analyzing multiple properties efficiently are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozqfO0vq2i5bVg90H21EOLACvtfcHk0ljcEOEPLqtGOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSit7rO&md5=4c20ba34c3d5397170b50242975ce25d</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fcn200100h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200100h%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DHerbertz%26aufirst%3DT.%26aulast%3DHudkins%26aufirst%3DR.%2BL.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26aulast%3DMallamo%26aufirst%3DJ.%2BP.%26atitle%3DKnowledge-based%252C%2520central%2520nervous%2520system%2520%2528CNS%2529%2520lead%2520selection%2520and%2520lead%2520optimization%2520for%2520CNS%2520drug%2520discovery%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D50%26epage%3D68%26doi%3D10.1021%2Fcn200100h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenz, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">Exploring new reactive species for cyclopropanation</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">8621</span>– <span class="NLM_lpage">8624</span>, <span class="refDoi"> DOI: 10.1016/s0040-4039(98)01954-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1016%2FS0040-4039%2898%2901954-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADyaK1cXntlans7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=8621-8624&author=Z.+Yangauthor=J.+C.+Lorenzauthor=Y.+Shi&title=Exploring+new+reactive+species+for+cyclopropanation&doi=10.1016%2Fs0040-4039%2898%2901954-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring new reactive species for cyclopropanation</span></div><div class="casAuthors">Yang, Zhiqiang; Lorenz, Jon C.; Shi, Yian</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">8621-8624</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">An organozinc species RXZnCH2I, generated by reacting Zn(CH2I)2 with RXH, was found to be an efficient reagent for the cyclopropanation of olefins at room temp.  A 50.7% ee was obtained for the cyclopropanation of trans-β-methylstyrene when a chiral alc. was used.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXqG6D2VQMZLVg90H21EOLACvtfcHk0ljcEOEPLqtGOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXntlans7k%253D&md5=b76bf484daf18cd44264ed5a56e5030c</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2898%2901954-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252898%252901954-6%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DLorenz%26aufirst%3DJ.%2BC.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DExploring%2520new%2520reactive%2520species%2520for%2520cyclopropanation%26jtitle%3DTetrahedron%2520Lett.%26date%3D1998%26volume%3D39%26spage%3D8621%26epage%3D8624%26doi%3D10.1016%2Fs0040-4039%2898%2901954-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simmons, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. D.</span></span> <span> </span><span class="NLM_article-title">A new synthesis of cyclopropanes from olefins</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1958</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">5323</span>– <span class="NLM_lpage">5324</span>, <span class="refDoi"> DOI: 10.1021/ja01552a080</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01552a080" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADyaG1MXjvFKgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1958&pages=5323-5324&author=H.+E.+Simmonsauthor=R.+D.+Smith&title=A+new+synthesis+of+cyclopropanes+from+olefins&doi=10.1021%2Fja01552a080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A new synthesis of cyclopropanes from olefins</span></div><div class="casAuthors">Simmons, Howard E.; Smith, Ronald D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1958</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5323-4</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">cf. Howard, C.A. 34, 62153.  A versatile, stereospecific synthesis is reported of cyclopropanes by the reaction of unsatd. compds. with CH2I2 and a Zn-Cu couple.  Cyclohexene (0.30 mole), 0.15 mole CH2I2, and Zn-Cu couple (0.22 mole Zn) refluxed 48 hrs. in Et2O and the product distd. yielded 48% pure bicyclo[4.1.0] heptane, b. 116.5°, n25D 1.4546.  Many functionally substituted olefins gave the corresponding cyclopropanes.  Yields (10-70%) depended greatly on the kind of couple used and in no case were isomeric or rearranged products encountered (starting compd., product, and % yield given): C2H4, cyclopropane, 29; cyclopentene, bicyclo[3.1.0]hexane, 27; bicyclo[2.2.1] hept-2-ene, tricyclo[3,2,1,0]octane, 47; PhCH2CH:CH2, benzylcyclopropane, 49; PhCH:CH2, phenylcyclopropane, 32; ο-MeOC6H4CH:CHMe, 1-(ο-methoxyphenyl)-2-methylcyclopropane, 70; MeCH:CHCO2Me, Me 2-methyl-cyclopropanecarboxylate, 9; AcOCH:CH2, cyclopropyl acetate, 31.  Ethereal solns. from the reaction of the Zn-Cu couple contained ICH2ZnI.  Mechanisms for the reaction are discussed.  The stereospecificity of the reaction is indicated by the following reactions: cis-EtCH:CHEt yielded 35.5% pure cis-1,2-diethylcyclopropane, b. 93.5°, n25D 1.4035; trans-EtCH:CHEt yielded 15.5% trans-1,2-diethylcyclopropane, b. 86.5°, n25D 1.3982.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHpnVTzAYovLVg90H21EOLACvtfcHk0lhQc8Z0oulRcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG1MXjvFKgug%253D%253D&md5=06d71e46354becf7287751ac835f51f7</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fja01552a080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01552a080%26sid%3Dliteratum%253Aachs%26aulast%3DSimmons%26aufirst%3DH.%2BE.%26aulast%3DSmith%26aufirst%3DR.%2BD.%26atitle%3DA%2520new%2520synthesis%2520of%2520cyclopropanes%2520from%2520olefins%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1958%26volume%3D80%26spage%3D5323%26epage%3D5324%26doi%3D10.1021%2Fja01552a080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/medium/jm0c01581_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/large/jm0c01581_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01581&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/medium/jm0c01581_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/large/jm0c01581_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. 2-PCCA scaffold-based GPR88 agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/large/jm0c01581_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01581&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/medium/jm0c01581_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/large/jm0c01581_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of 2-AMPP (<b>1</b>) and <b>2–4</b> and preliminary SAR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/large/jm0c01581_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01581&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/medium/jm0c01581_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/large/jm0c01581_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Target Compounds <b>12–28</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/large/jm0c01581_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01581&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Boc<sub>2</sub>O, DIPEA, DCM, rt, overnight; (b) PPh<sub>3</sub>, DEAD, alcohol, THF, rt, overnight; (c) NaBH<sub>4</sub>, LiCl, THF-EtOH (1:1), rt, 3 h; (d) 4 M HCl in dioxane, DCM, rt, 16 h; or TFA: DCM, rt, 6 h; (e) (<i>S</i>)-2-phenylpropionic acid, HBTU, TEA, MeCN, rt, 5 h; (f) TIPSCl, imidazole, DCM, rt, overnight; (g) TBAF, THF, 0 °C, 3 h; (h) alkyl <i>p</i>-toluenesulfonate, K<sub>2</sub>CO<sub>3</sub> MeCN, 65 °C, overnight.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/medium/jm0c01581_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/large/jm0c01581_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Target Compounds <b>30–69</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/large/jm0c01581_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01581&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: Method A (a) pyridine, dioxane, NH<sub>4</sub>HCO<sub>3</sub>, Boc<sub>2</sub>O, rt, overnight; Method B (a) EDC hydrochloride, HOBt, DIPEA, amine, DMF, rt, overnight; Method C (a) oxalyl chloride, DMF (cat.), DCM, rt; then amine, Et<sub>3</sub>N, rt, overnight.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/medium/jm0c01581_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/large/jm0c01581_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Target Compounds <b>71–74</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/large/jm0c01581_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01581&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) hydrazine monohydrate, EtOH, reflux, 3 h; (b) CH(OMe)<sub>3</sub>, PTSA, 85 °C, 2 h or CH<sub>3</sub>C(OMe)<sub>3</sub>, HOAc, <i>m</i>-xylene, reflux, 6 h.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/medium/jm0c01581_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/large/jm0c01581_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Target Compounds <b>82–91</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/large/jm0c01581_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01581&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) acetyl chloride, MeOH, reflux, overnight; (b) Boc<sub>2</sub>O, DIPEA, DCM, rt, overnight; (c) PPh<sub>3</sub>, DEAD, alcohol, rt, overnight; or alkyl <i>p</i>-toluenesulfonate, K<sub>2</sub>CO<sub>3</sub>, MeCN, 65 °C, overnight; (d) 4 M HCl in dioxane, DCM, rt, overnight; (e) (<i>S</i>)-2-phenylpropionic acid, HBTU, TEA, MeCN, rt, 5 h; (f) hydrazine monohydrate, EtOH, reflux, 3 h; (g) CH(OMe)<sub>3</sub>, PTSA, 85 °C, 2 h; or CH<sub>3</sub>C(OMe)<sub>3</sub>, HOAc, <i>m</i>-xylene, reflux, 6 h; or CNBr, MeOH, reflux, 3 h.</p></p></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/medium/jm0c01581_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/large/jm0c01581_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Concentration–response curves of RTI-13951-33, <b>84</b>, and <b>90</b> in the GPR88 Lance TR-FRET cAMP assay. The TR-FRET signal (665 nm) was converted to fmol cAMP by interpolating from the standard cAMP curve. Percent inhibition of forskolin-induced (300 nM) cAMP levels was plotted against the log of compound concentration, and data were fit to a three-parameter logistic curve to generate EC<sub>50</sub> values. Each data point is the mean ± S.D. of at least three independent experiments performed in duplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/large/jm0c01581_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01581&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/medium/jm0c01581_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/large/jm0c01581_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. [<sup>35</sup>S]GTPγS binding of compound <b>84</b> in WT mouse striatal membranes vs GPR88 KO mouse striatal membranes. The data are the means of triplicate measurements with standard deviation shown as error bars.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01581/20201203/images/large/jm0c01581_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01581&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i159">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23225" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23225" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 39 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mizushima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukahara, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, T.</span></span> <span> </span><span class="NLM_article-title">A novel G-protein-coupled receptor gene expressed in striatum</span>. <i>Genomics</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">314</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1006/geno.2000.6340</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1006%2Fgeno.2000.6340" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=11056049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosVCqsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2000&pages=314-321&author=K.+Mizushimaauthor=Y.+Miyamotoauthor=F.+Tsukaharaauthor=M.+Hiraiauthor=Y.+Sakakiauthor=T.+Ito&title=A+novel+G-protein-coupled+receptor+gene+expressed+in+striatum&doi=10.1006%2Fgeno.2000.6340"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">A novel G-protein-coupled receptor gene expressed in striatum</span></div><div class="casAuthors">Mizushima, Kazuyuki; Miyamoto, Yasuhide; Tsukahara, Fujiko; Hirai, Momoki; Sakaki, Yoshiyuki; Ito, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Genomics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">314-321</span>CODEN:
                <span class="NLM_cas:coden">GNMCEP</span>;
        ISSN:<span class="NLM_cas:issn">0888-7543</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Differential display screening for region-specific transcripts in rat brain revealed a novel striatum-specific transcript encoding an orphan G-protein-coupled receptor (GPCR) designated Strg/Gpr88 for striatum-specific GPCR.  We isolated its homologues from human (HGMW-approved symbol GPR88) and mouse and mapped them to chromosomes 1p21.3 and 3G1, resp.  These loci are syntenic to each other, thereby suggesting their orthol.  The predicted primary sequences of Strg/Gpr88 proteins are highly conserved between human and rodents and show the highest level of homol. to receptors for biogenic amines.  However, Strg/Gpr88 lacks some residues conserved in all known biogenic amine receptors and hence may represent a novel subtype of GPCR.  Northern blot and in situ hybridization analyses revealed that Strg/Gpr88 transcripts are expressed almost exclusively in striatum in both human and rodents.  Remarkable conservation in primary structure and a unique expression pattern may indicate a role for Strg/Gpr88 in the fundamental functions of striatum such as the control of motor behavior.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonYGGyr1F_rLVg90H21EOLACvtfcHk0lgqfCurivIS3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosVCqsr4%253D&md5=083f323e1b3596d57d622aad487e371b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1006%2Fgeno.2000.6340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fgeno.2000.6340%26sid%3Dliteratum%253Aachs%26aulast%3DMizushima%26aufirst%3DK.%26aulast%3DMiyamoto%26aufirst%3DY.%26aulast%3DTsukahara%26aufirst%3DF.%26aulast%3DHirai%26aufirst%3DM.%26aulast%3DSakaki%26aufirst%3DY.%26aulast%3DIto%26aufirst%3DT.%26atitle%3DA%2520novel%2520G-protein-coupled%2520receptor%2520gene%2520expressed%2520in%2520striatum%26jtitle%3DGenomics%26date%3D2000%26volume%3D69%26spage%3D314%26epage%3D321%26doi%3D10.1006%2Fgeno.2000.6340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghate, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Befort, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, J. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filliol, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bole-Feysot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demebele, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jost, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieffer, B. L.</span></span> <span> </span><span class="NLM_article-title">Identification of novel striatal genes by expression profiling in adult mouse brain</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>146</i></span>,  <span class="NLM_fpage">1182</span>– <span class="NLM_lpage">1192</span>, <span class="refDoi"> DOI: 10.1016/j.neuroscience.2007.02.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1016%2Fj.neuroscience.2007.02.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=17395390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1Sjtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2007&pages=1182-1192&author=A.+Ghateauthor=K.+Befortauthor=J.+A.+J.+Beckerauthor=D.+Filliolauthor=C.+Bole-Feysotauthor=D.+Demebeleauthor=B.+Jostauthor=M.+Kochauthor=B.+L.+Kieffer&title=Identification+of+novel+striatal+genes+by+expression+profiling+in+adult+mouse+brain&doi=10.1016%2Fj.neuroscience.2007.02.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of novel striatal genes by expression profiling in adult mouse brain</span></div><div class="casAuthors">Ghate, A.; Befort, K.; Becker, J. A. J.; Filliol, D.; Bole-Feysot, C.; Demebele, D.; Jost, B.; Koch, M.; Kieffer, B. L.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">146</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1182-1192</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Large-scale transcriptome anal. in the brain is a powerful approach to identify novel genes of potential interest toward understanding cerebral organization and function.  We utilized the microarray technol. to measure expression levels of about 24,000 genes and expressed sequence tags in mouse hippocampus, frontal cortex and striatum.  Using expression profile obtained from whole brain as a ref., we categorized the genes into groups of genes either enriched in, or restricted to, one of the three areas of interest.  We found enriched genes for each target area.  Further, we identified 14 genes in the category of genes restricted to the striatum, among which were the orphan G protein-coupled receptor GPR88 and retinoic acid receptor-beta.  These two genes were already reported to be selectively expressed in the striatum, thus validating our exptl. approach.  We selected 6 striatal-restricted genes, as well as 10 striatal-enriched candidates, that were previously undescribed.  We analyzed their expression by in situ hybridization anal. in the brain, and quant. RT-PCR in both brain and peripheral organs.  Two of these unknown genes displayed a notable expression pattern.  The striatal-restricted gene H3076B11 shows uniform expression throughout and uniquely in the striatum, representing a genuine striatal marker.  The striatal-enriched gene 4833421E05Rik is preferentially expressed in the rostral striatum, and is also abundant in kidney, liver and lung.  These two genes may contribute to some of the many striatal-controlled behaviors, including initiation of movement, habit formation, or reward and motivation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphf3vUv0FcfbVg90H21EOLACvtfcHk0lgqfCurivIS3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1Sjtr4%253D&md5=2c5b56fbbc6ea93e9ed698f90b0db3dc</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2007.02.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2007.02.040%26sid%3Dliteratum%253Aachs%26aulast%3DGhate%26aufirst%3DA.%26aulast%3DBefort%26aufirst%3DK.%26aulast%3DBecker%26aufirst%3DJ.%2BA.%2BJ.%26aulast%3DFilliol%26aufirst%3DD.%26aulast%3DBole-Feysot%26aufirst%3DC.%26aulast%3DDemebele%26aufirst%3DD.%26aulast%3DJost%26aufirst%3DB.%26aulast%3DKoch%26aufirst%3DM.%26aulast%3DKieffer%26aufirst%3DB.%2BL.%26atitle%3DIdentification%2520of%2520novel%2520striatal%2520genes%2520by%2520expression%2520profiling%2520in%2520adult%2520mouse%2520brain%26jtitle%3DNeuroscience%26date%3D2007%26volume%3D146%26spage%3D1182%26epage%3D1192%26doi%3D10.1016%2Fj.neuroscience.2007.02.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Massart, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guilloux, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mignon, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sokoloff, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, J.</span></span> <span> </span><span class="NLM_article-title">Striatal GPR88 expression is confined to the whole projection neuron population and is regulated by dopaminergic and glutamatergic afferents</span>. <i>Eur. J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">397</span>– <span class="NLM_lpage">414</span>, <span class="refDoi"> DOI: 10.1111/j.1460-9568.2009.06842.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1111%2Fj.1460-9568.2009.06842.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=19656174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A280%3ADC%252BD1MrmtVWgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=397-414&author=R.+Massartauthor=J.-P.+Guillouxauthor=V.+Mignonauthor=P.+Sokoloffauthor=J.+Diaz&title=Striatal+GPR88+expression+is+confined+to+the+whole+projection+neuron+population+and+is+regulated+by+dopaminergic+and+glutamatergic+afferents&doi=10.1111%2Fj.1460-9568.2009.06842.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Striatal GPR88 expression is confined to the whole projection neuron population and is regulated by dopaminergic and glutamatergic afferents</span></div><div class="casAuthors">Massart Renaud; Guilloux Jean-Philippe; Mignon Virginie; Sokoloff Pierre; Diaz Jorge</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">397-414</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">GPR88, an orphan G protein-coupled receptor, was designated Strg/GPR88 for striatum-specific G protein-coupled receptor (K.  Mizushima et al. (2000)Genomics, 69, 314-321).  In this study, we focused on striatal GPR88 protein localization using a polyclonal antibody.  We established that the distribution of immunoreactivity in rat brain matched that of GPR88 transcripts and provided evidence for its exclusive neuronal expression.  GPR88 protein is abundant throughout the striatum of rat and primate, with expression limited to the two subsets of striatal projection medium spiny neurons (MSNs) expressing preprotachykinin-substance P or preproenkephalin mRNAs.  Ultrastructural immunolabelling revealed the GPR88 concentration at post-synaptic sites along the somatodendritic compartments of MSNs, with pronounced preference for dendrites and dendritic spines.  The GPR88-rich expression, in both striatal output pathways, designates this receptor as a potential therapeutic target for diseases involving dysfunction of the basal ganglia, such as Parkinson's disease.  Hence, we investigated changes of GPR88 expression in a model of Parkinson's disease (unilateral 6-hydroxydopamine-lesioned rats) following repeated L-DOPA treatment.  In dopamine-depleted striatum, GPR88 expression was differentially regulated, i.e. decreased in striatopallidal and increased in striatonigral MSNs.  L-DOPA treatment led to a normalization of GPR88 levels through dopamine D1 and D2 receptor-mediated mechanisms in striatopallidal and striatonigral MSNs, respectively.  Moreover, the removal of corticostriatal inputs, by ibotenate infusion, downregulated GPR88 in striatopallidal MSNs.  These findings provide the first evidence that GPR88 is confined to striatal MSNs and indicate that L-DOPA-mediated behavioural effects in hemiparkinsonian rats may involve normalization of striatal GPR88 levels probably through dopamine receptor-mediated mechanisms and modulations of corticostriatal pathway activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT7FouKlwBWEftos8R3JUhXfW6udTcc2eabM57jB22s8Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MrmtVWgtQ%253D%253D&md5=a1d34c936414e98d4ae80d5670038d8a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fj.1460-9568.2009.06842.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1460-9568.2009.06842.x%26sid%3Dliteratum%253Aachs%26aulast%3DMassart%26aufirst%3DR.%26aulast%3DGuilloux%26aufirst%3DJ.-P.%26aulast%3DMignon%26aufirst%3DV.%26aulast%3DSokoloff%26aufirst%3DP.%26aulast%3DDiaz%26aufirst%3DJ.%26atitle%3DStriatal%2520GPR88%2520expression%2520is%2520confined%2520to%2520the%2520whole%2520projection%2520neuron%2520population%2520and%2520is%2520regulated%2520by%2520dopaminergic%2520and%2520glutamatergic%2520afferents%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2009%26volume%3D30%26spage%3D397%26epage%3D414%26doi%3D10.1111%2Fj.1460-9568.2009.06842.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
Waes, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, H.</span></span> <span> </span><span class="NLM_article-title">GPR88: A putative signaling molecule predominantly expressed in the striatum: Cellular localization and developmental regulation</span>. <i>Basal Ganglia</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">89</span>, <span class="refDoi"> DOI: 10.1016/j.baga.2011.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1016%2Fj.baga.2011.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=21804954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A280%3ADC%252BC2srisVClsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=83-89&author=V.+Van%0AWaesauthor=K.+Y.+Tsengauthor=H.+Steiner&title=GPR88%3A+A+putative+signaling+molecule+predominantly+expressed+in+the+striatum%3A+Cellular+localization+and+developmental+regulation&doi=10.1016%2Fj.baga.2011.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">GPR88 - a putative signaling molecule predominantly expressed in the striatum: Cellular localization and developmental regulation</span></div><div class="casAuthors">Van Waes Vincent; Tseng Kuei Y; Steiner Heinz</div><div class="citationInfo"><span class="NLM_cas:title">Basal ganglia</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">83-89</span>
        ISSN:<span class="NLM_cas:issn">2210-5336</span>.
    </div><div class="casAbstract">GPR88 is a putative G-protein-coupled receptor that is highly and almost exclusively expressed in the striatum.  Its function remains unknown.  We investigated GPR88 cellular localization and expression levels across development in different functional domains of the striatum in juvenile (P25), adolescent (P40), and adult (P70) rats, by in situ hybridization histochemistry.  At all ages, GPR88 mRNA expression was most robust in the sensorimotor (lateral) striatum and was detected in virtually every neuron.  Expression was highest in juveniles and decreased thereafter with regionally distinct trajectories.  Thus, in the dorsal striatum, there was a progressive decrease from juveniles to adolescents to adults.  In contrast, in the nucleus accumbens, the only (modest) decrease occurred between juveniles and adolescents.  These findings indicate that GPR88 is expressed in all striatal neurons, but is differentially regulated across development in different striatal regions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQlTwP-2_q2SJggzHGM8X5CfW6udTcc2eaQk0A_2xSDwrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2srisVClsA%253D%253D&md5=48eeca69729ca864b85f65198413f101</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.baga.2011.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.baga.2011.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BWaes%26aufirst%3DV.%26aulast%3DTseng%26aufirst%3DK.%2BY.%26aulast%3DSteiner%26aufirst%3DH.%26atitle%3DGPR88%253A%2520A%2520putative%2520signaling%2520molecule%2520predominantly%2520expressed%2520in%2520the%2520striatum%253A%2520Cellular%2520localization%2520and%2520developmental%2520regulation%26jtitle%3DBasal%2520Ganglia%26date%3D2011%26volume%3D1%26spage%3D83%26epage%3D89%26doi%3D10.1016%2Fj.baga.2011.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becker, J. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Befort, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blad, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filliol, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghate, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dembele, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thibault, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lardenois, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poch, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieffer, B. L.</span></span> <span> </span><span class="NLM_article-title">Transcriptome analysis identifies genes with enriched expression in the mouse central extended amygdala</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>156</i></span>,  <span class="NLM_fpage">950</span>– <span class="NLM_lpage">965</span>, <span class="refDoi"> DOI: 10.1016/j.neuroscience.2008.07.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1016%2Fj.neuroscience.2008.07.070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=18786617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlSgsrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2008&pages=950-965&author=J.+A.+J.+Beckerauthor=K.+Befortauthor=C.+Bladauthor=D.+Filliolauthor=A.+Ghateauthor=D.+Dembeleauthor=C.+Thibaultauthor=M.+Kochauthor=J.+Mullerauthor=A.+Lardenoisauthor=O.+Pochauthor=B.+L.+Kieffer&title=Transcriptome+analysis+identifies+genes+with+enriched+expression+in+the+mouse+central+extended+amygdala&doi=10.1016%2Fj.neuroscience.2008.07.070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Transcriptome analysis identifies genes with enriched expression in the mouse central extended amygdala</span></div><div class="casAuthors">Becker, J. A. J.; Befort, K.; Blad, C.; Filliol, D.; Ghate, A.; Dembele, D.; Thibault, C.; Koch, M.; Muller, J.; Lardenois, A.; Poch, O.; Kieffer, B. L.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">950-965</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The central extended amygdala (EAc) is an ensemble of highly interconnected limbic structures of the anterior brain, and forms a cellular continuum including the bed nucleus of the stria terminalis (BNST), the central nucleus of the amygdala (CeA) and the nucleus accumbens shell (AcbSh).  This neural network is a key site for interactions between brain reward and stress systems, and has been implicated in several aspects of drug abuse.  In order to increase our understanding of EAc function at the mol. level, we undertook a genome-wide screen (Affymetrix) to identify genes whose expression is enriched in the mouse EAc.  We focused on the less-well known BNST-CeA areas of the EAc, and identified 121 genes that exhibit more than twofold higher expression level in the EAc compared with whole brain.  Among these, 43 genes have never been described to be expressed in the EAc.  We mapped these genes throughout the brain, using non-radioactive in situ hybridization, and identified eight genes with a unique and distinct rostro-caudal expression pattern along AcbSh, BNST and CeA.  Q-PCR anal. performed in brain and peripheral organ tissues indicated that, with the exception of one (Spata13), all these genes are predominantly expressed in brain.  These genes encode signaling proteins (Adora2, GPR88, Arpp21 and Rem2), a transcription factor (Limh6) or proteins of unknown function (Rik130, Spata13 and Wfs1).  The identification of genes with enriched expression expands our knowledge of EAc at a mol. level, and provides useful information to toward genetic manipulations within the EAc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxgJBYmSPX1bVg90H21EOLACvtfcHk0lhbuXxWWmPDHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlSgsrbJ&md5=acddb2e181359ad30074a67401b23b63</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2008.07.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2008.07.070%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DJ.%2BA.%2BJ.%26aulast%3DBefort%26aufirst%3DK.%26aulast%3DBlad%26aufirst%3DC.%26aulast%3DFilliol%26aufirst%3DD.%26aulast%3DGhate%26aufirst%3DA.%26aulast%3DDembele%26aufirst%3DD.%26aulast%3DThibault%26aufirst%3DC.%26aulast%3DKoch%26aufirst%3DM.%26aulast%3DMuller%26aufirst%3DJ.%26aulast%3DLardenois%26aufirst%3DA.%26aulast%3DPoch%26aufirst%3DO.%26aulast%3DKieffer%26aufirst%3DB.%2BL.%26atitle%3DTranscriptome%2520analysis%2520identifies%2520genes%2520with%2520enriched%2520expression%2520in%2520the%2520mouse%2520central%2520extended%2520amygdala%26jtitle%3DNeuroscience%26date%3D2008%26volume%3D156%26spage%3D950%26epage%3D965%26doi%3D10.1016%2Fj.neuroscience.2008.07.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bates, B.</span>; <span class="NLM_string-name">Logue, S. F.</span>; <span class="NLM_string-name">Pausch, M.</span></span> <span> </span><span class="NLM_article-title">Methods of Identifying Agents for Treatment of Schizophrenia and Related Disorders</span>. U.S. Patent <span class="NLM_patent">0,040,819 A1</span>, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=B.+Bates&author=S.+F.+Logue&author=M.+Pausch&title=Methods+of+Identifying+Agents+for+Treatment+of+Schizophrenia+and+Related+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBates%26aufirst%3DB.%26atitle%3DMethods%2520of%2520Identifying%2520Agents%2520for%2520Treatment%2520of%2520Schizophrenia%2520and%2520Related%2520Disorders%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Logue, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grauer, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulsen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graf, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sung, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pulito, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig-Lipson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandon, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pausch, M.</span></span> <span> </span><span class="NLM_article-title">The orphan GPCR, GPR88, modulates function of the striatal dopamine system: a possible therapeutic target for psychiatric disorders?</span>. <i>Mol. Cell. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">438</span>– <span class="NLM_lpage">447</span>, <span class="refDoi"> DOI: 10.1016/j.mcn.2009.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1016%2Fj.mcn.2009.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=19796684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVaju73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2009&pages=438-447&author=S.+F.+Logueauthor=S.+M.+Grauerauthor=J.+Paulsenauthor=R.+Grafauthor=N.+Taylorauthor=M.+A.+Sungauthor=L.+Zhangauthor=Z.+Hughesauthor=V.+L.+Pulitoauthor=F.+Liuauthor=S.+Rosenzweig-Lipsonauthor=N.+J.+Brandonauthor=K.+L.+Marquisauthor=B.+Batesauthor=M.+Pausch&title=The+orphan+GPCR%2C+GPR88%2C+modulates+function+of+the+striatal+dopamine+system%3A+a+possible+therapeutic+target+for+psychiatric+disorders%3F&doi=10.1016%2Fj.mcn.2009.09.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The orphan GPCR, GPR88, modulates function of the striatal dopamine system: A possible therapeutic target for psychiatric disorders?</span></div><div class="casAuthors">Logue, Sheree F.; Grauer, Steven M.; Paulsen, Janet; Graf, Radka; Taylor, Noel; Sung, M. Amy; Zhang, Lynn; Hughes, Zoe; Pulito, Virginia L.; Liu, Feng; Rosenzweig-Lipson, Sharon; Brandon, Nicholas J.; Marquis, Karen L.; Bates, Brian; Pausch, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">438-447</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In rodents, the orphan G protein-coupled receptor, Gpr88, is highly expressed in brain regions implicated in the pathophysiol. of and is modulated by treatments for schizophrenia.  We compared striatal function of Gpr88 knockout mice (Gpr88KOs) to wild-type mice using mol., neurochem. and behavioral tests.  Gpr88KOs lacked expression of Gpr88 in striatum, nucleus accumbens and layer IV of cortex.  Gpr88KOs had normal striatal dopamine D2 receptor d. and affinity and DARPP-32 expression but Gpr88KOs had higher basal striatal phosphorylated DARPP-32 Thr-34.  In vivo microdialysis detected lower basal dopamine in Gpr88KOs while amphetamine-induced dopamine release was normal.  Behaviorally, Gpr88KOs demonstrated disrupted prepulse inhibition of startle (PPI) and increased sensitivity to apomorphine-induced climbing and stereotypy (AICS) and amphetamine-stimulated locomotor activity.  Antipsychotic administration to Gpr88KOs normalized the PPI deficit and blocked AICS.  The modulatory role of Gpr88 in striatal dopamine function suggests it may be a new target for treatments for psychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVBeUcz-AbdbVg90H21EOLACvtfcHk0lgJ7G2d3iQE0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVaju73I&md5=ffccbf40b5a945696b0ea10ebc19c39a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.mcn.2009.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mcn.2009.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DLogue%26aufirst%3DS.%2BF.%26aulast%3DGrauer%26aufirst%3DS.%2BM.%26aulast%3DPaulsen%26aufirst%3DJ.%26aulast%3DGraf%26aufirst%3DR.%26aulast%3DTaylor%26aufirst%3DN.%26aulast%3DSung%26aufirst%3DM.%2BA.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DHughes%26aufirst%3DZ.%26aulast%3DPulito%26aufirst%3DV.%2BL.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26aulast%3DBrandon%26aufirst%3DN.%2BJ.%26aulast%3DMarquis%26aufirst%3DK.%2BL.%26aulast%3DBates%26aufirst%3DB.%26aulast%3DPausch%26aufirst%3DM.%26atitle%3DThe%2520orphan%2520GPCR%252C%2520GPR88%252C%2520modulates%2520function%2520of%2520the%2520striatal%2520dopamine%2520system%253A%2520a%2520possible%2520therapeutic%2520target%2520for%2520psychiatric%2520disorders%253F%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D2009%26volume%3D42%26spage%3D438%26epage%3D447%26doi%3D10.1016%2Fj.mcn.2009.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quintana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storey, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Güler, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanat, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roller, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Torre, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amieux, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKnight, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bamford, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmiter, R. D.</span></span> <span> </span><span class="NLM_article-title">Lack of GPR88 enhances medium spiny neuron activity and alters motor- and cue-dependent behaviors</span>. <i>Nat. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1547</span>– <span class="NLM_lpage">1555</span>, <span class="refDoi"> DOI: 10.1038/nn.3239</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1038%2Fnn.3239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=23064379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsV2rsbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2012&pages=1547-1555&author=A.+Quintanaauthor=E.+Sanzauthor=W.+Wangauthor=G.+P.+Storeyauthor=A.+D.+G%C3%BClerauthor=M.+J.+Wanatauthor=B.+A.+Rollerauthor=A.+La+Torreauthor=P.+S.+Amieuxauthor=G.+S.+McKnightauthor=N.+S.+Bamfordauthor=R.+D.+Palmiter&title=Lack+of+GPR88+enhances+medium+spiny+neuron+activity+and+alters+motor-+and+cue-dependent+behaviors&doi=10.1038%2Fnn.3239"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Lack of GPR88 enhances medium spiny neuron activity and alters motor- and cue-dependent behaviors</span></div><div class="casAuthors">Quintana, Albert; Sanz, Elisenda; Wang, Wengang; Storey, Granville P.; Gueler, Ali D.; Wanat, Matthew J.; Roller, Bryan A.; La Torre, Anna; Amieux, Paul S.; McKnight, G. Stanley; Bamford, Nigel S.; Palmiter, Richard D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1547-1555</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The striatum regulates motor control, reward and learning.  Abnormal function of striatal GABAergic medium spiny neurons (MSNs) is believed to contribute to the deficits in these processes that are obsd. in many neuropsychiatric diseases.  The orphan G protein-coupled receptor GPR88 is robustly expressed in MSNs and is regulated by neuropharmacol. drugs, but its contribution to MSN physiol. and behavior is unclear.  We found that, in the absence of GPR88, MSNs showed increased glutamatergic excitation and reduced GABAergic inhibition, which promoted enhanced firing rates in vivo, resulting in hyperactivity, poor motor coordination and impaired cue-based learning in mice.  Targeted viral expression of GPR88 in MSNs rescued the mol. and electrophysiol. properties and normalized behavior, suggesting that aberrant MSN activation in the absence of GPR88 underlies behavioral deficits and its dysfunction may contribute to behaviors obsd. in neuropsychiatric disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgZhWCHnaKlrVg90H21EOLACvtfcHk0lgJ7G2d3iQE0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsV2rsbbF&md5=8241862c3f7a1a411d56b172e1aff36c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnn.3239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.3239%26sid%3Dliteratum%253Aachs%26aulast%3DQuintana%26aufirst%3DA.%26aulast%3DSanz%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DStorey%26aufirst%3DG.%2BP.%26aulast%3DG%25C3%25BCler%26aufirst%3DA.%2BD.%26aulast%3DWanat%26aufirst%3DM.%2BJ.%26aulast%3DRoller%26aufirst%3DB.%2BA.%26aulast%3DLa%2BTorre%26aufirst%3DA.%26aulast%3DAmieux%26aufirst%3DP.%2BS.%26aulast%3DMcKnight%26aufirst%3DG.%2BS.%26aulast%3DBamford%26aufirst%3DN.%2BS.%26aulast%3DPalmiter%26aufirst%3DR.%2BD.%26atitle%3DLack%2520of%2520GPR88%2520enhances%2520medium%2520spiny%2520neuron%2520activity%2520and%2520alters%2520motor-%2520and%2520cue-dependent%2520behaviors%26jtitle%3DNat.%2520Neurosci.%26date%3D2012%26volume%3D15%26spage%3D1547%26epage%3D1555%26doi%3D10.1038%2Fnn.3239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arefin, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mechling, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meirsman, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bienert, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben Hamida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehrlich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roquet, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennig, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Elverfeldt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieffer, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harsan, L.-A.</span></span> <span> </span><span class="NLM_article-title">Remodeling of sensorimotor brain connectivity in Gpr88-deficient mice</span>. <i>Brain Connect.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">526</span>– <span class="NLM_lpage">540</span>, <span class="refDoi"> DOI: 10.1089/brain.2017.0486</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1089%2Fbrain.2017.0486" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=28882062" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A280%3ADC%252BC1cblslWquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=526-540&author=T.+M.+Arefinauthor=A.+E.+Mechlingauthor=A.+C.+Meirsmanauthor=T.+Bienertauthor=N.+S.+H%C3%BCbnerauthor=H.-L.+Leeauthor=S.+Ben+Hamidaauthor=A.+Ehrlichauthor=D.+Roquetauthor=J.+Hennigauthor=D.+von+Elverfeldtauthor=B.+L.+Kiefferauthor=L.-A.+Harsan&title=Remodeling+of+sensorimotor+brain+connectivity+in+Gpr88-deficient+mice&doi=10.1089%2Fbrain.2017.0486"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Remodeling of Sensorimotor Brain Connectivity in Gpr88-Deficient Mice</span></div><div class="casAuthors">Arefin Tanzil Mahmud; Mechling Anna E; Bienert Thomas; Hubner Neele Saskia; Lee Hsu-Lei; Hennig Jurgen; von Elverfeldt Dominik; Harsan Laura-Adela; Arefin Tanzil Mahmud; Mechling Anna E; Hubner Neele Saskia; Arefin Tanzil Mahmud; Arefin Tanzil Mahmud; Meirsman Aura Carole; Ben Hamida Sami; Ehrlich Aliza; Kieffer Brigitte Lina; Meirsman Aura Carole; Ben Hamida Sami; Ehrlich Aliza; Kieffer Brigitte Lina; Roquet Dan; Harsan Laura-Adela; Harsan Laura-Adela</div><div class="citationInfo"><span class="NLM_cas:title">Brain connectivity</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">526-540</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Recent studies have demonstrated that orchestrated gene activity and expression support synchronous activity of brain networks.  However, there is a paucity of information on the consequences of single gene function on overall brain functional organization and connectivity and how this translates at the behavioral level.  In this study, we combined mouse mutagenesis with functional and structural magnetic resonance imaging (MRI) to determine whether targeted inactivation of a single gene would modify whole-brain connectivity in live animals.  The targeted gene encodes GPR88 (G protein-coupled receptor 88), an orphan G protein-coupled receptor enriched in the striatum and previously linked to behavioral traits relevant to neuropsychiatric disorders.  Connectivity analysis of Gpr88-deficient mice revealed extensive remodeling of intracortical and cortico-subcortical networks.  Most prominent modifications were observed at the level of retrosplenial cortex connectivity, central to the default mode network (DMN) whose alteration is considered a hallmark of many psychiatric conditions.  Next, somatosensory and motor cortical networks were most affected.  These modifications directly relate to sensorimotor gating deficiency reported in mutant animals and also likely underlie their hyperactivity phenotype.  Finally, we identified alterations within hippocampal and dorsal striatum functional connectivity, most relevant to a specific learning deficit that we previously reported in Gpr88(-/-) animals.  In addition, amygdala connectivity with cortex and striatum was weakened, perhaps underlying the risk-taking behavior of these animals.  This is the first evidence demonstrating that GPR88 activity shapes the mouse brain functional and structural connectome.  The concordance between connectivity alterations and behavior deficits observed in Gpr88-deficient mice suggests a role for GPR88 in brain communication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRh_DRjxLxXkvEeosoOnpOLfW6udTcc2eYgbjDBQG4JILntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cblslWquw%253D%253D&md5=4eceb22496981306c73fec973b9987d1</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1089%2Fbrain.2017.0486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fbrain.2017.0486%26sid%3Dliteratum%253Aachs%26aulast%3DArefin%26aufirst%3DT.%2BM.%26aulast%3DMechling%26aufirst%3DA.%2BE.%26aulast%3DMeirsman%26aufirst%3DA.%2BC.%26aulast%3DBienert%26aufirst%3DT.%26aulast%3DH%25C3%25BCbner%26aufirst%3DN.%2BS.%26aulast%3DLee%26aufirst%3DH.-L.%26aulast%3DBen%2BHamida%26aufirst%3DS.%26aulast%3DEhrlich%26aufirst%3DA.%26aulast%3DRoquet%26aufirst%3DD.%26aulast%3DHennig%26aufirst%3DJ.%26aulast%3Dvon%2BElverfeldt%26aufirst%3DD.%26aulast%3DKieffer%26aufirst%3DB.%2BL.%26aulast%3DHarsan%26aufirst%3DL.-A.%26atitle%3DRemodeling%2520of%2520sensorimotor%2520brain%2520connectivity%2520in%2520Gpr88-deficient%2520mice%26jtitle%3DBrain%2520Connect.%26date%3D2017%26volume%3D7%26spage%3D526%26epage%3D540%26doi%3D10.1089%2Fbrain.2017.0486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ben
Hamida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendonça-Netto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arefin, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasseef, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boulos, L.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNicholas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehrlich, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moquin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gratton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darcq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harsan, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maldonado, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieffer, B. L.</span></span> <span> </span><span class="NLM_article-title">Increased alcohol seeking in mice lacking Gpr88 involves dysfunctional mesocorticolimbic networks</span>. <i>Biol. Psychiatr.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1016/j.biopsych.2018.01.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1016%2Fj.biopsych.2018.01.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=29580570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmtVWqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2018&pages=202-212&author=S.+Ben%0AHamidaauthor=S.+Mendon%C3%A7a-Nettoauthor=T.+M.+Arefinauthor=M.+T.+Nasseefauthor=L.-J.+Boulosauthor=M.+McNicholasauthor=A.+T.+Ehrlichauthor=E.+Clarkeauthor=L.+Moquinauthor=A.+Grattonauthor=E.+Darcqauthor=L.+A.+Harsanauthor=R.+Maldonadoauthor=B.+L.+Kieffer&title=Increased+alcohol+seeking+in+mice+lacking+Gpr88+involves+dysfunctional+mesocorticolimbic+networks&doi=10.1016%2Fj.biopsych.2018.01.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Increased Alcohol Seeking in Mice Lacking Gpr88 Involves Dysfunctional Mesocorticolimbic Networks</span></div><div class="casAuthors">Ben Hamida, Sami; Mendonca-Netto, Sueli; Arefin, Tanzil Mahmud; Nasseef, Md. Taufiq; Boulos, Laura-Joy; McNicholas, Michael; Ehrlich, Aliza Toby; Clarke, Eleanor; Moquin, Luc; Gratton, Alain; Darcq, Emmanuel; Harsan, Laura Adela; Maldonado, Rafael; Kieffer, Brigitte Lina</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">202-212</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Alc. use disorder (AUD) is devastating and poorly treated, and innovative targets are actively sought for prevention and treatment.  The orphan G protein-coupled receptor GPR88 is enriched in mesocorticolimbic pathways, and Gpr88 knockout mice show hyperactivity and risk-taking behavior, but a potential role for this receptor in drug abuse has not been examd.  We tested Gpr88 knockout mice for alc.-drinking and -seeking behaviors.  To gain system-level understanding of their alc. endophenotype, we also analyzed whole-brain functional connectivity in naive mice using resting-state functional magnetic resonance imaging.  Gpr88 knockout mice showed increased voluntary alc. drinking at both moderate and excessive levels, with intact alc. sedation and metab.  Mutant mice also showed increased operant responding and motivation for alc., while food and chocolate operant self-administration were unchanged.  Alc. place conditioning and alc.-induced dopamine release in the nucleus accumbens were decreased, suggesting reduced alc. reward in mutant mice that may partly explain enhanced alc. drinking.  Seed-based voxelwise functional connectivity anal. revealed significant remodeling of mesocorticolimbic centers, whose hallmark was predominant weakening of prefrontal cortex, ventral tegmental area, and amygdala connectional patterns.  Also, effective connectivity from the ventral tegmental area to the nucleus accumbens and amygdala was reduced.  Gpr88 deletion disrupts executive, reward, and emotional networks in a configuration that reduces alc. reward and promotes alc. seeking and drinking.  The functional connectivity signature is reminiscent of alterations obsd. in individuals at risk for AUD.  The Gpr88 gene, therefore, may represent a vulnerability/resilience factor for AUD, and a potential drug target for AUD treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOfRTmTEAe5bVg90H21EOLACvtfcHk0ljtm0Q6B8jBVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmtVWqsbo%253D&md5=42c6ef0992d27ea61bb85cbdbc73e787</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2018.01.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2018.01.026%26sid%3Dliteratum%253Aachs%26aulast%3DBen%2BHamida%26aufirst%3DS.%26aulast%3DMendon%25C3%25A7a-Netto%26aufirst%3DS.%26aulast%3DArefin%26aufirst%3DT.%2BM.%26aulast%3DNasseef%26aufirst%3DM.%2BT.%26aulast%3DBoulos%26aufirst%3DL.-J.%26aulast%3DMcNicholas%26aufirst%3DM.%26aulast%3DEhrlich%26aufirst%3DA.%2BT.%26aulast%3DClarke%26aufirst%3DE.%26aulast%3DMoquin%26aufirst%3DL.%26aulast%3DGratton%26aufirst%3DA.%26aulast%3DDarcq%26aufirst%3DE.%26aulast%3DHarsan%26aufirst%3DL.%2BA.%26aulast%3DMaldonado%26aufirst%3DR.%26aulast%3DKieffer%26aufirst%3DB.%2BL.%26atitle%3DIncreased%2520alcohol%2520seeking%2520in%2520mice%2520lacking%2520Gpr88%2520involves%2520dysfunctional%2520mesocorticolimbic%2520networks%26jtitle%3DBiol.%2520Psychiatr.%26date%3D2018%26volume%3D84%26spage%3D202%26epage%3D212%26doi%3D10.1016%2Fj.biopsych.2018.01.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maroteaux, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arefin, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harsan, L.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darcq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben Hamida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieffer, B. L.</span></span> <span> </span><span class="NLM_article-title">Lack of anticipatory behavior in Gpr88 knockout mice showed by automatized home cage phenotyping</span>. <i>Genes, Brain Behav.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>, <span class="NLM_elocation-id">e12473</span> <span class="refDoi"> DOI: 10.1111/gbb.12473</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1111%2Fgbb.12473" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=29575471" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&author=G.+Maroteauxauthor=T.+M.+Arefinauthor=L.-A.+Harsanauthor=E.+Darcqauthor=S.+Ben+Hamidaauthor=B.+L.+Kieffer&title=Lack+of+anticipatory+behavior+in+Gpr88+knockout+mice+showed+by+automatized+home+cage+phenotyping&doi=10.1111%2Fgbb.12473"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1111%2Fgbb.12473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fgbb.12473%26sid%3Dliteratum%253Aachs%26aulast%3DMaroteaux%26aufirst%3DG.%26aulast%3DArefin%26aufirst%3DT.%2BM.%26aulast%3DHarsan%26aufirst%3DL.-A.%26aulast%3DDarcq%26aufirst%3DE.%26aulast%3DBen%2BHamida%26aufirst%3DS.%26aulast%3DKieffer%26aufirst%3DB.%2BL.%26atitle%3DLack%2520of%2520anticipatory%2520behavior%2520in%2520Gpr88%2520knockout%2520mice%2520showed%2520by%2520automatized%2520home%2520cage%2520phenotyping%26jtitle%3DGenes%252C%2520Brain%2520Behav.%26date%3D2018%26volume%3D17%26doi%3D10.1111%2Fgbb.12473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meirsman, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben Hamida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Kerchove d’Exaerde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darcq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieffer, B. L.</span></span> <span> </span><span class="NLM_article-title">GPR88 in D1R-type and D2R-type medium spiny neurons differentially regulates affective and motor behavior</span>. <i>eNeuro</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">ENEURO.0035-19.2019</span> <span class="refDoi"> DOI: 10.1523/eneuro.0035-19.2019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1523%2FENEURO.0035-19.2019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2019&author=A.+C.+Meirsmanauthor=S.+Ben+Hamidaauthor=E.+Clarkeauthor=A.+de+Kerchove+d%E2%80%99Exaerdeauthor=E.+Darcqauthor=B.+L.+Kieffer&title=GPR88+in+D1R-type+and+D2R-type+medium+spiny+neurons+differentially+regulates+affective+and+motor+behavior&doi=10.1523%2Feneuro.0035-19.2019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1523%2FENEURO.0035-19.2019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FENEURO.0035-19.2019%26sid%3Dliteratum%253Aachs%26aulast%3DMeirsman%26aufirst%3DA.%2BC.%26aulast%3DBen%2BHamida%26aufirst%3DS.%26aulast%3DClarke%26aufirst%3DE.%26aulast%3Dde%2BKerchove%2Bd%25E2%2580%2599Exaerde%26aufirst%3DA.%26aulast%3DDarcq%26aufirst%3DE.%26aulast%3DKieffer%26aufirst%3DB.%2BL.%26atitle%3DGPR88%2520in%2520D1R-type%2520and%2520D2R-type%2520medium%2520spiny%2520neurons%2520differentially%2520regulates%2520affective%2520and%2520motor%2520behavior%26jtitle%3DeNeuro%26date%3D2019%26volume%3D6%26doi%3D10.1523%2Feneuro.0035-19.2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meirsman, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Kerchove d’Exaerde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieffer, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouagazzal, A.-M.</span></span> <span> </span><span class="NLM_article-title">GPR88 in A2A receptor-expressing neurons modulates locomotor response to dopamine agonists but not sensorimotor gating</span>. <i>Eur. J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">2026</span>– <span class="NLM_lpage">2034</span>, <span class="refDoi"> DOI: 10.1111/ejn.13646</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1111%2Fejn.13646" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=28700108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A280%3ADC%252BC1cjmvVWjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2017&pages=2026-2034&author=A.+C.+Meirsmanauthor=A.+de+Kerchove+d%E2%80%99Exaerdeauthor=B.+L.+Kiefferauthor=A.-M.+Ouagazzal&title=GPR88+in+A2A+receptor-expressing+neurons+modulates+locomotor+response+to+dopamine+agonists+but+not+sensorimotor+gating&doi=10.1111%2Fejn.13646"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">GPR88 in A2A receptor-expressing neurons modulates locomotor response to dopamine agonists but not sensorimotor gating</span></div><div class="casAuthors">Meirsman A C; Kieffer B L; Ouagazzal A-M; Meirsman A C; de Kerchove d'Exaerde A; Kieffer B L; Ouagazzal A-M</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2026-2034</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The orphan receptor, GPR88, is emerging as a key player in the pathophysiology of several neuropsychiatric diseases, including psychotic disorders.  Knockout (KO) mice lacking GPR88 throughout the brain exhibit many abnormalities relevant to schizophrenia including locomotor hyperactivity, behavioural hypersensitivity to dopaminergic psychostimulants and deficient sensorimotor gating.  Here, we used conditional knockout (cKO) mice lacking GPR88 selectively in striatal medium spiny neurons expressing A2A receptor to determine neuronal circuits underlying these phenotypes.  We first studied locomotor responses of A2A R-Gpr88 KO mice and their control littermates to psychotomimetic, amphetamine, and to selective D1 and D2 receptor agonists, SKF-81297 and quinpirole, respectively.  To assess sensorimotor gating performance, mice were submitted to acoustic and visual prepulse inhibition (PPI) paradigms.  Total knockout GPR88 mice were also studied for comparison.  Like total GPR88 KO mice, A2A R-Gpr88 KO mice displayed a heightened sensitivity to locomotor stimulant effects of amphetamine and SKF-81297.  They also exhibited enhanced locomotor activity to quinpirole, which tended to suppress locomotion in control mice.  By contrast, they had normal acoustic and visual PPI, unlike total GPR88 KO mice that show impairments across different sensory modalities.  Finally, none of the genetic manipulations altered central auditory temporal processing assessed by gap-PPI.  Together, these findings support the role of GPR88 in the pathophysiology of schizophrenia and show that GPR88 in A2A receptor-expressing neurons modulates psychomotor behaviour but not sensorimotor gating.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4gdqrBWdvB1HFYivNCdPRfW6udTcc2eaiFmJcsLj6SLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cjmvVWjug%253D%253D&md5=42056f84558b350f0a6c7ee6f2a86ac2</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1111%2Fejn.13646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fejn.13646%26sid%3Dliteratum%253Aachs%26aulast%3DMeirsman%26aufirst%3DA.%2BC.%26aulast%3Dde%2BKerchove%2Bd%25E2%2580%2599Exaerde%26aufirst%3DA.%26aulast%3DKieffer%26aufirst%3DB.%2BL.%26aulast%3DOuagazzal%26aufirst%3DA.-M.%26atitle%3DGPR88%2520in%2520A2A%2520receptor-expressing%2520neurons%2520modulates%2520locomotor%2520response%2520to%2520dopamine%2520agonists%2520but%2520not%2520sensorimotor%2520gating%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2017%26volume%3D46%26spage%3D2026%26epage%3D2034%26doi%3D10.1111%2Fejn.13646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meirsman, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Merrer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellissier, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clesse, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieffer, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, J. A. J.</span></span> <span> </span><span class="NLM_article-title">Mice lacking GPR88 show motor deficit, improved spatial learning, and low anxiety reversed by delta opioid antagonist</span>. <i>Biol. Psychiatr.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">917</span>– <span class="NLM_lpage">927</span>, <span class="refDoi"> DOI: 10.1016/j.biopsych.2015.05.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1016%2Fj.biopsych.2015.05.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=26188600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtF2itbjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2016&pages=917-927&author=A.+C.+Meirsmanauthor=J.+Le+Merrerauthor=L.+P.+Pellissierauthor=J.+Diazauthor=D.+Clesseauthor=B.+L.+Kiefferauthor=J.+A.+J.+Becker&title=Mice+lacking+GPR88+show+motor+deficit%2C+improved+spatial+learning%2C+and+low+anxiety+reversed+by+delta+opioid+antagonist&doi=10.1016%2Fj.biopsych.2015.05.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Mice Lacking GPR88 Show Motor Deficit, Improved Spatial Learning, and Low Anxiety Reversed by Delta Opioid Antagonist</span></div><div class="casAuthors">Meirsman, Aura C.; Le Merrer, Julie; Pellissier, Lucie P.; Diaz, Jorge; Clesse, Daniel; Kieffer, Brigitte L.; Becker, Jerome A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">917-927</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">GPR88 is an orphan G protein coupled receptor highly enriched in the striatum, and previous studies have focused on GPR88 function in striatal physiol.  The receptor is also expressed in other brain areas, and here we examd. whether GPR88 function extends beyond striatal-mediated responses.  We created Gpr88 knockout mice and examd. both striatal and extrastriatal regions at mol. and cellular levels.  We also tested striatum-, hippocampus-, and amygdala-dependent behaviors in Gpr88-/- mice using extensive behavioral testing.  We found increased G protein coupling for delta opioid receptor (DOR) and mu opioid, but not other Gi/o coupled receptors, in the striatum of Gpr88 knockout mice.  We also found modifications in gene transcription, dopamine and serotonin contents, and dendritic morphol. inside and outside the striatum.  Behavioral testing confirmed striatal deficits (hyperactivity, stereotypies, motor impairment in rotarod).  In addn., mutant mice performed better in spatial tasks dependent on hippocampus (Y-maze, novel object recognition, dual soln. cross-maze) and also showed markedly reduced levels of anxiety (elevated plus maze, marble burying, novelty suppressed feeding).  Strikingly, chronic blockade of DOR using naltrindole partially improved motor coordination and normalized spatial navigation and anxiety of Gpr88-/- mice.  We demonstrate that GPR88 is implicated in a large repertoire of behavioral responses that engage motor activity, spatial learning, and emotional processing.  Our data also reveal functional antagonism between GPR88 and DOR activities in vivo.  The therapeutic potential of GPR88 therefore extends to cognitive and anxiety disorders, possibly in interaction with other receptor systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAlo6_6eKZqrVg90H21EOLACvtfcHk0lgSJhoS6FpT4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtF2itbjO&md5=6fd7b2f2d75066fd97668c7bf9b69786</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2015.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2015.05.020%26sid%3Dliteratum%253Aachs%26aulast%3DMeirsman%26aufirst%3DA.%2BC.%26aulast%3DLe%2BMerrer%26aufirst%3DJ.%26aulast%3DPellissier%26aufirst%3DL.%2BP.%26aulast%3DDiaz%26aufirst%3DJ.%26aulast%3DClesse%26aufirst%3DD.%26aulast%3DKieffer%26aufirst%3DB.%2BL.%26aulast%3DBecker%26aufirst%3DJ.%2BA.%2BJ.%26atitle%3DMice%2520lacking%2520GPR88%2520show%2520motor%2520deficit%252C%2520improved%2520spatial%2520learning%252C%2520and%2520low%2520anxiety%2520reversed%2520by%2520delta%2520opioid%2520antagonist%26jtitle%3DBiol.%2520Psychiatr.%26date%3D2016%26volume%3D79%26spage%3D917%26epage%3D927%26doi%3D10.1016%2Fj.biopsych.2015.05.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meirsman, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Kerchove
d’Exaerde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieffer, B. L.</span></span> <span> </span><span class="NLM_article-title">GPR88 in A2AR neurons enhances anxiety-like behaviors</span>. <i>eNeuro</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>3</i></span>, <span class="NLM_elocation-id">ENEURO.0202-16.2016</span> <span class="refDoi"> DOI: 10.1523/eneuro.0202-16.2016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1523%2FENEURO.0202-16.2016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2016&author=A.+C.+Meirsmanauthor=A.+Robeauthor=A.+de+Kerchove%0Ad%E2%80%99Exaerdeauthor=B.+L.+Kieffer&title=GPR88+in+A2AR+neurons+enhances+anxiety-like+behaviors&doi=10.1523%2Feneuro.0202-16.2016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1523%2FENEURO.0202-16.2016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FENEURO.0202-16.2016%26sid%3Dliteratum%253Aachs%26aulast%3DMeirsman%26aufirst%3DA.%2BC.%26aulast%3DRobe%26aufirst%3DA.%26aulast%3Dde%2BKerchove%2Bd%25E2%2580%2599Exaerde%26aufirst%3DA.%26aulast%3DKieffer%26aufirst%3DB.%2BL.%26atitle%3DGPR88%2520in%2520A2AR%2520neurons%2520enhances%2520anxiety-like%2520behaviors%26jtitle%3DeNeuro%26date%3D2016%26volume%3D3%26doi%3D10.1523%2Feneuro.0202-16.2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsunoda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumiyoshi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takasaki, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabuchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uehara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurachi, M.</span></span> <span> </span><span class="NLM_article-title">Effect of MK-801 on gene expressions in the amygdala of rats</span>. <i>Synapse</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">7</span>, <span class="refDoi"> DOI: 10.1002/syn.20455</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1002%2Fsyn.20455" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=17948890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A280%3ADC%252BD2snlvVKrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2008&pages=1-7&author=T.+Matsuokaauthor=M.+Tsunodaauthor=T.+Sumiyoshiauthor=I.+Takasakiauthor=Y.+Tabuchiauthor=T.+Seoauthor=K.+Tanakaauthor=T.+Ueharaauthor=H.+Itohauthor=M.+Suzukiauthor=M.+Kurachi&title=Effect+of+MK-801+on+gene+expressions+in+the+amygdala+of+rats&doi=10.1002%2Fsyn.20455"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of MK-801 on gene expressions in the amygdala of rats</span></div><div class="casAuthors">Matsuoka Tadasu; Tsunoda Masahiko; Sumiyoshi Tomiki; Takasaki Ichiro; Tabuchi Yoshiaki; Seo Tomonori; Tanaka Kodai; Uehara Takashi; Itoh Hiroko; Suzuki Michio; Kurachi Masayoshi</div><div class="citationInfo"><span class="NLM_cas:title">Synapse (New York, N.Y.)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-7</span>
        ISSN:<span class="NLM_cas:issn">0887-4476</span>.
    </div><div class="casAbstract">Rodents treated with N-methyl-D-aspartate (NMDA) antagonists have been thought to be an animal model of schizophrenia.  In this study, we examined gene expression in the amygdala of rats chronically treated with MK-801, as well as behavioral changes, such as social behavior, in these animals.  The social interaction test, a measure of social behavior, and locomotor activity was performed in male Wistar rats injected with MK-801 (0.13 mg/kg i.p.) or saline for 14 days.  Changes in mRNA levels were analyzed using a GeneChip microarray system.  Real-time quantitative PCR (RT-qPCR) assay was subsequently conducted to confirm the results of the microarray analysis.  MK-801 decreased social interaction and increased locomotor activity in rats, consistent with previous reports.  We found 23 downregulated genes and 16 upregulated genes, with the gene encoding arginine-vasopressin (AVP) being most downregulated, and that for transthyretin (Ttr) most upregulated. mRNA levels, quantified by RT-qPCR assay, were altered for genes related to neuropeptides (AVP, Sstr2), the arachidonic cascade (Ptgds), myelination (Mobp, Enpp2), neurotrophic factors (Igfbp2), and hormonal milieu (Ttr).  Downregulation of the AVP gene in the amygdala of MK-801-treated rats may provide a basis for the ability of AVP-analogues to ameliorate the behavioral disturbances caused by blockade of the NMDA receptor.  The results of this study provide an insight into the neural substrates responsible for the generation of psychotic symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS-X1qC28tJg7BItaL1WaVAfW6udTcc2eYeWWcRtcokL7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2snlvVKrtg%253D%253D&md5=b3e4474289bd3772bf4b1b3931bcf472</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fsyn.20455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsyn.20455%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuoka%26aufirst%3DT.%26aulast%3DTsunoda%26aufirst%3DM.%26aulast%3DSumiyoshi%26aufirst%3DT.%26aulast%3DTakasaki%26aufirst%3DI.%26aulast%3DTabuchi%26aufirst%3DY.%26aulast%3DSeo%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DUehara%26aufirst%3DT.%26aulast%3DItoh%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DKurachi%26aufirst%3DM.%26atitle%3DEffect%2520of%2520MK-801%2520on%2520gene%2520expressions%2520in%2520the%2520amygdala%2520of%2520rats%26jtitle%3DSynapse%26date%3D2008%26volume%3D62%26spage%3D1%26epage%3D7%26doi%3D10.1002%2Fsyn.20455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogden, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rich, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schork, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulus, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geyer, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohr, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuczenski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niculescu, A. B.</span></span> <span> </span><span class="NLM_article-title">Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach</span>. <i>Mol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1007</span>– <span class="NLM_lpage">1029</span>, <span class="refDoi"> DOI: 10.1038/sj.mp.4001547</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1038%2Fsj.mp.4001547" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=15314610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovVGit7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=1007-1029&author=C.+A.+Ogdenauthor=M.+E.+Richauthor=N.+J.+Schorkauthor=M.+P.+Paulusauthor=M.+A.+Geyerauthor=J.+B.+Lohrauthor=R.+Kuczenskiauthor=A.+B.+Niculescu&title=Candidate+genes%2C+pathways+and+mechanisms+for+bipolar+%28manic-depressive%29+and+related+disorders%3A+an+expanded+convergent+functional+genomics+approach&doi=10.1038%2Fsj.mp.4001547"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach</span></div><div class="casAuthors">Ogden, C. A.; Rich, M. E.; Schork, N. J.; Paulus, M. P.; Geyer, M. A.; Lohr, J. B.; Kuczenski, R.; Niculescu, A. B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1007-1029</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Identifying genes for bipolar mood disorders through classic genetics has proven difficult.  Here, we present a comprehensive convergent approach that translationally integrates brain gene expression data from a relevant pharmacogenomic mouse model (involving treatments with a stimulant-methamphetamine, and a mood stabilizer-valproate), with human data (linkage loci from human genetic studies, changes in postmortem brains from patients), as a bayesian strategy of crossvalidating findings.  Topping the list of candidate genes, we have DARPP-32 (dopamine- and cAMP-regulated phosphoprotein of 32 kDa) located at 17q12, PENK (preproenkephalin) located at 8q12.1, and TAC1 (tachykinin 1, substance P) located at 7q21.3.  These data suggest that more primitive mol. mechanisms involved in pleasure and pain may have been recruited by evolution to play a role in higher mental functions such as mood.  The anal. also revealed other high-probability candidates genes (neurogenesis, neurotrophic, neurotransmitter, signal transduction, circadian, synaptic, and myelin related), pathways and mechanisms of likely importance in pathophysiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeYC9brrU5L7Vg90H21EOLACvtfcHk0lial4llo8SV6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovVGit7s%253D&md5=42dd287af0bb5a71f8384f0d4ed5a314</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fsj.mp.4001547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.mp.4001547%26sid%3Dliteratum%253Aachs%26aulast%3DOgden%26aufirst%3DC.%2BA.%26aulast%3DRich%26aufirst%3DM.%2BE.%26aulast%3DSchork%26aufirst%3DN.%2BJ.%26aulast%3DPaulus%26aufirst%3DM.%2BP.%26aulast%3DGeyer%26aufirst%3DM.%2BA.%26aulast%3DLohr%26aufirst%3DJ.%2BB.%26aulast%3DKuczenski%26aufirst%3DR.%26aulast%3DNiculescu%26aufirst%3DA.%2BB.%26atitle%3DCandidate%2520genes%252C%2520pathways%2520and%2520mechanisms%2520for%2520bipolar%2520%2528manic-depressive%2529%2520and%2520related%2520disorders%253A%2520an%2520expanded%2520convergent%2520functional%2520genomics%2520approach%26jtitle%3DMol.%2520Psychiatry%26date%3D2004%26volume%3D9%26spage%3D1007%26epage%3D1029%26doi%3D10.1038%2Fsj.mp.4001547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brandish, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holder, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodor, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szumiloski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleinhanz, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forbes, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McWhorter, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duenwald, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parrish, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Na, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renger, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sankaranarayanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scolnick, E. M.</span></span> <span> </span><span class="NLM_article-title">Regulation of gene expression by lithium and depletion of inositol in slices of adult rat cortex</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">861</span>– <span class="NLM_lpage">872</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2005.02.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1016%2Fj.neuron.2005.02.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=15797548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjt1Oitb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2005&pages=861-872&author=P.+E.+Brandishauthor=M.+Suauthor=D.+J.+Holderauthor=P.+Hodorauthor=J.+Szumiloskiauthor=R.+R.+Kleinhanzauthor=J.+E.+Forbesauthor=M.+E.+McWhorterauthor=S.+J.+Duenwaldauthor=M.+L.+Parrishauthor=S.+Naauthor=Y.+Liuauthor=R.+L.+Phillipsauthor=J.+J.+Rengerauthor=S.+Sankaranarayananauthor=A.+J.+Simonauthor=E.+M.+Scolnick&title=Regulation+of+gene+expression+by+lithium+and+depletion+of+inositol+in+slices+of+adult+rat+cortex&doi=10.1016%2Fj.neuron.2005.02.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of gene expression by lithium and depletion of inositol in slices of adult rat cortex</span></div><div class="casAuthors">Brandish, Philip E.; Su, Ming; Holder, Daniel J.; Hodor, Paul; Szumiloski, John; Kleinhanz, Robert R.; Forbes, Jaime E.; McWhorter, Mollie E.; Duenwald, Sven J.; Parrish, Mark L.; Na, Sang; Liu, Yuan; Phillips, Robert L.; Renger, John J.; Sankaranarayanan, Sethu; Simon, Adam J.; Scolnick, Edward M.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">861-872</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Lithium inhibits inositol monophosphatase at therapeutically effective concns., and it has been hypothesized that depletion of brain inositol levels is an important chem. alteration for lithium's therapeutic efficacy in bipolar disorder.  We have employed adult rat cortical slices as a model to investigate the gene regulatory consequences of inositol depletion effected by lithium using cytidine diphosphoryl-diacylglycerol as a functionally relevant biochem. marker to define treatment conditions.  Genes coding for the neuropeptide hormone pituitary adenylate cyclase activating polypeptide (PACAP) and the enzyme that processes PACAP's precursor to the mature form, peptidylglycine α-amidating monooxygenase, were upregulated by inositol depletion.  Previous work has shown that PACAP can increase tyrosine hydroxylase (TH) activity and dopamine release, and we found that the gene for GTP cyclohydrolase, which effectively regulates TH through synthesis of tetrahydrobiopterin, was also upregulated by inositol depletion.  We propose that modulation of brain PACAP signaling might represent a new opportunity in the treatment of bipolar disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZgClt5tNV7rVg90H21EOLACvtfcHk0lial4llo8SV6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjt1Oitb8%253D&md5=d7d4d9b9a5295137c34bbb4497c3626b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2005.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2005.02.006%26sid%3Dliteratum%253Aachs%26aulast%3DBrandish%26aufirst%3DP.%2BE.%26aulast%3DSu%26aufirst%3DM.%26aulast%3DHolder%26aufirst%3DD.%2BJ.%26aulast%3DHodor%26aufirst%3DP.%26aulast%3DSzumiloski%26aufirst%3DJ.%26aulast%3DKleinhanz%26aufirst%3DR.%2BR.%26aulast%3DForbes%26aufirst%3DJ.%2BE.%26aulast%3DMcWhorter%26aufirst%3DM.%2BE.%26aulast%3DDuenwald%26aufirst%3DS.%2BJ.%26aulast%3DParrish%26aufirst%3DM.%2BL.%26aulast%3DNa%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DPhillips%26aufirst%3DR.%2BL.%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26aulast%3DSankaranarayanan%26aufirst%3DS.%26aulast%3DSimon%26aufirst%3DA.%2BJ.%26aulast%3DScolnick%26aufirst%3DE.%2BM.%26atitle%3DRegulation%2520of%2520gene%2520expression%2520by%2520lithium%2520and%2520depletion%2520of%2520inositol%2520in%2520slices%2520of%2520adult%2520rat%2520cortex%26jtitle%3DNeuron%26date%3D2005%26volume%3D45%26spage%3D861%26epage%3D872%26doi%3D10.1016%2Fj.neuron.2005.02.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maier, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barr, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morale, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanna, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilbe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartfai, T.</span></span> <span> </span><span class="NLM_article-title">Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine</span>. <i>Mol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">167</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.1038/sj.mp.4001897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1038%2Fsj.mp.4001897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=17033635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BD2sXoslSjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=167-189&author=B.+Contiauthor=R.+Maierauthor=A.+M.+Barrauthor=M.+C.+Moraleauthor=X.+Luauthor=P.+P.+Sannaauthor=G.+Bilbeauthor=D.+Hoyerauthor=T.+Bartfai&title=Region-specific+transcriptional+changes+following+the+three+antidepressant+treatments+electro+convulsive+therapy%2C+sleep+deprivation+and+fluoxetine&doi=10.1038%2Fsj.mp.4001897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Region-specific transcriptional changes following the three antidepressant treatments: electro convulsive therapy, sleep deprivation and fluoxetine</span></div><div class="casAuthors">Conti, B.; Maier, R.; Barr, A. M.; Morale, M. C.; Lu, X.; Sanna, P. P.; Bilbe, G.; Hoyer, D.; Bartfai, T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">167-189</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The significant proportion of depressed patients that are resistant to monoaminergic drug therapy and the slow onset of therapeutic effects of the selective serotonin reuptake inhibitors (SSRIs)/serotonin/noradrenaline reuptake inhibitors (SNRIs) are two major reasons for the sustained search for new antidepressants.  In an attempt to identify common underlying mechanisms for fast- and slow-acting antidepressant modalities, we have examd. the transcriptional changes in seven different brain regions of the rat brain induced by three clin. effective antidepressant treatments: electro convulsive therapy (ECT), sleep deprivation (SD), and fluoxetine (FLX), the most commonly used slow-onset antidepressant.  Each of these antidepressant treatments was applied with the same regimen known to have clin. efficacy: 2 days of ECT (four sessions per day), 24 h of SD, and 14 days of daily treatment of FLX, resp.  Transcriptional changes were evaluated on RNA extd. from seven different brain regions using the Affymetrix rat genome microarray 230 2.0.  The gene chip data were validated using in situ hybridization or autoradiog. for selected genes.  The transcriptional changes induced by SD, ECT and SSRI display a regionally specific distribution distinct to each treatment.  The fast-onset, short-lived antidepressant treatments ECT and SD evoked transcriptional changes primarily in the catecholaminergic system, whereas the slow-onset antidepressant FLX treatment evoked transcriptional changes in the serotonergic system.  ECT and SD affect in a similar manner the same brain regions, primarily the locus coeruleus, whereas the effects of FLX were primarily in the dorsal raphe and hypothalamus, suggesting that both different regions and pathways account for fast onset but short lasting effects as compared to slow-onset but long-lasting effects.  However, the similarity between effects of ECT and SD is somewhat confounded by the fact that the two treatments appear to regulate a no. of transcripts in an opposite manner.  Multiple transcripts (e.g. brain-derived neurotrophic factor (BDNF), serum/glucocorticoid-regulated kinase (Sgk1)), whose level was reported to be affected by antidepressants or behavioral manipulations, were also found to be regulated by the treatments used in the present study.  Several novel findings of transcriptional regulation upon one, two or all three treatments were made, for the latter we highlight homer, erg2, HSP27, the proto oncogene ret, sulfotransferase family 1A (Sult1a1), glycerol 3-phosphate dehydrogenase (GPD3), the orphan receptor G protein-coupled receptor 88 (GPR88) and a large no. of expressed sequence tags (ESTs).  Transcripts encoding proteins involved in synaptic plasticity in the hippocampus were strongly affected by ECT and SD, but not by FLX.  The novel transcripts, concomitantly regulated by several antidepressant treatments, may represent novel targets for fast onset, long-duration antidepressants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor-zqFvP0pHbVg90H21EOLACvtfcHk0ljEHivmtHiKNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXoslSjug%253D%253D&md5=7717a8f9e52b3e6197fd081e02ee388e</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fsj.mp.4001897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.mp.4001897%26sid%3Dliteratum%253Aachs%26aulast%3DConti%26aufirst%3DB.%26aulast%3DMaier%26aufirst%3DR.%26aulast%3DBarr%26aufirst%3DA.%2BM.%26aulast%3DMorale%26aufirst%3DM.%2BC.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DSanna%26aufirst%3DP.%2BP.%26aulast%3DBilbe%26aufirst%3DG.%26aulast%3DHoyer%26aufirst%3DD.%26aulast%3DBartfai%26aufirst%3DT.%26atitle%3DRegion-specific%2520transcriptional%2520changes%2520following%2520the%2520three%2520antidepressant%2520treatments%2520electro%2520convulsive%2520therapy%252C%2520sleep%2520deprivation%2520and%2520fluoxetine%26jtitle%3DMol.%2520Psychiatry%26date%3D2007%26volume%3D12%26spage%3D167%26epage%3D189%26doi%3D10.1038%2Fsj.mp.4001897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Befort, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filliol, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghate, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darcq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matifas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lardenois, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thibault, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dembele, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Merrer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, J. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poch, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieffer, B. L.</span></span> <span> </span><span class="NLM_article-title">Mu-opioid receptor activation induces transcriptional plasticity in the central extended amygdala</span>. <i>Eur. J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2973</span>– <span class="NLM_lpage">2984</span>, <span class="refDoi"> DOI: 10.1111/j.1460-9568.2008.06273.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1111%2Fj.1460-9568.2008.06273.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=18588537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A280%3ADC%252BD1cvhvVOltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=2973-2984&author=K.+Befortauthor=D.+Filliolauthor=A.+Ghateauthor=E.+Darcqauthor=A.+Matifasauthor=J.+Mullerauthor=A.+Lardenoisauthor=C.+Thibaultauthor=D.+Dembeleauthor=J.+Le+Merrerauthor=J.+A.+J.+Beckerauthor=O.+Pochauthor=B.+L.+Kieffer&title=Mu-opioid+receptor+activation+induces+transcriptional+plasticity+in+the+central+extended+amygdala&doi=10.1111%2Fj.1460-9568.2008.06273.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Mu-opioid receptor activation induces transcriptional plasticity in the central extended amygdala</span></div><div class="casAuthors">Befort K; Filliol D; Ghate A; Darcq E; Matifas A; Muller J; Lardenois A; Thibault C; Dembele D; Le Merrer J; Becker J A J; Poch O; Kieffer B L</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2973-84</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Addiction develops from the gradual adaptation of the brain to chronic drug exposure, and involves genetic reprogramming of neuronal function.  The central extended amygdala (EAc) is a network formed by the central amygdala and the bed nucleus of the stria terminalis.  This key site controls drug craving and seeking behaviors, and has not been investigated at the gene regulation level.  We used Affymetrix microarrays to analyze transcriptional activity in the murine EAc, with a focus on mu-opioid receptor-associated events because these receptors mediate drug reward and dependence.  We identified 132 genes whose expression is regulated by a chronic escalating morphine regimen in the EAc from wild-type but not mu-opioid receptor knockout mice.  These modifications are mostly EAc-specific.  Gene ontology analysis reveals an overrepresentation of neurogenesis, cell growth and signaling protein categories.  A separate quantitative PCR analysis of genes in the last of these groups confirms the dysregulation of both orphan (Gpr88) and known (DrD1A, Adora2A, Cnr1, Grm5, Gpr6) G protein-coupled receptors, scaffolding (PSD95, Homer1) and signaling (Sgk, Cap1) proteins, and neuropeptides (CCK, galanin).  These transcriptional modifications do not occur following a single morphine injection, and hence result from long-term adaptation to excessive mu receptor activation.  Proteins encoded by these genes are classically associated with spine modules function in other brain areas, and therefore our data suggest a remodeling of EAc circuits at sites where glutamatergic and monoaminergic afferences interact.  Together, mu receptor-dependent genes identified in this study potentially contribute to drug-induced neural plasticity, and provide a unique molecular repertoire towards understanding drug craving and relapse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTbQoHVgtNR9jEC-75aqa5AfW6udTcc2easEoxNREbj9bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cvhvVOltA%253D%253D&md5=d5b56f1be18d7ba5ea95ae37f452ff0f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1111%2Fj.1460-9568.2008.06273.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1460-9568.2008.06273.x%26sid%3Dliteratum%253Aachs%26aulast%3DBefort%26aufirst%3DK.%26aulast%3DFilliol%26aufirst%3DD.%26aulast%3DGhate%26aufirst%3DA.%26aulast%3DDarcq%26aufirst%3DE.%26aulast%3DMatifas%26aufirst%3DA.%26aulast%3DMuller%26aufirst%3DJ.%26aulast%3DLardenois%26aufirst%3DA.%26aulast%3DThibault%26aufirst%3DC.%26aulast%3DDembele%26aufirst%3DD.%26aulast%3DLe%2BMerrer%26aufirst%3DJ.%26aulast%3DBecker%26aufirst%3DJ.%2BA.%2BJ.%26aulast%3DPoch%26aufirst%3DO.%26aulast%3DKieffer%26aufirst%3DB.%2BL.%26atitle%3DMu-opioid%2520receptor%2520activation%2520induces%2520transcriptional%2520plasticity%2520in%2520the%2520central%2520extended%2520amygdala%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2008%26volume%3D27%26spage%3D2973%26epage%3D2984%26doi%3D10.1111%2Fj.1460-9568.2008.06273.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Del
Zompo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deleuze, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chillotti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cousin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niehaus, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebstein, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ardau, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macé, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warnich, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mujahed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Severino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dib, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordaan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murad, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soubigou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannoura, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocher, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurent, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derock, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faucon Biguet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meloni, R.</span></span> <span> </span><span class="NLM_article-title">Association study in three different populations between the GPR88 gene and major psychoses</span>. <i>Mol. Genet. Genomic Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">152</span>– <span class="NLM_lpage">159</span>, <span class="refDoi"> DOI: 10.1002/mgg3.54</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1002%2Fmgg3.54" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=24689078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVOgtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=152-159&author=M.+Del%0AZompoauthor=J.+F.+Deleuzeauthor=C.+Chillottiauthor=E.+Cousinauthor=D.+Niehausauthor=R.+P.+Ebsteinauthor=R.+Ardauauthor=S.+Mac%C3%A9author=L.+Warnichauthor=M.+Mujahedauthor=G.+Severinoauthor=C.+Dibauthor=E.+Jordaanauthor=I.+Muradauthor=S.+Soubigouauthor=L.+Koenauthor=I.+Bannouraauthor=C.+Rocherauthor=C.+Laurentauthor=M.+Derockauthor=N.+Faucon+Biguetauthor=J.+Malletauthor=R.+Meloni&title=Association+study+in+three+different+populations+between+the+GPR88+gene+and+major+psychoses&doi=10.1002%2Fmgg3.54"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Association study in three different populations between the GPR88 gene and major psychoses</span></div><div class="casAuthors">Del Zompo, Maria; Deleuze, Jean-Francois; Chillotti, Caterina; Cousin, Emmanuelle; Niehaus, Dana; Ebstein, Richard P.; Ardau, Raffaella; Mace, Sandrine; Warnich, Louise; Mujahed, Mustafa; Severino, Giovanni; Dib, Colette; Jordaan, Esme; Murad, Ibrahim; Soubigou, Stephane; Koen, Liezl; Bannoura, Issam; Rocher, Corinne; Laurent, Claudine; Derock, Murielle; Biguet, Nicole Faucon; Mallet, Jacques; Meloni, Rolando</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Genetics & Genomic Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">152-159, 8 pp.</span>CODEN:
                <span class="NLM_cas:coden">MGGMC6</span>;
        ISSN:<span class="NLM_cas:issn">2324-9269</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">GPR88, coding for a G protein-coupled orphan receptor that is highly represented in the striatum, is a strong functional candidate gene for neuropsychiatric disorders and is located at 1p22-p21, a chromosomal region that we have previously linked to bipolar disorder (BD) in the Sardinian population.  In order to ascertain the relevance of GPR88 as a risk factor for psychiatric diseases, we performed a genetic assocn. anal. between GPR88 and BD in a sample of triads (patient and both parents) recruited in the Sardinian and the Palestinian population as well as between GPR88 and schizophrenia (SZ) in triads from the Xhosa population in South Africa.  We found a pos. assocn. between GPR88 and BD in the Sardinian and Palestinian triads.  Moreover, we found a pos. assocn. between GPR88 and SZ in triads from the Xhosa population in South Africa.  When these results were cor. for multiple testing, the assocn. between GPR88 and BD was maintained in the Palestinian population.  Thus, these results suggest that GPR88 deserves consideration as a candidate gene for psychiatric diseases and requires to be further investigated in other populations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOk2Vftt3xZbVg90H21EOLACvtfcHk0likzpjh_6XNiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVOgtLs%253D&md5=2f29002cf8b9e4e565151a4f1f5c36e9</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fmgg3.54&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmgg3.54%26sid%3Dliteratum%253Aachs%26aulast%3DDel%2BZompo%26aufirst%3DM.%26aulast%3DDeleuze%26aufirst%3DJ.%2BF.%26aulast%3DChillotti%26aufirst%3DC.%26aulast%3DCousin%26aufirst%3DE.%26aulast%3DNiehaus%26aufirst%3DD.%26aulast%3DEbstein%26aufirst%3DR.%2BP.%26aulast%3DArdau%26aufirst%3DR.%26aulast%3DMac%25C3%25A9%26aufirst%3DS.%26aulast%3DWarnich%26aufirst%3DL.%26aulast%3DMujahed%26aufirst%3DM.%26aulast%3DSeverino%26aufirst%3DG.%26aulast%3DDib%26aufirst%3DC.%26aulast%3DJordaan%26aufirst%3DE.%26aulast%3DMurad%26aufirst%3DI.%26aulast%3DSoubigou%26aufirst%3DS.%26aulast%3DKoen%26aufirst%3DL.%26aulast%3DBannoura%26aufirst%3DI.%26aulast%3DRocher%26aufirst%3DC.%26aulast%3DLaurent%26aufirst%3DC.%26aulast%3DDerock%26aufirst%3DM.%26aulast%3DFaucon%2BBiguet%26aufirst%3DN.%26aulast%3DMallet%26aufirst%3DJ.%26aulast%3DMeloni%26aufirst%3DR.%26atitle%3DAssociation%2520study%2520in%2520three%2520different%2520populations%2520between%2520the%2520GPR88%2520gene%2520and%2520major%2520psychoses%26jtitle%3DMol.%2520Genet.%2520Genomic%2520Med.%26date%3D2014%26volume%3D2%26spage%3D152%26epage%3D159%26doi%3D10.1002%2Fmgg3.54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alkufri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaag, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abu-Libdeh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elpeleg, O.</span></span> <span> </span><span class="NLM_article-title">Deleterious mutation in GPR88 is associated with chorea, speech delay, and learning disabilities</span>. <i>Neurol.: Genet.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2</i></span>, <span class="NLM_elocation-id">e64</span> <span class="refDoi"> DOI: 10.1212/nxg.0000000000000064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1212%2FNXG.0000000000000064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=27123486" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&author=F.+Alkufriauthor=A.+Shaagauthor=B.+Abu-Libdehauthor=O.+Elpeleg&title=Deleterious+mutation+in+GPR88+is+associated+with+chorea%2C+speech+delay%2C+and+learning+disabilities&doi=10.1212%2Fnxg.0000000000000064"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1212%2FNXG.0000000000000064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FNXG.0000000000000064%26sid%3Dliteratum%253Aachs%26aulast%3DAlkufri%26aufirst%3DF.%26aulast%3DShaag%26aufirst%3DA.%26aulast%3DAbu-Libdeh%26aufirst%3DB.%26aulast%3DElpeleg%26aufirst%3DO.%26atitle%3DDeleterious%2520mutation%2520in%2520GPR88%2520is%2520associated%2520with%2520chorea%252C%2520speech%2520delay%252C%2520and%2520learning%2520disabilities%26jtitle%3DNeurol.%253A%2520Genet.%26date%3D2016%26volume%3D2%26doi%3D10.1212%2Fnxg.0000000000000064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Surgand, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellenberger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rognan, D.</span></span> <span> </span><span class="NLM_article-title">A chemogenomic analysis of the transmembrane binding cavity of human G-protein-coupled receptors</span>. <i>Proteins</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">509</span>– <span class="NLM_lpage">538</span>, <span class="refDoi"> DOI: 10.1002/prot.20768</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1002%2Fprot.20768" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=16294340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A280%3ADC%252BD2MnovFyrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=509-538&author=J.+S.+Surgandauthor=J.+Rodrigoauthor=E.+Kellenbergerauthor=D.+Rognan&title=A+chemogenomic+analysis+of+the+transmembrane+binding+cavity+of+human+G-protein-coupled+receptors&doi=10.1002%2Fprot.20768"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A chemogenomic analysis of the transmembrane binding cavity of human G-protein-coupled receptors</span></div><div class="casAuthors">Surgand Jean-Sebastien; Rodrigo Jordi; Kellenberger Esther; Rognan Didier</div><div class="citationInfo"><span class="NLM_cas:title">Proteins</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">509-38</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The amino acid sequences of 369 human nonolfactory G-protein-coupled receptors (GPCRs) have been aligned at the seven transmembrane domain (TM) and used to extract the nature of 30 critical residues supposed--from the X-ray structure of bovine rhodopsin bound to retinal--to line the TM binding cavity of ground-state receptors.  Interestingly, the clustering of human GPCRs from these 30 residues mirrors the recently described phylogenetic tree of full-sequence human GPCRs (Fredriksson et al., Mol Pharmacol 2003;63:1256-1272) with few exceptions.  A TM cavity could be found for all investigated GPCRs with physicochemical properties matching that of their cognate ligands.  The current approach allows a very fast comparison of most human GPCRs from the focused perspective of the predicted TM cavity and permits to easily detect key residues that drive ligand selectivity or promiscuity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTH-6l-CmE2uXWEEzDrymxmfW6udTcc2ebrPFCBL4bz2rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MnovFyrtw%253D%253D&md5=5f60612975dbffa52e440cd2d7ab080c</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fprot.20768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.20768%26sid%3Dliteratum%253Aachs%26aulast%3DSurgand%26aufirst%3DJ.%2BS.%26aulast%3DRodrigo%26aufirst%3DJ.%26aulast%3DKellenberger%26aufirst%3DE.%26aulast%3DRognan%26aufirst%3DD.%26atitle%3DA%2520chemogenomic%2520analysis%2520of%2520the%2520transmembrane%2520binding%2520cavity%2520of%2520human%2520G-protein-coupled%2520receptors%26jtitle%3DProteins%26date%3D2006%26volume%3D62%26spage%3D509%26epage%3D538%26doi%3D10.1002%2Fprot.20768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorn, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, C.</span></span> <span> </span><span class="NLM_article-title">The GPR88 receptor agonist 2-PCCA does not alter the behavioral effects of methamphetamine in rats</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>698</i></span>,  <span class="NLM_fpage">272</span>– <span class="NLM_lpage">277</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2012.10.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1016%2Fj.ejphar.2012.10.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=23123351" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslSlsrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=698&publication_year=2013&pages=272-277&author=J.-X.+Liauthor=D.+A.+Thornauthor=C.+Jin&title=The+GPR88+receptor+agonist+2-PCCA+does+not+alter+the+behavioral+effects+of+methamphetamine+in+rats&doi=10.1016%2Fj.ejphar.2012.10.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The GPR88 receptor agonist 2-PCCA does not alter the behavioral effects of methamphetamine in rats</span></div><div class="casAuthors">Li, Jun-Xu; Thorn, David A.; Jin, Chunyang</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">698</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">272-277</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">GPR88 is a novel orphan G protein-coupled receptor that is primarily located at the striatum.  Genetic knockout studies reveal phenotypes of increased dopamine D2 receptor sensitivity in mice, suggesting that GPR88 receptors may be involved in the modulation of dopaminergic system.  However, there is no study that examines the pharmacol. effects of GPR88 receptor ligands in in vivo prepns.  This study examd. the effects of a GPR88 receptor agonist, (1R, 2R)-2-pyridin-2-yl-cyclopropane carboxylic acid ((2S, 3S)-2-amino-3-methyl-pentyl)-(4'-propylbiphenyl-4-yl)-amide (2-PCCA), on the motor activity in rats and on methamphetamine-induced hyperactivity and discriminative stimulus effects.  2-PCCA (0.1-3.2 mg/kg) dose-dependently decreased the locomotor activity in rats and, when studied in combination with 1.0 mg/kg methamphetamine, also dose-dependently decreased methamphetamine-induced hyperactivity.  However, the dose of 2-PCCA that significantly attenuated methamphetamine-induced hyperactivity was also the dose that by itself markedly decreased the baseline locomotor activity.  In rats discriminating 0.32 mg/kg methamphetamine, 2-PCCA (1-3.2 mg/kg) itself did not produce methamphetamine-like discriminative stimulus effects and, when studied in combination, did not alter the discriminative stimulus effects of methamphetamine.  Together, these data have provided the first line of evidence that activation of GPR88 receptors does not alter the behavioral effects of methamphetamine.  The potential implications of these findings are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTSCwsmccgk7Vg90H21EOLACvtfcHk0likzpjh_6XNiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslSlsrvL&md5=ed2554d727a15175af0f5f40310e3b9f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2012.10.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2012.10.037%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.-X.%26aulast%3DThorn%26aufirst%3DD.%2BA.%26aulast%3DJin%26aufirst%3DC.%26atitle%3DThe%2520GPR88%2520receptor%2520agonist%25202-PCCA%2520does%2520not%2520alter%2520the%2520behavioral%2520effects%2520of%2520methamphetamine%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D698%26spage%3D272%26epage%3D277%26doi%3D10.1016%2Fj.ejphar.2012.10.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilmour, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blough, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. P.</span></span> <span> </span><span class="NLM_article-title">Synthesis, pharmacological characterization, and structure-activity relationship studies of small molecular agonists for the orphan GPR88 receptor</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">576</span>– <span class="NLM_lpage">587</span>, <span class="refDoi"> DOI: 10.1021/cn500082p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn500082p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntlGju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=576-587&author=C.+Jinauthor=A.+M.+Deckerauthor=X.-P.+Huangauthor=B.+P.+Gilmourauthor=B.+E.+Bloughauthor=B.+L.+Rothauthor=Y.+Huauthor=J.+B.+Gillauthor=X.+P.+Zhang&title=Synthesis%2C+pharmacological+characterization%2C+and+structure-activity+relationship+studies+of+small+molecular+agonists+for+the+orphan+GPR88+receptor&doi=10.1021%2Fcn500082p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Pharmacological Characterization, and Structure-Activity Relationship Studies of Small Molecular Agonists for the Orphan GPR88 Receptor</span></div><div class="casAuthors">Jin, Chunyang; Decker, Ann M.; Huang, Xi-Ping; Gilmour, Brian P.; Blough, Bruce E.; Roth, Bryan L.; Hu, Yang; Gill, Joseph B.; Zhang, X. Peter</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">576-587</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">GPR88 is an orphan G-protein-coupled receptor (GPCR) enriched in the striatum.  Genetic deletion and gene expression studies have suggested that GPR88 plays an important role in the regulation of striatal functions and is implicated in psychiatric disorders.  The signal transduction pathway and receptor functions of GPR88, however, are still largely unknown due to the lack of endogenous and synthetic ligands.  In this paper, we report the synthesis of a GPR88 agonist 2-PCCA (I) and its pure diastereomers, which were functionally characterized in both transiently and stably expressing GPR88 HEK293 cells.  I inhibited isoproterenol-stimulated cAMP accumulation in a concn.-dependent manner in cells expressing GPR88 but not in the control cells, suggesting that the obsd. cAMP inhibition is mediated through GPR88 and that GPR88 is coupled to Gαi.  I did not induce calcium mobilization in GPR88 cells, indicating no Gαq-mediated response.  A structure-activity relation (SAR) study of I was also conducted to explore the key structural features for GPR88 agonist activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKep9SfTAK_LVg90H21EOLACvtfcHk0lgLfQu48S4UaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntlGju7Y%253D&md5=ae1adf5b99e8309aca2660406fde88f4</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fcn500082p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn500082p%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DC.%26aulast%3DDecker%26aufirst%3DA.%2BM.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DGilmour%26aufirst%3DB.%2BP.%26aulast%3DBlough%26aufirst%3DB.%2BE.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DGill%26aufirst%3DJ.%2BB.%26aulast%3DZhang%26aufirst%3DX.%2BP.%26atitle%3DSynthesis%252C%2520pharmacological%2520characterization%252C%2520and%2520structure-activity%2520relationship%2520studies%2520of%2520small%2520molecular%2520agonists%2520for%2520the%2520orphan%2520GPR88%2520receptor%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2014%26volume%3D5%26spage%3D576%26epage%3D587%26doi%3D10.1021%2Fcn500082p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blough, B. E.</span></span> <span> </span><span class="NLM_article-title">Effect of substitution on the aniline moiety of the GPR88 agonist 2-PCCA: Synthesis, structure-activity relationships, and molecular modeling studies</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1418</span>– <span class="NLM_lpage">1432</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.6b00182</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.6b00182" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht12jsbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=1418-1432&author=C.+Jinauthor=A.+M.+Deckerauthor=D.+L.+Harrisauthor=B.+E.+Blough&title=Effect+of+substitution+on+the+aniline+moiety+of+the+GPR88+agonist+2-PCCA%3A+Synthesis%2C+structure-activity+relationships%2C+and+molecular+modeling+studies&doi=10.1021%2Facschemneuro.6b00182"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of Substitution on the Aniline Moiety of the GPR88 Agonist 2-PCCA: Synthesis, Structure-Activity Relationships, and Molecular Modeling Studies</span></div><div class="casAuthors">Jin, Chunyang; Decker, Ann M.; Harris, Danni L.; Blough, Bruce E.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1418-1432</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">GPR88, an orphan receptor richly expressed in the striatum, is implicated in a no. of basal ganglia-assocd. disorders.  In order to elucidate the functions of GPR88, an in vivo probe appropriate for CNS investigation is required.  We previously reported that 2-PCCA was able to modulate GPR88-mediated cAMP prodn. through a Gαi-coupled pathway.  Early structure-activity relationship (SAR) studies suggested that the aniline moiety of 2-PCCA is a suitable site for diverse modifications.  Aimed at elucidating structural requirements in this region, we have designed and synthesized a series of analogs bearing a variety of substituents at the Ph ring of the aniline moiety.  Several compds. (e.g., 5j, 5o) showed improved or comparable potency, but have lower lipophilicity than 2-PCCA (clogP 6.19).  These compds. provide the basis for further optimization to probe GPR88 in vivo functions.  Computational studies confirmed the SAR trends and supported the notion that 4'-substituents on the biphenyl ring exit through a largely hydrophobic binding site to the extracellular loop.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6kqs-lCWWirVg90H21EOLACvtfcHk0lgLfQu48S4UaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht12jsbbJ&md5=3923e7fbf09828f0435edd9269219458</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.6b00182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.6b00182%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DC.%26aulast%3DDecker%26aufirst%3DA.%2BM.%26aulast%3DHarris%26aufirst%3DD.%2BL.%26aulast%3DBlough%26aufirst%3DB.%2BE.%26atitle%3DEffect%2520of%2520substitution%2520on%2520the%2520aniline%2520moiety%2520of%2520the%2520GPR88%2520agonist%25202-PCCA%253A%2520Synthesis%252C%2520structure-activity%2520relationships%252C%2520and%2520molecular%2520modeling%2520studies%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26spage%3D1418%26epage%3D1432%26doi%3D10.1021%2Facschemneuro.6b00182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Decker, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gay, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathews, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosa, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langston, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maitra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, C.</span></span> <span> </span><span class="NLM_article-title">Development and validation of a high-throughput calcium mobilization assay for the orphan receptor GPR88</span>. <i>J. Biomed. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">23</span>, <span class="refDoi"> DOI: 10.1186/s12929-017-0330-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1186%2Fs12929-017-0330-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=28347302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A280%3ADC%252BC1cvhs1aitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=23&author=A.+M.+Deckerauthor=E.+A.+Gayauthor=K.+M.+Mathewsauthor=T.+C.+Rosaauthor=T.+L.+Langstonauthor=R.+Maitraauthor=C.+Jin&title=Development+and+validation+of+a+high-throughput+calcium+mobilization+assay+for+the+orphan+receptor+GPR88&doi=10.1186%2Fs12929-017-0330-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a high-throughput calcium mobilization assay for the orphan receptor GPR88</span></div><div class="casAuthors">Decker Ann M; Gay Elaine A; Mathews Kelly M; Rosa Taylor C; Langston Tiffany L; Maitra Rangan; Jin Chunyang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomedical science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  GPR88 is an orphan G protein-coupled receptor highly expressed in the striatum and is implicated in basal ganglia-associated disorders.  However, the receptor functions of GPR88 are still largely unknown due to the lack of potent and selective ligands appropriate for central nervous system investigation.  Development of a high-throughput screening assay for GPR88 should facilitate the discovery of novel ligands to probe GPR88 functions.  METHODS:  In this paper, we describe the development of a CHO-Gαqi5-GPR88 cell-based calcium mobilization assay.  The assay takes advantage of functional coupling of GPR88 with the promiscuous Gαqi5 protein and consequent mobilization of intracellular calcium, which can be measured in a 384-well format with a Fluorescent Imaging Plate Reader.  RESULTS:  The CHO-Gαqi5-GPR88 cell-based calcium mobilization assay was validated by the structure-activity relationship study of known GPR88 agonist (1R,2R)-2-PCCA analogues.  The assay was automated and miniaturized to a 384-well format, and was deemed robust and reproducible with a Z'-factor of 0.72 and tolerated dimethyl sulfoxide to a final concentration of 2%.  Screening a pilot neurotransmitter library consisting of 228 compounds yielded 10 hits, but none of the hits were confirmed as GPR88 agonists in follow-up assays.  CONCLUSIONS:  We have developed a high-throughput calcium mobilization assay for the orphan receptor GPR88.  This calcium mobilization assay can be used to identify several different types of GPR88 ligands including agonists, competitive and noncompetitive antagonists, inverse agonists, and allosteric modulators.  These ligands will serve as valuable tools to probe signaling mechanisms and in vivo functions of GPR88, and could expedite development of novel therapies for diseases potentially mediated by GPR88.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQP05P7u3hXiSSm0e6ZOaemfW6udTcc2eZUfSs6_x8BD7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cvhs1aitQ%253D%253D&md5=d7861bf0e7d6962d0c133563fee99ac7</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1186%2Fs12929-017-0330-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12929-017-0330-3%26sid%3Dliteratum%253Aachs%26aulast%3DDecker%26aufirst%3DA.%2BM.%26aulast%3DGay%26aufirst%3DE.%2BA.%26aulast%3DMathews%26aufirst%3DK.%2BM.%26aulast%3DRosa%26aufirst%3DT.%2BC.%26aulast%3DLangston%26aufirst%3DT.%2BL.%26aulast%3DMaitra%26aufirst%3DR.%26aulast%3DJin%26aufirst%3DC.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%2520high-throughput%2520calcium%2520mobilization%2520assay%2520for%2520the%2520orphan%2520receptor%2520GPR88%26jtitle%3DJ.%2520Biomed.%2520Sci.%26date%3D2017%26volume%3D24%26spage%3D23%26doi%3D10.1186%2Fs12929-017-0330-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langston, T. L.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and pharmacological evaluation of 4-hydroxyphenylglycine and 4-hydroxyphenylglycinol derivatives as GPR88 agonists</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">805</span>– <span class="NLM_lpage">812</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.11.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1016%2Fj.bmc.2016.11.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=27956039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVyjur%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=805-812&author=C.+Jinauthor=A.+M.+Deckerauthor=T.+L.+Langston&title=Design%2C+synthesis+and+pharmacological+evaluation+of+4-hydroxyphenylglycine+and+4-hydroxyphenylglycinol+derivatives+as+GPR88+agonists&doi=10.1016%2Fj.bmc.2016.11.058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and pharmacological evaluation of 4-hydroxyphenylglycine and 4-hydroxyphenylglycinol derivatives as GPR88 agonists</span></div><div class="casAuthors">Jin, Chunyang; Decker, Ann M.; Langston, Tiffany L.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">805-812</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The orphan receptor GPR88 is an attractive therapeutic target because of its implications in a no. of basal ganglia-assocd. disorders.  To date, pharmacol. characterization of GPR88 has been limited due to the lack of potent and selective agonists and antagonists appropriate for CNS investigations.  We have previously reported that GPR88 couples to Gαi proteins and modulates cAMP levels upon treatment with a small mol. agonist 2-PCCA.  Recently, another chemotype of GPR88 agonist, represented by 2-AMPP [(2S)-N-((1R)-2-amino-1-(4-(2-methylpentyloxy)-phenyl)ethyl)-2-phenylpropanamide], has also been discovered.  In this report, a new series of 2-AMPP structurally related 4-hydroxyphenylglycine and 4-hydroxyphenylglycinol derivs. have been designed and evaluated for agonist activity at GPR88.  The structure-activity relationship (SAR) studies suggest that the amine group in 2-AMPP can be replaced by hydroxyl, ester and amide groups, resulting in analogs with good to moderate potency, whereas the Ph group on the amide cap is essential for activity and has limited size, shape and electronic tolerance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQTVDfiQIu2LVg90H21EOLACvtfcHk0ljfkMgnFZtqnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVyjur%252FK&md5=08b74fc125213c2ac52846704d2e8661</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.11.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.11.058%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DC.%26aulast%3DDecker%26aufirst%3DA.%2BM.%26aulast%3DLangston%26aufirst%3DT.%2BL.%26atitle%3DDesign%252C%2520synthesis%2520and%2520pharmacological%2520evaluation%2520of%25204-hydroxyphenylglycine%2520and%25204-hydroxyphenylglycinol%2520derivatives%2520as%2520GPR88%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D805%26epage%3D812%26doi%3D10.1016%2Fj.bmc.2016.11.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makhijani, V. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besheer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darcq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieffer, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maitra, R.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Potent, selective, and brain-penetrant small molecule that activates the orphan receptor GPR88 and reduces alcohol intake</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">6748</span>– <span class="NLM_lpage">6758</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00566</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00566" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlWrtLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6748-6758&author=C.+Jinauthor=A.+M.+Deckerauthor=V.+H.+Makhijaniauthor=J.+Besheerauthor=E.+Darcqauthor=B.+L.+Kiefferauthor=R.+Maitra&title=Discovery+of+a+Potent%2C+selective%2C+and+brain-penetrant+small+molecule+that+activates+the+orphan+receptor+GPR88+and+reduces+alcohol+intake&doi=10.1021%2Facs.jmedchem.8b00566"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent, Selective, and Brain-Penetrant Small Molecule that Activates the Orphan Receptor GPR88 and Reduces Alcohol Intake</span></div><div class="casAuthors">Jin, Chunyang; Decker, Ann M.; Makhijani, Viren H.; Besheer, Joyce; Darcq, Emmanuel; Kieffer, Brigitte L.; Maitra, Rangan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6748-6758</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The orphan G-protein-coupled receptor GPR88 is highly expressed in the striatum.  Studies using GPR88 knockout mice have suggested that the receptor is implicated in alc. seeking and drinking behaviors.  To date, the biol. effects of GPR88 activation are still unknown due to the lack of a potent and selective agonist appropriate for in vivo investigation.  In this study, we report the discovery of the first potent, selective, and brain-penetrant GPR88 agonist RTI-13951-33 (6).  RTI-13951-33 exhibited an EC50 of 25 nM in an in vitro cAMP functional assay and had no significant off-target activity at 38 GPCRs, ion channels, and neurotransmitter transporters that were tested.  RTI-13951-33 displayed enhanced aq. soly. compared to (1R,2R)-2-PCCA (2) and had favorable pharmacokinetic properties for behavioral assessment.  Finally, RTI-13951-33 significantly reduced alc. self-administration and alc. intake in a dose-dependent manner without effects on locomotion and sucrose self-administration in rats when administered i.p.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoU1feawI2n0LVg90H21EOLACvtfcHk0ljfkMgnFZtqnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlWrtLrK&md5=1e9b99b4fda0398302cf52a5710c2707</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00566%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DC.%26aulast%3DDecker%26aufirst%3DA.%2BM.%26aulast%3DMakhijani%26aufirst%3DV.%2BH.%26aulast%3DBesheer%26aufirst%3DJ.%26aulast%3DDarcq%26aufirst%3DE.%26aulast%3DKieffer%26aufirst%3DB.%2BL.%26aulast%3DMaitra%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520a%2520Potent%252C%2520selective%252C%2520and%2520brain-penetrant%2520small%2520molecule%2520that%2520activates%2520the%2520orphan%2520receptor%2520GPR88%2520and%2520reduces%2520alcohol%2520intake%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D6748%26epage%3D6758%26doi%3D10.1021%2Facs.jmedchem.8b00566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzierba, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zipp, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burford, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrante, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertekap, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cacace, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westphal, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimball, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronson, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macor, J. E.</span></span> <span> </span><span class="NLM_article-title">The discovery of potent agonists for GPR88, an orphan GPCR, for the potential treatment of CNS disorders</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1443</span>– <span class="NLM_lpage">1447</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.02.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1016%2Fj.bmcl.2015.02.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=25754495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjsFCqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=1443-1447&author=Y.+Biauthor=C.+D.+Dzierbaauthor=C.+Finkauthor=Y.+Garciaauthor=M.+Greenauthor=J.+Hanauthor=S.+Kwonauthor=G.+Kumiauthor=Z.+Liangauthor=Y.+Liuauthor=Y.+Qiaoauthor=Y.+Zhangauthor=G.+Zippauthor=N.+Burfordauthor=M.+Ferranteauthor=R.+Bertekapauthor=M.+Lewisauthor=A.+Cacaceauthor=R.+S.+Westphalauthor=D.+Kimballauthor=J.+J.+Bronsonauthor=J.+E.+Macor&title=The+discovery+of+potent+agonists+for+GPR88%2C+an+orphan+GPCR%2C+for+the+potential+treatment+of+CNS+disorders&doi=10.1016%2Fj.bmcl.2015.02.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of potent agonists for GPR88, an orphan GPCR, for the potential treatment of CNS disorders</span></div><div class="casAuthors">Bi, Yingzhi; Dzierba, Carolyn D.; Fink, Cynthia; Garcia, Yudith; Green, Michael; Han, Jianxin; Kwon, Soojin; Kumi, Godwin; Liang, Zhi; Liu, Ying; Qiao, Ying; Zhang, Yulian; Zipp, Greg; Burford, Neil; Ferrante, Meredith; Bertekap, Robert; Lewis, Martin; Cacace, Angela; Westphal, Ryan S.; Kimball, David; Bronson, Joanne J.; Macor, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1443-1447</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Modulating GPR88 activity is suggested to have therapeutic utility in the treatment of CNS disorders, such as schizophrenia.  This Letter will describe the discovery and SAR development of a class of potent GPR88 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquM7yMUlK40LVg90H21EOLACvtfcHk0liddazbGdDFDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjsFCqsL4%253D&md5=ec62482f43cf71b6f7f2153b6535089f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.02.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.02.038%26sid%3Dliteratum%253Aachs%26aulast%3DBi%26aufirst%3DY.%26aulast%3DDzierba%26aufirst%3DC.%2BD.%26aulast%3DFink%26aufirst%3DC.%26aulast%3DGarcia%26aufirst%3DY.%26aulast%3DGreen%26aufirst%3DM.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DKwon%26aufirst%3DS.%26aulast%3DKumi%26aufirst%3DG.%26aulast%3DLiang%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DQiao%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZipp%26aufirst%3DG.%26aulast%3DBurford%26aufirst%3DN.%26aulast%3DFerrante%26aufirst%3DM.%26aulast%3DBertekap%26aufirst%3DR.%26aulast%3DLewis%26aufirst%3DM.%26aulast%3DCacace%26aufirst%3DA.%26aulast%3DWestphal%26aufirst%3DR.%2BS.%26aulast%3DKimball%26aufirst%3DD.%26aulast%3DBronson%26aufirst%3DJ.%2BJ.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26atitle%3DThe%2520discovery%2520of%2520potent%2520agonists%2520for%2520GPR88%252C%2520an%2520orphan%2520GPCR%252C%2520for%2520the%2520potential%2520treatment%2520of%2520CNS%2520disorders%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D1443%26epage%3D1447%26doi%3D10.1016%2Fj.bmcl.2015.02.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dzierba, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dasgupta, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartz, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahuja, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianchetta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aleem, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zipp, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burford, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrante, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertekap, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cacace, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grace, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nouraldeen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westphal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimball, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronson, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macor, J. E.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of phenylglycinols and phenyl amines as agonists of GPR88</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1448</span>– <span class="NLM_lpage">1452</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.01.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1016%2Fj.bmcl.2015.01.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=25690789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslSnur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=1448-1452&author=C.+D.+Dzierbaauthor=Y.+Biauthor=B.+Dasguptaauthor=R.+A.+Hartzauthor=V.+Ahujaauthor=G.+Cianchettaauthor=G.+Kumiauthor=L.+Dongauthor=S.+Aleemauthor=C.+Finkauthor=Y.+Garciaauthor=M.+Greenauthor=J.+Hanauthor=S.+Kwonauthor=Y.+Qiaoauthor=J.+Wangauthor=Y.+Zhangauthor=Y.+Liuauthor=G.+Zippauthor=Z.+Liangauthor=N.+Burfordauthor=M.+Ferranteauthor=R.+Bertekapauthor=M.+Lewisauthor=A.+Cacaceauthor=J.+Graceauthor=A.+Wilsonauthor=A.+Nouraldeenauthor=R.+Westphalauthor=D.+Kimballauthor=K.+Carsonauthor=J.+J.+Bronsonauthor=J.+E.+Macor&title=Design%2C+synthesis%2C+and+evaluation+of+phenylglycinols+and+phenyl+amines+as+agonists+of+GPR88&doi=10.1016%2Fj.bmcl.2015.01.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and evaluation of phenylglycinols and phenylamines as agonists of GPR88</span></div><div class="casAuthors">Dzierba, Carolyn D.; Bi, Yingzhi; Dasgupta, Bireshwar; Hartz, Richard A.; Ahuja, Vijay; Cianchetta, Giovanni; Kumi, Godwin; Dong, Li; Aleem, Saadat; Fink, Cynthia; Garcia, Yudith; Green, Michael; Han, Jianxin; Kwon, Soojin; Qiao, Ying; Wang, Jiancheng; Zhang, Yulian; Liu, Ying; Zipp, Greg; Liang, Zhi; Burford, Neil; Ferrante, Meredith; Bertekap, Robert; Lewis, Martin; Cacace, Angela; Grace, James; Wilson, Alan; Nouraldeen, Amr; Westphal, Ryan; Kimball, David; Carson, Kenneth; Bronson, Joanne J.; Macor, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1448-1452</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Small mol. modulators of GPR88 activity (agonists, antagonists, or modulators) are of interest as potential agents for the treatment of a variety of psychiatric disorders including schizophrenia.  A series of phenylglycinol and phenylamine analogs, e.g., I [R1 = iso-Bu, (S)-2-methylbutyl, 2-methylpentyl, (oxetan-2-yl)methyl, (S)-2-methoxypropyl, 1-methoxy-2-propyl] and II [R2 = R3 = H, Me; NR2R3 = (4-methylpiperazin-1-yl), morpholin-4-yl, pyrrolidin-1-yl], resp., have been prepd. and evaluated for their GPR88 agonist activity and pharmacokinetic (PK) properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohypcmQcdKqLVg90H21EOLACvtfcHk0liddazbGdDFDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslSnur0%253D&md5=003075f447e1c76b56b885fe8cd21f4e</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.01.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.01.036%26sid%3Dliteratum%253Aachs%26aulast%3DDzierba%26aufirst%3DC.%2BD.%26aulast%3DBi%26aufirst%3DY.%26aulast%3DDasgupta%26aufirst%3DB.%26aulast%3DHartz%26aufirst%3DR.%2BA.%26aulast%3DAhuja%26aufirst%3DV.%26aulast%3DCianchetta%26aufirst%3DG.%26aulast%3DKumi%26aufirst%3DG.%26aulast%3DDong%26aufirst%3DL.%26aulast%3DAleem%26aufirst%3DS.%26aulast%3DFink%26aufirst%3DC.%26aulast%3DGarcia%26aufirst%3DY.%26aulast%3DGreen%26aufirst%3DM.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DKwon%26aufirst%3DS.%26aulast%3DQiao%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZipp%26aufirst%3DG.%26aulast%3DLiang%26aufirst%3DZ.%26aulast%3DBurford%26aufirst%3DN.%26aulast%3DFerrante%26aufirst%3DM.%26aulast%3DBertekap%26aufirst%3DR.%26aulast%3DLewis%26aufirst%3DM.%26aulast%3DCacace%26aufirst%3DA.%26aulast%3DGrace%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DA.%26aulast%3DNouraldeen%26aufirst%3DA.%26aulast%3DWestphal%26aufirst%3DR.%26aulast%3DKimball%26aufirst%3DD.%26aulast%3DCarson%26aufirst%3DK.%26aulast%3DBronson%26aufirst%3DJ.%2BJ.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520phenylglycinols%2520and%2520phenyl%2520amines%2520as%2520agonists%2520of%2520GPR88%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D1448%26epage%3D1452%26doi%3D10.1016%2Fj.bmcl.2015.01.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wold, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Orphan receptor GPR88 as an emerging neurotherapeutic target</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">190</span>– <span class="NLM_lpage">200</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.8b00572</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.8b00572" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVyhs7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=190-200&author=N.+Yeauthor=B.+Liauthor=Q.+Maoauthor=E.+A.+Woldauthor=S.+Tianauthor=J.+A.+Allenauthor=J.+Zhou&title=Orphan+receptor+GPR88+as+an+emerging+neurotherapeutic+target&doi=10.1021%2Facschemneuro.8b00572"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Orphan Receptor GPR88 as an Emerging Neurotherapeutic Target</span></div><div class="casAuthors">Ye, Na; Li, Bang; Mao, Qi; Wold, Eric A.; Tian, Sheng; Allen, John A.; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">190-200</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Although G protein-coupled receptors (GPCRs) are recognized as pivotal drug targets involved in multiple physiol. and pathol. processes, the majority of GPCRs including orphan GPCRs (oGPCRs) are unexploited.  GPR88, a brain-specific oGPCR with particularly robust expression in the striatum, regulates diverse brain and behavioral functions, including cognition, mood, movement control, and reward-based learning, and is thus emerging as a novel drug target for central nervous system disorders including schizophrenia, Parkinson's disease, anxiety, and addiction.  Nevertheless, no effective GPR88 synthetic ligands have yet entered into clin. trials, and GPR88 endogenous ligands remain unknown.  Despite the recent discovery and early stage study of several GPR88 agonists, such as 2-PCCA, RTI-13951-33, and phenylglycinol derivs., further research into GPR88 pharmacol., medicinal chem., and chem. biol. is urgently needed to yield structurally diversified GPR88-specific ligands.  Drug-like pharmacol. tool function and relevant signaling elucidation will also accelerate the evaluation of this receptor as a viable neurotherapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoP8O0djL7NL7Vg90H21EOLACvtfcHk0liddazbGdDFDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVyhs7fO&md5=0511e92dd00711cb2b4f83a6e5b82818</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.8b00572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.8b00572%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DMao%26aufirst%3DQ.%26aulast%3DWold%26aufirst%3DE.%2BA.%26aulast%3DTian%26aufirst%3DS.%26aulast%3DAllen%26aufirst%3DJ.%2BA.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DOrphan%2520receptor%2520GPR88%2520as%2520an%2520emerging%2520neurotherapeutic%2520target%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2019%26volume%3D10%26spage%3D190%26epage%3D200%26doi%3D10.1021%2Facschemneuro.8b00572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laboute, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellissier, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corde, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebeillard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauthier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leaute, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poupon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieffer, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Merrer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, J. A.</span></span> <span> </span><span class="NLM_article-title">The orphan receptor GPR88 blunts the signaling of opioid receptors and multiple striatal GPCRs</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e50519</span> <span class="refDoi"> DOI: 10.7554/elife.50519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.7554%2FeLife.50519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=32003745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtlarsLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2020&author=T.+Labouteauthor=J.+Gandiaauthor=L.+P.+Pellissierauthor=Y.+Cordeauthor=F.+Rebeillardauthor=M.+Galloauthor=C.+Gauthierauthor=A.+Leauteauthor=J.+Diazauthor=A.+Pouponauthor=B.+L.+Kiefferauthor=J.+Le+Merrerauthor=J.+A.+Becker&title=The+orphan+receptor+GPR88+blunts+the+signaling+of+opioid+receptors+and+multiple+striatal+GPCRs&doi=10.7554%2Felife.50519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The orphan receptor GPR88 blunts the signaling of opioid receptors and multiple striatal GPCRs</span></div><div class="casAuthors">Laboute, Thibaut; Gandia, Jorge; Pellissier, Lucie P.; Corde, Yannick; Rebeillard, Florian; Gallo, Maria; Gauthier, Christophe; Leaute, Audrey; Diaz, Jorge; Poupon, Anne; Kieffer, Brigitte L.; Le Merrer, Julie; Becker, Jerome A. J.</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e50519</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">GPR88 is an orphan G protein-coupled receptor (GPCR) considered as a promising therapeutic target for neuropsychiatric disorders; its pharmacol., however, remains scarcely understood.  Based on our previous report of increased delta opioid receptor activity in Gpr88 null mice, we investigated the impact of GPR88 co-expression on the signaling of opioid receptors in vitro and revealed that GPR88 inhibits the activation of both their G protein- and β-arrestindependent signaling pathways.  In Gpr88 knockout mice, morphine-induced locomotor sensitization, withdrawal and supra-spinal analgesia were facilitated, consistent with a tonic inhibitory action of GPR88 on μOR signaling.  We then explored GPR88 interactions with more striatal vs. nonneuronal GPCRs, and revealed that GPR88 can decrease the G protein-dependent signaling of most receptors in close proximity, but impedes β-arrestin recruitment by all receptors tested.  Our study unravels an unsuspected buffering role of GPR88 expression on GPCR signaling, with intriguing consequences for opioid and striatal functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9Wb2Oy7Vz1bVg90H21EOLACvtfcHk0lj86a6zY9diNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtlarsLbP&md5=5ff9500c552a41fd51dc26aa318f9d08</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.7554%2FeLife.50519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.50519%26sid%3Dliteratum%253Aachs%26aulast%3DLaboute%26aufirst%3DT.%26aulast%3DGandia%26aufirst%3DJ.%26aulast%3DPellissier%26aufirst%3DL.%2BP.%26aulast%3DCorde%26aufirst%3DY.%26aulast%3DRebeillard%26aufirst%3DF.%26aulast%3DGallo%26aufirst%3DM.%26aulast%3DGauthier%26aufirst%3DC.%26aulast%3DLeaute%26aufirst%3DA.%26aulast%3DDiaz%26aufirst%3DJ.%26aulast%3DPoupon%26aufirst%3DA.%26aulast%3DKieffer%26aufirst%3DB.%2BL.%26aulast%3DLe%2BMerrer%26aufirst%3DJ.%26aulast%3DBecker%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520orphan%2520receptor%2520GPR88%2520blunts%2520the%2520signaling%2520of%2520opioid%2520receptors%2520and%2520multiple%2520striatal%2520GPCRs%26jtitle%3DeLife%26date%3D2020%26volume%3D9%26doi%3D10.7554%2Felife.50519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Synopsis of some recent tactical application of bioisosteres in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2529</span>– <span class="NLM_lpage">2591</span>, <span class="refDoi"> DOI: 10.1021/jm1013693</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&author=N.+A.+Meanwell&title=Synopsis+of+some+recent+tactical+application+of+bioisosteres+in+drug+design&doi=10.1021%2Fjm1013693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0lj86a6zY9diNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520some%2520recent%2520tactical%2520application%2520of%2520bioisosteres%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2529%26epage%3D2591%26doi%3D10.1021%2Fjm1013693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boström, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llinàs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wellner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plowright, A. T.</span></span> <span> </span><span class="NLM_article-title">Oxadiazoles in medicinal chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1817</span>– <span class="NLM_lpage">1830</span>, <span class="refDoi"> DOI: 10.1021/jm2013248</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2013248" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A280%3ADC%252BC383pt1Oisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1817-1830&author=J.+Bostr%C3%B6mauthor=A.+Hognerauthor=A.+Llin%C3%A0sauthor=E.+Wellnerauthor=A.+T.+Plowright&title=Oxadiazoles+in+medicinal+chemistry&doi=10.1021%2Fjm2013248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Oxadiazoles in medicinal chemistry</span></div><div class="casAuthors">Bostrom Jonas; Hogner Anders; Llinas Antonio; Wellner Eric; Plowright Alleyn T</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1817-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Oxadiazoles are five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom, and they exist in different regioisomeric forms.  Oxadiazoles are frequently occurring motifs in druglike molecules, and they are often used with the intention of being bioisosteric replacements for ester and amide functionalities.  The current study presents a systematic comparison of 1,2,4- and 1,3,4-oxadiazole matched pairs in the AstraZeneca compound collection.  In virtually all cases, the 1,3,4-oxadiazole isomer shows an order of magnitude lower lipophilicity (log D), as compared to its isomeric partner.  Significant differences are also observed with respect to metabolic stability, hERG inhibition, and aqueous solubility, favoring the 1,3,4-oxadiazole isomers.  The difference in profile between the 1,2,4 and 1,3,4 regioisomers can be rationalized by their intrinsically different charge distributions (e.g., dipole moments).  To facilitate the use of these heteroaromatic rings, novel synthetic routes for ready access of a broad spectrum of 1,3,4-oxadiazoles, under mild conditions, are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSO9RQiG9xFS2Zyxfu64m4ffW6udTcc2eYJ2RhF4sAV0rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC383pt1Oisw%253D%253D&md5=b934995431ced1be297e6f126262f3cb</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm2013248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2013248%26sid%3Dliteratum%253Aachs%26aulast%3DBostr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DHogner%26aufirst%3DA.%26aulast%3DLlin%25C3%25A0s%26aufirst%3DA.%26aulast%3DWellner%26aufirst%3DE.%26aulast%3DPlowright%26aufirst%3DA.%2BT.%26atitle%3DOxadiazoles%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1817%26epage%3D1830%26doi%3D10.1021%2Fjm2013248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Summerfield, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Begley, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obradovic, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hidalgo, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coggon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, P.</span></span> <span> </span><span class="NLM_article-title">Central nervous system drug disposition: the relationship between in situ brain permeability and brain free fraction</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>322</i></span>,  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">213</span>, <span class="refDoi"> DOI: 10.1124/jpet.107.121525</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1124%2Fjpet.107.121525" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=17405866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntl2jt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=2007&pages=205-213&author=S.+G.+Summerfieldauthor=K.+Readauthor=D.+J.+Begleyauthor=T.+Obradovicauthor=I.+J.+Hidalgoauthor=S.+Coggonauthor=A.+V.+Lewisauthor=R.+A.+Porterauthor=P.+Jeffrey&title=Central+nervous+system+drug+disposition%3A+the+relationship+between+in+situ+brain+permeability+and+brain+free+fraction&doi=10.1124%2Fjpet.107.121525"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Central nervous system drug disposition: the relationship between in situ brain permeability and brain free fraction</span></div><div class="casAuthors">Summerfield, Scott G.; Read, Kevin; Begley, David J.; Obradovic, Tanja; Hidalgo, Ismael J.; Coggon, Sara; Lewis, Ann V.; Porter, Rod A.; Jeffrey, Phil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">322</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">205-213</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The dispositions of 50 marketed central nervous system (CNS) drugs into the brain have been examd. in terms of their rat in situ (P) and in vitro apparent membrane permeability (Papp) alongside lipophilicity and free fraction in rat brain tissue.  The inter-relation between these parameters highlights that both permeability and brain tissue binding influence the uptake of drugs into the CNS.  Hydrophilic compds. characterized by low brain tissue binding display a strong correlation (R2 = 0.82) between P and Papp, whereas the uptake of more lipophilic compds. seems to be influenced by both Papp and brain free fraction.  A nonlinear relation is obsd. between logPoct and P over the 6 orders of magnitude range in lipophilicity studied.  These findings corroborate recent reports in the literature that brain penetration is a function of both rate and extent of drug uptake into the CNS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYr8NNFNDFz7Vg90H21EOLACvtfcHk0ljQyl4UNN6Dpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntl2jt7g%253D&md5=006fd227474b6d404de1c44cf76289ba</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.121525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.121525%26sid%3Dliteratum%253Aachs%26aulast%3DSummerfield%26aufirst%3DS.%2BG.%26aulast%3DRead%26aufirst%3DK.%26aulast%3DBegley%26aufirst%3DD.%2BJ.%26aulast%3DObradovic%26aufirst%3DT.%26aulast%3DHidalgo%26aufirst%3DI.%2BJ.%26aulast%3DCoggon%26aufirst%3DS.%26aulast%3DLewis%26aufirst%3DA.%2BV.%26aulast%3DPorter%26aufirst%3DR.%2BA.%26aulast%3DJeffrey%26aufirst%3DP.%26atitle%3DCentral%2520nervous%2520system%2520drug%2520disposition%253A%2520the%2520relationship%2520between%2520in%2520situ%2520brain%2520permeability%2520and%2520brain%2520free%2520fraction%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D322%26spage%3D205%26epage%3D213%26doi%3D10.1124%2Fjpet.107.121525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghose, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbertz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudkins, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsey, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallamo, J. P.</span></span> <span> </span><span class="NLM_article-title">Knowledge-based, central nervous system (CNS) lead selection and lead optimization for CNS drug discovery</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1021/cn200100h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn200100h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSit7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=50-68&author=A.+K.+Ghoseauthor=T.+Herbertzauthor=R.+L.+Hudkinsauthor=B.+D.+Dorseyauthor=J.+P.+Mallamo&title=Knowledge-based%2C+central+nervous+system+%28CNS%29+lead+selection+and+lead+optimization+for+CNS+drug+discovery&doi=10.1021%2Fcn200100h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery</span></div><div class="casAuthors">Ghose, Arup K.; Herbertz, Torsten; Hudkins, Robert L.; Dorsey, Bruce D.; Mallamo, John P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-68</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The central nervous system (CNS) is the major area that is affected by aging.  Alzheimer's disease (AD), Parkinson's disease (PD), brain cancer, and stroke are the CNS diseases that will cost trillions of dollars for their treatment.  Achievement of appropriate blood-brain barrier (BBB) penetration is often considered a significant hurdle in the CNS drug discovery process.  On the other hand, BBB penetration may be a liability for many of the non-CNS drug targets, and a clear understanding of the physicochem. and structural differences between CNS and non-CNS drugs may assist both research areas.  Because of the numerous and challenging issues in CNS drug discovery and the low success rates, pharmaceutical companies are beginning to deprioritize their drug discovery efforts in the CNS arena.  Prompted by these challenges and to aid in the design of high-quality, efficacious CNS compds., we analyzed the physicochem. property and the chem. structural profiles of 317 CNS and 626 non-CNS oral drugs.  The conclusions derived provide an ideal property profile for lead selection and the property modification strategy during the lead optimization process.  A list of substructural units that may be useful for CNS drug design was also provided here.  A classification tree was also developed to differentiate between CNS drugs and non-CNS oral drugs.  The combined anal. provided the following guidelines for designing high-quality CNS drugs: (i) topol. mol. polar surface area of <76 Å2 (25-60 Å2), (ii) at least one (one or two, including one aliph. amine) nitrogen, (iii) fewer than seven (two to four) linear chains outside of rings, (iv) fewer than three (zero or one) polar hydrogen atoms, (v) vol. of 740-970 Å3, (vi) solvent accessible surface area of 460-580 Å2, and (vii) pos. QikProp parameter CNS.  The ranges within parentheses may be used during lead optimization.  One violation to this proposed profile may be acceptable.  The chemoinformatics approaches for graphically analyzing multiple properties efficiently are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozqfO0vq2i5bVg90H21EOLACvtfcHk0ljQyl4UNN6Dpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSit7rO&md5=4c20ba34c3d5397170b50242975ce25d</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fcn200100h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200100h%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DHerbertz%26aufirst%3DT.%26aulast%3DHudkins%26aufirst%3DR.%2BL.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26aulast%3DMallamo%26aufirst%3DJ.%2BP.%26atitle%3DKnowledge-based%252C%2520central%2520nervous%2520system%2520%2528CNS%2529%2520lead%2520selection%2520and%2520lead%2520optimization%2520for%2520CNS%2520drug%2520discovery%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D50%26epage%3D68%26doi%3D10.1021%2Fcn200100h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenz, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">Exploring new reactive species for cyclopropanation</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">8621</span>– <span class="NLM_lpage">8624</span>, <span class="refDoi"> DOI: 10.1016/s0040-4039(98)01954-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=10.1016%2FS0040-4039%2898%2901954-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADyaK1cXntlans7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=8621-8624&author=Z.+Yangauthor=J.+C.+Lorenzauthor=Y.+Shi&title=Exploring+new+reactive+species+for+cyclopropanation&doi=10.1016%2Fs0040-4039%2898%2901954-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring new reactive species for cyclopropanation</span></div><div class="casAuthors">Yang, Zhiqiang; Lorenz, Jon C.; Shi, Yian</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">8621-8624</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">An organozinc species RXZnCH2I, generated by reacting Zn(CH2I)2 with RXH, was found to be an efficient reagent for the cyclopropanation of olefins at room temp.  A 50.7% ee was obtained for the cyclopropanation of trans-β-methylstyrene when a chiral alc. was used.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXqG6D2VQMZLVg90H21EOLACvtfcHk0ljQyl4UNN6Dpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXntlans7k%253D&md5=b76bf484daf18cd44264ed5a56e5030c</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2898%2901954-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252898%252901954-6%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DLorenz%26aufirst%3DJ.%2BC.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DExploring%2520new%2520reactive%2520species%2520for%2520cyclopropanation%26jtitle%3DTetrahedron%2520Lett.%26date%3D1998%26volume%3D39%26spage%3D8621%26epage%3D8624%26doi%3D10.1016%2Fs0040-4039%2898%2901954-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simmons, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. D.</span></span> <span> </span><span class="NLM_article-title">A new synthesis of cyclopropanes from olefins</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1958</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">5323</span>– <span class="NLM_lpage">5324</span>, <span class="refDoi"> DOI: 10.1021/ja01552a080</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01552a080" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;key=1%3ACAS%3A528%3ADyaG1MXjvFKgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1958&pages=5323-5324&author=H.+E.+Simmonsauthor=R.+D.+Smith&title=A+new+synthesis+of+cyclopropanes+from+olefins&doi=10.1021%2Fja01552a080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A new synthesis of cyclopropanes from olefins</span></div><div class="casAuthors">Simmons, Howard E.; Smith, Ronald D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1958</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5323-4</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">cf. Howard, C.A. 34, 62153.  A versatile, stereospecific synthesis is reported of cyclopropanes by the reaction of unsatd. compds. with CH2I2 and a Zn-Cu couple.  Cyclohexene (0.30 mole), 0.15 mole CH2I2, and Zn-Cu couple (0.22 mole Zn) refluxed 48 hrs. in Et2O and the product distd. yielded 48% pure bicyclo[4.1.0] heptane, b. 116.5°, n25D 1.4546.  Many functionally substituted olefins gave the corresponding cyclopropanes.  Yields (10-70%) depended greatly on the kind of couple used and in no case were isomeric or rearranged products encountered (starting compd., product, and % yield given): C2H4, cyclopropane, 29; cyclopentene, bicyclo[3.1.0]hexane, 27; bicyclo[2.2.1] hept-2-ene, tricyclo[3,2,1,0]octane, 47; PhCH2CH:CH2, benzylcyclopropane, 49; PhCH:CH2, phenylcyclopropane, 32; ο-MeOC6H4CH:CHMe, 1-(ο-methoxyphenyl)-2-methylcyclopropane, 70; MeCH:CHCO2Me, Me 2-methyl-cyclopropanecarboxylate, 9; AcOCH:CH2, cyclopropyl acetate, 31.  Ethereal solns. from the reaction of the Zn-Cu couple contained ICH2ZnI.  Mechanisms for the reaction are discussed.  The stereospecificity of the reaction is indicated by the following reactions: cis-EtCH:CHEt yielded 35.5% pure cis-1,2-diethylcyclopropane, b. 93.5°, n25D 1.4035; trans-EtCH:CHEt yielded 15.5% trans-1,2-diethylcyclopropane, b. 86.5°, n25D 1.3982.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHpnVTzAYovLVg90H21EOLACvtfcHk0ljvTlZjz8psQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG1MXjvFKgug%253D%253D&md5=06d71e46354becf7287751ac835f51f7</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fja01552a080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01552a080%26sid%3Dliteratum%253Aachs%26aulast%3DSimmons%26aufirst%3DH.%2BE.%26aulast%3DSmith%26aufirst%3DR.%2BD.%26atitle%3DA%2520new%2520synthesis%2520of%2520cyclopropanes%2520from%2520olefins%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1958%26volume%3D80%26spage%3D5323%26epage%3D5324%26doi%3D10.1021%2Fja01552a080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i156"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01581">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_08434"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01581?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01581</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline"><sup>1</sup>H NMR, <sup>13</sup>C NMR, and HPLC analysis results of target compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01581/suppl_file/jm0c01581_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings with biological data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01581/suppl_file/jm0c01581_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01581/suppl_file/jm0c01581_si_001.pdf">jm0c01581_si_001.pdf (19.92 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01581/suppl_file/jm0c01581_si_002.csv">jm0c01581_si_002.csv (5.6 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01581&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-23%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01581%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01581" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679aa2a84aa03de3","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
